TY  - JOUR
AD  - [Aasen, D.; Hammermeister, K.; Prochazka, A.; Meguid, R.] Univ Colorado, Sch Med, Aurora, CO USA.
AN  - WOS:000432007400221
AU  - Aasen, D.
AU  - Hammermeister, K.
AU  - Prochazka, A.
AU  - Meguid, R.
DA  - Jan
DO  - 10.1136/jim-2017-000663.209
IS  - 1
J2  - J. Invest. Med.
KW  - General & Internal Medicine
Research & Experimental Medicine
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GF5LA
Times Cited: 0
Cited Reference Count: 0
Aasen, D. Hammermeister, K. Prochazka, A. Meguid, R.
Western Medical Research Conference
Jan 25-27, 2018
Carmel, CA
Amer Federat Med Res
0
Bmj publishing group
London
1708-8267
PY  - 2018
SN  - 1081-5589
SP  - 153-153
ST  - SYSTEMATIC REVIEW OF SURGICAL RISK COMMUNICATION TO AND RETENTION BY PATIENTS
T2  - Journal of Investigative Medicine
TI  - SYSTEMATIC REVIEW OF SURGICAL RISK COMMUNICATION TO AND RETENTION BY PATIENTS
UR  - <Go to ISI>://WOS:000432007400221
VL  - 66
ID  - 37
ER  - 

TY  - JOUR
AB  - Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of individual drugs, and the optimal number and duration of treatment with those drugs in patients with multidrug-resistant tuberculosis. Methods In this individual patient data meta-analysis, we searched MEDLINE, Embase, and the Cochrane Library to identify potentially eligible observational and experimental studies published between Jan 1, 2009, and April 30, 2016. We also searched reference lists from all systematic reviews of treatment of multidrug-resistant tuberculosis published since 2009. To be eligible, studies had to report original results, with end of treatment outcomes (treatment completion [success], failure, or relapse) in cohorts of at least 25 adults (aged >18 years). We used anonymised individual patient data from eligible studies, provided by study investigators, regarding clinical characteristics, treatment, and outcomes. Using propensity score-matched generalised mixed effects logistic, or linear regression, we calculated adjusted odds ratios and adjusted risk differences for success or death during treatment, for specific drugs currently used to treat multidrug-resistant tuberculosis, as well as the number of drugs used and treatment duration. Findings Of 12030 patients from 25 countries in 50 studies, 7346 (61%) had treatment success, 1017 (8%) had failure or relapse, and 1729 (14%) died. Compared with failure or relapse, treatment success was positively associated with the use of linezolid (adjusted risk difference 0.15, 95% CI 0.11 to 0.18), levofloxacin (0.15, 0.13 to 0.18), carbapenems (0.14,0.06 to 0.21), moxifloxacin (0.11, 0.08 to 0.14), bedaquiline (0.10, 0.05 to 0.14), and clofazimine (0.06, 0.01 to 0.10). There was a significant association between reduced mortality and use of linezolid (-0.20, -0.23 to -0.16), levofloxacin (-0.06, -0.09 to -0.04), moxifloxacin (-0.07, -0.10 to -0.04), or bedaquiline (-0.14, -0.19 to -0.10). Compared with regimens without any injectable drug, amikacin provided modest benefits, but kanamycin and capreomycin were associated with worse outcomes. The remaining drugs were associated with slight or no improvements in outcomes. Treatment outcomes were significantly worse for most drugs if they were used despite in-vitro resistance. The optimal number of effective drugs seemed to be five in the initial phase, and four in the continuation phase. In these adjusted analyses, heterogeneity, based on a simulated I-2 method, was high for approximately half the estimates for specific drugs, although relatively low for number of drugs and durations analyses. Interpretation Although inferences are limited by the observational nature of these data, treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis. These findings emphasise the need for trials to ascertain the optimal combination and duration of these drugs for treatment of this condition.
AD  - [Ahmad, Nafees] Univ Baluchistan, Fac Pharm & Hlth Sci, Quetta, Pakistan. [Ahuja, Shama D.; Trieu, Lisa] New York City Dept Hlth & Mental Hyg, Bur TB Control, New York, NY 10013 USA. [Akkerman, Onno W.; van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands. [Akkerman, Onno W.] Univ Groningen, Univ Med Ctr Groningen, TB Ctr Beatrixoord, Groningen, Netherlands. [Alffenaar, Jan-Willem C.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands. [van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands. [Anderson, Laura F.; Gegia, Medea; Zignol, Matteo] WHO, Global TB Program, Geneva, Switzerland. [Baghaei, Parvaneh; Tabarsi, Payam] Shahid Beheshti Univ Med Sci, Clin TB & Epidemiol Res Ctr, NRITLD, Tehran, Iran. [Bang, Didi] Statens Serum Inst, Copenhagen, Denmark. [Barry, Pennan M.; Flood, Jennifer; Lowenthal, Phil; Westenhouse, Janice] Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, TB Control Branch, Sacramento, CA USA. [Bastos, Mayara L.; Trajman, Anete] Univ Estado Rio De Janeiro, Epidemiol Dept, Social Med Inst, Rio De Janeiro, Brazil. [Behera, Digamber] WHO, Collaborating Ctr Res & Capac Bldg Chron Resp Dis, Dept Pulm Med, Chandigarh, India. [Behera, Digamber] Postgrad Inst Med Educ & Res, Chandigarh, India. [Benedetti, Andrea; Khan, Faiz Ahmad; Lan, Zhiyi; Li, Pei Zhi; Trajman, Anete; Menzies, Dick] McGill Univ, Hlth Ctr, Res Inst, Montreal Chest Inst, Montreal, PQ, Canada. [Bisson, Gregory P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA. [Boeree, Martin J.] Radboud Univ Nijmegen, Med Ctr Nijmegen & Dekkerswald Radboudumc, Dept Pulm Dis, Groesbeek, Netherlands. [Bonnet, Maryline] Epictr MSF, Paris, France. [Bonnet, Maryline] Univ Montpellier, INSERM, U1175, Inst Rech Dev UM233, Montpellier, France. [Brode, Sarah K.] Univ Toronto, Univ Hlth Network, West Pk Healthcare Ctr, Dept Med,Div Respirol, Toronto, ON, Canada. [Brode, Sarah K.] Sinai Hlth Syst, Toronto, ON, Canada. [Brust, James C. M.] Albert Einstein Coll Med, Montefiore Med Ctr, Div Gen Internal Med, New York, NY USA. [Brust, James C. M.] Albert Einstein Coll Med, Montefiore Med Ctr, Div Infect Dis, New York, NY USA. [Cai, Ying] NIAID, TB Res Sect, Lab Clin Immunol & Microbiol, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA. [Fregona, Geisa; Maciel, Ethel L.] Univ Fed Espirito Santo, Vitoria, Brazil. [Caumes, Eric] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Serv Malad Infectieuses & Trop, Paris, France. [Cegielski, J. Peter; Holtz, Timothy H.; Podewils, Laura J.; Smith, Sarah E.] Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA. [Centis, Rosella; D'Ambrosio, Lia; Migliori, Giovanni B.] WHO, Collaborating Ctr TB & Lung Dis, Maugeri Care & Res Inst, Tradate, Italy. [Chan, Pei-Chun] Taiwan Ctr Dis Control, Div Chron Infect Dis, Taipei, Taiwan. [Chan, Edward D.; Gu, Sue; Reynolds, Ian] Univ Colorado Denver, Dept Med, Aurora, CO USA. [Chan, Edward D.] Natl Jewish Hlth, Dept Med, Denver, CO USA. [Chan, Edward D.] VA Med Ctr, Denver, CO USA. [Chang, Kwok-Chiu; Leung, Chi-Chiu; Leung, Eric Chung-Ching] Ctr Hlth Protect, Dept Hlth, TB & Chest Serv, Hong Kong, Hong Kong, Peoples R China. [Charles, Macarthur] Haiti Country Off, Ctr Dis Control & Prevent, Port Au Prince, Haiti. [Kuksa, Liga] Riga East Univ Hosp, Dept MDR TB, Riga, Latvia. [Cirule, Andra; Leimane, Vaira; Riekstina, Vija] Riga East Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia. [Dalcolmo, Margareth Pretti; Gayoso, Regina] Ctr Referencia Helio Fraga, Fiocruz, Brazil. [D'Ambrosio, Lia] Publ Hlth Consulting Grp, Lugano, Switzerland. [de Vries, Gerard] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands. [de Vries, Gerard] KNCV TB Fdn, The Hague, Netherlands. [Dheda, Keertan] Univ Cape Town, Ctr Lung Infect & Immun, Dept Med, Cape Town, South Africa. [Dheda, Keertan] Univ Cape Town, UCT Lung Inst, Cape Town, South Africa. [Schnippel, Kathryn] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Cape Town, South Africa. [Fox, Gregory J.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia. [Gler, Maria Tarcela] Trop Dis Fdn, Manila, Philippines. [Guglielmetti, Lorenzo; Robert, Jerome; Veziris, Nicolas] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Lab Bacteriol Hyg, Ctr Natl Reference Mycobacteries & Resistance Myc, Paris, France. [Guglielmetti, Lorenzo; Robert, Jerome; Veziris, Nicolas] Sorbonne Univ, CIMI, INSERM, U1135,UMRS CR7,CNRS,ERL 8255,Bacteriol Fac Med, Paris, France. [Frechet-Jachym, Mathilde; Guglielmetti, Lorenzo] Ctr Hosp Bligny, Briis Sous Forges, France. [Hughes, Jennifer; Mohr, Erika] Med Sans Frontieres, Khayelitsha, South Africa. [Isaakidis, Petros] Med Sans Frontieres, Bombay, Maharashtra, India. [Jarlsberg, Leah; Nahid, Payam] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA. [Kempker, Russell R.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA. [Keshavjee, Salmaan; Miller, Ann C.; Mitnick, Carole D.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA. [Keshavjee, Salmaan; Koenig, Serena P.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA. [Kipiani, Maia] Natl Ctr TB & Lung Dis, Tbilisi, Rep of Georgia. [Koenig, Serena P.; Pape, Jean William; Vilbrun, Stalz Charles; Walsh, Kathleen] Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti. [Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea. [Kritski, Afranio; Trajman, Anete] Univ Fed Rio de Janeiro, Sch Med, Acad TB Program, Rio De Janeiro, Brazil. [Kvasnovsky, Charlotte L.] Cohen Childrens Med Ctr, Hofstra Northwell Sch Med, Div Pediat Surg, New Hyde Pk, NY USA. [Kwak, Nakwon; Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med, Seoul, South Korea. [Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, Sulfeld, Germany. [Lange, Christoph] German Ctr Infect Res, Clin TB Unit, Borstel, Germany. [Lange, Christoph] Univ Lubeck, Int Hlth Infect Dis, Lubeck, Germany. [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden. [Laniado-Laborin, Rafael] Tijuana Gen Hosp, TB Clin & Lab, Tijuana, Mexico. [Lee, Myungsun] Int TB Res Ctr, Seoul, South Korea. [Marks, Suzanne M.; Mase, Sundari] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA. [Mase, Sundari] Reg WHO Off, New Delhi, India. [Mbuagbaw, Lawrence] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada. [Mbuagbaw, Lawrence] St Josephs Healthcare Hamilton, Father Sean OSullivan Res Ctr, Biostat Unit, Hamilton, ON, Canada. [Milanov, Vladimir] Med Univ Sofia, Med Fac, Univ Hosp Resp Dis St Sofia, Sofia, Bulgaria. [Modongo, Chawangwa; Zetola, Nicola M.] Botswana UPenn Partnership, Gaborone, Botswana. [Monedero, Ignacio] Int Union TB & Lung Dis, TB HIV Dept, Paris, France. [Ndjeka, Norbert] South African Natl Dept Hlth, Natl TB Programme, Pretoria, South Africa. [O'Donnell, Max R.] Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, New York, NY USA. [O'Donnell, Max R.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA. [O'Donnell, Max R.; Padayatchi, Nesri] CAPRISA, MRC TB HIV Treatment & Pathogenesis Res Unit, Durban, South Africa. [Palmero, Domingo] Municipal Hosp FJ Muniz, Pulmonol Div, Buenos Aires, DF, Argentina. [Pape, Jean William] Weill Cornell Med Coll, Ctr Global Hlth, Dept Med, New York, NY USA. [Rodriguez, Maria] Natl TB Control Program, Santo Domingo, Dominican Rep. [Seaworth, Barbara] Univ Texas Hlth Sci Ctr Tyler, Heartland Natl TB Ctr, Tyler, TX USA. [Seung, Kwonjune J.] Partners Hlth, Boston, MA USA. [Shim, Tae Sun] Univ Ulsan, Coll Med, Dept Pulm & Crit Care Med, Seoul, South Korea. [Singla, Rupak] Natl Inst TB & Resp Dis, New Delhi, India. [Sotgiu, Giovanni] Univ Sassari, Clin Epidemiol & Med Stat Unit, Dept Med Surg & Expt Sci, Sassari, Italy. [Sukhbaatar, Ganzaya] Minist Hlth Mongolia, Ulaanbaatar, Mongol Peo Rep. [Tiberi, Simon] Royal London Hosp, Barts Hlth NHS Trust, London, England. [Tiberi, Simon] Queen Mary Univ London, Blizard Inst, London, England. [Tiberi, Simon] Queen Mary Univ London, London Sch Med & Dent, London, England. [Udwadia, Zarir F.] Hinduja Hosp & Res Ctr, Bombay, Maharashtra, India. [Viiklepp, Piret] Natl Inst Hlth Dev, Estonian TB Registry, Tallinn, Estonia. [Yew, Wing-Wai] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
Menzies, D (reprint author), McGill Univ, RECRU, Montreal Chest Inst, Hlth Ctr,Res Inst, Montreal, PQ H4A 3S5, Canada.
dick.menzies@mcgill.ca
AN  - WOS:000444130000028
AU  - Ahmad, N.
AU  - Ahuja, S. D.
AU  - Akkerman, O. W.
AU  - Alffenaar, J. W. C.
AU  - Anderson, L. F.
AU  - Baghaei, P.
AU  - Bang, D.
AU  - Barry, P. M.
AU  - Bastos, M. L.
AU  - Behera, D.
AU  - Benedetti, A.
AU  - Bisson, G. P.
AU  - Boeree, M. J.
AU  - Bonnet, M.
AU  - Brode, S. K.
AU  - Brust, J. C. M.
AU  - Cai, Y.
AU  - Caumes, E.
AU  - Cegielski, J. P.
AU  - Centis, R.
AU  - Chan, P. C.
AU  - Chan, E. D.
AU  - Chang, K. C.
AU  - Charles, M.
AU  - Cirule, A.
AU  - Dalcolmo, M. P.
AU  - D'Ambrosio, L.
AU  - de Vries, G.
AU  - Dheda, K.
AU  - Esmail, A.
AU  - Flood, J.
AU  - Fox, G. J.
AU  - Frechet-Jachym, M.
AU  - Fregona, G.
AU  - Gayoso, R.
AU  - Gegia, M.
AU  - Gler, M. T.
AU  - Gu, S.
AU  - Guglielmetti, L.
AU  - Holtz, T. H.
AU  - Hughes, J.
AU  - Isaakidis, P.
AU  - Jarlsberg, L.
AU  - Kempker, R. R.
AU  - Keshavjee, S.
AU  - Khan, F. A.
AU  - Kipiani, M.
AU  - Koenig, S. P.
AU  - Koh, W. J.
AU  - Kritski, A.
AU  - Kuksa, L.
AU  - Kvasnovsky, C. L.
AU  - Kwak, N.
AU  - Lan, Z. Y.
AU  - Lange, C.
AU  - Laniado-Laborin, R.
AU  - Lee, M.
AU  - Leimane, V.
AU  - Leung, C. C.
AU  - Leung, E. C. C.
AU  - Li, P. Z.
AU  - Lowenthal, P.
AU  - Maciel, E. L.
AU  - Marks, S. M.
AU  - Mase, S.
AU  - Mbuagbaw, L.
AU  - Migliori, G. B.
AU  - Milanov, V.
AU  - Miller, A. C.
AU  - Mitnick, C. D.
AU  - Modongo, C.
AU  - Mohr, E.
AU  - Monedero, I.
AU  - Nahid, P.
AU  - Ndjeka, N.
AU  - O'Donnell, M. R.
AU  - Padayatchi, N.
AU  - Palmero, D.
AU  - Pape, J. W.
AU  - Podewils, L. J.
AU  - Reynolds, I.
AU  - Riekstina, V.
AU  - Robert, J.
AU  - Rodriguez, M.
AU  - Seaworth, B.
AU  - Seung, K. J.
AU  - Schnippel, K.
AU  - Shim, T. S.
AU  - Singla, R.
AU  - Smith, S. E.
AU  - Sotgiu, G.
AU  - Sukhbaatar, G.
AU  - Tabarsi, P.
AU  - Tiberi, S.
AU  - Trajman, A.
AU  - Trieu, L.
AU  - Udwadia, Z. F.
AU  - van der Werf, T. S.
AU  - Veziris, N.
AU  - Viiklepp, P.
AU  - Vilbrun, S. C.
AU  - Walsh, K.
AU  - Westenhouse, J.
AU  - Yew, W. W.
AU  - Yim, J. J.
AU  - Zetola, N. M.
AU  - Zignol, M.
AU  - Menzies, D.
AU  - Collaborative Grp Meta-Analysis, In
DA  - Sep
DO  - 10.1016/s0140-6736(18)31644-1
IS  - 10150
J2  - Lancet
KW  - south-africa
high-rates
xdr-tb
drug
bedaquiline
regimens
safety
management
program
surgery
General & Internal Medicine
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GT0KV
Times Cited: 51
Cited Reference Count: 80
Ahmad, Nafees Ahuja, Shama D. Akkerman, Onno W. Alffenaar, Jan-Willem C. Anderson, Laura F. Baghaei, Parvaneh Bang, Didi Barry, Pennan M. Bastos, Mayara L. Behera, Digamber Benedetti, Andrea Bisson, Gregory P. Boeree, Martin J. Bonnet, Maryline Brode, Sarah K. Brust, James C. M. Cai, Ying Caumes, Eric Cegielski, J. Peter Centis, Rosella Chan, Pei-Chun Chan, Edward D. Chang, Kwok-Chiu Charles, Macarthur Cirule, Andra Dalcolmo, Margareth Pretti D'Ambrosio, Lia de Vries, Gerard Dheda, Keertan Esmail, Aliasgar Flood, Jennifer Fox, Gregory J. Frechet-Jachym, Mathilde Fregona, Geisa Gayoso, Regina Gegia, Medea Gler, Maria Tarcela Gu, Sue Guglielmetti, Lorenzo Holtz, Timothy H. Hughes, Jennifer Isaakidis, Petros Jarlsberg, Leah Kempker, Russell R. Keshavjee, Salmaan Khan, Faiz Ahmad Kipiani, Maia Koenig, Serena P. Koh, Won-Jung Kritski, Afranio Kuksa, Liga Kvasnovsky, Charlotte L. Kwak, Nakwon Lan, Zhiyi Lange, Christoph Laniado-Laborin, Rafael Lee, Myungsun Leimane, Vaira Leung, Chi-Chiu Leung, Eric Chung-Ching Li, Pei Zhi Lowenthal, Phil Maciel, Ethel L. Marks, Suzanne M. Mase, Sundari Mbuagbaw, Lawrence Migliori, Giovanni B. Milanov, Vladimir Miller, Ann C. Mitnick, Carole D. Modongo, Chawangwa Mohr, Erika Monedero, Ignacio Nahid, Payam Ndjeka, Norbert O'Donnell, Max R. Padayatchi, Nesri Palmero, Domingo Pape, Jean William Podewils, Laura J. Reynolds, Ian Riekstina, Vija Robert, Jerome Rodriguez, Maria Seaworth, Barbara Seung, Kwonjune J. Schnippel, Kathryn Shim, Tae Sun Singla, Rupak Smith, Sarah E. Sotgiu, Giovanni Sukhbaatar, Ganzaya Tabarsi, Payam Tiberi, Simon Trajman, Anete Trieu, Lisa Udwadia, Zarir F. van der Werf, Tjip S. Veziris, Nicolas Viiklepp, Piret Vilbrun, Stalz Charles Walsh, Kathleen Westenhouse, Janice Yew, Wing-Wai Yim, Jae-Joon Zetola, Nicola M. Zignol, Matteo Menzies, Dick
Tiberi, Simon/I-2552-2019; Maciel, Ethel Leonor LN/G-1027-2012; padayatchi, nesri/Q-2780-2019; Koh, Won-Jung/D-9586-2018; Mbuagbaw, Lawrence/D-9381-2015; Mbuagbaw, Lawrence/H-3205-2019; Koh, Won Jung/C-9595-2011; Lange, Christoph/J-6289-2012; ROBERT, Jerome/C-3993-2011
Tiberi, Simon/0000-0001-9424-6551; Maciel, Ethel Leonor LN/0000-0003-4826-3355; padayatchi, nesri/0000-0003-2543-9071; Koh, Won-Jung/0000-0002-4756-3527; Mbuagbaw, Lawrence/0000-0001-5855-5461; Lange, Christoph/0000-0002-9691-4741; ROBERT, Jerome/0000-0002-9380-0570; Isaakidis, Petros/0000-0002-7881-1554; Nahid, Payam/0000-0003-2811-1311; Schnippel, Kathryn/0000-0003-0757-4325
American Thoracic Society; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); US Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; European Respiratory Society; Infectious Diseases Society of America
American Thoracic Society, Canadian Institutes of Health Research, US Centers for Disease Control and Prevention, European Respiratory Society, Infectious Diseases Society of America.
52
5
19
Elsevier science inc
New york
1474-547x
PY  - 2018
SN  - 0140-6736
SP  - 821-834
ST  - Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
T2  - Lancet
TI  - Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
UR  - <Go to ISI>://WOS:000444130000028
VL  - 392
ID  - 8
ER  - 

TY  - JOUR
AB  - Background: Children are highly susceptible to tuberculosis; thus, there is need for safe and effective preventive interventions. Our objective was to evaluate the efficacy of isoniazid in prevention of tuberculosis morbidity and mortality in children aged 15 years or younger by performing a meta-analysis of randomized controlled trials. To our knowledge, this is the first meta-analysis evaluating efficacy of isoniazid prophylaxis in prevention of tuberculosis in children. Methods: A systematic search of the literature was done to identify randomized controlled trials evaluating isoniazid prophylaxis efficacy among children. Each study was evaluated for relevance and validity for inclusion in the analysis. Subgroup analyses were conducted based on study quality, HIV status, tuberculosis endemicity, type of prophylaxis and age of participants. Results: Eight studies comprising 10,320 participants were included in this analysis. Upon combining data from all eight studies, isoniazid prophylaxis was found to be efficacious in preventing development of tuberculosis, with a pooled RR of 0.65 (95% CI 0.47, 0.89) p = 0.004, with confidence intervals adjusted for heterogeneity. Among the sub-group analyses conducted, only age of the participants yielded dramatic differences in the summary estimate of efficacy, suggesting that age might be an effect modifier of the efficacy of isoniazid among children, with no effect realised in children initiating isoniazid at four months of age or earlier and an effect being present in older children. Excluding studies in which isoniazid was initiated at four months of age or earlier yielded an even stronger effect (RR = 0.41 (95% CI 0.31, 0.55) p < 0.001). Data on the effect of isoniazid on all-cause mortality, excluding studies in which isoniazid was initiated in infants, yielded an imprecise estimate of mortality benefit (RR = 0.58 (95% CI 0.31, 1.09) p = 0.092). Conclusion: Isoniazid prophylaxis reduces the risk of developing tuberculosis by 59% among children aged 15 years or younger excluding children initiated during early infancy for primary prophylaxis (RR = 0.41, 95% CI 0.31, 0.55 p < 0.001). However, further studies are needed to assess effects on mortality and to determine prophylaxis effectiveness in very young children and among HIV-infected children.
AD  - [Ayieko, James; Bukusi, Elizabeth A.] Kenya Med Res Inst Kisumu, Ctr Microbiol Res, FACES, Nairobi, Kenya. [Abuogi, Lisa] Univ Colorado, Dept Pediat, Denver, CO 80202 USA. [Simchowitz, Brett] Univ Calif San Francisco, Sch Med, San Francisco, CA USA. [Ayieko, James; Simchowitz, Brett; Smith, Allan H.; Reingold, Arthur] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
Ayieko, J (reprint author), Kenya Med Res Inst Kisumu, Ctr Microbiol Res, FACES, Nairobi, Kenya.
jimayieko@gmail.com
AN  - WOS:000332625500003
AU  - Ayieko, J.
AU  - Abuogi, L.
AU  - Simchowitz, B.
AU  - Bukusi, E. A.
AU  - Smith, A. H.
AU  - Reingold, A.
C7  - 91
DA  - Feb
DO  - 10.1186/1471-2334-14-91
J2  - BMC Infect. Dis.
KW  - Tuberculosis
Isoniazid
Prophylaxis
Meta-analysis
Efficacy
Children
hiv
household
chemoprophylaxis
morbidity
trial
bias
Infectious Diseases
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AC6IN
Times Cited: 43
Cited Reference Count: 37
Ayieko, James Abuogi, Lisa Simchowitz, Brett Bukusi, Elizabeth A. Smith, Allan H. Reingold, Arthur
43
0
5
Bmc
London
1471-2334
PY  - 2014
SP  - 10
ST  - Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis
T2  - Bmc Infectious Diseases
TI  - Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis
UR  - <Go to ISI>://WOS:000332625500003
VL  - 14
ID  - 147
ER  - 

TY  - JOUR
AB  - Background: Many of the world's population live in rural areas. However, access and dissemination of the advances taking place in the field of palliative care to patients living in rural areas have been limited. Methods: We searched 2 large databases of the medical literature and found 248 relevant articles; we also identified another 59 articles through networking and a hand search of reference lists. Of those 307 articles, 39 met the inclusion criteria and were grouped into the following subcategories: intervention (n = 4), needs assessment (n = 2), program planning (n = 3), program evaluation (n = 4), education (n = 7), financial (n = 8), and comprehensive/systematic literature reviews (n = 11). Results: We synthesized the current state of rural palliative care research and practice to identify important gaps for future research. Studies were conducted in the United States, Australia, Canada, Africa, Sweden, and India. Two randomized control trials were identified, both of which used telehealth approaches and had positive survival outcomes. One study demonstrated positive patient quality of life and depression outcomes. Conclusions: Research to guide rural palliative care practice is sparse. Approaches to telehealth, community-academic partnerships, and training rural health care professionals show promise, but more research is needed to determine best practices for providing palliative care to patients living in rural settings.
AD  - [Bakitas, Marie A.; Dionne-Odom, J. Nicholas] Univ Alabama Birmingham, Sch Nursing, Birmingham, AL 35233 USA. [Bakitas, Marie A.; Kvale, Elizabeth] Univ Alabama Birmingham, Ctr Palliat & Support Care, Birmingham, AL 35233 USA. [Astin, Meka] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35233 USA. [Elk, Ronit] Univ S Carolina, Coll Nursing, Columbia, SC 29208 USA. [Levkoff, Sue] Univ S Carolina, Coll Social Work, Columbia, SC 29208 USA. [Ceronsky, Lyn] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA. [Clifford, Kathleen N.] St Lukes Mt States Tumor Inst, Boise, ID USA. [Emanuel, Linda L.] Northwesterns Feinberg Sch Med, Buehler Ctr Aging Hlth & Soc, Chicago, IL USA. [Fink, Regina M.] Univ Colorado Hosp, Aurora, CO USA. [Fink, Regina M.] Univ Colorado, Coll Nursing, Aurora, CO USA. [Ritchie, Christine] Univ Calif San Francisco, San Francisco, CA 94143 USA. [Smith, Thomas] Johns Hopkins Med Inst, Baltimore, MD 21205 USA. [Smith, Thomas] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA.
Bakitas, MA (reprint author), Univ Alabama Birmingham, Ctr Palliat & Support Care, Sch Nursing, 1701 Univ Blvd, Birmingham, AL 35233 USA.
mbakitas@uab.edu
AN  - WOS:000368051500010
AU  - Bakitas, M. A.
AU  - Elk, R.
AU  - Astin, M.
AU  - Ceronsky, L.
AU  - Clifford, K. N.
AU  - Dionne-Odom, J. N.
AU  - Emanuel, L. L.
AU  - Fink, R. M.
AU  - Kvale, E.
AU  - Levkoff, S.
AU  - Ritchie, C.
AU  - Smith, T.
DA  - Oct
DO  - 10.1177/107327481502200411
IS  - 4
J2  - Cancer Control
KW  - of-life care
cancer outreach program
long-term-care
family
caregivers
oncology care
in-home
patient
integration
cost
intervention
Oncology
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: DA8JS
Times Cited: 24
Cited Reference Count: 60
Bakitas, Marie A. Elk, Ronit Astin, Meka Ceronsky, Lyn Clifford, Kathleen N. Dionne-Odom, J. Nicholas Emanuel, Linda L. Fink, Regina M. Kvale, Elizabeth Levkoff, Sue Ritchie, Christine Smith, Thomas
Smith, Thomas/0000-0003-3040-6434
American Cancer Society Research Scholar GrantAmerican Cancer Society; University of Alabama at Birmingham Cancer Prevention and Control Training Program [5R25CA047888]; National Palliative Care Research Center Junior Faculty Career Development Award; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1R21AG046772-01A1]; [R01NR011871-01]
Dr Bakitas receives support from R01NR011871-01 and the American Cancer Society Research Scholar Grant. Dr Dionne-Odom is a post-doctoral fellow supported by the University of Alabama at Birmingham Cancer Prevention and Control Training Program (5R25CA047888) and by a National Palliative Care Research Center Junior Faculty Career Development Award. Dr Elk receives support from NIH/NIA:1R21AG046772-01A1. No significant relationships exist between the other authors and the companies/organizations whose products or services may be referenced in this article.
24
0
8
Sage publications inc
Thousand oaks
PY  - 2015
SN  - 1073-2748
SP  - 450-464
ST  - Systematic Review of Palliative Care in the Rural Setting
T2  - Cancer Control
TI  - Systematic Review of Palliative Care in the Rural Setting
UR  - <Go to ISI>://WOS:000368051500010
VL  - 22
ID  - 104
ER  - 

TY  - JOUR
AD  - [Barber, Claire] Univ Calgary, Med, Calgary, AB, Canada. [Zell, JoAnn] Natl Jewish Med Ctr, Denver, CO USA. [Yazdany, Jinoos] Univ Calif San Francisco, Med Rheumatol, San Francisco, CA 94143 USA. [Davis, Aileen] Univ Toronto, Hlth Care & Outcomes Rsrch, Toronto Western Res Inst, Univ Hlth Network,Inst Hlth Policy Management & E, Toronto, ON, Canada. [Ehrlich-Jones, Linda S.] Rehabil Inst Chicago, Chicago, IL 60611 USA. [Thorne, Carter] Southlake Reg Hlth Ctr, Newmarket, ON, Canada. [Everix, Donna] OnMyCare Home Hlth, Fremont, CA USA. [Cappelli, Laura] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA. [Michaud, Kaleb] Univ Nebraska Med Ctr, Rheumatol & Immunol, Omaha, NE USA. [Michaud, Kaleb] Natl Data Bank Rheumat Dis, Omaha, NE USA.
AN  - WOS:000411824102020
AU  - Barber, C.
AU  - Zell, J.
AU  - Yazdany, J.
AU  - Davis, A.
AU  - Ehrlich-Jones, L. S.
AU  - Thorne, C.
AU  - Everix, D.
AU  - Cappelli, L.
AU  - Michaud, K.
DA  - Oct
J2  - Arthritis Rheumatol.
KW  - Rheumatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: FI2ZP
Times Cited: 2
Cited Reference Count: 0
Barber, Claire Zell, JoAnn Yazdany, Jinoos Davis, Aileen Ehrlich-Jones, Linda S. Thorne, Carter Everix, Donna Cappelli, Laura Michaud, Kaleb
2
0
1
Wiley
Hoboken
2326-5205
10
PY  - 2017
SN  - 2326-5191
SP  - 2
ST  - Towards Recommendations on Functional Assessment Status Measures for Rheumatoid Arthritis: Preliminary Results from a Systematic Review
T2  - Arthritis & Rheumatology
TI  - Towards Recommendations on Functional Assessment Status Measures for Rheumatoid Arthritis: Preliminary Results from a Systematic Review
UR  - <Go to ISI>://WOS:000411824102020
VL  - 69
ID  - 48
ER  - 

TY  - JOUR
AB  - The diverse circuits and functional contributions of the basal ganglia, coupled with known differences in dopaminergic function in patients with schizophrenia, suggest they may be an important contributor to the etiology of the hallmark symptoms and cognitive dysfunction experienced by these patients. Using activation-likelihood-estimation meta-analysis of functional imaging research, we investigated differences in activation patterns in the basal ganglia in patients with schizophrenia, relative to healthy controls across task domains. This analysis included 42 functional neuroimaging studies, representing a variety of behavioral domains that have been linked to basal ganglia function in prior work. We provide important new information about the functional activation patterns and functional topography of the basal ganglia for different task domains in healthy controls. Crucially however, we demonstrate that across task domains, patients with schizophrenia show markedly decreased activation in the basal ganglia relative to healthy controls. Our results provide further support for basal ganglia dysfunction in patients with schizophrenia, and the broad dysfunction across task domains may contribute to the symptoms and cognitive deficits associated with schizophrenia. (C) 2017 The Authors. Published by Elsevier Inc.
AD  - [Bernard, Jessica A.; Goen, James R. M.] Texas A&M Univ, Dept Psychol, 4235 TAMU, College Stn, TX 77843 USA. [Bernard, Jessica A.] Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX 77843 USA. [Russell, Courtney E.; Newberry, Raeana E.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA. [Mittal, Vijay A.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA. [Mittal, Vijay A.] Northwestern Univ, Dept Psychiat, Evanston, IL 60208 USA. [Mittal, Vijay A.] Northwestern Univ, Inst Policy Res, Evanston, IL 60208 USA. [Mittal, Vijay A.] Northwestern Univ, Dept Med Social Sci, Evanston, IL 60208 USA.
Bernard, JA (reprint author), Texas A&M Univ, Dept Psychol, 4235 TAMU, College Stn, TX 77843 USA.
Jessica.Bernard@tamu.edu
AN  - WOS:000405984300048
AU  - Bernard, J. A.
AU  - Russell, C. E.
AU  - Newberry, R. E.
AU  - Goen, J. R. M.
AU  - Mittal, V. A.
DO  - 10.1016/j.nicl.2017.01.034
J2  - NeuroImage-Clin.
KW  - Basal ganglia
Schizophrenia
Meta-analysis
Dopamine hypothesis
Neuroimaging
likelihood estimation metaanalysis
preclinical huntingtons-disease
dorsolateral prefrontal cortex
differential neural response
spatial
working-memory
functional connectivity
high-risk
cognitive
neuroscience
parkinsons-disease
movement-disorders
Neurosciences & Neurology
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: FB2OY
Times Cited: 9
Cited Reference Count: 125
Bernard, Jessica A. Russell, Courtney E. Newberry, Raeana E. Goen, James R. M. Mittal, Vijay A.
Brain and Behavior Research Foundation NARSAD Young Investigator Award; [R01MH094650]; [R21/R33MH103231]
J.A.B. was supported in part by a Brain and Behavior Research Foundation NARSAD Young Investigator Award as the Donald and Janet Boardman Family Investigator. V.A.M. was supported by R01MH094650 and R21/R33MH103231. V.A.M. is a consultant to Takeda Pharmaceuticals.
9
0
2
Elsevier sci ltd
Oxford
PY  - 2017
SN  - 2213-1582
SP  - 450-463
ST  - Patients with schizophrenia show aberrant patterns of basal ganglia activation: Evidence from ALE meta-analysis
T2  - Neuroimage-Clinical
TI  - Patients with schizophrenia show aberrant patterns of basal ganglia activation: Evidence from ALE meta-analysis
UR  - <Go to ISI>://WOS:000405984300048
VL  - 14
ID  - 72
ER  - 

TY  - JOUR
AB  - Alopecia areata (AA) is a prevalent autoimmune disease with 10 known susceptibility loci. Here we perform the first meta-analysis of research on AA by combining data from two genome-wide association studies (GWAS), and replication with supplemented ImmunoChip data for a total of 3,253 cases and 7,543 controls. The strongest region of association is the major histocompatibility complex, where we fine-map four independent effects, all implicating human leukocyte antigen-DR as a key aetiologic driver. Outside the major histocompatibility complex, we identify two novel loci that exceed the threshold of statistical significance, containing ACOXL/BCL2L11(BIM) (2q13); GARP (LRRC32) (11q13.5), as well as a third nominally significant region SH2B3(LNK)/ATXN2 (12q24.12). Candidate susceptibility gene expression analysis in these regions demonstrates expression in relevant immune cells and the hair follicle. We integrate our results with data from seven other autoimmune diseases and provide insight into the alignment of AA within these disorders. Our findings uncover new molecular pathways disrupted in AA, including autophagy/apoptosis, transforming growth factor beta/Tregs and JAK kinase signalling, and support the causal role of aberrant immune processes in AA.
AD  - [Betz, Regina C.; Redler, Silke; Heilmann, Stefanie; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany. [Petukhova, Lynn; Yamany, Tarek; Mackay-Wiggan, Julian; de Jong, Annemieke; Bian, Li; Clynes, Raphael; Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA. [Petukhova, Lynn] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA. [Ripke, Stephan; Huang, Hailiang; Altshuler, David; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA. [Ripke, Stephan; Huang, Hailiang; Altshuler, David; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA 02114 USA. [Ripke, Stephan; Huang, Hailiang; Altshuler, David; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02114 USA. [Menelaou, Androniki; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CG Utrecht, Netherlands. [Becker, Tim] German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany. [Becker, Tim] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53127 Bonn, Germany. [Heilmann, Stefanie; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany. [Duvic, Madeliene] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA. [Hordinsky, Maria] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA. [Norris, David] Univ Colorado, Dept Dermatol, Denver, CO 80204 USA. [Price, Vera H.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94110 USA. [DeStefano, Gina M.; Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA. [Moebus, Susanne] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, D-45122 Essen, Germany. [Boehm, Markus] Univ Munster, Dept Dermatol, D-48149 Munster, Germany. [Blume-Peytavi, Ulrike] Charite, Clin Res Ctr Hair & Skin Sci, Dept Dermatol & Allergy, D-10117 Berlin, Germany. [Wolff, Hans] Univ Munich, Dept Dermatol, D-80337 Munich, Germany. [Amos, Christopher I.] Dartmouth Coll, Hanover, NH 03755 USA. [Lee, Annette; Gregersen, Peter K.] Feinstein Inst Med Res, Manhasset, NY 11030 USA. [Blaumeiser, Bettina] Univ Antwerp, Dept Med Genet, BE-2650 Antwerp, Belgium. [Clynes, Raphael] Columbia Univ, Dept Med, New York, NY 10032 USA. [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, NL-3584 CG Utrecht, Netherlands.
Christiano, AM (reprint author), Columbia Univ, Dept Dermatol, New York, NY 10032 USA.
amc65@columbia.edu
AN  - WOS:000348811100010
AU  - Betz, R. C.
AU  - Petukhova, L.
AU  - Ripke, S.
AU  - Huang, H. L.
AU  - Menelaou, A.
AU  - Redler, S.
AU  - Becker, T.
AU  - Heilmann, S.
AU  - Yamany, T.
AU  - Duvic, M.
AU  - Hordinsky, M.
AU  - Norris, D.
AU  - Price, V. H.
AU  - Mackay-Wiggan, J.
AU  - de Jong, A.
AU  - DeStefano, G. M.
AU  - Moebus, S.
AU  - Bohm, M.
AU  - Blume-Peytavi, U.
AU  - Wolff, H.
AU  - Lutz, G.
AU  - Kruse, R.
AU  - Bian, L.
AU  - Amos, C. I.
AU  - Lee, A.
AU  - Gregersen, P. K.
AU  - Blaumeiser, B.
AU  - Altshuler, D.
AU  - Clynes, R.
AU  - de Bakker, P. I. W.
AU  - Nothen, M. M.
AU  - Daly, M. J.
AU  - Christiano, A. M.
C7  - 5966
DA  - Jan
DO  - 10.1038/ncomms6966
J2  - Nat. Commun.
KW  - latent tgf-beta
risk locus
garp
autophagosomes
expression
rationale
apoptosis
proteins
disease
surface
Science & Technology - Other Topics
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: CA3MO
Times Cited: 71
Cited Reference Count: 41
Betz, Regina C. Petukhova, Lynn Ripke, Stephan Huang, Hailiang Menelaou, Androniki Redler, Silke Becker, Tim Heilmann, Stefanie Yamany, Tarek Duvic, Madeliene Hordinsky, Maria Norris, David Price, Vera H. Mackay-Wiggan, Julian de Jong, Annemieke DeStefano, Gina M. Moebus, Susanne Boehm, Markus Blume-Peytavi, Ulrike Wolff, Hans Lutz, Gerhard Kruse, Roland Bian, Li Amos, Christopher I. Lee, Annette Gregersen, Peter K. Blaumeiser, Bettina Altshuler, David Clynes, Raphael de Bakker, Paul I. W. Noethen, Markus M. Daly, Mark J. Christiano, Angela M.
Heilmann-Heimbach, Stefanie/H-5942-2018; de Bakker, Paul IW/B-8730-2009; Petukhova, Lynn/W-6858-2019; Betz, Regina/E-8591-2011
Heilmann-Heimbach, Stefanie/0000-0003-1057-465X; de Bakker, Paul IW/0000-0001-7735-7858; Betz, Regina/0000-0001-5024-3623; Nothen, Markus/0000-0002-8770-2464; de Jong, Annemieke/0000-0001-6707-6585
National Alopecia Areata Foundation; Heinz Nixdorf Foundation; DFG-funded Excellence Cluster ImmunoSensation; German Research Foundation (DFG)German Research Foundation (DFG); DFGGerman Research Foundation (DFG) [BE 2346/5-1]; BONFOR; Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [016.126.354]; USPHS NIH/NIAMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)United States Public Health Service [R01AR52579, R01AR56016]
We are deeply indebted to the many patients and their family members who participated in this study. We are thankful to Drs Lawrence Shapiro and Tatyana Gindin for guidance on the structural effects of HLA associations. We thank Spandon V. Shah, Holly Jiang, Matthew Ding and Steven Chiu for their assistance and contributions in isolating the immune cells by FACS and Jane E. Cerise for her bioinformatic expertise. We are most grateful for the support of the National Alopecia Areata Foundation for funding the initial studies, and Ms Vicki Kalabokes and her staff at NAAF for their efforts on our behalf. The US patient cohort was collected and maintained by the National Alopecia Areata Registry (N01-AR62279) (to M.D.). Some controls were drawn from the Heinz Nixdorf Recall Study cohort, which was established with the support of the Heinz Nixdorf Foundation. R.C.B. and M.M.N. are members, T.B. is an associate member, of the DFG-funded Excellence Cluster ImmunoSensation. R.C.B. is a recipient of a Heisenberg Professorship of the German Research Foundation (DFG). This work was supported in part by the DFG grant BE 2346/5-1, as well as by local funding (BONFOR) to R.C.B., Vernieuwingsimpuls VIDI Award from the Netherlands Organization for Scientific Research for project 016.126.354 to P.I.W.d.B., and USPHS NIH/NIAMS grants R01AR52579 and R01AR56016 (to A.M.C.).
72
2
29
Nature publishing group
London
PY  - 2015
SN  - 2041-1723
SP  - 8
ST  - Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci
T2  - Nature Communications
TI  - Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci
UR  - <Go to ISI>://WOS:000348811100010
VL  - 6
ID  - 128
ER  - 

TY  - JOUR
AB  - Background: The optimal duration of dual antiplatelet therapy (DAPT) after implantation of newer-generation drug-eluting stents (DES) remains uncertain. Similarly, questions remain about the role of DAPT in long-term therapy of stable post-myocardial infarction (MI) patients. Aim: Our objective was to compare the incidence of death, major hemorrhage, MI, stent thrombosis, and major adverse cardiac events in patients randomized to prolonged or short-course DAPT after implantation of newer-generation DES and in secondary prevention after MI. Methods: We used traditional frequentist statistical and Bayesian approaches to address the following questions: Q1) What is the minimum duration of DAPT required after DES implantation? Q2) What is the clinical benefit of prolonging DAPT up to 18 to 48 months? Q3) What is the clinical effect of DAPT in stable patients who are >1 year past an MI? Results: We reviewed evidence from 11 randomized controlled trials (RCTs) that enrolled 33051 patients who received predominantly newer-generation DES to answer: A1) Use of DAPT for 12 months, as compared with use for 3 to 6 months, resulted in no significant differences in incidence of death (odds ratio [OR]: 1.17; 95% confidence interval [CI]: 0.85 to 1.63), major hemorrhage (OR: 1.65; 95% CI: 0.97 to 2.82), MI (OR: 0.87; 95% CI: 0.65 to 1.18), or stent thrombosis (OR: 0.87; 95% CI: 0.49 to 1.55). Bayesian models confirmed the primary analysis. A2) Use of DAPT for 18 to 48 months, compared with use for 6 to 12 months, was associated with no difference in incidence of all-cause death (OR: 1.14; 95% CI: 0.92 to 1.42) but was associated with increased major hemorrhage (OR: 1.58; 95% CI: 1.20 to 2.09), decreased MI (OR: 0.67; 95% CI: 0.47 to 0.95), and decreased stent thrombosis (OR: 0.45; 95% CI: 0.24 to 0.74). A risk-benefit analysis found 3 fewer stent thromboses (95% CI: 2 to 5) and 6 fewer MIs (95% CI: 2 to 11) but 5 more major bleeds (95% CI: 3 to 9) per 1000 patients treated with prolonged DAPT per year. Post hoc analyses provided weak evidence of increased mortality with prolonged DAPT. We reviewed evidence from 1 RCT of 21162 patients and a post hoc analysis of 1 RCT of 15603 patients to answer: A3): Use of DAPT >1 year after MI reduced the composite risk of cardiovascular death, MI, or stroke (hazard ratio: 0.84; 95% CI: 0.74 to 0.95) but increased major bleeding (hazard ratio: 2.32; 95% CI: 1.68 to 3.21). A meta-analysis and a post hoc analysis of an RCT in patients with stable cardiovascular disease produced similar findings. Conclusions: The primary analysis provides moderately strong evidence that prolonged DAPT after implantation of newer-generation DES entails a tradeoff between reductions in stent thrombosis and MI and increases in major hemorrhage. Secondary analyses provide weak evidence of increased mortality with prolonged DAPT after DES implantation. In patients whose coronary thrombotic risk was defined by a prior MI rather than by DES implantation, the primary analysis provides moderately strong evidence of reduced cardiovascular events at the expense of increased bleeding.
AD  - [Bittl, John A.] Munroe Reg Med Ctr, Rostov Na Donu 344711, Russia. [Baber, Usman] Mt Sinai Med Ctr, New York, NY 10029 USA. [Bradley, Steven M.] VA Eastern Colorado Heath Care Syst, Denver, CO USA. [Bradley, Steven M.] Univ Colorado, Med Cardiol, Boulder, CO 80309 USA. [Wijeysundera, Duminda N.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada. [Wijeysundera, Duminda N.] Toronto Gen Hosp, Toronto, ON, Canada. [Wijeysundera, Duminda N.] Univ Toronto, Dept Anesthesia & Pain Management, Toronto, ON M5S 1A1, Canada. [Wijeysundera, Duminda N.] Inst Clin Evaluat Sci, Dept Anesthesia, Toronto, ON, Canada. [Wijeysundera, Duminda N.] Inst Clin Evaluat Sci, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
Bittl, JA (reprint author), Munroe Reg Med Ctr, Rostov Na Donu 344711, Russia.
AN  - WOS:000384041300002
AU  - Bittl, J. A.
AU  - Baber, U.
AU  - Bradley, S. M.
AU  - Wijeysundera, D. N.
DA  - Sep
DO  - 10.1161/cir.0000000000000405
IS  - 10
J2  - Circulation
KW  - AHA Scientific Statements
acute coronary syndrome
aspirin
coronary
artery disease
coronary stents
dual antiplatelet therapy (DAPT)
focused update
P2Y(12) inhibitor
stable ischemic heart disease
eluting stent implantation
prior myocardial-infarction
st-segment
elevation
controlled-trial
randomized-trials
of-cardiology
cardiovascular angiography
network metaanalysis
double-blind
bare-metal
Cardiovascular System & Cardiology
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: DX0HB
Times Cited: 31
Cited Reference Count: 72
Bittl, John A. Baber, Usman Bradley, Steven M. Wijeysundera, Duminda N.
Wijeysundera, Duminda/L-3350-2018
Wijeysundera, Duminda/0000-0002-5897-8605
32
2
9
Lippincott williams & wilkins
Philadelphia
1524-4539
PY  - 2016
SN  - 0009-7322
SP  - E156-E178
ST  - Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
T2  - Circulation
TI  - Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
UR  - <Go to ISI>://WOS:000384041300002
VL  - 134
ID  - 76
ER  - 

TY  - JOUR
AD  - [Blanton, Emily; Patanwala, Insiyyah] Florida Hosp, Dept Grad Med Educ, Orlando, FL 32803 USA. [Blanton, Emily; Lamvu, Georgine; Patanwala, Insiyyah] Orlando Vet Affairs Med Ctr, Gynecol Sect, Div Surg, Orlando, FL 32803 USA. [Blanton, Emily; Lamvu, Georgine; Patanwala, Insiyyah] Univ Cent Florida, Dept Obstet & Gynecol, Orlando, FL 32816 USA. [Barron, Kenneth I.] Univ Virginia Hlth Syst, Dept Obstet & Gynecol, Div Adv & Minimally Invas Gynecol Surg, Charlottesville, VA USA. [Witzeman, Kathryn] Denver Hlth Med Ctr, Dept Obstet & Gynecol, Denver, CO USA. [Tu, Frank F.] Northshore Univ Hlth Syst, Dept Obstet & Gynecol, Highland Pk, IL USA. [As-Sanie, Sawsan] Univ Michigan, Dept Obstet & Gynecol, Womens Hosp, Ann Arbor, MI 48109 USA.
Blanton, E (reprint author), Florida Hosp, Dept Grad Med Educ, Orlando, FL 32803 USA.; Blanton, E (reprint author), Orlando Vet Affairs Med Ctr, Gynecol Sect, Div Surg, Orlando, FL 32803 USA.; Blanton, E (reprint author), Univ Cent Florida, Dept Obstet & Gynecol, Orlando, FL 32816 USA.
AN  - WOS:000414515500009
AU  - Blanton, E.
AU  - Lamvu, G.
AU  - Patanwala, I.
AU  - Barron, K. I.
AU  - Witzeman, K.
AU  - Tu, F. F.
AU  - As-Sanie, S.
DA  - Oct
IS  - 10
J2  - Obstet. Gynecol. Surv.
KW  - Obstetrics & Gynecology
LA  - English
M3  - Editorial Material
N1  - ISI Document Delivery No.: FL8QR
Times Cited: 0
Cited Reference Count: 2
Blanton, Emily Lamvu, Georgine Patanwala, Insiyyah Barron, Kenneth I. Witzeman, Kathryn Tu, Frank F. As-Sanie, Sawsan
0
Lippincott williams & wilkins
Philadelphia
1533-9866
PY  - 2017
SN  - 0029-7828
SP  - 589-590
ST  - Non-opioid Pain Management in Benign Minimally Invasive Hysterectomy: A Systematic Review EDITORIAL COMMENT
T2  - Obstetrical & Gynecological Survey
TI  - Non-opioid Pain Management in Benign Minimally Invasive Hysterectomy: A Systematic Review EDITORIAL COMMENT
UR  - <Go to ISI>://WOS:000414515500009
VL  - 72
ID  - 50
ER  - 

TY  - JOUR
AD  - [Boylan, Jennifer Morozink] Univ Colorado, Hlth & Behav Sci, Denver, CO 80202 USA. [Cundiff, Jenny M.] Texas Tech Univ, Psychol Sci, Lubbock, TX 79409 USA. [Matthews, Karen A.] Univ Pittsburgh, Psychiat, Pittsburgh, PA USA.
AN  - WOS:000401250500409
AU  - Boylan, J. M.
AU  - Cundiff, J. M.
AU  - Matthews, K. A.
DA  - May
IS  - 4
J2  - Psychosom. Med.
KW  - Psychiatry
Psychology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: EU7XW
Times Cited: 0
Cited Reference Count: 0
Boylan, Jennifer Morozink Cundiff, Jenny M. Matthews, Karen A.
75th Annual Scientific Meeting on Mobilizing Technology to Advance Biobehavioral Science and Health
Mar 15-18, 2017
Sevilla, SPAIN
0
Lippincott williams & wilkins
Philadelphia
1534-7796
PY  - 2017
SN  - 0033-3174
SP  - A153-A154
ST  - Socioeconomic Status and Acute Cardiovascular Responses to Stress in the Laboratory: A Systematic Review
T2  - Psychosomatic Medicine
TI  - Socioeconomic Status and Acute Cardiovascular Responses to Stress in the Laboratory: A Systematic Review
UR  - <Go to ISI>://WOS:000401250500409
VL  - 79
ID  - 63
ER  - 

TY  - JOUR
AB  - Objective: Disparities in cardiovascular health by socioeconomic status (SES) are a pressing public health concern. Hypothesized mechanisms linking low SES to poor health are large cardiovascular responses to and delayed recovery from psychological stress. The current study presents a meta-analysis of the literature on the association of SES with blood pressure and heart rate reactivity to and recovery from acute stress tasks. Methods: The PubMed database was searched, and 26 unique studies with relevant data were identified (k = 25 reactivity [n = 14,617], k = 6 recovery [n = 1,324]). Results: Using random-effects models, no significant association between SES and cardiovascular reactivity to stress emerged (r = .008, 95% confidence interval = -.02 to .04), although higher SES was associated with better recovery from stress (r = -.14, 95% confidence interval -. 23 to -. 05). Stressor type moderated the reactivity effect, wherein higher SES was associated with greater reactivity to cognitive stressors (r = .036, p = .024), not with reactivity to interpersonal stressors (r = -.02, p = .62), but was associated with lower reactivity to tasks with combinations of cognitive, interpersonal, and physical challenges (r = -.12, p = .029). Accounting for publication bias revealed a significant association between SES and reactivity in the opposite direction of hypotheses. Conclusions: Cardiovascular recovery from acute stress, but not reactivity to stress, may be a key pathway between low SES and risk for cardiovascular diseases. Heterogeneity in effect size and direction, challenges related to working across temporal dynamics, and recommendations for future research are discussed.
AD  - [Boylan, Jennifer Morozink] Univ Colorado Denver, Dept Hlth & Behav Sci, Denver, CO USA. [Cundiff, Jenny M.] Texas Tech Univ, Dept Psychol Sci, Lubbock, TX 79409 USA. [Matthews, Karen A.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA.
Boylan, JM (reprint author), Dept Hlth & Behav Sci, Campus Box 188,POB 173364, Denver, CO 80217 USA.
jennifer.boylan@ucdenver.edu
AN  - WOS:000436027400406
AU  - Boylan, J. M.
AU  - Cundiff, J. M.
AU  - Matthews, K. A.
DA  - Apr
DO  - 10.1097/psy.0000000000000561
IS  - 3
J2  - Psychosom. Med.
KW  - blood pressure
cardiovascular reactivity
cardiovascular recovery
heart rate
socioeconomic status
blood-pressure reactivity
random-effects models
psychosocial factors
mental stress
psychological stress
childhood poverty
african-american
physical health
united-states
risk
Psychiatry
Psychology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: GK3FN
Times Cited: 3
Cited Reference Count: 75
Boylan, Jennifer Morozink Cundiff, Jenny M. Matthews, Karen A.
National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL07560]
This research was supported by the National Heart, Lung, and Blood Institute (HL07560). The authors declare no conflicts of interest.
4
1
6
Lippincott williams & wilkins
Philadelphia
1534-7796
PY  - 2018
SN  - 0033-3174
SP  - 278-293
ST  - Socioeconomic Status and Cardiovascular Responses to Standardized Stressors: A Systematic Review and Meta-Analysis
T2  - Psychosomatic Medicine
TI  - Socioeconomic Status and Cardiovascular Responses to Standardized Stressors: A Systematic Review and Meta-Analysis
UR  - <Go to ISI>://WOS:000436027400406
VL  - 80
ID  - 25
ER  - 

TY  - JOUR
AD  - [Brewer, Sarah E.; Morrato, Elaine H.] Univ Colorado, ACCORDS, Anschutz Med Campus, Aurora, CO USA. [Morrato, Elaine H.] Univ Colorado, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA.
AN  - WOS:000385483502179
AU  - Brewer, S. E.
AU  - Morrato, E. H.
DA  - Aug
J2  - Pharmacoepidemiol. Drug Saf.
KW  - Public, Environmental & Occupational Health
Pharmacology & Pharmacy
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: DY9VP
Times Cited: 0
Cited Reference Count: 0
Brewer, Sarah E. Morrato, Elaine H.
0
Wiley-blackwell
Hoboken
1099-1557
S3
PY  - 2016
SN  - 1053-8569
SP  - 319-319
ST  - Regulatory Considerations for Knowledge, Attitude, and Belief Surveys: A Systematic Review of Physician Survey Response
T2  - Pharmacoepidemiology and Drug Safety
TI  - Regulatory Considerations for Knowledge, Attitude, and Belief Surveys: A Systematic Review of Physician Survey Response
UR  - <Go to ISI>://WOS:000385483502179
VL  - 25
ID  - 78
ER  - 

TY  - JOUR
AB  - IMPORTANCE The total cost of psoriasis in the United States is unknown. Defining the US economic burden of psoriasis is needed because it provides the foundation for research, advocacy, and educational efforts. OBJECTIVE To determine the US economic burden of psoriasis from a societal perspective. EVIDENCE REVIEW PubMed and MEDLINE databases were searched between January 1, 2008, and September 20, 2013, for economic investigations on the direct, indirect, intangible, and comorbidity costs of adult psoriasis in the United States. The base year costs were adjusted to 2013 US dollars using the Consumer Price Index for All Urban Consumers and multiplied by the estimated number of US patients with psoriasis in 2013 to determine the 2013 psoriasis cost burden. FINDINGS Among 100 identified articles, 22 studies were included in the systematic review. The direct psoriasis costs ranged from $51.7 billion to $63.2 billion, the indirect costs ranged from $23.9 billion to $35.4 billion, and medical comorbidities were estimated to contribute $36.4 billion annually in 2013 US dollars. Patients with psoriasis would pay a lifetime cost of $11 498 for relief of physical symptoms and emotional health; however, intangible cost data are limited. The annual US cost of psoriasis amounted to approximately $112 billion in 2013. CONCLUSIONS AND RELEVANCE The economic burden of psoriasis is substantial and significant in the United States.
AD  - [Brezinski, Elizabeth A.; Dhillon, Jaskaran S.] Univ Calif Davis, Dept Dermatol, Sacramento, CA USA. [Armstrong, April W.] Univ Colorado Denver, Dept Dermatol, Aurora, CO 80045 USA.
Armstrong, AW (reprint author), Univ Colorado Denver, Dept Dermatol, 12801 E 17th Ave,Mail Stop 8127, Aurora, CO 80045 USA.
aprilarmstrong@post.harvard.edu
AN  - WOS:000356177700019
AU  - Brezinski, E. A.
AU  - Dhillon, J. S.
AU  - Armstrong, A. W.
DA  - Jun
DO  - 10.1001/jamadermatol.2014.3593
IS  - 6
J2  - JAMA Dermatol.
KW  - quality-of-life
cost-effectiveness
health-care
biologic therapies
plaque psoriasis
moderate
patient
etanercept
arthritis
prevalence
Dermatology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: CK4FN
Times Cited: 74
Cited Reference Count: 39
Brezinski, Elizabeth A. Dhillon, Jaskaran S. Armstrong, April W.
74
2
18
Amer medical assoc
Chicago
2168-6084
PY  - 2015
SN  - 2168-6068
SP  - 651-658
ST  - Economic Burden of Psoriasis in the United States A Systematic Review
T2  - Jama Dermatology
TI  - Economic Burden of Psoriasis in the United States A Systematic Review
UR  - <Go to ISI>://WOS:000356177700019
VL  - 151
ID  - 112
ER  - 

TY  - JOUR
AB  - Background: The majority of young people in need of palliative care live in low- and middle-income countries, where curative treatment is less available. Objective: We systematically reviewed published data describing palliative care services available to young people with life-limiting conditions in low- and middle-income countries and assessed core elements with respect to availability, gaps, and under-reported aspects. Methods: PubMed, CINAHL, EMBASE (1980-2013), and secondary bibliographies were searched for publications that included patients younger than 25 years with life-limiting conditions and described palliative care programs in low- and middle-income countries. A data extraction checklist considered 15 items across seven domains: access, education/capacity building, health system support, pain management, symptom management, end-of-life care, and bereavement. Data were aggregated by program and country. Results: Of 1572 records, 238 met criteria for full-text review; 34 qualified for inclusion, representing 30 programs in 21 countries. The median checklist score was 7 (range, 1-14) of 10 reported (range, 3-14). The most pervasive gaps were in national health system support (unavailable in 7 of 17 countries with programs reporting), specialized education (unavailable in 7 of 19 countries with programs reporting), and comprehensive opioid access (unavailable in 14 of 21 countries with programs reporting). Underreported elements included specified practices for pain management and end-of-life support. Conclusion: Comprehensive pediatric palliative care provision is possible even in markedly impoverished settings. Improved national health system support, specialized training and opioid access are key targets for research and advocacy. Application of a checklist methodology can promote awareness of gaps to guide program evaluation, reporting, and strengthening.
AD  - [Brown, Amy E. Caruso] SUNY Upstate Med Univ, Ctr Bioeth & Humanities, Syracuse, NY 13210 USA. [Brown, Amy E. Caruso] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA. [Howard, Scott C.; Baker, Justin N.; Ribeiro, Raul C.; Lam, Catherine G.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA.
Brown, AEC (reprint author), Childrens Hosp Colorado, Ctr Canc & Blood Disorders, 13123 East 16th Ave,Campus Box B115, Denver, CO 80218 USA.
amy.brown@childrenscolorado.org
AN  - WOS:000346336200016
AU  - Brown, A. E. C.
AU  - Howard, S. C.
AU  - Baker, J. N.
AU  - Ribeiro, R. C.
AU  - Lam, C. G.
DA  - Dec
DO  - 10.1089/jpm.2014.0095
IS  - 12
J2  - J. Palliat. Med.
KW  - sub-saharan africa
cancer
children
health
world
life
challenges
mortality
services
end
Health Care Sciences & Services
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AW5TH
Times Cited: 18
Cited Reference Count: 48
Brown, Amy E. Caruso Howard, Scott C. Baker, Justin N. Ribeiro, Raul C. Lam, Catherine G.
Lam, Catherine/K-6328-2014; Baker, Justin/N-8117-2018
Lam, Catherine/0000-0003-1363-5331; Baker, Justin/0000-0002-6584-6483
National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 CA080208-06]; American Lebanese Syrian Associated CharitiesAmerican Lebanese Syrian Associated Charities (ALSAC)
This work was supported in part by institutional training grant T32 CA080208-06 from the National Institutes of Health (A.C.B.) and the American Lebanese Syrian Associated Charities (S.C.H., J.N.B., R.C.R., C.G.L.). Sources of funding were not involved in any aspect of the review.
18
0
10
Mary ann liebert, inc
New rochelle
1557-7740
PY  - 2014
SN  - 1096-6218
SP  - 1369-1383
ST  - Reported Availability and Gaps of Pediatric Palliative Care in Low- and Middle-Income Countries: A Systematic Review of Published Data
T2  - Journal of Palliative Medicine
TI  - Reported Availability and Gaps of Pediatric Palliative Care in Low- and Middle-Income Countries: A Systematic Review of Published Data
UR  - <Go to ISI>://WOS:000346336200016
VL  - 17
ID  - 130
ER  - 

TY  - JOUR
AB  - Patients express multiple cues, ranging from subtle to overt. Clinical cues may signal changes or the presence of stability in the patient's condition. Little is known about the number and types of cues recognized by beginning nurses. This article reports the results of an integrative review of the literature published between 1964 and 2013 concerning recognition of clinical cues by undergraduate nursing students. Search terms included cue, cue recognition, clinical cue, and clinical reasoning. Twenty-seven studies met inclusion criteria. Initial evidence exists of differences in cue recognition between novice and expert nurses. Influences on cue recognition include familiarity with the patient or the patient's health condition. Cue recognition does not necessarily predict presence or quality of nursing actions. International research concerning cue recognition by nurses is in its infancy. Opportunities exist to further the science through use of rigorous design and multisite sampling.
AD  - [Burbach, Beth E.] Univ Nebraska Med Ctr, Norfolk, NE 68701 USA. [Thompson, Sarah A.] Univ Colorado, Coll Nursing, Aurora, CO USA.
Burbach, BE (reprint author), Univ Nebraska Med Ctr, 801 East Benjamin Ave, Norfolk, NE 68701 USA.
bburbach@unmc.edu
AN  - WOS:000345263600003
AU  - Burbach, B. E.
AU  - Thompson, S. A.
DA  - Sep
DO  - 10.3928/01484834-20140806-07
IS  - 9
J2  - J. Nurs. Educ.
KW  - clinical decision-making
nurses
judgment
simulation
expert
deterioration
environment
diagnosis
knowledge
novice
Nursing
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AT9RJ
Times Cited: 5
Cited Reference Count: 54
Burbach, Beth E. Thompson, Sarah A.
5
0
Slack inc
Thorofare
1938-2421
S
PY  - 2014
SN  - 0148-4834
SP  - S73-S81
ST  - Cue Recognition by Undergraduate Nursing Students: An Integrative Review
T2  - Journal of Nursing Education
TI  - Cue Recognition by Undergraduate Nursing Students: An Integrative Review
UR  - <Go to ISI>://WOS:000345263600003
VL  - 53
ID  - 135
ER  - 

TY  - JOUR
AD  - [Busch, R.; Hobbs, B. D.; Castaldi, P. J.; Litonjua, A. A.; Silverman, E. K.; Cho, M. H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA. [Zhou, J.] Univ Arizona, Tucson, AZ USA. [Hawrylkiewicz, I.; Sliwinski, P.] Natl TB & Lung Dis Res Inst, Warsaw, Poland. [Yim, J. J.] Seoul Natl Univ, Coll Med, Seoul, South Korea. [Kim, W. J.] Kangwon Natl Univ, Chunchon, South Korea. [Kim, D. K.] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea. [Agusti, A.] Univ Barcelona, Hosp Clin, Barcelona, Spain. [Make, B. J.; Crapo, J. D.] Natl Jewish Hlth, Denver, CO USA. [Calverley, P.] Univ Liverpool, Liverpool, Merseyside, England. [Donner, C. F.] Mondo Med IFIM Srl, Borgomanero, Italy. [Lomas, D. A.] UCL, London, England. [Wouters, E. F.] Univ Hosp Maastricht, Maastricht, Netherlands. [Vestbo, J.] Univ Hosp South Manchester, Manchester, Lancs, England. [Tal-Singer, R.] GSK, King Of Prussia, PA USA. [Bakke, P.; Gulsvik, A.] Univ Bergen, Bergen, Norway. [Sparrow, D.] Brigham & Womens Hosp, Jamaica Plain, MA USA. [Sparrow, D.] VA Med Ctr, Jamaica Plain, MA USA. [Pare, P. D.; Levy, R. D.] Univ British Columbia, Vancouver, BC, Canada. [Rennard, S. I.] Univ Nebraska Med Ctr, Omaha, NE USA. [Beaty, T. H.] Johns Hopkins Univ, Baltimore, MD USA. [Hokanson, J.] Univ Colorado, Colorado Sch Publ Hlth, Aurora, CO USA.
AN  - WOS:000390749607413
AU  - Busch, R.
AU  - Hobbs, B. D.
AU  - Zhou, J.
AU  - Castaldi, P. J.
AU  - Hawrylkiewicz, I.
AU  - Sliwinski, P.
AU  - Yim, J. J.
AU  - Kim, W. J.
AU  - Kim, D. K.
AU  - Agusti, A.
AU  - Make, B. J.
AU  - Crapo, J. D.
AU  - Calverley, P.
AU  - Donner, C. F.
AU  - Lomas, D. A.
AU  - Wouters, E. F.
AU  - Vestbo, J.
AU  - Tal-Singer, R.
AU  - Bakke, P.
AU  - Gulsvik, A.
AU  - Litonjua, A. A.
AU  - Sparrow, D.
AU  - Pare, P. D.
AU  - Levy, R. D.
AU  - Rennard, S. I.
AU  - Beaty, T. H.
AU  - Hokanson, J.
AU  - Silverman, E. K.
AU  - Cho, M. H.
AU  - Investigator, Eclipse
AU  - Investigator, C. OPDGene
J2  - Am. J. Respir. Crit. Care Med.
KW  - General & Internal Medicine
Respiratory System
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: EG0VE
Times Cited: 0
Cited Reference Count: 0
Busch, R. Hobbs, B. D. Zhou, J. Castaldi, P. J. Hawrylkiewicz, I. Sliwinski, P. Yim, J. J. Kim, W. J. Kim, D. K. Agusti, A. Make, B. J. Crapo, J. D. Calverley, P. Donner, C. F. Lomas, D. A. Wouters, E. F. Vestbo, J. Tal-Singer, R. Bakke, P. Gulsvik, A. Litonjua, A. A. Sparrow, D. Pare, P. D. Levy, R. D. Rennard, S. I. Beaty, T. H. Hokanson, J. Silverman, E. K. Cho, M. H.
International Conference of the American-Thoracic-Society (ATS)
May 13-18, 2016
San Francisco, CA
Amer Thorac Soc
Vestbo, Jorgen/Y-2912-2019; Pare, Peter D/C-7425-2011
0
1
Amer thoracic soc
New york
1535-4970
PY  - 2016
SN  - 1073-449X
SP  - 2
ST  - Variants Tagging Serpina1 And Il27 Show Significant Association With COPD In A Meta-Analysis With Over 16,700 Subjects
T2  - American Journal of Respiratory and Critical Care Medicine
TI  - Variants Tagging Serpina1 And Il27 Show Significant Association With COPD In A Meta-Analysis With Over 16,700 Subjects
UR  - <Go to ISI>://WOS:000390749607413
VL  - 193
ID  - 98
ER  - 

TY  - JOUR
AD  - [Buxbaum, James L.; Ko, Christopher; Yu, Chung Yao; Lee, Alice A.; Laput, Gieric P.; Gupta, Nikhil] Univ Southern Calif, Div Gastrointestinal & Liver Dis, Los Angeles, CA USA. [Kysh, Lynn] Univ Southern Calif, Lib Sci, Los Angeles, CA USA. [Wani, Sachin B.] Univ Colorado, Gastroenterol, Aurora, CA USA. [Cortessis, Victoria] Univ Southern Calif, Prevent Med, Los Angeles, CA USA. [Fehmi, Syed M.] Univ Calif San Diego, Gastroenterol, La Jolla, CA 92093 USA.
AN  - WOS:000434248200309
AU  - Buxbaum, J. L.
AU  - Ko, C.
AU  - Yu, C. Y.
AU  - Lee, A. A.
AU  - Laput, G. P.
AU  - Gupta, N.
AU  - Kysh, L.
AU  - Wani, S. B.
AU  - Cortessis, V.
AU  - Fehmi, S. M.
DA  - Jun
IS  - 6
J2  - Gastrointest. Endosc.
KW  - Gastroenterology & Hepatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GI3CH
Times Cited: 0
Cited Reference Count: 0
Buxbaum, James L. Ko, Christopher Yu, Chung Yao Lee, Alice A. Laput, Gieric P. Gupta, Nikhil Kysh, Lynn Wani, Sachin B. Cortessis, Victoria Fehmi, Syed M.
Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week
Jun 02-05, 2018
Washington, DC
Amer Soc Gastrointestinal Endoscopy
0
1
Mosby-elsevier
New york
1097-6779
S
PY  - 2018
SN  - 0016-5107
SP  - AB196-AB197
ST  - INTRADUCTAL COMPARED TO CONVENTIONAL THERAPY FOR DIFFICULT BILE DUCT STONES, A COMPREHENSIVE META ANALYSIS
T2  - Gastrointestinal Endoscopy
TI  - INTRADUCTAL COMPARED TO CONVENTIONAL THERAPY FOR DIFFICULT BILE DUCT STONES, A COMPREHENSIVE META ANALYSIS
UR  - <Go to ISI>://WOS:000434248200309
VL  - 87
ID  - 19
ER  - 

TY  - JOUR
AB  - Background: Global climate change is expected to increase the risk of diarrhoeal diseases, a leading cause of childhood mortality. However, there is considerable uncertainty about the magnitude of these effects and which populations bear the greatest risks. Methods: We conducted a systematic review using defined search terms across four major databases and, additionally, examined the references of 54 review articles captured by the search. We evaluated sources of heterogeneity by pathogen taxon, exposure measure, study quality, country income level and regional climate, and estimated pooled effect estimates for the subgroups identified in the heterogeneity analysis, using meta-analysis methods. Results: We identified 26 studies with 49 estimates. Pathogen taxa were a source of heterogeneity. There was a positive association between ambient temperature and all-cause diarrhoea (incidence rate ratio (IRR) 1.07; 95% confidence interval (CI) 1.03, 1.10) and bacterial diarrhoea (IRR 1.07; 95% CI 1.04, 1.10), but not viral diarrhoea (IRR 0.96; 95% CI 0.82, 1.11). These associations were observed in low-, middle- and high-income countries. Only one study of protozoan diarrhoea was identified. Conclusions: Changes in temperature due to global climate change can and may already be affecting diarrhoeal disease incidence. The vulnerability of populations may depend, in part, on local pathogen distribution. However, evidence of publication bias and the uneven geographical distribution of studies limit the precision and generalizability of the pooled estimates.
AD  - [Carlton, Elizabeth J.; Woster, Andrew P.] Univ Colorado, Dept Environm & Occupat Hlth, Aurora, CO USA. [DeWitt, Peter] Univ Colorado, Dept Biostat, Aurora, CO USA. [Goldstein, Rebecca S.; Levy, Karen] Emory Univ, Dept Environm Hlth, Atlanta, GA 30322 USA.
Carlton, EJ (reprint author), Colorado Sch Publ Hlth, Dept Environm Hlth Sci, 13001 E 17th Pl B119, Aurora, CO 80045 USA.
elizabeth.carlton@ucdenver.edu
AN  - WOS:000374230100019
AU  - Carlton, E. J.
AU  - Woster, A. P.
AU  - DeWitt, P.
AU  - Goldstein, R. S.
AU  - Levy, K.
DA  - Feb
DO  - 10.1093/ije/dyv296
IS  - 1
J2  - Int. J. Epidemiol.
KW  - Ambient temperature
weather
diarrhoea
climate change
vulnerability
time-series analysis
robust variance-estimation
climate variability
global burden
developing-countries
weather variability
meta-regression
21 regions
rotavirus
transmission
Public, Environmental & Occupational Health
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: DJ5ER
Times Cited: 24
Cited Reference Count: 62
Carlton, Elizabeth J. Woster, Andrew P. DeWitt, Peter Goldstein, Rebecca S. Levy, Karen
DeWitt, Peter/0000-0002-6391-0795; Carlton, Elizabeth/0000-0002-8664-9606
Colorado School of Public Health; National Institutes of Health (Fogarty International Center)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R21TW009032]; National Institutes of Health (National Institute of Allergy and Infectious Diseases)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [K01AI103544]; National Institutes of Health (National Center for Advancing Translational Sciences) [UL1 TR000154]
This work was supported by the Colorado School of Public Health and by grants from the National Institutes of Health (Fogarty International Center grant R21TW009032, National Institute of Allergy and Infectious Diseases grant K01AI103544 and the National Center for Advancing Translational Sciences grant UL1 TR000154). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
24
1
15
Oxford univ press
Oxford
1464-3685
PY  - 2016
SN  - 0300-5771
SP  - 117-130
ST  - A systematic review and meta-analysis of ambient temperature and diarrhoeal diseases
T2  - International Journal of Epidemiology
TI  - A systematic review and meta-analysis of ambient temperature and diarrhoeal diseases
UR  - <Go to ISI>://WOS:000374230100019
VL  - 45
ID  - 92
ER  - 

TY  - JOUR
AB  - Background: Intra-articular cellular therapy injections constitute an appealing strategy that may modify the intra-articular milieu or regenerate cartilage in the settings of osteoarthritis and focal cartilage defects. However, little consensus exists regarding the indications for cellular therapies, optimal cell sources, methods of preparation and delivery, or means by which outcomes should be reported. Methods: We present a systematic review of the current literature regarding the safety and efficacy of cellular therapy delivered by intra-articular injection in the knee that provided a Level of Evidence of III or higher. A total of 420 papers were screened. Methodological quality was assessed using a modified Coleman methodology score. Results: Only 6 studies (4 Level II and 2 Level III) met the criteria to be included in this review; 3 studies were on treatment of osteoarthritis and 3 were on treatment of focal cartilage defects. These included 4 randomized controlled studies without blinding, 1 prospective cohort study, and 1 retrospective therapeutic case-control study. The studies varied widely with respect to cell sources, cell characterization, adjuvant therapies, and assessment of outcomes. Outcome was reported in a total of 300 knees (124 in the osteoarthritis studies and 176 in the cartilage defect studies). Mean follow-up was 21.0 months (range, 12 to 36 months). All studies reported improved outcomes with intra-articular cellular therapy and no major adverse events. The mean modified Coleman methodology score was 59.1 +/- 16 (range, 32 to 82). Conclusions: The studies of intra-articular cellular therapy injections for osteoarthritis and focal cartilage defects in the human knee suggested positive results with respect to clinical improvement and safety. However, the improvement was modest and a placebo effect cannot be disregarded. The overall quality of the literature was poor, and the methodological quality was fair, even among Level-II and III studies. Effective clinical assessment and optimization of injection therapies will demand greater attention to study methodology, including blinding; standardized quantitative methods for cell harvesting, processing, characterization, and delivery; and standardized reporting of clinical and structural outcomes.
AD  - Cleveland Clin, Cleveland, OH 44106 USA. [LaPrade, Robert F.] Steadman Clin, Vail, CO USA. Italian Hosp Buenos Aires, Buenos Aires, DF, Argentina. [Chahla, Jorge; Mitchell, Justin J.; Dean, Chase S.; LaPrade, Robert F.] Steadman Philippon Res Inst, Vail, CO 81657 USA. [Piuzzi, Nicolas S.] Carlos E Ottolenghi Italian Hosp Buenos Aires, Inst Orthoped, Buenos Aires, DF, Argentina. [Pascual-Garrido, Cecilia] Univ Colorado, Aurora, CO USA. [Muschler, George F.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.
Chahla, J (reprint author), Steadman Philippon Res Inst, Vail, CO 81657 USA.
jchahla@sprivail.org; nicolas.piuzzi@hospitalitaliano.org.ar; jmitchell@thesteadmanclinic.com; cdean@sprivail.org; cecilia.pascualgarrido@gmail.com; drlaprade@sprivail.org; muschlg@ccf.org
AN  - WOS:000395949300007
AU  - Chahla, J.
AU  - Piuzzi, N. S.
AU  - Mitchell, J. J.
AU  - Dean, C. S.
AU  - Pascual-Garrido, C.
AU  - LaPrade, R. F.
AU  - Muschler, G. F.
DA  - Sep
DO  - 10.2106/jbjs.15.01495
IS  - 18
J2  - J. Bone Joint Surg.-Am. Vol.
KW  - mesenchymal stem-cells
platelet-rich plasma
autologous chondrocyte
implantation
high tibial osteotomy
human bone-marrow
clinically
superior
hyaluronic-acid
outcomes
repair
viscosupplementation
Orthopedics
Surgery
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: EN4AK
Times Cited: 35
Cited Reference Count: 51
Chahla, Jorge Piuzzi, Nicolas S. Mitchell, Justin J. Dean, Chase S. Pascual-Garrido, Cecilia LaPrade, Robert F. Muschler, George F.
Piuzzi, Nicolas S./0000-0003-3007-7538
35
1
7
Lippincott williams & wilkins
Philadelphia
1535-1386
PY  - 2016
SN  - 0021-9355
SP  - 1511-1521
ST  - Intra-Articular Cellular Therapy for Osteoarthritis and Focal Cartilage Defects of the Knee A Systematic Review of the Literature and Study Quality Analysis
T2  - Journal of Bone and Joint Surgery-American Volume
TI  - Intra-Articular Cellular Therapy for Osteoarthritis and Focal Cartilage Defects of the Knee A Systematic Review of the Literature and Study Quality Analysis
UR  - <Go to ISI>://WOS:000395949300007
VL  - 98
ID  - 75
ER  - 

TY  - JOUR
AB  - Background: In 2008, the National Heart, Lung, and Blood Institute convened an Implementation Science Work Group to assess evidence-based strategies for effectively implementing clinical practice guidelines. This was part of a larger effort to update existing clinical practice guidelines on cholesterol, blood pressure, and overweight/obesity. Objectives: Review evidence from the published implementation science literature and identify effective or promising strategies to enhance the adoption and implementation of clinical practice guidelines. Methods: This systematic review was conducted on 4 critical questions, each focusing on the adoption and effectiveness of 4 intervention strategies: (1) reminders, (2) educational outreach visits, (3) audit and feedback, and (4) provider incentives. A scoping review of the Rx for Change database of systematic reviews was used to identify promising guideline implementation interventions aimed at providers. Inclusion and exclusion criteria were developed a priori for each question, and the published literature was initially searched up to 2012, and then updated with a supplemental search to 2015. Two independent reviewers screened the returned citations to identify relevant reviews and rated the quality of each included review. Results: Audit and feedback and educational outreach visits were generally effective in improving both process of care (15 of 21 reviews and 12 of 13 reviews, respectively) and clinical outcomes (7 of 12 reviews and 3 of 5 reviews, respectively). Provider incentives showed mixed effectiveness for improving both process of care (3 of 4 reviews) and clinical outcomes (3 reviews equally distributed between generally effective, mixed, and generally ineffective). Reminders showed mixed effectiveness for improving process of care outcomes (27 reviews with 11 mixed and 3 generally ineffective results) and were generally ineffective for clinical outcomes (18 reviews with 6 mixed and 9 generally ineffective results). Educational outreach visits (2 of 2 reviews), reminders (3 of 4 reviews), and provider incentives (1 of 1 review) were generally effective for cost reduction. Educational outreach visits (1 of 1 review) and provider incentives (1 of 1 review) were also generally effective for cost-effectiveness outcomes. Barriers to clinician adoption or adherence to guidelines included time constraints (8 reviews/overviews); limited staffing resources (2 overviews); timing (5 reviews/overviews); clinician skepticism (5 reviews/overviews); clinician knowledge of guidelines (4 reviews/overviews); and higher age of the clinician (1 overview). Facilitating factors included guideline characteristics such as format, resources, and end-user involvement (6 reviews/overviews); involving stakeholders (5 reviews/overviews); leadership support (5 reviews/overviews); scope of implementation (5 reviews/overviews); organizational culture such as multidisciplinary teams and low-baseline adherence (9 reviews/overviews); and electronic guidelines systems (3 reviews). Conclusion: The strategies of audit and feedback and educational outreach visits were generally effective in improving both process of care and clinical outcomes. Reminders and provider incentives showed mixed effectiveness, or were generally ineffective. No general conclusion could be reached about cost effectiveness, because of limitations in the evidence. Important gaps exist in the evidence on effectiveness of implementation interventions, especially regarding clinical outcomes, cost effectiveness and contextual issues affecting successful implementation.
AD  - [Chan, Wiley V.] Kaiser Permanente Northwest, Guidelines & Evidence Based Med, Portland, OR 97210 USA. [Pearson, Thomas A.] Univ Rochester, Med Ctr, Res & Educ, Rochester, NY 14627 USA. [Bennett, Glen C.] NHLBI, Bldg 10, Bethesda, MD 20892 USA. [Cushman, William C.] Univ Tennessee, Hlth Sci Ctr, Preventat Med, Knoxville, TN 37996 USA. [Gaziano, Thomas A.] Harvard Med Sch, Boston, MA USA. [Gaziano, Thomas A.] Brigham & Womens Hosp, Cardiovasc Med, Boston, MA 02115 USA. [Gorman, Paul N.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA. [Handler, Joel] Southern Calif Permanente Med Grp, Portland, OR USA. [Krumholz, Harlan M.] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA. [Kushner, Robert F.] Northwestern Univ, Med, Evanston, IL 60208 USA. [MacKenzie, Thomas D.] Denver Hlth Fdn, Denver, CO USA. [Sacco, Ralph L.] Univ Miami, Hlth Syst, Dept Neurol, Coral Gables, FL 33124 USA. [Smith, Sidney C., Jr.] Univ North Carolina Chapel Hill, Med, Chapel Hill, NC USA. [Stevens, Victor J.] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA. [Wells, Barbara L.] NIH, Bldg 10, Bethesda, MD 20892 USA.
Chan, WV (reprint author), Kaiser Permanente Northwest, Guidelines & Evidence Based Med, Portland, OR 97210 USA.
AN  - WOS:000395549700002
AU  - Chan, W. V.
AU  - Pearson, T. A.
AU  - Bennett, G. C.
AU  - Cushman, W. C.
AU  - Gaziano, T. A.
AU  - Gorman, P. N.
AU  - Handler, J.
AU  - Krumholz, H. M.
AU  - Kushner, R. F.
AU  - MacKenzie, T. D.
AU  - Sacco, R. L.
AU  - Smith, S. C.
AU  - Stevens, V. J.
AU  - Wells, B. L.
DA  - Feb
DO  - 10.1161/cir.0000000000000481
IS  - 9
J2  - Circulation
KW  - AHA Scientific Statements
cost
detailing
effectiveness
evidence-based
incentives
interventions
reminders
systematic review
decision-support-systems
venous thromboembolism
improve prophylaxis
disease management
medication use
care
interventions
quality
professionals
prevention
Cardiovascular System & Cardiology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: EM8GO
Times Cited: 14
Cited Reference Count: 54
Chan, Wiley V. Pearson, Thomas A. Bennett, Glen C. Cushman, William C. Gaziano, Thomas A. Gorman, Paul N. Handler, Joel Krumholz, Harlan M. Kushner, Robert F. MacKenzie, Thomas D. Sacco, Ralph L. Smith, Sidney C., Jr. Stevens, Victor J. Wells, Barbara L.
Sacco, Ralph/Y-9278-2019
federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services, under GSA [GS-10F-0112J, HHSN2268201100098U]
This project was funded in whole or in part with federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services, under GSA contract No. GS-10F-0112J, Order No. HHSN2268201100098U.
14
1
Lippincott williams & wilkins
Philadelphia
1524-4539
PY  - 2017
SN  - 0009-7322
SP  - E122-E137
ST  - ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
T2  - Circulation
TI  - ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
UR  - <Go to ISI>://WOS:000395549700002
VL  - 135
ID  - 69
ER  - 

TY  - JOUR
AD  - [Chandra-Mouli, Venkatraman; Fernando, Asanthi] WHO, Washington, DC USA. [Hoopes, Andrea J.] Univ Colorado, Sch Med, Boulder, CO 80309 USA.
AN  - WOS:000373428800095
AU  - Chandra-Mouli, V.
AU  - Hoopes, A. J.
AU  - Fernando, A.
DA  - Feb
DO  - 10.1016/j.jadohealth.2015.10.113
IS  - 2
J2  - J. Adolesc. Health
KW  - Psychology
Public, Environmental & Occupational Health
Pediatrics
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: DI3VW
Times Cited: 1
Cited Reference Count: 0
Chandra-Mouli, Venkatraman Hoopes, Andrea J. Fernando, Asanthi
1
0
Elsevier science inc
New york
1879-1972
S
PY  - 2016
SN  - 1054-139X
SP  - S50-S51
ST  - MAKING HEALTH SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES MORE ADOLESCENT-FRIENDLY: A SCOPING REVIEW
T2  - Journal of Adolescent Health
TI  - MAKING HEALTH SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES MORE ADOLESCENT-FRIENDLY: A SCOPING REVIEW
UR  - <Go to ISI>://WOS:000373428800095
VL  - 58
ID  - 93
ER  - 

TY  - JOUR
AD  - [Chen, M.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA. [Orkaby, A.; Driver, J.] VA Boston Healthcare Syst, Boston, MA USA. [Orkaby, A.; Driver, J.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA. [Rosenberg, M.] Univ Colorado, Sch Med, Aurora, CO USA.
AN  - WOS:000402876300702
AU  - Chen, M.
AU  - Orkaby, A.
AU  - Rosenberg, M.
AU  - Driver, J.
DA  - May
J2  - J. Am. Geriatr. Soc.
KW  - Geriatrics & Gerontology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: EW9YW
Times Cited: 0
Cited Reference Count: 0
Chen, M. Orkaby, A. Rosenberg, M. Driver, J.
Annual Scientific Meeting of the American-Geriatrics-Society (AGS)
May 18-20, 2017
San Antonio, TX
Amer Geriatr Soc
Orkaby, Ariela/M-3401-2019; Orkaby, Ariela R/H-9244-2019
0
Wiley
Hoboken
1532-5415
1
Si
PY  - 2017
SN  - 0002-8614
SP  - S243-S243
ST  - Frailty May Identify Older Patients Who Do Not Benefit From Implantable Cardioverter-Defibrillators: A Systematic Review
T2  - Journal of the American Geriatrics Society
TI  - Frailty May Identify Older Patients Who Do Not Benefit From Implantable Cardioverter-Defibrillators: A Systematic Review
UR  - <Go to ISI>://WOS:000402876300702
VL  - 65
ID  - 62
ER  - 

TY  - JOUR
AB  - Background The genetic risk factors for susceptibility to chronic obstructive pulmonary disease (COPD) are still largely unknown. Additional genetic variants are likely to be identified by genome-wide association studies in larger cohorts or specific subgroups. We sought to identify risk loci for moderate to severe and severe COPD with data from several cohort studies. Methods We combined genome-wide association analysis data from participants in the COPDGene study (non-Hispanic white and African-American ethnic origin) and the ECLIPSE, NETT/NAS, and Norway GenKOLS studies (self-described white ethnic origin). We did analyses comparing control individuals with individuals with moderate to severe COPD and with a subset of individuals with severe COPD. Single nucleotide polymorphisms yielding a p value of less than 5x10(-7) in the meta-analysis at loci not previously described were genotyped in individuals from the family-based ICGN study. We combined results in a joint meta-analysis (threshold for significance p<5x10(-8)). Findings Analysis of 6633 individuals with moderate to severe COPD and 5704 control individuals confirmed association at three known loci: CHRNA3 (p=6.38x10(-14)), FAM13A (p=1.12x10(-14)), and HHIP (p=1.57x10(-12)). We also showed significant evidence of association at a novel locus near RIN3 (p=5.25x10(-9)). In the overall meta-analysis (ie, including data from 2859 ICGN participants), the association with RIN3 remained significant (p=5.4x10(-9)). 3497 individuals were included in our analysis of severe COPD. The effect estimates for the loci near HHIP and CHRNA3 were significantly stronger in severe disease than in moderate to severe disease (p<0.01). We also identified associations at two additional loci: MMP12 (overall joint meta-analysis p=2.6x10(-9)) and TGFB2 (overall joint meta-analysis p=8.3x10(-9)). Interpretation We have confirmed associations with COPD at three known loci and identified three new genome-wide significant associations. Genetic variants other than in alpha-1 antitrypsin increase the risk of COPD.
AD  - [Cho, Michael H.; McDonald, Merry-Lynn N.; Zhou, Xiaobo; Mattheisen, Manuel; Castaldi, Peter J.; Hersh, Craig P.; DeMeo, Dawn L.; Sylvia, Jody S.; Ziniti, John; Litonjua, Augusto A.; Silverman, Edwin K.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA. [Cho, Michael H.; Zhou, Xiaobo; Hersh, Craig P.; DeMeo, Dawn L.; Litonjua, Augusto A.; Silverman, Edwin K.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA. [Mattheisen, Manuel; Laird, Nan M.; Lange, Christoph] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA. [Sparrow, David] Boston Univ, Sch Publ Hlth, Boston, MA USA. [Sparrow, David] Boston Univ, Sch Med, Boston, MA 02118 USA. [Sparrow, David] Vet Adm Boston Healthcare Syst, Boston, MA USA. [Casaburi, Richard] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA. [Barr, R. Graham] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA. [Barr, R. Graham] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA. [Regan, Elizabeth A.; Make, Barry J.; Crapo, James D.] Natl Jewish Hlth, Denver, CO USA. [Regan, Elizabeth A.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA. [Lutz, Sharon] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Bioinformat & Stat, Aurora, CO USA. [Dudenkov, Tanda Murray; Farzadegan, Homayoon; Hetmanski, Jacqueline B.; Beaty, Terri H.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA. [Tal-Singer, Ruth] GlaxoSmithKline Res & Dev Ltd, King Of Prussia, PA USA. [Lomas, David A.] UCL, London, England. [Bakke, Per; Gulsvik, Amund] Univ Bergen, Dept Clin Sci, Bergen, Norway. [Bakke, Per; Gulsvik, Amund] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway.
Cho, MH (reprint author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
remhc@channing.harvard.edu
AN  - WOS:000336715100019
AU  - Cho, M. H.
AU  - McDonald, M. L. N.
AU  - Zhou, X. B.
AU  - Mattheisen, M.
AU  - Castaldi, P. J.
AU  - Hersh, C. P.
AU  - DeMeo, D. L.
AU  - Sylvia, J. S.
AU  - Ziniti, J.
AU  - Laird, N. M.
AU  - Lange, C.
AU  - Litonjua, A. A.
AU  - Sparrow, D.
AU  - Casaburi, R.
AU  - Barr, R. G.
AU  - Regan, E. A.
AU  - Make, B. J.
AU  - Hokanson, J. E.
AU  - Lutz, S.
AU  - Dudenkov, T. M.
AU  - Farzadegan, H.
AU  - Hetmanski, J. B.
AU  - Tal-Singer, R.
AU  - Lomas, D. A.
AU  - Bakke, P.
AU  - Gulsvik, A.
AU  - Crapo, J. D.
AU  - Silverman, E. K.
AU  - Beaty, T. H.
AU  - Genetics, Nett
AU  - Icgn
AU  - Eclipse
AU  - Investigators, C. OPDGene
DA  - Mar
DO  - 10.1016/s2213-2600(14)70002-5
IS  - 3
J2  - Lancet Resp. Med.
KW  - hedgehog-interacting protein
bronchial epithelial-cells
air-flow
obstruction
cigarette-smoking
lung-function
matrix
metalloproteinase-12
genetic epidemiology
severe emphysema
common
variants
copd
General & Internal Medicine
Respiratory System
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AI2VB
Times Cited: 144
Cited Reference Count: 106
Cho, Michael H. McDonald, Merry-Lynn N. Zhou, Xiaobo Mattheisen, Manuel Castaldi, Peter J. Hersh, Craig P. DeMeo, Dawn L. Sylvia, Jody S. Ziniti, John Laird, Nan M. Lange, Christoph Litonjua, Augusto A. Sparrow, David Casaburi, Richard Barr, R. Graham Regan, Elizabeth A. Make, Barry J. Hokanson, John E. Lutz, Sharon Dudenkov, Tanda Murray Farzadegan, Homayoon Hetmanski, Jacqueline B. Tal-Singer, Ruth Lomas, David A. Bakke, Per Gulsvik, Amund Crapo, James D. Silverman, Edwin K. Beaty, Terri H.
Mattheisen, Manuel/S-3725-2019; Coxson, Harvey/A-9861-2017; Mattheisen, Manuel/B-4949-2012; Mattheisen, Manuel/Z-1428-2019
Mattheisen, Manuel/0000-0002-8442-493X; Coxson, Harvey/0000-0001-5750-9711; Mattheisen, Manuel/0000-0002-8442-493X; MacNee, William/0000-0002-3692-1448; Comellas, Alejandro/0000-0003-1521-7520; Vestbo, Jorgen/0000-0001-6355-6362
US National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); Alpha-1 Foundation; COPD Foundation through AstraZeneca; COPD Foundation through Boehringer Ingelheim; COPD Foundation through Novartis; COPD Foundation through Sepracor; GlaxoSmithKlineGlaxoSmithKline; Centers for Medicare and Medicaid Services; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality; US Department of Veterans AffairsUS Department of Veteran Affairs; Medical Research CouncilMedical Research Council UK (MRC) [G0901786]
US National Heart, Lung, and Blood Institute; the Alpha-1 Foundation; the COPD Foundation through contributions from AstraZeneca, Boehringer Ingelheim, Novartis, and Sepracor; GlaxoSmithKline; Centers for Medicare and Medicaid Services; Agency for Healthcare Research and Quality; and US Department of Veterans Affairs.
149
2
44
Elsevier sci ltd
Oxford
PY  - 2014
SN  - 2213-2600
SP  - 214-225
ST  - Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis
T2  - Lancet Respiratory Medicine
TI  - Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis
UR  - <Go to ISI>://WOS:000336715100019
VL  - 2
ID  - 146
ER  - 

TY  - JOUR
AB  - Objective: To determine the effect of skin-to-skin mother-infant holding, touch, and/or massage on full-term, healthy newborns and their primary caregivers. Data Sources: A seven-member scientific advisory panel searched the databases PubMed, CINAHL, and Scopus using the search terms massage, skin-to-skin contact, kangaroo care, touch, therapeutic touch, and full-term newborns for research with human participants published in English with no date parameters. Study Selection: The initial search yielded 416 articles. After reviewing titles and retaining only articles that met the review criteria, 280 articles remained. The panel co-chairs reviewed and discussed the abstracts of these articles and retained 90 for review. Data Extraction: Each article was assigned to one panel member and one co-chair for review. Members of the panel met via teleconference to present articles and to determine whether they had scientific merit and addressed the research question. Articles that did not meet these standards were eliminated. Forty articles included relevant evidence: 33 articles on skin-to-skin holding and 7 on infant massage. Data Synthesis: We created a table that included the purpose, design, and findings of each study. This information was synthesized into a feasibility report by the co-chairs. Conclusion: Evidence supports recommendations for skin-to-skin care for all full-term, healthy newborns. Although there is inadequate evidence to recommend massage as standard care for all newborns, massage has been shown to help consolidate sleep patterns and reduce jaundice.
AD  - [Cleveland, Lisa] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA. [Hill, Catherine M.] Assoc Womens Hlth Obstetr & Neonatal Nurses, 1800 M St NW,Ste 740, Washington, DC 20036 USA. [Pulse, Wendi Strauss] Kaiser Permanente, Nursing Practice, Aurora, CO USA. [DiCioccio, Heather Condo] Cleveland Clin Hillcrest Hosp, Mother Baby Unit, Mayfield, OH USA. [Field, Tiffany] Univ Miami, Miller Sch Med, Touch Res Inst, Miami, FL 33136 USA. [White-Traut, Rosemary] Childrens Hosp Wisconsin, Nursing Res, Milwaukee, WI 53201 USA. [White-Traut, Rosemary] Univ Illinois, Chicago, IL USA.
Hill, CM (reprint author), Assoc Womens Hlth Obstetr & Neonatal Nurses, 1800 M St NW,Ste 740, Washington, DC 20036 USA.
chill@awhonn.org
AN  - WOS:000417111900008
AU  - Cleveland, L.
AU  - Hill, C. M.
AU  - Pulse, W. S.
AU  - DiCioccio, H. C.
AU  - Field, T.
AU  - White-Traut, R.
DA  - Nov-Dec
DO  - 10.1016/j.jogn.2017.08.005
IS  - 6
J2  - Jognn
KW  - bonding
breastfeeding
infant massage
infant touch
jaundice
maternal
attachment
newborn growth and development
skin-to-skin
thermoregulation
randomized controlled-trial
mother-infant interaction
breast-feeding
status
preterm infants
massage therapy
kangaroo care
weight-gain
underlying mechanisms
procedural pain
hospital stay
Nursing
Obstetrics & Gynecology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FO8DG
Times Cited: 5
Cited Reference Count: 85
Cleveland, Lisa Hill, Catherine M. Pulse, Wendi Strauss DiCioccio, Heather Condo Field, Tiffany White-Traut, Rosemary
Johnson and Johnson Consumer, Inc. through the Power of Touch program
Funded by Johnson and Johnson Consumer, Inc. through the Power of Touch program provided to the Association of Women's Health, Obstetric and Neonatal Nurses.
5
6
24
Elsevier science inc
New york
1552-6909
PY  - 2017
SN  - 0884-2175
SP  - 857-869
ST  - Systematic Review of Skin-to-Skin Care for Full-Term, Healthy Newborns
T2  - Jognn-Journal of Obstetric Gynecologic and Neonatal Nursing
TI  - Systematic Review of Skin-to-Skin Care for Full-Term, Healthy Newborns
UR  - <Go to ISI>://WOS:000417111900008
VL  - 46
ID  - 45
ER  - 

TY  - JOUR
AD  - [Colombo, F.; D'ascenzo, F.; Moretti, C.; Omede, P.; Gaita, F.] Univ Hosp S Giovanni Battista, Dept Cardiol, Hosp Molinette, Turin, Italy. [Fox, K. A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland. [Rumsfeld, J. S.] Denver VA Med Ctr, Denver, CO USA. [Tarantini, G.] Univ Padua, Div Cardiol, Dept Cardiac Thorac & Vasc Sci, Padua, Italy. [Biondi-Zoccai, G.] Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, I-00185 Rome, Italy.
AN  - WOS:000343001300088
AU  - Colombo, F.
AU  - D'Ascenzo, F.
AU  - Moretti, C.
AU  - Omede, P.
AU  - Fox, K. A. A.
AU  - Rumsfeld, J. S.
AU  - Tarantini, G.
AU  - Biondi-Zoccai, G.
AU  - Gaita, F.
DA  - Sep
J2  - Eur. Heart J.
KW  - Cardiovascular System & Cardiology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: AQ7MG
Times Cited: 0
Cited Reference Count: 0
Colombo, F. D'ascenzo, F. Moretti, C. Omede, P. Fox, K. A. A. Rumsfeld, J. S. Tarantini, G. Biondi-Zoccai, G. Gaita, F.
Annual Meeting of the European-Society-of-Cardiology (ESC)
Aug 30-sep 03, 2014
Barcelona, SPAIN
European Soc Cardiol
Biondi-Zoccai, Giuseppe/C-9670-2012
Biondi-Zoccai, Giuseppe/0000-0001-6103-8510; Gaita, Fiorenzo/0000-0003-3178-6205
0
Oxford univ press
Oxford
1522-9645
1
PY  - 2014
SN  - 0195-668X
SP  - 25-26
ST  - Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with pci: systematic review and meta-analysis
T2  - European Heart Journal
TI  - Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with pci: systematic review and meta-analysis
UR  - <Go to ISI>://WOS:000343001300088
VL  - 35
ID  - 136
ER  - 

TY  - JOUR
AB  - The identification of small molecules that target specific CFTR variants has ushered in a new era of treatment for cystic fibrosis (CF), yet optimal, individualized treatment of CF will require identification and targeting of disease modifiers. Here we use genome-wide association analysis to identify genetic modifiers of CF lung disease, the primary cause of mortality. Meta-analysis of 6,365 CF patients identifies five loci that display significant association with variation in lung disease. Regions on chr3q29 (MUC4/MUC20; P = 3.3 x 10(-11)), chr5p15.3 (SLC9A3; P = 6.8 x 10(-12)), chr6p21.3 (HLA Class II; P = 1.2 x 10(-8)) and chrXq22-q23 (AGTR2/SLC6A14; P = 1.8 x 10(-9)) contain genes of high biological relevance to CF pathophysiology. The fifth locus, on chr11p12-p13 (EHF/APIP; P = 1.9 x 10(-10)), was previously shown to be associated with lung disease. These results provide new insights into potential targets for modulating lung disease severity in CF.
AD  - [Corvol, Harriet; Clement, Annick; Guillot, Loic] Hop Trousseau, AP HP, Dept Pulm, F-75012 Paris, France. [Corvol, Harriet; Clement, Annick; Guillot, Loic] INSERM, U938, F-75012 Paris, France. [Corvol, Harriet; Boelle, Pierre-Yves; Clement, Annick] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France. [Blackman, Scott M.] Johns Hopkins Univ, Sch Med, Div Pediat Endocrinol, Baltimore, MD 21287 USA. [Boelle, Pierre-Yves] Hop St Antoine, AP HP, Biostat Dept, F-75012 Paris, France. [Boelle, Pierre-Yves] INSERM, U1136, F-75012 Paris, France. [Gallins, Paul J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA. [Pace, Rhonda G.; Stonebraker, Jaclyn R.; Dang, Hong; Dang, Anthony T.; Patrone, Michael V.; O'Neal, Wanda K.; Knowles, Michael R.] Univ N Carolina, Sch Med, UNC CF Res Ctr, Marsico Lung Inst, Chapel Hill, NC 27599 USA. [Accurso, Frank J.; Sontag, Marci K.] Univ Colorado Denver, Colorado Sch Publ Hlth, Anschutz Med Ctr, Dept Epidemiol, Aurora, CO 80045 USA. [Accurso, Frank J.; Sontag, Marci K.] Childrens Hosp Colorado, Anschutz Med Ctr, Aurora, CO 80045 USA. [Accurso, Frank J.; Sontag, Marci K.] Anschutz Med Ctr, Sch Med, Dept Pediat, Aurora, CO 80045 USA. [Collaco, Joseph M.] Johns Hopkins Univ, Sch Med, Div Pediat Pulmonol, Baltimore, MD 21287 USA. [Franca, Arianna; Raraigh, Karen S.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA. [Gong, Jiafen; Li, Weili; Lin, Fan; Rommens, Johanna M.; Strug, Lisa J.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada. [Keenan, Katherine; Durie, Peter R.] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON M5G 0A4, Canada. [Sun, Lei] Univ Toronto, Dept Stat Sci, Toronto, ON M5S 3G3, Canada. [Sun, Lei; Strug, Lisa J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON M5T 3M7, Canada. [Zhou, Yi-Hui; Wright, Fred A.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA. [Zhou, Yi-Hui] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA. [Levy, Hara] Northwestern Univ, Ann & Robert Lurie Childrens Hosp Chicago, Stanley Manne Res Inst, Div Pulm Med,Dept Pediat,Feinberg Sch Med, Chicago, IL 60611 USA. [Durie, Peter R.] Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada. [Rommens, Johanna M.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada. [Drumm, Mitchell L.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA. [Wright, Fred A.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA. [Wright, Fred A.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA. [Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA.
Strug, LJ (reprint author), Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada.
lisa.strug@utoronto.ca; gcutting@jhmi.edu; michael_knowles@med.unc.edu
AN  - WOS:000363136500001
AU  - Corvol, H.
AU  - Blackman, S. M.
AU  - Boelle, P. Y.
AU  - Gallins, P. J.
AU  - Pace, R. G.
AU  - Stonebraker, J. R.
AU  - Accurso, F. J.
AU  - Clement, A.
AU  - Collaco, J. M.
AU  - Dang, H.
AU  - Dang, A. T.
AU  - Franca, A.
AU  - Gong, J. F.
AU  - Guillot, L.
AU  - Keenan, K.
AU  - Li, W. L.
AU  - Lin, F.
AU  - Patrone, M. V.
AU  - Raraigh, K. S.
AU  - Sun, L.
AU  - Zhou, Y. H.
AU  - O'Neal, W. K.
AU  - Sontag, M. K.
AU  - Levy, H.
AU  - Durie, P. R.
AU  - Rommens, J. M.
AU  - Drumm, M. L.
AU  - Wright, F. A.
AU  - Strug, L. J.
AU  - Cutting, G. R.
AU  - Knowles, M. R.
C7  - 8382
DA  - Sep
DO  - 10.1038/ncomms9382
J2  - Nat. Commun.
KW  - allergic bronchopulmonary aspergillosis
methionine salvage enzyme
fetal-hemoglobin
epithelial-cells
gene
susceptibility
expression
bcl11a
thresholds
population
Science & Technology - Other Topics
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: CT9KS
Times Cited: 104
Cited Reference Count: 49
Corvol, Harriet Blackman, Scott M. Boelle, Pierre-Yves Gallins, Paul J. Pace, Rhonda G. Stonebraker, Jaclyn R. Accurso, Frank J. Clement, Annick Collaco, Joseph M. Dang, Hong Dang, Anthony T. Franca, Arianna Gong, Jiafen Guillot, Loic Keenan, Katherine Li, Weili Lin, Fan Patrone, Michael V. Raraigh, Karen S. Sun, Lei Zhou, Yi-Hui O'Neal, Wanda K. Sontag, Marci K. Levy, Hara Durie, Peter R. Rommens, Johanna M. Drumm, Mitchell L. Wright, Fred A. Strug, Lisa J. Cutting, Garry R. Knowles, Michael R.
Guillot, Loic/D-8893-2011; Corvol, Harriet/N-5922-2018
Guillot, Loic/0000-0001-6853-7945; Corvol, Harriet/0000-0002-7026-7523; Patrone, Michael/0000-0002-7519-794X; Zhou, Yi-Hui/0000-0002-4092-7463
National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1DP2OD007031, R01HL068890, R01HL095396, R01HL68927]; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1R01DK61886-01, K23DK083551, P30DK079637]; National Human Genome Research InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [R21HG007840]; Cystic Fibrosis Foundation [SONTAG07A0, KNOW-LE00A0, DRUMM0A00, CUTT00AO, CUTT06PO, COLLAC13IO]; PES Clinical Scholars Award, Schwachman [COLLACO09A0]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 258916]; Cystic Fibrosis Canada (CFC) [2626]; Genome Canada through the Ontario Genomics InstituteGenome Canada [2004-OGI-3-05]; Institut National de la Sante et de la Recherche MedicaleInstitut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique-Hopitaux de Paris; Agence Nationale de la RechercheFrench National Research Agency (ANR) [R09186DS]; Universite Pierre et Marie Curie Paris; DGS; Association Vaincre La Mucoviscidose, Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose, GIS-Institut des Maladies Rares
National Heart, Lung and Blood Institute 1DP2OD007031, R01HL068890, R01HL095396, R01HL68927; National Institute of Diabetes and Digestive and Kidney Diseases 1R01DK61886-01, K23DK083551, P30DK079637; National Human Genome Research Institute R21HG007840; Cystic Fibrosis Foundation SONTAG07A0, KNOW-LE00A0, DRUMM0A00, CUTT00AO, CUTT06PO, COLLAC13IO; PES Clinical Scholars Award, Schwachman (COLLACO09A0); Canadian Institutes of Health Research (MOP 258916), Cystic Fibrosis Canada (CFC; #2626), Genome Canada through the Ontario Genomics Institute (2004-OGI-3-05); Institut National de la Sante et de la Recherche Medicale, Assistance Publique-Hopitaux de Paris, Universite Pierre et Marie Curie Paris, Agence Nationale de la Recherche (R09186DS), DGS, Association Vaincre La Mucoviscidose, Chancellerie des Universites (Legs Poix), Association Agir Informer Contre la Mucoviscidose, GIS-Institut des Maladies Rares. Genome-wide genotyping of subjects in North America provided by the US and CFC Foundations. We thank the US CF Foundation for the use of CF Foundation Patient Registry data. We thank the patients, care providers and clinic coordinators at CF Centers throughout the US and Canada (see list in Supplementary Information) for their contributions to the CF Foundation Patient Registry and Canadian Gene Modifier Study. We thank the following: P-F. Busson, J-F. Vibert, A. Blondel, P. Touche (French study design/patient recruitment); R. Bersie, M. Reske (Children's Hospitals of Wisconsin and Boston data collection); M. Anthony (Denver study design/patient recruitment); P. Diaz, S. Norris (UNC recruitment); A. Infanzon (UNC editorial assistance); H. Kelkar, A. Xu (UNC bioinformatics); W. Wolf (UNC genotyping); Canadian Genome Sequencing Resource for CF; M. Corey, R. Dorfman, A. Sandford, P. Pare, Y. Berthiaume (CGS recruitment); P. Hu (genotype calling/quality control, The Centre for Applied Genomics, The Hospital for Sick Children); K. Naughton, P. Cornwall, B. Vecchio (TSS recruitment/data analysis). We also acknowledge the contributions of our dear colleague, the late Dr. Julian Zielenski.
105
0
21
Nature publishing group
London
PY  - 2015
SN  - 2041-1723
SP  - 8
ST  - Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
T2  - Nature Communications
TI  - Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
UR  - <Go to ISI>://WOS:000363136500001
VL  - 6
ID  - 107
ER  - 

TY  - JOUR
AD  - [Costello, James C.; Powers, Rani; Goodspeed, Andrew; Cramer, Scott D.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA.
AN  - WOS:000468819502523
AU  - Costello, J. C.
AU  - Powers, R.
AU  - Goodspeed, A.
AU  - Cramer, S. D.
DA  - Jul
DO  - 10.1158/1538-7445.Am2018-4332
IS  - 13
J2  - Cancer Res.
KW  - Oncology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: HZ4LO
Times Cited: 0
Cited Reference Count: 0
Costello, James C. Powers, Rani Goodspeed, Andrew Cramer, Scott D.
Annual Meeting of the American-Association-for-Cancer-Research (AACR)
Apr 14-18, 2018
Chicago, IL
Amer Assoc Canc Res
0
Amer assoc cancer research
Philadelphia
1538-7445
S
PY  - 2018
SN  - 0008-5472
SP  - 2
ST  - Meta-analysis of molecular features associated with aggressive prostate cancer
T2  - Cancer Research
TI  - Meta-analysis of molecular features associated with aggressive prostate cancer
UR  - <Go to ISI>://WOS:000468819502523
VL  - 78
ID  - 13
ER  - 

TY  - JOUR
AB  - Background: It has yet to be established whether gender moderates or predicts outcome of psychological and pharmacological treatments for adult depression because: (1) individual randomized trials typically lack sufficient statistical power to detect moderators and predictors and (2) meta-analyses cannot examine such associations directly. Methods: We conducted an "individual patient data" meta-analysis with the primary data of 1,766 patients from 14 eligible randomized trials comparing cognitive behavior therapy (CBT) with pharmacotherapy. Five studies also compared CBT and pharmacotherapy with pill placebo. We examined the extent to which gender moderates or predicts outcome, using the Hamilton Rating Scale for Depression-17-item (HAM-D-17), with mixed effects models. Results: Despite the high statistical power, we did not find any indication (P > 0.05) that gender moderates outcome (i.e., no indication that either men or women respond better or worse to CBT than to pharmacotherapy or vice versa). Gender was neither a nonspecific predictor (indicating whether gender is related to improvement, regardless of comparison or control groups), nor a specific predictor (predicting outcome of CBT and pharmacotherapy compared to pill placebo). The average differences between men and women within three conditions (CBT, pharmacotherapy, and pill placebo) were less than one point on the HAM-D-17. Conclusions: The lack of predictive relations in a this good sized sample suggests that gender does not moderate differential response to CBT versus medication treatment and that it neither predicts nonspecific response across the treatments nor the specificity of response for either treatment with respect to pill placebo. (C) 2014 Wiley Periodicals, Inc.
AD  - [Cuijpers, Pim; Weitz, Erica] Vrije Univ Amsterdam, Dept Clin Psychol, NL-1081 BT Amsterdam, Netherlands. [Cuijpers, Pim; Weitz, Erica; Twisk, Jos] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands. [Kuehner, Christine] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Mannheim, Germany. [Cristea, Ioana; David, Daniel] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania. [DeRubeis, Robert J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA. [Dimidjian, Sona] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA. [Dunlop, Boadie W.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA. [Faramarzi, Mahbobeh; Kheirkhah, Farzan] Babol Univ Med Sci, Fatemeh Zahra Infertil & Reprod Hlth Res Ctr, Babol Sar, Iran. [Hegerl, Ulrich; Mergl, Roland] Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany. [Jarrett, Robin B.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA. [Kennedy, Sidney H.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada. [Miranda, Jeanne] Univ Calif Los Angeles, Inst Neuropsychiat, Hlth Serv Res Ctr, Los Angeles, CA 90024 USA. [Mohr, David C.] Northwestern Univ, Feinberg Sch Med, Ctr Behav Intervent Technol, Chicago, IL 60611 USA. [Segal, Zindel V.] Univ Toronto Scarborough, Dept Psychol, Toronto, ON, Canada. [Siddique, Juned] Northwestern Univ, Feinberg Sch Med, Dept Preventat Med, Chicago, IL 60611 USA. [Simons, Anne D.] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA. [Vittengl, Jeffrey R.] Truman State Univ, Kirksville, MO USA. [Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.
Cuijpers, P (reprint author), Vrije Univ Amsterdam, Dept Clin Psychol, Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.
p.cuijpers@vu.nl
AN  - WOS:000345321500010
AU  - Cuijpers, P.
AU  - Weitz, E.
AU  - Twisk, J.
AU  - Kuehner, C.
AU  - Cristea, I.
AU  - David, D.
AU  - DeRubeis, R. J.
AU  - Dimidjian, S.
AU  - Dunlop, B. W.
AU  - Faramarzi, M.
AU  - Hegerl, U.
AU  - Jarrett, R. B.
AU  - Kennedy, S. H.
AU  - Kheirkhah, F.
AU  - Mergl, R.
AU  - Miranda, J.
AU  - Mohr, D. C.
AU  - Segal, Z. V.
AU  - Siddique, J.
AU  - Simons, A. D.
AU  - Vittengl, J. R.
AU  - Hollon, S. D.
DA  - Nov
DO  - 10.1002/da.22328
IS  - 11
J2  - Depress. Anxiety
KW  - gender
meta-analysis
cognitive-behavior therapy
pharmacotherapy
major depressive disorder
major depression
randomized-trial
women
medication
psychotherapy
disorder
men
Psychology
Psychiatry
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AU0OB
Times Cited: 34
Cited Reference Count: 42
Cuijpers, Pim Weitz, Erica Twisk, Jos Kuehner, Christine Cristea, Ioana David, Daniel DeRubeis, Robert J. Dimidjian, Sona Dunlop, Boadie W. Faramarzi, Mahbobeh Hegerl, Ulrich Jarrett, Robin B. Kennedy, Sidney H. Kheirkhah, Farzan Mergl, Roland Miranda, Jeanne Mohr, David C. Segal, Zindel V. Siddique, Juned Simons, Anne D. Vittengl, Jeffrey R. Hollon, Steven D.
Dunlop, Boadie/N-3362-2017; Faramarzi, mahbobeh/I-8814-2016; Cuijpers, Pim/G-1703-2013; Cristea, Ioana Alina/E-7490-2011
Dunlop, Boadie/0000-0002-4653-0483; Cristea, Ioana Alina/0000-0002-9854-7076; DeRubeis, Robert/0000-0003-3129-0277; Hegerl, Ulrich/0000-0002-3039-7470; Faramarzi, Mahbobeh/0000-0002-3568-7039; kheirkha, farzan/0000-0003-1420-5480; Cuijpers, Pim/0000-0001-5497-2743; Mohr, David/0000-0002-5443-7596
ZonMwNetherlands Organization for Health Research and Development; European CommissionEuropean Commission Joint Research Centre; NutsOhra Foundation; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Center for Minority Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD); National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); Center for Medicare and Medicaid Services (CMS); Patient Centered Outcomes Research Institute (PCORI); Commonwealth of Pennsylvania; John A Hartford Foundation; National Palliative Care Research Center (NPCRC); Clinical and Translational Science Institute (CTSI); American Foundation for Suicide Prevention; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P60 MD000207, P30 MH090333, UL1RR024153, UL1TR000005]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH60998, MH60713, MH01697]
Contract grant sponsors: ZonMw, the European Commission; NutsOhra Foundation; Contract grant sponsors: National Institute of Mental Health; National Institute on Aging; National Center for Minority Health Disparities; National Heart Lung and Blood Institute; Center for Medicare and Medicaid Services (CMS); Patient Centered Outcomes Research Institute (PCORI); Commonwealth of Pennsylvania; John A Hartford Foundation; National Palliative Care Research Center (NPCRC); Clinical and Translational Science Institute (CTSI); American Foundation for Suicide Prevention; Contract grant sponsors: National Institutes of Health; Contract grant numbers: P60 MD000207; P30 MH090333; UL1RR024153; UL1TR000005; Contract grant sponsor: NIMH; Contract grant number: MH60998; Contract grant sponsor: NIMH; Contract grant numbers: MH60713; MH01697.
37
1
48
Wiley
Hoboken
1520-6394
PY  - 2014
SN  - 1091-4269
SP  - 941-951
ST  - GENDER AS PREDICTOR AND MODERATOR OF OUTCOME IN COGNITIVE BEHAVIOR THERAPY AND PHARMACOTHERAPY FOR ADULT DEPRESSION: AN "INDIVIDUAL PATIENT DATA" META-ANALYSIS
T2  - Depression and Anxiety
TI  - GENDER AS PREDICTOR AND MODERATOR OF OUTCOME IN COGNITIVE BEHAVIOR THERAPY AND PHARMACOTHERAPY FOR ADULT DEPRESSION: AN "INDIVIDUAL PATIENT DATA" META-ANALYSIS
UR  - <Go to ISI>://WOS:000345321500010
VL  - 31
ID  - 131
ER  - 

TY  - JOUR
AD  - [Darras, Basil] Harvard Med Sch, Childrens Hosp Boston, Boston, MA USA. [Riebling, Peter; O'Mara, Edward; Elfring, Gary; Luo, Xiaohui; Trifillis, Panayiota; McIntosh, Joseph; Santos, Claudio] PTC Therapeut Inc, South Plainfield, NJ USA. [Parsons, Julie] Childrens Hosp Colorado, Aurora, CO USA. [Shieh, Perry B.] Univ Calif Los Angeles, Los Angeles, CA USA. [Apkon, Susan] Seattle Childrens Hosp, Seattle, WA USA. [Campbell, Craig] Childrens Hosp London, Hlth Sci Ctr, London, ON, Canada. [McDonald, Craig] UC Davis, Dept PM&R, Sacramento, CA USA.
AN  - WOS:000453090801297
AU  - Darras, B.
AU  - Riebling, P.
AU  - O'Mara, E.
AU  - Elfring, G.
AU  - Luo, X. H.
AU  - Trifillis, P.
AU  - McIntosh, J.
AU  - Santos, C.
AU  - Parsons, J.
AU  - Shieh, P. B.
AU  - Apkon, S.
AU  - Campbell, C.
AU  - McDonald, C.
DA  - Apr
J2  - Neurology
KW  - Neurosciences & Neurology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: HE2FF
Times Cited: 0
Cited Reference Count: 0
Darras, Basil Riebling, Peter O'Mara, Edward Elfring, Gary Luo, Xiaohui Trifillis, Panayiota McIntosh, Joseph Santos, Claudio Parsons, Julie Shieh, Perry B. Apkon, Susan Campbell, Craig McDonald, Craig
70th Annual Meeting of the American-Academy-of-Neurology (AAN)
Apr 21-27, 2018
Los Angeles, CA
Amer Acad Neurol
PTC Therapeutics, Inc
0
Lippincott williams & wilkins
Philadelphia
1526-632x
15
PY  - 2018
SN  - 0028-3878
SP  - 3
ST  - Meta-Analysis of Deflazacort vs Prednisone/Prednisolone in Patients with Duchenne Muscular Dystrophy
T2  - Neurology
TI  - Meta-Analysis of Deflazacort vs Prednisone/Prednisolone in Patients with Duchenne Muscular Dystrophy
UR  - <Go to ISI>://WOS:000453090801297
VL  - 90
ID  - 21
ER  - 

TY  - JOUR
AD  - [Desai, Madhav; Nutalapati, Venkat; Pant, Chaitanya; Kanakadandi, Vijay; Bansal, Ajay; Rastogi, Amit; Olyaee, Mojtaba S.] Univ Kansas, Med Ctr, Gastroenterol & Hepatol, Kansas City, KS 66103 USA. [Saligram, Shreyas] UCSF Fresno, Gastroenterol, Fresno, CA USA. [Saligram, Shreyas] VA Cent Calif Healthcare Syst, Fresno, CA USA. [Wani, Sachin B.] Univ Colorado, Gastroenterol, Aurora, CO USA.
AN  - WOS:000403087401035
AU  - Desai, M.
AU  - Nutalapati, V.
AU  - Saligram, S.
AU  - Pant, C.
AU  - Kanakadandi, V.
AU  - Bansal, A.
AU  - Wani, S. B.
AU  - Rastogi, A.
AU  - Olyaee, M. S.
DA  - May
DO  - 10.1016/j.gie.2017.03.838
IS  - 5
J2  - Gastrointest. Endosc.
KW  - Gastroenterology & Hepatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: EX2VK
Times Cited: 0
Cited Reference Count: 0
Desai, Madhav Nutalapati, Venkat Saligram, Shreyas Pant, Chaitanya Kanakadandi, Vijay Bansal, Ajay Wani, Sachin B. Rastogi, Amit Olyaee, Mojtaba S.
Digestive Disease Week
May 06-09, 2017
Chicago, IL
Asge
Desai, Madhav/H-3755-2019
Desai, Madhav/0000-0001-8871-3627
0
1
Mosby-elsevier
New york
1097-6779
S
PY  - 2017
SN  - 0016-5107
SP  - AB362-AB362
ST  - Improved Overall Adenoma Detection Rate and Sessile Serrated Adenoma Detection Rate With Endocuff: A Systematic Review and Meta-Analysis
T2  - Gastrointestinal Endoscopy
TI  - Improved Overall Adenoma Detection Rate and Sessile Serrated Adenoma Detection Rate With Endocuff: A Systematic Review and Meta-Analysis
UR  - <Go to ISI>://WOS:000403087401035
VL  - 85
ID  - 61
ER  - 

TY  - JOUR
AB  - Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for Allergic Asthma. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic asthma. Methods: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised. Discussion: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.
AD  - [Dhami, Sangeeta] Evidence Based Hlth Care Ltd, Edinburgh, Midlothian, Scotland. [Nurmatov, Ulugbek] Abacus Int, Systemat Review Decis Resources Grp, Oxford, England. [Agache, Ioana] Transylvania Univ Brasov, Dept Allergy & Clin Immunol, Fac Med, Brasov, Romania. [Lau, Susanne] Charite Med Univ, Dept Pediat Pneumol & Immunol, Berlin, Germany. [Muraro, Antonella] Univ Hosp Padua, Food Allergy Referral Ctr Veneto Reg, Padua, Italy. [Jutel, Marek] Wroclaw Med Univ, Wroclaw, Poland. [Roberts, Graham] Univ Hosp Southampton NHS Fdn Trust, David Hide Asthma & Allergy Res Ctr, St Marys Hosp, NIHR Resp Biomed Res Unit, Southampton, Hants, England. [Roberts, Graham] Univ Southampton, Fac Med, Southampton, Hants, England. [Akdis, Cezmi] Swiss Inst Allergy & Asthma Res, Davos, Switzerland. [Bonini, Matteo] Sapienza Univ Rome, Rome, Italy. [Calderon, Moises] Imperial Coll, Natl Heart & Lung Inst, London, England. [Casale, Thomas] Univ S Florida, Tampa, FL USA. [Cavkaytar, Ozlem] Sami Ulus Matern & Children Training & Res Hosp, Dept Allergy & Clin Immunol, Ankara, Turkey. [Cox, Linda] Nova Southeastern Univ, Ft Lauderdale, FL USA. [Demoly, Pascal] Univ Montpellier, Montpellier, France. [Demoly, Pascal] Hosp Montpellier, Montpellier, France. [Demoly, Pascal] Inserm Paris Sorbonnes, Montpellier, France. [Flood, Breda] European Federat Allergy & Airways Dis Patients A, Brussels, Belgium. [Hamelmann, Eckard] EvKB, Childrens Ctr Bethel, Bieledelf, Germany. [Hamelmann, Eckard] Ruhr Univ, Allergy Ctr, Bochum, Germany. [Izuhara, Kenji] Saga Med Sch, Saga, Japan. [Kalayci, Omer] Hacettepe Univ, Ankara, Turkey. [Kleine-Tebbe, Jorg] Allergy & Asthma Ctr Westend AAZW, Berlin, Germany. [Nieto, Antonio] Childrens Hosp La Fe, Valencia, Spain. [Papadopoulos, Nikolaos] Univ Athens, Dept Allergy, Pediat Clin 2, Athens, Greece. [Pfaar, Oliver] Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany. [Pfaar, Oliver] Ctr Rhinol & Allergol, Wiesbaden, Germany. [Rosenwasser, Lanny] Childrens Mercy Hosp, Kentucky, MO USA. [Ryan, Dermot] Univ Edinburgh, Edinburgh, Midlothian, Scotland. [Schmidt-Weber, Carsten] Tech Univ, Munich, Germany. [Schmidt-Weber, Carsten] Helmholtz Ctr Munich, Munich, Germany. [Szefler, Stan] Univ Colorado, Childrens Hosp Colorado, Sch Med, Aurora, CO USA. [Wahn, Ulrich] Charite, Dept Pediat Pulmonol, Berlin, Germany. [van Wijk, Roy-Gerth] Erasmus MC, Sect Allergol, Dept Internal Med, Rotterdam, Netherlands. [Wilkinson, Jamie] European Union, Pharmaceut Grp, Brussels, Belgium. [Sheikh, Aziz] Univ Edinburgh, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland.
Dhami, S (reprint author), Evidence Based Hlth Care Ltd, Edinburgh, Midlothian, Scotland.
sangeetadhami@hotmail.com
AN  - WOS:000390112200001
AU  - Dhami, S.
AU  - Nurmatov, U.
AU  - Agache, I.
AU  - Lau, S.
AU  - Muraro, A.
AU  - Jutel, M.
AU  - Roberts, G.
AU  - Akdis, C.
AU  - Bonini, M.
AU  - Calderon, M.
AU  - Casale, T.
AU  - Cavkaytar, O.
AU  - Cox, L.
AU  - Demoly, P.
AU  - Flood, B.
AU  - Hamelmann, E.
AU  - Izuhara, K.
AU  - Kalayci, O.
AU  - Kleine-Tebbe, J.
AU  - Nieto, A.
AU  - Papadopoulos, N.
AU  - Pfaar, O.
AU  - Rosenwasser, L.
AU  - Ryan, D.
AU  - Schmidt-Weber, C.
AU  - Szefler, S.
AU  - Wahn, U.
AU  - van Wijk, R. G.
AU  - Wilkinson, J.
AU  - Sheikh, A.
C7  - 5
DA  - Feb
DO  - 10.1186/s13601-016-0094-y
J2  - Clin. Transl. Allergy
KW  - Allergy
Allergic asthma
Allergen immunotherapy
Disease-modifying
Respiratory allergy
Allergy
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: EF1VE
Times Cited: 12
Cited Reference Count: 10
Dhami, Sangeeta Nurmatov, Ulugbek Agache, Ioana Lau, Susanne Muraro, Antonella Jutel, Marek Roberts, Graham Akdis, Cezmi Bonini, Matteo Calderon, Moises Casale, Thomas Cavkaytar, Ozlem Cox, Linda Demoly, Pascal Flood, Breda Hamelmann, Eckard Izuhara, Kenji Kalayci, Omer Kleine-Tebbe, Jorg Nieto, Antonio Papadopoulos, Nikolaos Pfaar, Oliver Rosenwasser, Lanny Ryan, Dermot Schmidt-Weber, Carsten Szefler, Stan Wahn, Ulrich van Wijk, Roy-Gerth Wilkinson, Jamie Sheikh, Aziz
Demoly, Pascal/Y-9938-2019; DR. FARID, S.H. M.H. M.Kn, DR. FARID SALIM SEFF, S.H. M.H. M.Kn./O-7277-2017
Demoly, Pascal/0000-0001-7827-7964; DR. FARID, S.H. M.H. M.Kn, DR. FARID SALIM SEFF, S.H. M.H. M.Kn./0000-0003-0372-4963; Lau, Susanne/0000-0002-5189-4265; Schmidt-Weber, Carsten B./0000-0002-3203-8084; BONINI, Matteo/0000-0002-3042-0765
Eaaci
Eaaci.
12
2
6
Bmc
London
2045-7022
PY  - 2016
SP  - 5
ST  - Allergen immunotherapy for allergic asthma: protocol for a systematic review
T2  - Clinical and Translational Allergy
TI  - Allergen immunotherapy for allergic asthma: protocol for a systematic review
UR  - <Go to ISI>://WOS:000390112200001
VL  - 6
ID  - 91
ER  - 

TY  - JOUR
AD  - [Dhami, Sangeeta] Evidence Based Hlth Care Ltd, Edinburgh, Midlothian, Scotland. [Nurmatov, Ulugbek] Systemat Review Decis Resources Grp Abacus Int, Oxford, England. [Agache, Ioana] Transylvania Univ Brasov, Fac Med, Dept Allergy & Clin Immunol, Brasov, Romania. [Lau, Susanne] Charite Med Univ, Dept Pediat Pneumol & Immunol, Berlin, Germany. [Muraro, Antonella] Univ Hosp Padua, Food Allergy Referral Ctr Veneto Reg, Padua, Italy. [Jutel, Marek] Wroclaw Med Univ, Wroclaw, Poland. [Roberts, Graham] Univ Hosp Southampton NHS Fdn, NIHR Resp Biomed Res Unit, David Hide Asthma & Allergy Res Ctr, St Marys Hosp, Southampton, Hants, England. [Roberts, Graham] Univ Southampton, Fac Med, Southampton, Hants, England. [Akdis, Cezmi] Swiss Inst Allergy & Asthma Res, Davos, Switzerland. [Bonini, Matteo] Sapienza Univ Rome, Rome, Italy. [Calderon, Moises] Imperial Coll, Natl Heart & Lung Inst, London, England. [Casale, Thomas] Univ S Florida, Tampa, FL USA. [Cavkaytar, Ozlem] Sami Ulus Matern & Children Training & Res Hosp, Dept Allergy & Clin Immunol, Ankara, Turkey. [Cox, Linda] Nova Southeastern Univ, Ft Lauderdale, FL USA. [Demoly, Pascal] Univ & Hosp Montpellier, Montpellier, France. [Demoly, Pascal] Inserm Paris Sorbonnes, Montpellier, France. [Flood, Breda] European Federat Allergy & Airways Dis Patients A, Brussels, Belgium. [Hamelmann, Eckard] Childrens Ctr Bethel, EvKB, Bieledelf, Germany. [Hamelmann, Eckard] Ruhr Univ, Allergy Ctr, Bochum, Germany. [Izuhara, Kenji] Saga Med Sch, Saga, Japan. [Kalayci, Omer] Hacettepe Univ, Ankara, Turkey. [Kleine-Tebbe, Jorg] Allergy & Asthma Ctr Westend AAZW, Berlin, Germany. [Nieto, Antonio] Childrens Hosp La Fe, Valencia, Spain. [Papadopoulos, Nikolaos] Univ Athens, Pediat Clin 2, Dept Allergy, Athens, Greece. [Pfaar, Oliver] Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany. [Pfaar, Oliver] Ctr Rhinol & Allergol, Wiesbaden, Germany. [Rosenwasser, Lanny] Childrens Mercy Hosp, Kentucky, MO USA. [Ryan, Dermot] Univ Edinburgh, Edinburgh, Midlothian, Scotland. [Schmidt-Weber, Carsten] Tech Univ, Munich, Germany. [Schmidt-Weber, Carsten] Helmholtz Ctr Munich, Munich, Germany. [Szefler, Stan] Univ Colorado, Sch Med, Childrens Hosp Colorado, Aurora, CO USA. [Wahn, Ulrich] Charite, Dept Pediat Pulmonol, Berlin, Germany. [van Wijk, Roy-Gerth] Erasmus MC, Sect Allergol, Dept Internal Med, Rotterdam, Netherlands. [Wilkinson, Jamie] European Union, Pharmaceut Grp, Brussels, Belgium. [Sheikh, Aziz] Univ Edinburgh, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland.
Dhami, S (reprint author), Evidence Based Hlth Care Ltd, Edinburgh, Midlothian, Scotland.
sangeetadhami@hotmail.com
AN  - WOS:000411014200004
AU  - Dhami, S.
AU  - Nurmatov, U.
AU  - Agache, I.
AU  - Lau, S.
AU  - Muraro, A.
AU  - Jutel, M.
AU  - Roberts, G.
AU  - Akdis, C.
AU  - Bonini, M.
AU  - Calderon, M.
AU  - Casale, T.
AU  - Cavkaytar, O.
AU  - Cox, L.
AU  - Demoly, P.
AU  - Flood, B.
AU  - Hamelmann, E.
AU  - Izuhara, K.
AU  - Kalayci, O.
AU  - Kleine-Tebbe, J.
AU  - Nieto, A.
AU  - Papadopoulos, N.
AU  - Pfaar, O.
AU  - Rosenwasser, L.
AU  - Ryan, D.
AU  - Schmidt-Weber, C.
AU  - Szefler, S.
AU  - Wahn, U.
AU  - van Wijk, R. G.
AU  - Wilkinson, J.
AU  - Sheikh, A.
C7  - 32
DA  - Sep
DO  - 10.1186/s13601-017-0167-6
J2  - Clin. Transl. Allergy
KW  - Allergy
LA  - English
M3  - Correction
N1  - ISI Document Delivery No.: FH3AB
Times Cited: 0
Cited Reference Count: 1
Dhami, Sangeeta Nurmatov, Ulugbek Agache, Ioana Lau, Susanne Muraro, Antonella Jutel, Marek Roberts, Graham Akdis, Cezmi Bonini, Matteo Calderon, Moises Casale, Thomas Cavkaytar, Ozlem Cox, Linda Demoly, Pascal Flood, Breda Hamelmann, Eckard Izuhara, Kenji Kalayci, Omer Kleine-Tebbe, Jorg Nieto, Antonio Papadopoulos, Nikolaos Pfaar, Oliver Rosenwasser, Lanny Ryan, Dermot Schmidt-Weber, Carsten Szefler, Stan Wahn, Ulrich van Wijk, Roy-Gerth Wilkinson, Jamie Sheikh, Aziz
EAACI; BM4SIT project in the European Union's Seventh Framework Programme FP7 [601763]
EAACI and the BM4SIT project (Grant Number 601763) in the European Union's Seventh Framework Programme FP7.
0
1
Biomed central ltd
London
PY  - 2017
SN  - 2045-7022
SP  - 1
ST  - Allergen immunotherapy for allergic asthma: protocol for a systematic review (vol 6, 5, 2016)
T2  - Clinical and Translational Allergy
TI  - Allergen immunotherapy for allergic asthma: protocol for a systematic review (vol 6, 5, 2016)
UR  - <Go to ISI>://WOS:000411014200004
VL  - 7
ID  - 51
ER  - 

TY  - JOUR
AD  - [Dunnick, C. A.; Mounessa, J.] Univ Colorado Hosp, Aurora, CO USA. [Chapman, S.] Michigan State Univ, Grand Rapids, MI USA. [Braunberger, T.] Univ North Dakota, Grand Forks, ND USA. [Qin, R.] Duke Univ, Sch Med, Durham, NC USA. [Lipoff, J. B.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA. [Dellavalle, R. P.] Eastern Colorado Hlth Care Syst, US Dept Vet Affairs, Denver, CO USA.
AN  - WOS:000406862400366
AU  - Dunnick, C. A.
AU  - Mounessa, J.
AU  - Chapman, S.
AU  - Braunberger, T.
AU  - Qin, R.
AU  - Lipoff, J. B.
AU  - Dellavalle, R. P.
DA  - May
DO  - 10.1016/j.jid.2017.02.384
IS  - 5
J2  - J. Invest. Dermatol.
KW  - Dermatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: FC5DQ
Times Cited: 0
Cited Reference Count: 0
Dunnick, C. A. Mounessa, J. Chapman, S. Braunberger, T. Qin, R. Lipoff, J. B. Dellavalle, R. P.
76th Annual Meeting of the Society-for-Investigative-Dermatology (SID)
Apr 26-29, 2017
Portland, OR
Soc Investigat Dermatol
0
1
Elsevier science inc
New york
1523-1747
PY  - 2017
SN  - 0022-202X
SP  - S63-S63
ST  - Patient and provider satisfaction with teledermatology: A systematic review
T2  - Journal of Investigative Dermatology
TI  - Patient and provider satisfaction with teledermatology: A systematic review
UR  - <Go to ISI>://WOS:000406862400366
VL  - 137
ID  - 60
ER  - 

TY  - JOUR
AB  - Background: Evidence suggests that genetic factors may influence both schizophrenia (Scz) and its clinical presentation. In recent years, genome-wide association studies (GWAS) have demonstrated considerable success in identifying risk loci. Detection of "modifier loci" has the potential to further elucidate underlying disease processes. Methods: We performed GWAS of empirically derived positive and negative symptom scales in Irish cases from multiply affected pedigrees and a larger, independent case-control sample, subsequently combining these into a large Irish meta-analysis. In addition to single-SNP associations, we considered gene-based and pathway analyses to better capture convergent genetic effects, and to facilitate biological interpretation of these findings. Replication and testing of aggregate genetic effects was conducted using an independent European-American sample. Results: Though no single marker met the genome-wide significance threshold, genes and ontologies/pathways were significantly associated with negative and positive symptoms; notably, NKAIN2 and NRG1, respectively. We observed limited overlap in ontologies/pathways associated with different symptom profiles, with immune-related categories over-represented for negative symptoms, and addiction-related categories for positive symptoms. Replication analyses suggested that genes associated with clinical presentation are generalizable to non-Irish samples. Conclusions: These findings strongly support the hypothesis that modifier loci contribute to the etiology of distinct Scz symptom profiles. The finding that previously implicated "risk loci" actually influence particular symptom dimensions has the potential to better delineate the roles of these genes in Scz etiology. Furthermore, the over-representation of distinct gene ontologies/pathways across symptom profiles suggests that the clinical heterogeneity of Scz is due in part to complex and diverse genetic factors.
AD  - [Edwards, Alexis C.; Bigdeli, Tim B.; Docherty, Anna R.; Bacanu, Silviu; Lee, Donghyung; Moscati, Arden; Thiselton, Dawn L.; Wormley, Brandon K.; Kendler, Kenneth S.; Riley, Brien P.; Fanous, Ayman H.] Virginia Commonwealth Univ, Sch Med, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, POB 980126, Richmond, VA 23298 USA. [de Candia, Teresa R.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA. [de Candia, Teresa R.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA. [Maher, Brion S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA. [Walsh, Dermot] Hlth Res Board, Dublin, Ireland. [O'Neill, Francis A.] Queens Univ Belfast, Inst Clin Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland. [Fanous, Ayman H.] Washington VA Med Ctr, Mental Hlth Serv Line, Washington, DC USA. [Fanous, Ayman H.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA. [Thiselton, Dawn L.] Hlth Diagnost Lab Inc, Richmond, VA USA.
Edwards, AC (reprint author), Virginia Commonwealth Univ, Sch Med, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, POB 980126, Richmond, VA 23298 USA.
alexis.edwards@vcuhealth.org
AN  - WOS:000376401500006
AU  - Edwards, A. C.
AU  - Bigdeli, T. B.
AU  - Docherty, A. R.
AU  - Bacanu, S.
AU  - Lee, D.
AU  - de Candia, T. R.
AU  - Moscati, A.
AU  - Thiselton, D. L.
AU  - Maher, B. S.
AU  - Wormley, B. K.
AU  - Walsh, D.
AU  - O'Neill, F. A.
AU  - Kendler, K. S.
AU  - Riley, B. P.
AU  - Fanous, A. H.
AU  - Mol Genetics Schizophrenia, Collabo
DA  - Mar
DO  - 10.1093/schbul/sbv119
IS  - 2
J2  - Schizophr. Bull.
KW  - schizophrenia
meta-analysis
clinical heterogeneity
modifier genes
negative symptoms
positive symptoms
genome-wide association
clinical symptomatology
stress granules
neuregulin-1
population
genotype
disease
dimensions
disorder
families
Psychiatry
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: DM5PG
Times Cited: 14
Cited Reference Count: 68
Edwards, Alexis C. Bigdeli, Tim B. Docherty, Anna R. Bacanu, Silviu Lee, Donghyung de Candia, Teresa R. Moscati, Arden Thiselton, Dawn L. Maher, Brion S. Wormley, Brandon K. Walsh, Dermot O'Neill, Francis A. Kendler, Kenneth S. Riley, Brien P. Fanous, Ayman H.
Fanous, Ayman/O-1263-2017
Docherty, Anna/0000-0001-7139-7007; O'Neill, Francis Anthony/0000-0002-7531-7657
National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH083094, MH068881, MH041953, AA021399, MH020030, MH016880, DA026119]; Department of Veterans AffairsUS Department of Veteran Affairs [I01 CX000278]; Wellcome TrustWellcome Trust [WTCCC-084710]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH67257, MH59588, MH59571, MH59565, MH59587, MH60870, MH59566, MH59586, MH61675, MH60879, MH81800, MH79469, MH79470]; Veterans' AdministrationUS Department of Veteran Affairs [1I01CX000278]; National Alliance for Research on Schizophrenia and Depression Young Investigator AwardsNARSAD
National Institutes of Health (MH083094, MH068881, MH041953, AA021399, MH020030, MH016880, and DA026119), Department of Veterans Affairs (I01 CX000278), and the Wellcome Trust (WTCCC-084710). For the MGS, recruitment, clinical evaluation and clinical data analyses of the MGS cohort were supported by NIH R01 grants (MH67257 to N.G.B., MH59588 to B.J.M., MH59571 to P.V.G., MH59565 to R.F., MH59587 to F.A., MH60870 to W.F.B., MH59566 to D.W.B., MH59586 to J.M.S., MH61675 to D.F.L., MH60879 to C.R.C., and MH81800 to P.V.G.), NIH U01 grants (MH79469 to P.V.G., and MH79470 to D.F.L.), Veterans' Administration grant 1I01CX000278 to A.F., and National Alliance for Research on Schizophrenia and Depression Young Investigator Awards (to A.R.S.).
14
0
13
Oxford univ press
Oxford
1745-1701
PY  - 2016
SN  - 0586-7614
SP  - 279-287
ST  - Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes
T2  - Schizophrenia Bulletin
TI  - Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes
UR  - <Go to ISI>://WOS:000376401500006
VL  - 42
ID  - 90
ER  - 

TY  - JOUR
AB  - Background Comprehensive geriatric assessment (CGA) is a multi-dimensional, multi-disciplinary diagnostic and therapeutic process conducted to determine the medical, mental, and functional problems of older people with frailty so that a co-ordinated and integrated plan for treatment and follow-up can be developed. This is an update of a previously published Cochrane review. Objectives We sought to critically appraise and summarise current evidence on the effectiveness and resource use of CGA for older adults admitted to hospital, and to use these data to estimate its cost-effectiveness. Search methods We searched CENTRAL, MEDLINE, Embase, three other databases, and two trials registers on 5 October 2016; we also checked reference lists and contacted study authors. Selection criteria We included randomised trials that compared inpatient CGA (delivered on geriatric wards or by mobile teams) versus usual care on a general medical ward or on a ward for older people, usually admitted to hospital for acute care or for inpatient rehabilitation after an acute admission. Data collection and analysis We followed standard methodological procedures expected by Cochrane and Effective Practice and Organisation of Care (EPOC). We used the GRADE approach to assess the certainty of evidence for the most important outcomes. For this update, we requested individual patient data (IPD) from trialists, and we conducted a survey of trialists to obtain details of delivery of CGA. We calculated risk ratios (RRs), mean differences (MDs), or standardised mean differences (SMDs), and combined data using fixed-effect meta-analysis. We estimated cost-effectiveness by comparing inpatient CGA versus hospital admission without CGA in terms of cost per quality-adjusted life year (QALY) gained, cost per life year (LY) gained, and cost per life year living at home (LYLAH) gained. Main results We included 29 trials recruiting 13,766 participants across nine, mostly high-income countries. CGA increases the likelihood that patients will be alive and in their own homes at 3 to 12 months' follow-up (risk ratio (RR) 1.06, 95% confidence interval (CI) 1.01 to 1.10; 16 trials, 6799 participants; high-certainty evidence), results in little or no difference in mortality at 3 to 12 months' follow-up (RR 1.00, 95% CI 0.93 to 1.07; 21 trials, 10,023 participants; high-certainty evidence), decreases the likelihood that patients will be admitted to a nursing home at 3 to 12 months follow-up (RR 0.80, 95% CI 0.72 to 0.89; 14 trials, 6285 participants; high-certainty evidence) and results in little or no difference in dependence (RR 0.97, 95% CI 0.89 to 1.04; 14 trials, 6551 participants; high-certainty evidence). CGA may make little or no difference to cognitive function (SMD ranged from -0.22 to 0.35 (5 trials, 3534 participants; low-certainty evidence)). Mean length of stay ranged from 1.63 days to 40.7 days in the intervention group, and ranged from 1.8 days to 42.8 days in the comparison group. Healthcare costs per participant in the CGA group were on average GBP 234 (95% CI GBP -144 to GBP 605) higher than in the usual care group (17 trials, 5303 participants; low-certainty evidence). CGA may lead to a slight increase in QALYs of 0.012 (95% CI -0.024 to 0.048) at GBP 19,802 per QALY gained (3 trials; low-certainty evidence), a slight increase in LYs of 0.037 (95% CI 0.001 to 0.073), at GBP 6305 per LY gained (4 trials; low-certainty evidence), and a slight increase in LYLAH of 0.019 (95% CI -0.019 to 0.155) at GBP 12,568 per LYLAH gained (2 trials; low-certainty evidence). The probability that CGA would be cost-effective at a GBP 20,000 ceiling ratio for QALY, LY, and LYLAH was 0.50, 0.89, and 0.47, respectively (17 trials, 5303 participants; low-certainty evidence). Authors' conclusions Older patients are more likely to be alive and in their own homes at follow-up if they received CGA on admission to hospital. We are uncertain whether data show a difference in effect between wards and teams, as this analysis was underpowered. CGA may lead to a small increase in costs, and evidence for cost-effectiveness is of low-certainty due to imprecision and inconsistency among studies. Further research that reports cost estimates that are setting-specific across different sectors of care are required.
AD  - [Ellis, Graham] Monklands Hosp, Med Elderly, Monkscourt Ave, Airdrie ML6 0JS, Scotland. [Gardner, Mike; Tsiachristas, Apostolos; Burke, Orlaith; Shepperd, Sasha] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England. [Langhorne, Peter] Univ Glasgow, Acad Sect Geriatr Med, ICAMS, Glasgow, Lanark, Scotland. [Harwood, Rowan H.] Nottingham Univ Hosp NHS Trust, Hlth Care Older People, Queens Med Ctr, Nottingham, England. [Conroy, Simon P.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England. [Kircher, Tilo] Philipps Univ Marburg UKGM, Klin Psychiat & Psychotherapie, Marburg, Germany. [Somme, Dominique] Univ Rennes 1, Hop Pontchaillou, Ctr Rech Act Polit Europe, Fac Med,Serv Geriatrie,CHU Rennes, Rennes, France. [Saltvedt, Ingvild] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway. [Wald, Heidi] Univ Colorado, Sch Med, Div Hlth Care Policy & Res, Dept Med, Aurora, CO USA. [O'Neill, Desmond] Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland. [Robinson, David] St James Hosp, Med Elderly, Dublin, Ireland.
Ellis, G (reprint author), Monklands Hosp, Med Elderly, Monkscourt Ave, Airdrie ML6 0JS, Scotland.
g.ellis@nhs.net
AN  - WOS:000411959500053
AU  - Ellis, G.
AU  - Gardner, M.
AU  - Tsiachristas, A.
AU  - Langhorne, P.
AU  - Burke, O.
AU  - Harwood, R. H.
AU  - Conroy, S. P.
AU  - Kircher, T.
AU  - Somme, D.
AU  - Saltvedt, I.
AU  - Wald, H.
AU  - O'Neill, D.
AU  - Robinson, D.
AU  - Shepperd, S.
C7  - Cd006211
DO  - 10.1002/14651858.CD006211.pub3
IS  - 9
J2  - Cochrane Database Syst Rev.
KW  - randomized controlled-trial
controlled clinical-trial
post-acute care
consultation team
cost-effectiveness
functional status
assessment
intervention
interdisciplinary team
occupational-therapy
assessment
program
General & Internal Medicine
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FI4QZ
Times Cited: 67
Cited Reference Count: 128
Ellis, Graham Gardner, Mike Tsiachristas, Apostolos Langhorne, Peter Burke, Orlaith Harwood, Rowan H. Conroy, Simon P. Kircher, Tilo Somme, Dominique Saltvedt, Ingvild Wald, Heidi O'Neill, Desmond Robinson, David Shepperd, Sasha
Conroy, Simon/B-8832-2009; O'Neill, Desmond/D-1486-2013
Shepperd, Sasha/0000-0001-6384-8322; O'Neill, Desmond/0000-0002-5542-9897; Tsiachristas, Apostolos/0000-0002-4662-8915; Kircher, Tilo/0000-0002-2514-2625
NIHR, UKNational Institute for Health Research (NIHR) [12/5003//01]
NIHR, UK.; (12/5003//01; "How to Implement Cost-Effective Comprehensive Geriatric Assessment")
68
4
18
Wiley
Hoboken
1361-6137
PY  - 2017
SN  - 1469-493X
SP  - 110
ST  - Comprehensive geriatric assessment for older adults admitted to hospital
T2  - Cochrane Database of Systematic Reviews
TI  - Comprehensive geriatric assessment for older adults admitted to hospital
UR  - <Go to ISI>://WOS:000411959500053
ID  - 71
ER  - 

TY  - JOUR
AB  - Background: Special events are common community-based strategies for health promotion. This paper presents findings from a systematic literature review on the impact of special events to promote breast, cervical or colorectal cancer education and screening. Methods: Articles in English that focused on special events involving breast, cervical, and/or colorectal cancer conducted in the U. S. and published between January 1990 and December 2011 were identified from seven databases: Ovid, Web of Science, CINAHL, PsycINFO, Sociological Abstract, Cochrane Libraries, and EconLit. Study inclusion and data extraction were independently validated by two researchers. Results: Of the 20 articles selected for screening out of 1,409, ten articles on special events reported outcome data. Five types of special events were found: health fairs, parties, cultural events, special days, and plays. Many focused on breast cancer only, or in combination with other cancers. Reach ranged from 50-1732 participants. All special events used at least one evidence-based strategy suggested by the Community Guide to Preventive Services, such as small media, one-on-one education, and reducing structural barriers. For cancer screening as an outcome of the events, mammography screening rates ranged from 4.8% to 88%, Pap testing was 3.9%, and clinical breast exams ranged from 9.1% to 100%. For colorectal screening, FOBT ranged from 29.4% to 76%, and sigmoidoscopy was 100% at one event. Outcome measures included intentions to get screened, scheduled appointments, uptake of clinical exams, and participation in cancer screening. Conclusions: Special events found in the review varied and used evidence-based strategies. Screening data suggest that some special events can lead to increases in cancer screening, especially if they provide onsite screening services. However, there is insufficient evidence to demonstrate that special events are effective in increasing cancer screening. The heterogeneity of populations served, event activities, outcome variables assessed, and the reliance on self- report to measure screening limit conclusions. This study highlights the need for further research to determine the effectiveness of special events to increase cancer screening.
AD  - [Escoffery, Cam; Rodgers, Kirsten C.; Kegler, Michelle C.; Haardoerfer, Regine; Liang, Shuting] Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA. [Howard, David H.] Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA USA. [Pinsker, Erika] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA. [Roland, Katherine B.] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Epidemiol & Appl Res Branch, Atlanta, GA USA. [Allen, Jennifer D.] Tufts Univ, Medford, MA 02155 USA. [Ory, Marcia G.] Texas A&M Univ, Sch Rural Publ Hlth, Dept Social & Behav Hlth, College Stn, TX USA. [Bastani, Roshan] Univ Calif Los Angeles, Dept Hlth Policy & Management, Los Angeles, CA USA. [Fernandez, Maria E.] Univ Texas Houston, Dept Behav Sci, Houston, TX USA. [Risendal, Betsy C.] Univ Colorado, Dept Community & Behav Hlth, Aurora, CO USA. [Byrd, Theresa L.] Texas Tech Paul L Foster Sch Med, El Paso, TX USA. [Coronado, Gloria D.] Kaiser Permanente, Ctr Canc Res, Portland, OR USA.
Escoffery, C (reprint author), Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, 1518 Clifton Rd, Atlanta, GA 30322 USA.
cescoff@emory.edu
AN  - WOS:000335351900001
AU  - Escoffery, C.
AU  - Rodgers, K. C.
AU  - Kegler, M. C.
AU  - Haardorfer, R.
AU  - Howard, D. H.
AU  - Liang, S.
AU  - Pinsker, E.
AU  - Roland, K. B.
AU  - Allen, J. D.
AU  - Ory, M. G.
AU  - Bastani, R.
AU  - Fernandez, M. E.
AU  - Risendal, B. C.
AU  - Byrd, T. L.
AU  - Coronado, G. D.
C7  - 274
DA  - Mar
DO  - 10.1186/1471-2458-14-274
J2  - BMC Public Health
KW  - Cancer screening
Early detection of cancer
Health promotion
Community
health education
Breast neoplasms
Cervical neoplasms
Colorectal
neoplasms
client-directed interventions
services task-force
preventive services
health fairs
risk-factors
nation
access
Public, Environmental & Occupational Health
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AG3WZ
Times Cited: 18
Cited Reference Count: 40
Escoffery, Cam Rodgers, Kirsten C. Kegler, Michelle C. Haardoerfer, Regine Howard, David H. Liang, Shuting Pinsker, Erika Roland, Katherine B. Allen, Jennifer D. Ory, Marcia G. Bastani, Roshan Fernandez, Maria E. Risendal, Betsy C. Byrd, Theresa L. Coronado, Gloria D.
Allen, Jennifer/M-2113-2015; Escoffery, Cam/F-8030-2011; Ory, Marcia/L-4025-2019
Escoffery, Cam/0000-0003-4445-009X
Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; National Cancer Institute through the Cancer Prevention and Control Research Network
This publication was supported by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute through the Cancer Prevention and Control Research Network, a network within the CDC's Prevention Research Centers Program (Emory University, U48DP001909, SIP 10-030; Harvard University, U48D001946; University of California at Los Angeles, U48 DP001934; University of Colorado, U48DP001938; Texas A & M University, U48DP001924; University of Texas at Houston, U48DP001949). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
18
0
17
Biomed central ltd
London
PY  - 2014
SN  - 1471-2458
SP  - 13
ST  - A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States
T2  - Bmc Public Health
TI  - A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States
UR  - <Go to ISI>://WOS:000335351900001
VL  - 14
ID  - 144
ER  - 

TY  - JOUR
AB  - Background: Nearly 25% of patients hospitalized with heart failure (HF) are readmitted within 30 days. Purpose: To assess the efficacy, comparative effectiveness, and harms of transitional care interventions to reduce readmission and mortality rates for adults hospitalized with HF. Data Sources: MEDLINE, Cochrane Library, CINAHL, ClinicalTrials.gov, and World Health Organization International Clinical Trials Registry Platform (1 January 1990 to late October 2013). Study Selection: Two reviewers independently selected randomized, controlled trials published in English reporting a readmission or mortality rate within 6 months of an index hospitalization. Data Extraction: One reviewer extracted data, and another checked accuracy. Two reviewers assessed risk of bias and graded strength of evidence (SOE). Data Synthesis: Forty-seven trials were included. Most enrolled adults with moderate to severe HF and a mean age of 70 years. Few trials reported 30-day readmission rates. At 30 days, a high-intensity home-visiting program reduced all-cause readmission and the composite end point (all-cause readmission or death; low SOE). Over 3 to 6 months, home-visiting programs and multidisciplinary heart failure (MDS-HF) clinic interventions reduced all-cause readmission (high SOE). Home-visiting programs reduced HF-specific readmission and the composite end point (moderate SOE). Structured telephone support (STS) interventions reduced HF-specific readmission (high SOE) but not all-cause readmissions (moderate SOE). Home-visiting programs, MDS-HF clinics, and STS interventions produced a mortality benefit. Neither telemonitoring nor primarily educational interventions reduced readmission or mortality rates. Limitations: Few trials reported 30-day readmission rates. Usual care was heterogeneous and sometimes not adequately described. Conclusion: Home-visiting programs and MDS-HF clinics reduced all-cause readmission and mortality; STS reduced HF-specific readmission and mortality. These interventions should receive the greatest consideration by systems or providers seeking to implement transitional care interventions for persons with HF.
AD  - Univ N Carolina, Chapel Hill, NC 27599 USA. Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA. Univ Colorado, Aurora, CO USA. [Lohr, Kathleen N.] RTI Int, Res Triangle Pk, NC 27709 USA. [Zheng, Zhi-Jie] RTI Int, Rockville, MD 20852 USA.
Feltner, C (reprint author), Univ N Carolina, Dept Med, 5034 Old Clin Bldg,CB 7110, Chapel Hill, NC 27599 USA.
cindy_feltner@med.unc.edu
AN  - WOS:000337348700004
AU  - Feltner, C.
AU  - Jones, C. D.
AU  - Cene, C. W.
AU  - Zheng, Z. J.
AU  - Sueta, C. A.
AU  - Coker-Schwimmer, E. J. L.
AU  - Arvanitis, M.
AU  - Lohr, K. N.
AU  - Middleton, J. C.
AU  - Jonas, D. E.
DA  - Jun
DO  - 10.7326/m14-0083
IS  - 11
J2  - Ann. Intern. Med.
KW  - randomized controlled-trial
home-based intervention
acute
myocardial-infarction
disease management program
multidisciplinary
care
self-care
elderly-patients
high-risk
hospital discharge
clinical-outcomes
General & Internal Medicine
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: AJ0MT
Times Cited: 255
Cited Reference Count: 72
Feltner, Cynthia Jones, Christine D. Cene, Crystal W. Zheng, Zhi-Jie Sueta, Carla A. Coker-Schwimmer, Emmanuel J. L. Arvanitis, Marina Lohr, Kathleen N. Middleton, Jennifer C. Jonas, Daniel E.
Arvanitis, Marina/0000-0002-2186-5164
AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [HHSA290201200008I]; U.S. Department of Health and Human Services [HHSA29032003T]
In part by AHRQ (grant HHSA290201200008I) and the U.S. Department of Health and Human Services (contract HHSA29032003T).
262
2
103
Amer coll physicians
Philadelphia
1539-3704
PY  - 2014
SN  - 0003-4819
SP  - 774-+
ST  - Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure A Systematic Review and Meta-analysis
T2  - Annals of Internal Medicine
TI  - Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure A Systematic Review and Meta-analysis
UR  - <Go to ISI>://WOS:000337348700004
VL  - 160
ID  - 139
ER  - 

TY  - JOUR
AB  - Objective: As prehospital research advances, more evidence-based guidelines (EBGs) are implemented into emergency medical services (EMS) practice. However, incomplete or suboptimal prehospital EBG implementation may hinder improvement in patient outcomes. To inform future efforts, this study's objective was to review existing evidence pertaining to prehospital EBG implementation methods. Methods: This study was a systematic literature review and evaluation following the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. PubMed, EMBASE, Scopus, and Google Advanced Search were searched without language or publication date filters for articles addressing prehospital EBG implementation. Conference proceedings, textbooks, and non-English articles were excluded. GRADE was applied to the remaining articles independently by three of five study investigators. Study characteristics and salient findings from the included articles are reported. Results: The systematic literature review identified 1,367 articles, with 41 meeting inclusion criteria. Most articles described prehospital EBG implementation (n = 24, 59%), or implementation barriers (n = 13, 32%). Common study designs were statement documents (n = 12, 29%), retrospective cohort studies (n = 12, 29%), and cross-sectional studies (n = 9, 22%). Using GRADE, evidence quality was rated low (n = 18, 44%), or very low (n = 23, 56%). Salient findings from the articles included: (i) EBG adherence and patient outcomes depend upon successful implementation, (ii) published studies generally lack detailed implementation methods, (iii) EBG implementation takes longer than planned (mostly for EMS education), (iv) EMS systems' heterogeneity affects EBG implementation, and (v) multiple barriers limit successful implementation (e.g., financial constraints, equipment purchasing, coordination with hospitals, and regulatory agencies). This review found no direct evidence for best prehospital EBG implementation practices. There were no studies comparing implementation methods or implementation in different prehospital settings (e.g., urban vs. rural, advanced vs. basic life support). Conclusions: While prehospital EBG implementation barriers are well described, there is a paucity of evidence for optimal implementation methods. For scientific advances to reach prehospital patients, EBG development efforts must translate into EMS practice. Future research should consider comparing implementation methodologies in different prehospital settings, with a goal of defining detailed, reproducible best practices.
AD  - [Fishe, Jennifer N.] Univ Florida, Coll Med Jacksonville, Dept Emergency Med, Jacksonville, FL USA. [Crowe, Remle P.; Cash, Rebecca E.] Natl Registry EMTs, Columbus, OH USA. [Crowe, Remle P.; Cash, Rebecca E.] Natl Registry EMTs, Ft Collins, OH USA. [Nudell, Nikiah G.] Univ Colorado, Hlth EMS, Ft Collins, CO USA. [Nudell, Nikiah G.] Paramed Fdn, St Cloud, MN USA. [Martin-Gill, Christian] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA. [Richards, Christopher T.] Northwestern Feinberg Sch Med, Dept Emergency Med, Chicago, IL USA. [Richards, Christopher T.] Chicago EMS Syst, Chicago, IL USA. [Richards, Christopher T.] Northwestern Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL USA.
Fishe, JN (reprint author), 655 West 8th St, Jacksonville, FL 32205 USA.
Jennifer.Fishe@jax.ufl.edu
AN  - WOS:000436977600015
AU  - Fishe, J. N.
AU  - Crowe, R. P.
AU  - Cash, R. E.
AU  - Nudell, N. G.
AU  - Martin-Gill, C.
AU  - Richards, C. T.
AU  - Prehosp Guidelines, Consortium
DO  - 10.1080/10903127.2017.1413466
IS  - 4
J2  - Prehosp. Emerg. Care
KW  - evidence-based guideline (EBG)
grading of recommendations
assessment
development
and evaluation (GRADE)
implementation
systematic review
emergency medical-services
hospital cardiac-arrest
triage decision
scheme
cardiopulmonary-resuscitation
knowledge translation
stroke
systems
care
survival
statement
barriers
Emergency Medicine
Public, Environmental & Occupational Health
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: GL2TI
Times Cited: 4
Cited Reference Count: 57
Fishe, Jennifer N. Crowe, Remle P. Cash, Rebecca E. Nudell, Nikiah G. Martin-Gill, Christian Richards, Christopher T.
Richards, Christopher/0000-0003-3728-3860; Fishe, Jennifer/0000-0001-9037-8143
4
0
1
Taylor & francis inc
Philadelphia
1545-0066
PY  - 2018
SN  - 1090-3127
SP  - 511-519
ST  - Implementing Prehospital Evidence-Based Guidelines: A Systematic Literature Review
T2  - Prehospital Emergency Care
TI  - Implementing Prehospital Evidence-Based Guidelines: A Systematic Literature Review
UR  - <Go to ISI>://WOS:000436977600015
VL  - 22
ID  - 35
ER  - 

TY  - JOUR
AD  - [Florek, Aleksandra; Armstrong, April] Univ Colorado Denver, Aurora, CO USA. [Rachakonda, Tara] MSUniv Utah, Salt Lake City, UT USA. [Dhillon, Jaskaran] Univ Colorado Davis, Sacramento, CA USA.
AN  - WOS:000360942902032
AU  - Florek, A.
AU  - Rachakonda, T.
AU  - Dhillon, J.
AU  - Armstrong, A.
DA  - May
IS  - 5
J2  - J. Am. Acad. Dermatol.
KW  - Dermatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: CQ9NW
Times Cited: 0
Cited Reference Count: 0
Florek, Aleksandra Rachakonda, Tara Dhillon, Jaskaran Armstrong, April
0
3
Mosby-elsevier
New york
1
PY  - 2015
SN  - 0190-9622
SP  - AB223-AB223
ST  - A systematic review of tonsillectomy as a treatment for guttate or plaque psoriasis
T2  - Journal of the American Academy of Dermatology
TI  - A systematic review of tonsillectomy as a treatment for guttate or plaque psoriasis
UR  - <Go to ISI>://WOS:000360942902032
VL  - 72
ID  - 114
ER  - 

TY  - JOUR
AB  - Background. Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be used as an adjunct to medical therapy, with the intent of reducing bacterial burden and improving cure rates. We conducted an individual patient data metaanalysis to evaluate the effectiveness of surgery as adjunctive therapy for MDR-tuberculosis. Methods. Individual patient data, was obtained from the authors of 26 cohort studies, identified from 3 systematic reviews of MDR-tuberculosis treatment. Data included the clinical characteristics and medical and surgical therapy of each patient. Primary analyses compared treatment success (cure and completion) to a combined outcome of failure, relapse, or death. The effects of all forms of resection surgery, pneumonectomy, and partial lung resection were evaluated. Results. A total of 4238 patients from 18 surgical studies and 2193 patients from 8 nonsurgical studies were included. Pulmonary resection surgery was performed on 478 patients. Partial lung resection surgery was associated with improved treatment success (adjusted odds ratio [aOR], 3.0; 95% confidence interval [CI], 1.5-5.9; I-R(2), 11.8%), but pneumonectomy was not (aOR, 1.1; 95% CI,.6-2.3; I-R(2), 13.2%). Treatment success was more likely when surgery was performed after culture conversion than before conversion (aOR, 2.6; 95% CI, 0.9-7.1; I-R(2), 0.2%). Conclusions. Partial lung resection, but not pneumonectomy, was associated with improved treatment success among patients with MDR-tuberculosis. Although improved outcomes may reflect patient selection, partial lung resection surgery after culture conversion may improve treatment outcomes in patients who receive optimal medical therapy.
AD  - [Fox, Gregory J.; Benedetti, Andrea; Menzies, Dick] McGill Univ, Montreal Chest Inst, Montreal, PQ H3A 2T5, Canada. [Mitnick, Carole D.; Becerra, Mercedes; Keshavjee, Salmaan] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA. [Chan, Edward D.] Denver Vet Affairs Med Ctr, Dept Med, Denver, CO USA. [Chan, Edward D.] Denver Vet Affairs Med Ctr, Dept Acad Affairs, Denver, CO USA. [Chiang, Chen-Yuan] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan. [Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea. [Shiraishi, Yuji] Fukujuji Hosp, Sect Chest Surg, Tokyo, Japan. [Viiklepp, Piret] Natl Inst Hlth Dev, Estonian TB Registry, Tallinn, Estonia. [Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea. [Pasvol, Geoffrey] Univ London Imperial Coll Sci Technol & Med, Dept Infect & Trop Med, London, England. [Robert, Jerome] Univ Paris 06, Lab Bacteriol Hyg, Paris, France. [Shim, Tae Sun] Univ Ulsan, Coll Med, Dept Pulm & Crit Care Med, Asan Med Ctr, Seoul, South Korea. [Shin, Sonya S.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.
Menzies, D (reprint author), 2155 Guy St, Montreal, PQ H3H 2R9, Canada.
dick.menzies@mcgill.ca
AN  - WOS:000374248700011
AU  - Fox, G. J.
AU  - Mitnick, C. D.
AU  - Benedetti, A.
AU  - Chan, E. D.
AU  - Becerra, M.
AU  - Chiang, C. Y.
AU  - Keshavjee, S.
AU  - Koh, W. J.
AU  - Shiraishi, Y.
AU  - Viiklepp, P.
AU  - Yim, J. J.
AU  - Pasvol, G.
AU  - Robert, J.
AU  - Shim, T. S.
AU  - Shin, S. S.
AU  - Menzies, D.
AU  - Collaborative Grp Meta-Anal, Indivi
DA  - Apr
DO  - 10.1093/cid/ciw002
IS  - 7
J2  - Clin. Infect. Dis.
KW  - multidrug resistant tuberculosis
thoracic surgery
pneumonectomy
metaanalysis
individual patient data
treatment outcomes
Immunology
Infectious Diseases
Microbiology
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: DJ5LD
Times Cited: 27
Cited Reference Count: 17
Fox, Gregory J. Mitnick, Carole D. Benedetti, Andrea Chan, Edward D. Becerra, Mercedes Chiang, Chen-Yuan Keshavjee, Salmaan Koh, Won-Jung Shiraishi, Yuji Viiklepp, Piret Yim, Jae-Joon Pasvol, Geoffrey Robert, Jerome Shim, Tae Sun Shin, Sonya S. Menzies, Dick
Koh, Won Jung/C-9595-2011; ROBERT, Jerome/C-3993-2011; Lange, Christoph/J-6289-2012; Koh, Won-Jung/D-9586-2018
ROBERT, Jerome/0000-0002-9380-0570; Lange, Christoph/0000-0002-9691-4741; Koh, Won-Jung/0000-0002-4756-3527; Hollm-Delgado, Maria-Graciela/0000-0003-1067-8520
CJ Martin post-doctoral fellowship [APP1054107]; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia
This work was supported by a CJ Martin post-doctoral fellowship (APP1054107) to G. J. F. from the Australian National Health and Medical Research Council.
30
0
3
Oxford univ press inc
Cary
1537-6591
PY  - 2016
SN  - 1058-4838
SP  - 887-895
ST  - Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis
T2  - Clinical Infectious Diseases
TI  - Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis
UR  - <Go to ISI>://WOS:000374248700011
VL  - 62
ID  - 88
ER  - 

TY  - JOUR
AD  - [Krebs, Erin E.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA. [Dobscha, Steven] Portland VA Med Ctr, Portland, OR USA. [Koenig, Christopher J.] Univ Calif San Francisco, San Francisco, CA 94143 USA. [Koenig, Christopher J.] San Francisco Vet Affairs, San Francisco, CA USA. [Frank, Joseph W.] Univ Colorado, Sch Med, Aurora, CO USA. [Becker, William] VA Connecticut Healthcare Syst, West Haven, CT USA. [Frank, Joseph W.; Dischinger, Hannah R.] VA Eastern Colorado Hlth Care Syst, Denver, CO USA. [Morasco, Benjamin J.] Portland VA Med Ctr, Portland, OR USA.
AN  - WOS:000392201600199
AU  - Frank, J. W.
AU  - Lovejoy, T.
AU  - Becker, W.
AU  - Morasco, B. J.
AU  - Koenig, C. J.
AU  - Dischinger, H. R.
AU  - Dobscha, S.
AU  - Krebs, E. E.
DA  - May
J2  - J. Gen. Intern. Med.
KW  - Health Care Sciences & Services
General & Internal Medicine
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: EI0YL
Times Cited: 0
Cited Reference Count: 0
Frank, Joseph W. Lovejoy, Travis Becker, William Morasco, Benjamin J. Koenig, Christopher J. Dischinger, Hannah R. Dobscha, Steven Krebs, Erin E.
Meeting of the Society-of-General-Internal-Medicine (SGIM)
May 11-14, 2015-2016
Hollywood, FL
Soc Gen Internal Med
0
Springer
New york
1525-1497
2
PY  - 2016
SN  - 0884-8734
SP  - S200-S201
ST  - DOSE REDUCTION AND DISCONTINUATION OF LONG-TERM OPIOID THERAPY: A SYSTEMATIC REVIEW
T2  - Journal of General Internal Medicine
TI  - DOSE REDUCTION AND DISCONTINUATION OF LONG-TERM OPIOID THERAPY: A SYSTEMATIC REVIEW
UR  - <Go to ISI>://WOS:000392201600199
VL  - 31
ID  - 83
ER  - 

TY  - JOUR
AB  - Background Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most common form of drug resistance, and is associated with failure, relapse, and acquired rifampicin resistance if treated with first-line anti-tuberculosis drugs. The aim of the study was to compare success, mortality, and acquired rifampicin resistance in patients with INH-R pulmonary tuberculosis given different durations of rifampicin, ethambutol, and pyrazinamide (REZ); a fluoroquinolone plus 6 months or more of REZ; and streptomycin plus a core regimen of REZ. Methods Studies with regimens and outcomes known for individual patients with INH-R tuberculosis were eligible, irrespective of the number of patients if randomised trials, or with at least 20 participants if a cohort study. Studies were identified from two relevant systematic reviews, an updated search of one of the systematic reviews (for papers published between April 1, 2015, and Feb 10, 2016), and personal communications. Individual patient data were obtained from authors of eligible studies. The individual patient data meta-analysis was performed with propensity score matched logistic regression to estimate adjusted odds ratios (aOR) and risk differences of treatment success (cure or treatment completion), death during treatment, and acquired rifampicin resistance. Outcomes were measured across different treatment regimens to assess the effects of: different durations of REZ (<= 6 months vs >6 months); addition of a fluoroquinolone to REZ (fluoroquinolone plus 6 months or more of REZ vs 6 months or more of REZ); and addition of streptomycin to REZ (streptomycin plus 6 months of rifampicin and ethambutol and 1-3 months of pyrazinamide vs 6 months or more of REZ). The overall quality of the evidence was assessed using GRADE methodology. Findings Individual patient data were requested for 57 cohort studies and 17 randomised trials including 8089 patients with INH-R tuberculosis. We received 33 datasets with 6424 patients, of which 3923 patients in 23 studies received regimens related to the study objectives. Compared with a daily regimen of 6 months of (H) REZ (REZ with or without isoniazid), extending the duration to 8-9 months had similar outcomes; as such, 6 months or more of (H) REZ was used for subsequent comparisons. Addition of a fluoroquinolone to 6 months or more of (H) REZ was associated with significantly greater treatment success (aOR 2.8, 95% CI 1.1-7.3), but no significant effect on mortality (aOR 0.7, 0.4-1.1) or acquired rifampicin resistance (aOR 0.1, 0.0-1.2). Compared with 6 months or more of (H) REZ, the standardised retreatment regimen (2 months of streptomycin, 3 months of pyrazinamide, and 8 months of isoniazid, rifampicin, and ethambutol) was associated with significantly worse treatment success (aOR 0.4, 0.2-0.7). The quality of the evidence was very low for all outcomes and treatment regimens assessed, owing to the observational nature of most of the data, the diverse settings, and the imprecision of estimates. Interpretation In patients with INH-R tuberculosis, compared with treatment with at least 6 months of daily REZ, addition of a fluoroquinolone was associated with better treatment success, whereas addition of streptomycin was associated with less treatment success; however, the quality of the evidence was very low. These results support the conduct of randomised trials to identify the optimum regimen for this important and common form of drug-resistant tuberculosis. (C) 2016. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved.
AD  - [Fregonese, Federica; Benedetti, Andrea; Lan, Zhi Yi; Li, Pei Zhi; Trajman, Anete; Menzies, Dick] McGill Univ, Ctr Hlth, Res Inst, Montreal Chest Inst, Montreal, PQ, Canada. [Benedetti, Andrea; Lan, Zhi Yi] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada. [Ahuja, Shama D.; Trieu, Lisa] New York City Dept Hlth & Mental Hyg, Bur TB Control, New York City Dept Hlth, Queens, NY USA. [Akkerman, Onno W.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands. [Arakaki-Sanchez, Denise] Natl TB Control Program, Brasilia, DF, Brazil. [Ayakaka, Irene] Uganda TB Res Consortium, Kampala, Uganda. [Baghaei, Parvaneh; Tabarsi, Payam] Shahid Beheshti Univ Med Sci, NRITLD, Clin TB & Epidemiol Res Ctr, Tehran, Iran. [Bang, Didi] Statens Serum Inst, Copenhagen, Denmark. [Bastos, Mayara; Trajman, Anete] Univ Rio De Janeiro, Social Med Inst, Epidemiol Dept, BR-21941 Rio De Janeiro, Brazil. [Bonnet, Maryline] Univ Montpellier, INSERM, Inst Rech Dev, UM233,U1175, Montpellier, France. [Bonnet, Maryline] Epicentre MSF, Paris, France. [Cattamanchi, Adithya] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA. [Cattamanchi, Adithya] Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA. [Phillips, Patrick P. J.] Univ Calif San Francisco, Div Pulm & Crit Med, San Francisco, CA 94143 USA. [Cegielski, Peter] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Atlanta, GA USA. [Goldberg, Stefan; Khan, Awal] Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA USA. [Chien, Jung-Yien; Wang, Jann-Yuan] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan. [Cox, Helen] Univ Cape Town, Div Med Microbiol, Cape Town, South Africa. [Cox, Helen] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa. [Dedicoat, Martin; Munang, Melinda] Heart England NHS Fdn Trust, Birmingham, W Midlands, England. [Erkens, Connie] KNCV TB Fdn, Team Netherlands & Eliminat, The Hague, Netherlands. [Escalante, Patricio] Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN USA. [Escalante, Patricio] Mayo Clin, Mayo Clin Ctr TB, Rochester, MN USA. [Falzon, Dennis; Gegia, Medea] WHO, Global TB Programme, Geneva, Switzerland. [Merle, Corinne S. C.] WHO, Special Programme Res & Training Trop Dis, Geneva, Switzerland. [Garcia-Prats, Anthony J.; Schaaf, H. Simon] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa. [Gillespie, Stephen H.] Univ St Andrews North Haugh, Sch Med, St Andrews, Fife, Scotland. [Glynn, Judith R.; Merle, Corinne S. C.; Nunn, Andrew] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England. [Griffith, David] Univ Texas Hlth Ctr Tyler, Tyler, TX USA. [Jacobson, Karen R.; Jones-Lopez, Edward C.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA. [Jacobson, Karen R.; Jones-Lopez, Edward C.] Boston Med Ctr, Boston, MA USA. [Johnston, James C.] Univ British Columbia, Dept Med, Vancouver, BC, Canada. [Johnston, James C.; Romanowski, Kamila] British Columbia Ctr Dis Control, Vancouver, BC, Canada. [Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea. [Kritski, Afranio] Univ Fed Rio de Janeiro, Sch Med, Acad TB Program, Rio De Janeiro, Brazil. [Galliez, Rafael Mello] Univ Fed Rio de Janeiro, Fac Med, Ctr Res & TB, State Inst Infectol Sao Sebastiao, Rio De Janeiro, Brazil. [Lee, Jae Ho; Park, Jong Sun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea. [Maciel, Ethel L.] Univ Fed Espirito Santo, Lab Epidemiol, Espirito Santo, Brazil. [Narendran, Gopalan; Banurekha, Velayutham V.] Natl Inst Res TB, Dept Clin Res, Madras, Tamil Nadu, India. [Viet Nhung Nguyen] Natl Lung Hosp, Hanoi, Vietnam. [Viet Nhung Nguyen] Hanoi Med Univ, Hanoi, Vietnam. [Ohkado, Akihiro] Japan AntiTB Assoc, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan. [Ohkado, Akihiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan. [Ponnuraja, Chinnaiyan] Natl Inst Res TB, Chetpet, India. [Reves, Randall] Denver Publ Hlth Dept, Denver, CO USA. [Seung, Kwonjune] Partners Hlth, Boston, MA USA. [Skrahina, Alena] Minist Hlth, Republican Sci & Pract Ctr Pulmonol & TB, Minsk, BELARUS. [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, TB Reference Lab, Bilthoven, Netherlands. [Viiklepp, Piret] Natl Inst Hlth Dev, Estonian TB Registry, Tallinn, Estonia. [Yoshiyama, Takashi] Res Inst TB, Tokyo, Japan.
Menzies, D (reprint author), McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ H4A 3S5, Canada.
dick.menzies@mcgill.ca
AN  - WOS:000428231000024
AU  - Fregonese, F.
AU  - Ahuja, S. D.
AU  - Akkerman, O. W.
AU  - Arakaki-Sanchez, D.
AU  - Ayakaka, I.
AU  - Baghaei, P.
AU  - Bang, D. D.
AU  - Bastos, M.
AU  - Benedetti, A.
AU  - Bonnet, M.
AU  - Cattamanchi, A.
AU  - Cegielski, P.
AU  - Chien, J. Y.
AU  - Cox, H.
AU  - Dedicoat, M.
AU  - Erkens, C.
AU  - Escalante, P.
AU  - Falzon, D.
AU  - Garcia-Prats, A. J.
AU  - Gegia, M.
AU  - Gillespie, S. H.
AU  - Glynn, J. R.
AU  - Goldberg, S.
AU  - Griffith, D.
AU  - Jacobson, K. R.
AU  - Johnston, J. C.
AU  - Jones-Lopez, E. C.
AU  - Khan, A.
AU  - Koh, W. J.
AU  - Kritski, A.
AU  - Lan, Z. Y.
AU  - Lee, J. H.
AU  - Li, P. Z.
AU  - Maciel, E. L.
AU  - Galliez, R. M.
AU  - Merle, C. S. C.
AU  - Munang, M.
AU  - Narendran, G.
AU  - Nguyen, V. N.
AU  - Nunn, A.
AU  - Ohkado, A.
AU  - Park, J. S.
AU  - Phillips, P. P. J.
AU  - Ponnuraja, C.
AU  - Reves, R.
AU  - Romanowski, K.
AU  - Seung, K.
AU  - Schaaf, H. S.
AU  - Skrahina, A.
AU  - van Soolingen, D.
AU  - Tabarsi, P.
AU  - Trajman, A.
AU  - Trieu, L.
AU  - Banurekha, V. V.
AU  - Viiklepp, P.
AU  - Wang, J. Y.
AU  - Yoshiyama, T.
AU  - Menzies, D.
DA  - Apr
IS  - 4
J2  - Lancet Resp. Med.
KW  - treatment outcomes
drug-resistance
mycobacterium-tuberculosis
pulmonary tuberculosis
clinical-trial
regimen
efficacy
relapse
retreatment
mutations
General & Internal Medicine
Respiratory System
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GA3LQ
Times Cited: 11
Cited Reference Count: 50
Fregonese, Federica Ahuja, Shama D. Akkerman, Onno W. Arakaki-Sanchez, Denise Ayakaka, Irene Baghaei, Parvaneh Bang, Didi Bastos, Mayara Benedetti, Andrea Bonnet, Maryline Cattamanchi, Adithya Cegielski, Peter Chien, Jung-Yien Cox, Helen Dedicoat, Martin Erkens, Connie Escalante, Patricio Falzon, Dennis Garcia-Prats, Anthony J. Gegia, Medea Gillespie, Stephen H. Glynn, Judith R. Goldberg, Stefan Griffith, David Jacobson, Karen R. Johnston, James C. Jones-Lopez, Edward C. Khan, Awal Koh, Won-Jung Kritski, Afranio Lan, Zhi Yi Lee, Jae Ho Li, Pei Zhi Maciel, Ethel L. Galliez, Rafael Mello Merle, Corinne S. C. Munang, Melinda Narendran, Gopalan Viet Nhung Nguyen Nunn, Andrew Ohkado, Akihiro Park, Jong Sun Phillips, Patrick P. J. Ponnuraja, Chinnaiyan Reves, Randall Romanowski, Kamila Seung, Kwonjune Schaaf, H. Simon Skrahina, Alena van Soolingen, Dick Tabarsi, Payam Trajman, Anete Trieu, Lisa Banurekha, Velayutham V. Viiklepp, Piret Wang, Jann-Yuan Yoshiyama, Takashi Menzies, Dick
Maciel, Ethel Leonor LN/G-1027-2012; Koh, Won-Jung/D-9586-2018; Koh, Won Jung/C-9595-2011; Phillips, Patrick/B-6347-2008
Maciel, Ethel Leonor LN/0000-0003-4826-3355; Koh, Won-Jung/0000-0002-4756-3527; Schaaf, Hendrik Simon/0000-0001-5755-4133; baghaei shiva, parvaneh/0000-0002-6361-315X; Gillespie, Stephen/0000-0001-6537-7712; Jacobson, Karen/0000-0003-4239-3685; Jones Lopez, Edward/0000-0001-6323-286X; Phillips, Patrick/0000-0002-6336-7024
World Health OrganizationWorld Health Organization; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)
World Health Organization and Canadian Institutes of Health Research.
11
0
5
Elsevier sci ltd
Oxford
PY  - 2018
SN  - 2213-2600
SP  - 265-275
ST  - Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
T2  - Lancet Respiratory Medicine
TI  - Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
UR  - <Go to ISI>://WOS:000428231000024
VL  - 6
ID  - 23
ER  - 

TY  - JOUR
AB  - Background: Preventing and/or delaying cognitive impairment is a public health priority. To increase awareness of and participation in behaviors that may help maintain cognitive function or reduce risk of impairment, we need to understand public perceptions about risk and protective factors. Methods: We conducted a scoping review of studies examining the public's perceptions about risk and protective factors related to cognitive health and impairment published since the 2007 National Public Health Road Map to Maintaining Cognitive Health. Results: A search of five databases yielded 1,115 documents published between June 2007 and December 2013. Initial review of abstracts identified 90 potentially eligible studies. After full-article review, 30 met inclusion criteria; four additional articles identified in reference lists also met inclusion criteria. Of the 34, 16 studies addressed Alzheimer's disease (AD) specifically, 15 dementia broadly, 5 mild to moderate cognitive impairment, and 8 normal functioning, with some content overlap. Across studies, respondents reported genetics (n = 14 studies), older age (n = 8), stress (n = 7), brain/head injury (n = 6), and mental illness/brain disease (n = 6) as perceived risk factors for AD and dementia. Protective factors most commonly identified for maintaining cognitive health were intellectual/mental stimulation (n = 13), physical activity (n = 12), healthy diet (n = 10), and social/leisure activities (n = 10). Conclusions: Studies identified genetics and older age as key perceived risk factors more so than behaviors such as smoking. Individuals perceived that numerous lifestyle factors (e.g. intellectual stimulation, physical activity) could protect against cognitive impairment, AD, and/or dementia. Results can inform national and international education efforts about AD and other dementias.
AD  - [Friedman, Daniela B.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA. [Becofsky, Katie] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA. [Anderson, Lynda A.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Hlth Aging Program, Atlanta, GA USA. [Anderson, Lynda A.] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA. [Bryant, Lucinda L.; Brannon, Sarah] Univ Colorado, Dept Community & Behav Hlth, Colorado Sch Publ Hlth, Aurora, CO USA. [Hunter, Rebecca H.] Univ N Carolina, Ctr Hlth Promot & Dis Prevent, Chapel Hill, NC USA. [Ivey, Susan L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA. [Belza, Basia] Univ Washington, Hlth Promot Res Ctr, Seattle, WA 98195 USA. [Belza, Basia; Lin, Shih-Yin] Univ Washington, Sch Nursing, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA. [Logsdon, Rebecca G.] Univ Washington, Sch Nursing, Dept Psychosocial & Community Hlth, Seattle, WA 98195 USA. [Vandenberg, Ann E.] Emory Univ, Dept Med, Ctr Hlth Aging, Atlanta, GA 30322 USA.
Friedman, DB (reprint author), Univ S Carolina, Arnold Sch Publ Hlth, 915 Greene St,Suite 235, Columbia, SC 29208 USA.
dbfriedman@sc.edu
AN  - WOS:000361384500004
AU  - Friedman, D. B.
AU  - Becofsky, K.
AU  - Anderson, L. A.
AU  - Bryant, L. L.
AU  - Hunter, R. H.
AU  - Ivey, S. L.
AU  - Belza, B.
AU  - Logsdon, R. G.
AU  - Brannon, S.
AU  - Vandenberg, A. E.
AU  - Lin, S. Y.
DA  - Aug
DO  - 10.1017/s1041610214002877
IS  - 8
J2  - Int. Psychogeriatr.
KW  - cognition
Alzheimer's disease
dementia
scoping review
public
perceptions
risk factors
protective factors
alzheimer-disease
older-adults
translating science
ethnic-differences
family caregivers
physical-activity
aging
population
united-states
brain health
beliefs
Psychology
Geriatrics & Gerontology
Psychiatry
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: CR5LR
Times Cited: 12
Cited Reference Count: 52
Friedman, Daniela B. Becofsky, Katie Anderson, Lynda A. Bryant, Lucinda L. Hunter, Rebecca H. Ivey, Susan L. Belza, Basia Logsdon, Rebecca G. Brannon, Sarah Vandenberg, Ann E. Lin, Shih-Yin
Lin, Shih-Yin/0000-0001-8033-2889
CDC Healthy Aging Program; CDC's Prevention Research Centers Program [U48-DP-001908, U48-DP001938, U48-DP-001944, U48-DP-001936, U48-DP-001911]
This research is the result of work conducted by the Centers for Disease Control and Prevention (CDC) Healthy Aging Research Network. The CDC Healthy Aging Research Network is a Prevention Research Centers program funded by the CDC Healthy Aging Program. The research was supported in part by cooperative agreements from CDC's Prevention Research Centers Program: U48-DP-001908, U48-DP001938, U48-DP-001944, U48-DP-001936, and U48-DP-001911.
12
1
33
Cambridge univ press
New york
1741-203x
PY  - 2015
SN  - 1041-6102
SP  - 1263-1275
ST  - Public perceptions about risk and protective factors for cognitive health and impairment: a review of the literature
T2  - International Psychogeriatrics
TI  - Public perceptions about risk and protective factors for cognitive health and impairment: a review of the literature
UR  - <Go to ISI>://WOS:000361384500004
VL  - 27
ID  - 108
ER  - 

TY  - JOUR
AB  - Background Whether statin therapy is as effective in women as in men is debated, especially for primary prevention. We undertook a meta-analysis of statin trials in the Cholesterol Treatment Trialists' (CTT) Collaboration database to compare the effects of statin therapy between women and men. Methods We performed meta-analyses on data from 22 trials of statin therapy versus control (n=134 537) and five trials of more-intensive versus less-intensive statin therapy (n=39 612). Effects on major vascular events, major coronary events, stroke, coronary revascularisation and mortality were weighted per 1.0 mmol/L reduction in LDL cholesterol and effects in men and women compared with a Cox model that adjusted for non-sex differences. For subgroup analyses, we used 99% CIs to make allowance for the multiplicity of comparisons. Findings 46 675 (27%) of 174 149 randomly assigned participants were women. Allocation to a statin had similar absolute effects on 1 year lipid concentrations in both men and women (LDL cholesterol reduced by about 1.1 mmol/L in statin vs control trials and roughly 0.5 mmol/L for more-intensive vs less-intensive therapy). Women were generally at lower cardiovascular risk than were men in these trials. The proportional reductions per 1.0 mmol/L reduction in LDL cholesterol in major vascular events were similar overall for women (rate ratio [RR] 0.84, 99% CI 0.78-0.91) and men (RR 0.78, 99% CI 0.75-0.81, adjusted p value for heterogeneity by sex=0.33) and also for those women and men at less than 10% predicted 5 year absolute cardiovascular risk (adjusted heterogeneity p=0.11). Likewise, the proportional reductions in major coronary events, coronary revascularisation, and stroke did not differ significantly by sex. No adverse effect on rates of cancer incidence or non-cardiovascular mortality was noted for either sex. These net benefits translated into all-cause mortality reductions with statin therapy for both women (RR 0.91, 99% CI 0.84-0.99) and men (RR 0.90, 99% CI 0.86-0.95; adjusted heterogeneity p=0.43). Interpretation In men and women at an equivalent risk of cardiovascular disease, statin therapy is of similar effectiveness for the prevention of major vascular events.
AD  - [Braunwald, Eugene; de Lemos, J.; Blazing, M.; Murphy, S.] AFCAPS TEXCAPS AirForce Texas Coronary Atherosc, Bethesda, MD USA. [Downs, J. R.; Gotto, A.; Clearfield, M.] ALERT Assessment Lescol Renal Transplantat, Bethesda, MD USA. ALLHAT Antihypertens & Lipid Lowering Treatment P, Bethesda, MD USA. [Davis, Barry; Gordon, D.] ALLIANCE Aggress Lipid Lowering Initiat Abates Ne, Bethesda, MD USA. [Koren, M.] ASCOT Angloscandinavian Cardiac Outcomes Trial, Bethesda, MD USA. [Dahloef, B.; Poulter, N.; Sever, P.] ASPEN Atorvastatin Study Prevent Coronary Heart D, Bethesda, MD USA. [Knopp, R. H.] AURORA Study Evaluate Use Rosuvastatin Subjects R, Bethesda, MD USA. [Holdaas, H.; Fellstroem, B.; Jardine, A.; Schmieder, R.; Zannad, F.] BIP Bezafibrate Infarct Prevent Study, Tel Hashomer, Israel. [Goldbourt, U.; Kaplinsky, E.] CARDS Collaborat Atorvastatin Diabet Study, Dublin, Ireland. [Colhoun, H. M.; Betteridge, D. J.; Durrington, P. N.; Hitman, G. A.; Fuller, J.; Neil, A.] 4D Die Deutsch Diabet Dialyse Studie, Wurzburg, Germany. [Wanner, C.; Krane, V.] CARE Cholesterol & Recurrent Events Study, Bethesda, MD USA. [Braunwald, Eugene; Sacks, F.; Moye, L.; Pfeffer, M.; Hawkins, C. M.] CORONA Controlled Rosuvastatin Multinat Trial Hea, Bethesda, MD USA. [Barter, P.] GISSI Grp Italiano Studio Sopravvivenza Infarto M, Chieti, Italy. [Tavazzi, L.; Maggioni, A.] GISSI Prevent, Chieti, Italy. [Franzosi, Maria Grazia; Maggioni, A.; Marchioli, R.; Tognoni, G.] HIT Vet Affairs HDL Intervent Trial, Bethesda, MD USA. [Bloomfield, H.; Robins, S.] Heart Protect Study, Bethesda, MD USA. [Collins, Rory; Sleight, Peter; Keech, Anthony; Armitage, J.; Parish, S.; Peto, R.] IDEAL Incremental Decrease Endpoints Aggress Lipi, Oslo, Norway. [Pedersen, T. R.] JUPITER Justificat Use Statins Prevent Intervent, Bethesda, MD USA. [Ridker, P. M.] Lipids Diabet Study, Bethesda, MD USA. [Holman, R.] LEADER Lower Extrem Arterial Dis Event Reduct Tri, Bethesda, MD USA. [Meade, T.] LIPID Long Term Intervent Pravastatin Ischaem Dis, Bethesda, MD USA. [Simes, John; Tonkin, Andrew; Keech, Anthony; MacMahon, S.; Marschner, I.; Shaw, J.] Lescol Intervent Prevent Study, Iowa City, IA USA. [Serruys, P. W.] MEGA Management Elevated Cholesterol Primary Prev, Bethesda, MD USA. [Nakamura, H.] Post CABG Postcoronary Artery Bypass Graft Study, Bethesda, MD USA. Post CABG Postcoronary Artery Bypass Graft Study, Bethesda, MD USA. [Knatterud, G.] Pravastatin Pooling Project, Bethesda, MD USA. [Furberg, C.; Byington, R.] PROSPER Prospect Study Pravastatin Elderly Risk, Bethesda, MD USA. [Kjekshus, J.; Pedersen, T.; Wilhelmsen, L.] PROVE IT Pravastatin Atorvastatin Evaluat & Infec, Bethesda, MD USA. [Braunwald, Eugene; Murphy, S.; Cannon, C.] Study Effectiveness Addit Reduct Cholesterol & Ho, Bethesda, MD USA. [Collins, Rory; Sleight, Peter; Armitage, J.; Parish, S.; Peto, R.; Bowman, L.] SHARP Study Heart & Renal Protect, Bethesda, MD USA. [Collins, Rory; Baigent, Colin; Landray, M.] Treating New Targets, Bethesda, MD USA. [La Rosa, John] Womens Hlth Initiat, Bethesda, MD USA. [Rossouw, J.; Probstfield, J.] WOSCOPS West Scotland Coronary Prevent Study, Glasgow, Lanark, Scotland. [Simes, John; Barnes, E. H.; Keech, A. C.; Kirby, A.; Marschner, I. C.] Univ Sydney, CTC, Sydney, NSW 2006, Australia. [Collins, Rory; Baigent, Colin; Blackwell, L.; Emberson, J.; Herrington, W. G.; Holland, L. E.; Mihaylova, B.; Reith, C.] Univ Oxford, CTSU, Oxford OX1 2JD, England.
Fulcher, J (reprint author), Natl Hlth & Med Res Council NHMRC Clin Trials Ctr, Level 6 Med Fdn Bldg,92-94 Parramatta Rd, Camperdown, NSW 2050, Australia.
ctt@ctc.usyd.edu.au
AN  - WOS:000352719800028
AU  - Fulcher, J.
AU  - O'Connell, R.
AU  - Voysey, M.
AU  - Emberson, J.
AU  - Blackwell, L.
AU  - Mihaylova, B.
AU  - Simes, J.
AU  - Collins, R.
AU  - Kirby, A.
AU  - Colhoun, H.
AU  - Braunwald, E.
AU  - La Rosa, J.
AU  - Pedersen, T. R.
AU  - Tonkin, A.
AU  - Davis, B.
AU  - Sleight, P.
AU  - Franzosi, M. G.
AU  - Baigent, C.
AU  - Keech, A.
AU  - de Lemos, J.
AU  - Blazing, M.
AU  - Murphy, S.
AU  - Downs, J. R.
AU  - Gotto, A.
AU  - Clearfield, M.
AU  - Holdaas, H.
AU  - Gordon, D.
AU  - Koren, M.
AU  - Dahlof, B.
AU  - Poulter, N.
AU  - Sever, P.
AU  - Knopp, R. H.
AU  - Fellstrom, B.
AU  - Holdaas, H.
AU  - Jardine, A.
AU  - Schmieder, R.
AU  - Zannad, F.
AU  - Goldbourt, U.
AU  - Kaplinsky, E.
AU  - Colhoun, H. M.
AU  - Betteridge, D. J.
AU  - Durrington, P. N.
AU  - Hitman, G. A.
AU  - Fuller, J.
AU  - Neil, A.
AU  - Wanner, C.
AU  - Krane, V.
AU  - Sacks, F.
AU  - Moye, L.
AU  - Pfeffer, M.
AU  - Hawkins, C. M.
AU  - Kjekshus, J.
AU  - Wedel, H.
AU  - Wikstrand, J.
AU  - Barter, P.
AU  - Tavazzi, L.
AU  - Maggioni, A.
AU  - Marchioli, R.
AU  - Tognoni, G.
AU  - Bloomfield, H.
AU  - Robins, S.
AU  - Armitage, J.
AU  - Parish, S.
AU  - Peto, R.
AU  - Pedersen, T. R.
AU  - Ridker, P. M.
AU  - Holman, R.
AU  - Meade, T.
AU  - MacMahon, S.
AU  - Marschner, I.
AU  - Shaw, J.
AU  - Serruys, P. W.
AU  - Nakamura, H.
AU  - Knatterud, G.
AU  - Furberg, C.
AU  - Byington, R.
AU  - Macfarlane, P.
AU  - Cobbe, S.
AU  - Ford, I.
AU  - Murphy, M.
AU  - Blauw, G. J.
AU  - Packard, C.
AU  - Shepherd, J.
AU  - Kjekshus, J.
AU  - Pedersen, T.
AU  - Wilhelmsen, L.
AU  - Cannon, C.
AU  - Murphy, S.
AU  - Armitage, J.
AU  - Bowman, L.
AU  - Parish, S.
AU  - Peto, R.
AU  - Landray, M.
AU  - Rossouw, J.
AU  - Probstfield, J.
AU  - Shepherd, J.
AU  - Cobbe, S.
AU  - Macfarlane, P.
AU  - Ford, I.
AU  - Flather, M.
AU  - Kastelein, J.
AU  - Newman, C.
AU  - Shear, C.
AU  - Tobert, J.
AU  - Varigos, J.
AU  - White, H.
AU  - Yusuf, S.
AU  - Barnes, E. H.
AU  - Keech, A. C.
AU  - Kirby, A.
AU  - Marschner, I. C.
AU  - Blackwell, L.
AU  - Emberson, J.
AU  - Herrington, W. G.
AU  - Holland, L. E.
AU  - Mihaylova, B.
AU  - Reith, C.
AU  - Cholesterol Treatment Trialists, C.
DA  - Apr
DO  - 10.1016/s0140-6736(14)61368-4
IS  - 9976
J2  - Lancet
KW  - coronary-heart-disease
primary prevention
cardiovascular events
myocardial-infarction
secondary prevention
statin therapy
simvastatin
rosuvastatin
guidelines
gender
General & Internal Medicine
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: CF7EU
Times Cited: 436
Cited Reference Count: 36
Fulcher, Jordan O'Connell, Rachel Voysey, Merryn Emberson, Jonathan Blackwell, Lisa Mihaylova, Borislava Simes, John Collins, Rory Kirby, Adrienne Colhoun, Helen Braunwald, Eugene La Rosa, John Pedersen, T. R. Tonkin, Andrew Davis, Barry Sleight, Peter Franzosi, Maria Grazia Baigent, Colin Keech, Anthony de Lemos, J. Blazing, M. Murphy, S. Downs, J. R. Gotto, A. Clearfield, M. Holdaas, H. Gordon, D. Koren, M. Dahloef, B. Poulter, N. Sever, P. Knopp, R. H. Fellstroem, B. Holdaas, H. Jardine, A. Schmieder, R. Zannad, F. Goldbourt, U. Kaplinsky, E. Colhoun, H. M. Betteridge, D. J. Durrington, P. N. Hitman, G. A. Fuller, J. Neil, A. Wanner, C. Krane, V. Sacks, F. Moye, L. Pfeffer, M. Hawkins, C. M. Kjekshus, J. Wedel, H. Wikstrand, J. Barter, P. Tavazzi, L. Maggioni, A. Marchioli, R. Tognoni, G. Bloomfield, H. Robins, S. Armitage, J. Parish, S. Peto, R. Pedersen, T. R. Ridker, P. M. Holman, R. Meade, T. MacMahon, S. Marschner, I. Shaw, J. Serruys, P. W. Nakamura, H. Knatterud, G. Furberg, C. Byington, R. Macfarlane, P. Cobbe, S. Ford, I. Murphy, M. Blauw, G. J. Packard, C. Shepherd, J. Kjekshus, J. Pedersen, T. Wilhelmsen, L. Cannon, C. Murphy, S. Armitage, J. Bowman, L. Parish, S. Peto, R. Landray, M. Rossouw, J. Probstfield, J. Shepherd, J. Cobbe, S. Macfarlane, P. Ford, I. Flather, M. Kastelein, J. Newman, C. Shear, C. Tobert, J. Varigos, J. White, H. Yusuf, S. Barnes, E. H. Keech, A. C. Kirby, A. Marschner, I. C. Blackwell, L. Emberson, J. Herrington, W. G. Holland, L. E. Mihaylova, B. Reith, C.
Jardine, Alan/L-5770-2019; Zannad, Faiez/K-4649-2019
Jardine, Alan/0000-0001-5815-9370; Colhoun, Helen/0000-0002-8345-3288; Venkatasubramanian, Siddharth/0000-0002-5860-0768; bloomfield, hanna/0000-0002-0756-7064; Maggioni, Aldo Pietro/0000-0003-2764-6779; Marschner, Ian/0000-0002-6225-1572; Mihaylova, Borislava/0000-0002-0951-1304; Voysey, Merryn/0000-0001-6324-6559; Emberson, Jonathan/0000-0001-7792-9422; Herrington, William/0000-0003-1172-8243
UK Medical Research CouncilMedical Research Council UK (MRC); British Heart FoundationBritish Heart Foundation; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; European Community Biomed Program; Medical Research CouncilMedical Research Council UK (MRC) [MC_U137686849]
UK Medical Research Council, British Heart Foundation, Australian National Health and Medical Research Council, European Community Biomed Program.
446
11
74
Elsevier science inc
New york
1474-547x
PY  - 2015
SN  - 0140-6736
SP  - 1397-1405
ST  - Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
T2  - Lancet
TI  - Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
UR  - <Go to ISI>://WOS:000352719800028
VL  - 385
ID  - 116
ER  - 

TY  - JOUR
AB  - Background: A main concern that remains with the continued growth of online nursing education programs is the way educator and student relationships can be affected by new technologies. This interpretive study aims to gain an understanding of how technology influences the development of interpersonal relationships between the student and faculty in a virtual learning environment. Method: Using an established structured approach to qualitative metasynthesis, a search was conducted using PubMed, EBSCO, CINAHL, Medline, ProQuest, Ovid Nursing databases, and Google Scholar, focused on caring and relational aspects of online nursing education. Results: Technology alters communication, thereby positioning the intentionality of the educator at the heart of interpersonal relationship development in virtual learning spaces. Conclusion: This interpretive synthesis of prior qualitative research supports the development of a framework for online nursing courses, the need for continuing education of nursing faculty, the value of caring intentions, and enhancement of the educator's technological proficiency.
AD  - [Gdanetz, Lorraine M.; Thomas, Eileen; Tarasenko, Lindsey M.; Horton-Deutsch, Sara; Jones, Jacqueline] Univ Colorado, Coll Nursing, Denver, CO 80202 USA. [Hamer, Mika K.] Colorado Sch Publ Hlth, Dept Hlth Syst Management & Policy, Aurora, CO USA. [Gdanetz, Lorraine M.] Gannon Univ, Villa Maria Sch Nursing, Erie, PA USA. [Tarasenko, Lindsey M.] Univ New Mexico Hosp, Dept Nursing Excellence, Albuquerque, NM USA.
Gdanetz, LM (reprint author), 10588 Wattsburg Rd, Erie, PA 16509 USA.
lorraine.gdanetz@ucdenver.edu
AN  - WOS:000429491000002
AU  - Gdanetz, L. M.
AU  - Hamer, M. K.
AU  - Thomas, E.
AU  - Tarasenko, L. M.
AU  - Horton-Deutsch, S.
AU  - Jones, J.
DA  - Apr
DO  - 10.3928/01484834-20180322-02
IS  - 4
J2  - J. Nurs. Educ.
KW  - student perceptions
Nursing
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GC0TP
Times Cited: 1
Cited Reference Count: 32
Gdanetz, Lorraine M. Hamer, Mika K. Thomas, Eileen Tarasenko, Lindsey M. Horton-Deutsch, Sara Jones, Jacqueline
1
5
Slack inc
Thorofare
1938-2421
PY  - 2018
SN  - 0148-4834
SP  - 197-+
ST  - Technology, Educator Intention, and Relationships in Virtual Learning Spaces: A Qualitative Metasynthesis
T2  - Journal of Nursing Education
TI  - Technology, Educator Intention, and Relationships in Virtual Learning Spaces: A Qualitative Metasynthesis
UR  - <Go to ISI>://WOS:000429491000002
VL  - 57
ID  - 22
ER  - 

TY  - JOUR
AB  - Purpose: In this systematic review, we aimed to synthesize data that identify factors contributing to patient satisfaction in dermatology care using qualitative methods. Materials and methods: We performed a comprehensive search of the literature using the PubMed database for articles published between January 1, 2000 and February 9, 2015. The initial search yielded 186 articles, of which 13 were included after applying inclusion and exclusion criteria. Results: The systematic review of 13 articles included a total of 330 patients. Using in-field observations and semistructured interviews, studies found that qualitative methods and analysis increased the provider's sensitivity to patient needs and enhanced patient care. Analyses using qualitative methods found increased patient satisfaction in their healthcare provider is associated with (1) confidence in the provider's diagnosis, (2) perception of patient-centered, individualized recommendations and (3) quality of patient education and provider explanation during a visit. Conclusions: Patient satisfaction is measured using either quantitative or qualitative methods. Quantitative methods result in standardized data that often does not capture the nuances of patient experience. In contrast, qualitative methodology is integral to gathering patient perspectives on patient care and satisfaction and should be included in future research models.
AD  - [Gibbons, Caitlin; Gibbons, Brittany; Torres, Josefina; Armstrong, April W.] Univ Southern Calif, Keck Sch Med USC, Dept Dermatol, Los Angeles, CA 90089 USA. [Singh, Sanminder; Cheng, Michelle Y.; Wang, Elizabeth A.] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA. [Clark, Caitlin] Univ Hawaii, John A Burns Sch Med, Dept Dermatol, Honolulu, HI 96822 USA. [Clark, Caitlin] Univ Colorado Denver, Dept Dermatol, Anschutz Med Campus, Aurora, CO USA.
Armstrong, AW (reprint author), Univ Southern Calif, 1975 Zonal Ave,KAM 510,MC 9034, Los Angeles, CA 90089 USA.
aprilarmstrong@post.harvard.edu
AN  - WOS:000431742500017
AU  - Gibbons, C.
AU  - Singh, S.
AU  - Gibbons, B.
AU  - Clark, C.
AU  - Torres, J.
AU  - Cheng, M. Y.
AU  - Wang, E. A.
AU  - Armstrong, A. W.
DO  - 10.1080/09546634.2017.1364688
IS  - 3
J2  - J. Dermatol. Treat.
KW  - Qualitative research
patient satisfaction
dermatology
review
epidermolysis-bullosa
psoriasis
children
doctors
eczema
care
Dermatology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: GF2BE
Times Cited: 1
Cited Reference Count: 14
Gibbons, Caitlin Singh, Sanminder Gibbons, Brittany Clark, Caitlin Torres, Josefina Cheng, Michelle Y. Wang, Elizabeth A. Armstrong, April W.
1
0
Taylor & francis ltd
Abingdon
1471-1753
PY  - 2018
SN  - 0954-6634
SP  - 290-294
ST  - Using qualitative methods to understand factors contributing to patient satisfaction among dermatology patients: a systematic review
T2  - Journal of Dermatological Treatment
TI  - Using qualitative methods to understand factors contributing to patient satisfaction among dermatology patients: a systematic review
UR  - <Go to ISI>://WOS:000431742500017
VL  - 29
ID  - 38
ER  - 

TY  - JOUR
AB  - Background: Vascularized grafts from the femur, including the medial femoral condyle and medial femoral trochlea, are increasingly being used. It is critical to understand the lower extremity complications from flap harvest. Methods: The authors searched available literature reporting on femoral flaps using PubMed, Embase, Cochrane Database, and Web of Science. After article selection, data were collected regarding demographics, procedure details, outcomes, and complications. The authors classified outcomes as good, fair, or poor based on pain, range-of-motion, sensory changes, subjective reporting, patient-reported outcomes, and other donor-site complications, including the need for additional procedures. Results: Two hundred twenty articles were identified. Forty-five met criteria for review, with data available for 283 patients. No patients had range-of-motion deficits beyond 1 year. Two percent of patients (six of 283) required additional donor-site procedures, with one report of a femur fracture after medial femoral condyle harvest. Only one study on 45 medial femoral trochlea patients presented patient-reported outcomes regarding the knee. Few objective data were presented. Twenty-eight articles presented adequate complication data for 252 patients to be rated as good, fair, or poor. Overall, 89 percent had good outcomes without donor-site complications. Of the 176 medial femoral condyle patients with outcomes reported, 92 percent had good outcomes; and 71 percent of the 48 medial femoral trochlea patients had good outcomes reported. Conclusions:Overall, the reported donor-site morbidity from medial femoral condyle and medial femoral trochlea harvest is low. Chronic knee pain and sensory changes are most frequently reported, especially in medial femoral trochlea patients.
AD  - [Giladi, Aviram M.] MedStar Union Mem Hosp, Curtis Natl Hand Ctr, 3333 North Calvert St, Baltimore, MD 21218 USA. Beth Israel Deaconess Med Ctr, Div Plast & Reconstruct Surg, Boston, MA 02215 USA. Univ Colorado, Div Plast & Reconstruct Surg, Med Ctr, Boulder, CO 80309 USA.
Giladi, AM (reprint author), MedStar Union Mem Hosp, Curtis Natl Hand Ctr, 3333 North Calvert St, Baltimore, MD 21218 USA.
anne.mattson@medstar.net
AN  - WOS:000442857300015
AU  - Giladi, A. M.
AU  - Rinkinen, J. R.
AU  - Higgins, J. P.
AU  - Iorio, M. L.
DA  - Sep
DO  - 10.1097/prs.0000000000004691
IS  - 3
J2  - Plast. Reconstr. Surg.
KW  - medial femoral condyle
proximal pole
osteochondral flaps
reconstruction
graft
knee
expectations
defects
harvest
satisfaction
Surgery
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: GR7GQ
Times Cited: 2
Cited Reference Count: 60
Giladi, Aviram M. Rinkinen, Jacob R. Higgins, James P. Iorio, Matthew L.
Giladi, Aviram/Y-3204-2019
Giladi, Aviram/0000-0001-7688-957X
2
0
4
Lippincott williams & wilkins
Philadelphia
1529-4242
PY  - 2018
SN  - 0032-1052
SP  - 363E-372E
ST  - Donor-Site Morbidity of Vascularized Bone Flaps from the Distal Femur: A Systematic Review
T2  - Plastic and Reconstructive Surgery
TI  - Donor-Site Morbidity of Vascularized Bone Flaps from the Distal Femur: A Systematic Review
UR  - <Go to ISI>://WOS:000442857300015
VL  - 142
ID  - 9
ER  - 

TY  - JOUR
AB  - BACKGROUND: It is estimated that 40% to 60% of patients with obsessive-compulsive disorder (OCD) continue to experience symptoms despite adequate medical management. For this population of treatment-refractory patients, promising results have been reported with the use of deep brain stimulation (DBS). OBJECTIVE: To conduct a systematic review of the literature and develop evidence-based guidelines on DBS for OCD. METHODS: A systematic literature search was undertaken using the PubMed database for articles published between 1966 and October 2012 combining the following words: "deep brain stimulation and obsessive-compulsive disorder" or "electrical stimulation and obsessive-compulsive disorder." Of 353 articles, 7 were retrieved for full-text review and analysis. The quality of the articles was assigned to each study and the strength of recommendation graded according to the guidelines development methodology of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Guidelines Committee. RESULTS: Of the 7 studies, 1 class I and 2 class II double-blind, randomized, controlled trials reported that bilateral DBS is more effective in improving OCD symptoms than sham treatment. CONCLUSION: Based on the data published in the literature, the following recommendations can be made: (1) There is Level I evidence, based on a single class I study, for the use of bilateral subthalamic nucleus DBS for the treatment of medically refractory OCD. (2) There is Level II evidence, based on a single class II study, for the use of bilateral nucleus accumbens DBS for the treatment of medically refractory OCD. (3) There is insufficient evidence to make a recommendation for the use of unilateral DBS for the treatment of medically refractory OCD.
AD  - [Hamani, Clement] Toronto Western Hosp, Div Neurosurg, Ctr Addict & Mental Hlth, Toronto, ON M5T 2S8, Canada. [Pilitsis, Julie] Albany Med Coll, Dept Neurosurg, Albany, NY 12208 USA. [Pilitsis, Julie] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA. [Rughani, Anand I.] Maine Med Ctr, Neurosci Inst, Portland, ME 04102 USA. [Rosenow, Joshua M.] Northwestern Univ, Dept Neurosurg, Chicago, IL 60611 USA. [Patil, Parag G.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA. [Patil, Parag G.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA. [Patil, Parag G.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA. [Patil, Parag G.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA. [Slavin, Konstantin S.] Univ Chicago, Dept Neurosurg, Chicago, IL 60637 USA. [Abosch, Aviva] Univ Colorado, Dept Neurosurg, Denver, CO 80202 USA. [Eskandar, Emad] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA. [Mitchell, Laura S.] Congress Neurol Surg, Guidelines Dept, Schaumburg, IL USA. [Kalkanis, Steven] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA.
Hamani, C (reprint author), Toronto Western Hosp, Div Neurosurg, 399 Bathurst St,WW 4-437, Toronto, ON M5T 2S8, Canada.
Clement.Hamani@uhn.on.ca
AN  - WOS:000342662300013
AU  - Hamani, C.
AU  - Pilitsis, J.
AU  - Rughani, A. I.
AU  - Rosenow, J. M.
AU  - Patil, P. G.
AU  - Slavin, K. S.
AU  - Abosch, A.
AU  - Eskandar, E.
AU  - Mitchell, L. S.
AU  - Kalkanis, S.
DA  - Oct
DO  - 10.1227/neu.0000000000000499
IS  - 4
J2  - Neurosurgery
KW  - Deep brain stimulation
Guidelines
Obsessive-compulsive disorder
Neuromodulation
Psychiatry
nucleus-accumbens
electrical-stimulation
internal capsules
anterior
limbs
pharmacotherapy
outcomes
Neurosciences & Neurology
Surgery
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: AQ3AY
Times Cited: 38
Cited Reference Count: 33
Hamani, Clement Pilitsis, Julie Rughani, Anand I. Rosenow, Joshua M. Patil, Parag G. Slavin, Konstantin S. Abosch, Aviva Eskandar, Emad Mitchell, Laura S. Kalkanis, Steven
Patil, Parag G/D-1618-2016; Abosch, Aviva/U-7963-2019; Slavin, Konstantin/H-3269-2019
Slavin, Konstantin/0000-0002-7946-8639
Boston ScientificBoston Scientific; St JudeSt. Jude Medical; MedtronicMedtronic; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA
Dr Hamani is a consultant for St. Jude Medical; Dr Pilitsis is a consultant for St. Jude Medical, Boston Scientific, and Medtronic and has grant support from Boston Scientific, St Jude, Medtronic, and the NIH; Dr Rosenow is a consultant for Boston Scientific; Dr Patil receives research support from Medtronic; Dr Abosch has an ad hoc consulting agreement with Medtronic; Dr Slavin is a consultant, advisory board member, and/or received honoraria from Medtronic, St. Jude Medical, Boston Scientific, Bioness, Greatbatch, Stimwave, and Nevro. The authors have no personal, financial, or institutional interest in any drugs, materials, or devices described in this article.
38
1
9
Oxford univ press inc
Cary
1524-4040
PY  - 2014
SN  - 0148-396X
SP  - 327-333
ST  - Deep Brain Stimulation for Obsessive-Compulsive Disorder: Systematic Review and Evidence-Based Guideline Sponsored by the American Society for Stereotactic and Functional Neurosurgery and the Congress of Neurological Surgeons (CNS) and Endorsed by the CNS and American Association of Neurological Surgeons
T2  - Neurosurgery
TI  - Deep Brain Stimulation for Obsessive-Compulsive Disorder: Systematic Review and Evidence-Based Guideline Sponsored by the American Society for Stereotactic and Functional Neurosurgery and the Congress of Neurological Surgeons (CNS) and Endorsed by the CNS and American Association of Neurological Surgeons
UR  - <Go to ISI>://WOS:000342662300013
VL  - 75
ID  - 133
ER  - 

TY  - JOUR
AB  - We conducted a 1000 Genomes-imputed genome-wide association study (GWAS) meta-analysis for nicotine dependence, defined by the Fagerstrom Test for Nicotine Dependence in 17 074 ever smokers from five European-ancestry samples. We followed up novel variants in 7469 ever smokers from five independent European-ancestry samples. We identified genome-wide significant association in the alpha-4 nicotinic receptor subunit (CHRNA4) gene on chromosome 20q13: lowest P = 8.0 x 10(-9) across all the samples for rs2273500-C (frequency = 0.15; odds ratio = 1.12 and 95% confidence interval = 1.08-1.17 for severe vs mild dependence). rs2273500-C, a splice site acceptor variant resulting in an alternate CHRNA4 transcript predicted to be targeted for nonsense-mediated decay, was associated with decreased CHRNA4 expression in physiologically normal human brains (lowest P = 7.3 x 10(-4)). Importantly, rs2273500-C was associated with increased lung cancer risk (N = 28 998, odds ratio = 1.06 and 95% confidence interval = 1.00-1.12), likely through its effect on smoking, as rs2273500-C was no longer associated with lung cancer after adjustment for smoking. Using criteria for smoking behavior that encompass more than the single 'cigarettes per day' item, we identified a common CHRNA4 variant with important regulatory properties that contributes to nicotine dependence and smoking-related consequences.
AD  - [Hancock, D. B.; Glasheen, C.] Res Triangle Inst Int, Behav Hlth & Criminal Justice Res Div, Behav & Urban Hlth Program, Res Triangle Pk, NC 27709 USA. [Reginsson, G. W.; Steinberg, S.; Zink, F.; Stacey, S. N.; Gudbjartsson, D. F.; Thorgeirsson, T. E.; Stefansson, K.] deCODE Genet Amgen, Reykjavik, Iceland. [Gaddis, N. C.] Res Triangle Inst Int, Res Comp Div, Res Triangle Pk, NC USA. [Chen, X.; Chen, J.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA. [Chen, X.] Univ Nevada, Nevada Inst Personalized Med, Las Vegas, NV 89154 USA. [Chen, X.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA. [Saccone, N. L.] Washington Univ, Dept Genet, St Louis, MO 63110 USA. [Lutz, S. M.] Univ Colorado, Dept Biostat & Informat, Aurora, CO USA. [Qaiser, B.; Loukola, A.; Kaprio, J.] Univ Helsinki, Dept Publ Hlth, Fac Med, Helsinki, Finland. [Sherva, R.; Farrer, L.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA. [Gu, F.; Landi, M. T.; Caporaso, N. E.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,United States Dept Hlth & Human Serv, Bethesda, MD 20892 USA. [Frederiksen, B. N.] Iowa Dept Publ Hlth, Des Moines, IA 50319 USA. [Brueske, I.] German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany. [Bickeboeller, H.] Univ Gottingen, Dept Genet Epidemiol, D-37073 Gottingen, Germany. [Madden, P.; Bierut, L. J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA. [Farrer, L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA. [Farrer, L.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA. [Farrer, L.] Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA. [Farrer, L.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA. [Farrer, L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA. [Kaprio, J.] Natl Inst Hlth & Welf, Helsinki, Finland. [Kaprio, J.] Univ Helsinki, Inst Mol Med, Helsinki, Finland. [Kranzler, H. R.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA. [Kranzler, H. R.] Philadelphia VA Med Ctr, Educ & Clin Ctr, VISN Mental Illness Res 4, Philadelphia, PA USA. [Gelernter, J.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA. [Gelernter, J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA. [Gelernter, J.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA. [Gelernter, J.] VA CT Healthcare Ctr, Dept Psychiat, West Haven, CT USA. [Baker, T. B.] Univ Wisconsin, Ctr Tobacco Res & Intervent, Madison, WI USA. [Kraft, P.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA. [Kraft, P.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA. [Amos, C. I.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH USA. [Amos, C. I.] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH USA. [Amos, C. I.] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Hanoven, NH USA. [Hokanson, J. E.] Univ Colorado, Dept Epidemiol, Aurora, CO USA. [Johnson, E. O.] Res Triangle Inst Int, Fellow Program, Res Triangle Pk, NC 27709 USA. [Johnson, E. O.] Res Triangle Inst Int, Behav Hlth & Criminal Justice Res Div, Res Triangle Pk, NC 27709 USA. [Stefansson, K.] Univ Iceland, Fac Med, Reykjavik, Iceland.
Hancock, DB (reprint author), Res Triangle Inst Int, Behav Hlth & Criminal Justice Res Div, Behav & Urban Hlth Program, East Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA.
dhancock@rti.org
AN  - WOS:000367663600002
AU  - Hancock, D. B.
AU  - Reginsson, G. W.
AU  - Gaddis, N. C.
AU  - Chen, X.
AU  - Saccone, N. L.
AU  - Lutz, S. M.
AU  - Qaiser, B.
AU  - Sherva, R.
AU  - Steinberg, S.
AU  - Zink, F.
AU  - Stacey, S. N.
AU  - Glasheen, C.
AU  - Chen, J.
AU  - Gu, F.
AU  - Frederiksen, B. N.
AU  - Loukola, A.
AU  - Gudbjartsson, D. F.
AU  - Bruske, I.
AU  - Landi, M. T.
AU  - Bickeboller, H.
AU  - Madden, P.
AU  - Farrer, L.
AU  - Kaprio, J.
AU  - Kranzler, H. R.
AU  - Gelernter, J.
AU  - Baker, T. B.
AU  - Kraft, P.
AU  - Amos, C. I.
AU  - Caporaso, N. E.
AU  - Hokanson, J. E.
AU  - Bierut, L. J.
AU  - Thorgeirsson, T. E.
AU  - Johnson, E. O.
AU  - Stefansson, K.
C7  - e651
DA  - Oct
DO  - 10.1038/tp.2015.149
J2  - Transl. Psychiatr.
KW  - lung-cancer risk
acetylcholine-receptors
genotype imputation
smoking-behavior
susceptibility locus
european-americans
controlled-trial
candidate genes
fagerstrom test
quality-control
Psychiatry
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: DA2YR
Times Cited: 33
Cited Reference Count: 92
Hancock, D. B. Reginsson, G. W. Gaddis, N. C. Chen, X. Saccone, N. L. Lutz, S. M. Qaiser, B. Sherva, R. Steinberg, S. Zink, F. Stacey, S. N. Glasheen, C. Chen, J. Gu, F. Frederiksen, B. N. Loukola, A. Gudbjartsson, D. F. Brueske, I. Landi, M. T. Bickeboeller, H. Madden, P. Farrer, L. Kaprio, J. Kranzler, H. R. Gelernter, J. Baker, T. B. Kraft, P. Amos, C. I. Caporaso, N. E. Hokanson, J. E. Bierut, L. J. Thorgeirsson, T. E. Johnson, E. O. Stefansson, K.
Bierut, Laura Jean/W-6806-2019; Bickeboller, Heike/V-2318-2018
Bierut, Laura Jean/0000-0002-9952-4810; Bickeboller, Heike/0000-0002-3361-5488; Loukola, Anu-Maria/0000-0003-0542-5967; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Hancock, Dana/0000-0003-2240-3604; Johnson, Eric Otto/0000-0002-8870-1949; Gaddis, Nathan/0000-0001-5205-7138; Sherva, Richard/0000-0003-2133-1493; Farrer, Lindsay/0000-0001-5533-4225; Kaprio, Jaakko/0000-0002-3716-2455; Chen, Jingchun/0000-0001-9408-0117; Gelernter, Joel/0000-0002-4067-1859
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA035825]
This work was supported by the National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) grant number R01 DA035825. Acknowledgments for the study samples used to conduct the GWAS meta-analysis, independent replication testing for nicotine dependence and follow-up association testing with lung cancer are included in the Supplementary Information.
33
1
7
Nature publishing group
New york
PY  - 2015
SN  - 2158-3188
SP  - 11
ST  - Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence
T2  - Translational Psychiatry
TI  - Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence
UR  - <Go to ISI>://WOS:000367663600002
VL  - 5
ID  - 101
ER  - 

TY  - JOUR
AB  - Background An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB; Mycobacterium tuberculosis resistant to isoniazid and rifampin) each year. Little is known about the optimal treatment for these children. Methods and findings To inform the pediatric aspects of the revised World Health Organization (WHO) MDR-TB treatment guidelines, we performed a systematic review and individual patient data (IPD) meta-analysis, describing treatment outcomes in children treated for MDR-TB. To identify eligible reports we searched PubMed, LILACS, Embase, The Cochrane Library, PsychINFO, and BioMedCentral databases through 1 October 2014. To identify unpublished data, we reviewed conference abstracts, contacted experts in the field, and requested data through other routes, including at national and international conferences and through organizations working in pediatric MDR-TB. A cohort was eligible for inclusion if it included a minimum of three children (aged <15 years) who were treated for bacteriologically confirmed or clinically diagnosed MDR-TB, and if treatment outcomes were reported. The search yielded 2,772 reports; after review, 33 studies were eligible for inclusion, with IPD provided for 28 of these. All data were from published or unpublished observational cohorts. We analyzed demographic, clinical, and treatment factors as predictors of treatment outcome. In order to obtain adjusted estimates, we used a random-effects multivariable logistic regression (random intercept and random slope, unless specified otherwise) adjusted for the following covariates: age, sex, HIV infection, malnutrition, severe extrapulmonary disease, or the presence of severe disease on chest radiograph. We analyzed data from 975 children from 18 countries; 731 (75%) had bacteriologically confirmed and 244 (25%) had clinically diagnosed MDR-TB. The median age was 7.1 years. Of 910 (93%) children with documented HIV status, 359 (39%) were infected with HIV. When compared to clinically diagnosed patients, children with confirmed MDR-TB were more likely to be older, to be infected with HIV, to be malnourished, and to have severe tuberculosis (TB) on chest radiograph (p < 0.001 for all characteristics). Overall, 764 of 975 (78%) had a successful treatment outcome at the conclusion of therapy: 548/731 (75%) of confirmed and 216/244 (89%) of clinically diagnosed children (absolute difference 14%, 95% confidence interval [CI] 8% +/- 19%, p < 0.001). Treatment was successful in only 56% of children with bacteriologically confirmed TB who were infected with HIV who did not receive any antiretroviral treatment (ART) during MDR-TB therapy, compared to 82% in children infected with HIV who received ART during MDR-TB therapy (absolute difference 26%, 95% CI 5% +/- 48%, p = 0.006). In children with confirmed MDR-TB, the use of second-line injectable agents and high-dose isoniazid (15 +/- 20 mg/kg/day) were associated with treatment success (adjusted odds ratio [aOR] 2.9, 95% CI 1.0 +/- 8.3, p = 0.041 and aOR 5.9, 95% CI 1.7 +/- 20.5, p = 0.007, respectively). These findings for high-dose isoniazid may have been affected by site effect, as the majority of patients came from Cape Town. Limitations of this study include the difficulty of estimating the treatment effects of individual drugs within multidrug regimens, only observational cohort studies were available for inclusion, and treatment decisions were based on the clinician's perception of illness, with resulting potential for bias. Conclusions This study suggests that children respond favorably to MDR-TB treatment. The low success rate in children infected with HIV who did not receive ART during their MDR-TB treatment highlights the need for ART in these children. Our findings of individual drug effects on treatment outcome should be further evaluated.
AD  - [Harausz, Elizabeth P.; Garcia-Prats, Anthony J.; Schaaf, H. Simon; Hesseling, Anneke C.] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Tygerberg, South Africa. [Harausz, Elizabeth P.] Mil HIV Res Program, Bethesda, MD 20817 USA. [Law, Stephanie; Menzies, Dick] McGill Univ, Montreal Chest Inst, Montreal, PQ, Canada. [Kredo, Tamara] South African Med Res Council, Cochrane South Africa, Cape Town, South Africa. [Seddon, James A.] Imperial Coll, Ctr Int Child Hlth, London, England. [Turkova, Anna] Imperial Coll Healthcare NHS Trust, Inst Clin Trials & Methodol, London, England. [Achar, Jay] MSF, Manson Unit, London, England. [Amanullah, Farhana] Ind Hosp, Karachi, Pakistan. [Barry, Pennan; Flood, Jennifer] Calif Dept Publ Hlth, Sacramento, CA USA. [Becerra, Mercedes; Drobac, Peter C.] Harvard Med Sch, Partners Hlth, Boston, MA USA. [Becerra, Mercedes; Drobac, Peter C.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA. [Chan, Edward D.] Natl Jewish Hlth, Denver Vet Affairs Med Ctr, Denver, CO USA. [Chan, Pei Chun] Ctr Dis Control, Div Chron Infect Dis, Taipei, Taiwan. [Chiotan, Domnica Ioana] Romanian Natl TB Program, Epidemiol Surveillance Dept, Bucharest, Romania. [Crossa, Aldo] New York City Dept Hlth & Mental Hyg, New York, NY USA. [Fairlie, Lee] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst WRHI, Johannesburg, South Africa. [Falzon, Dennis] World Hlth Org, Global TB Programme, Labs Diagnost & Drug Resistance Unit, Geneva, Switzerland. [Gegia, Medea] World Hlth Org, Global TB Programme, Tech Support Coordinat, Geneva, Switzerland. [Hicks, Robert M.; Shah, N. Sarita] Albert Einstein Coll Med, Bronx, NY 10467 USA. [Isaakidis, Petros] MSF, Doctors Borders, Bombay, Maharashtra, India. [Kadri, S. M.] Directorate Hlth Serv, Dis Control, Kashmir, India. [Kampmann, Beate] Imperial Coll London, Ctr Int Child Hlth, Paediat Infect & Immun, London, England. [Kampmann, Beate] MRC Unit Gambia, Vaccines & Immun Theme, Banjul, Gambia. [Madhi, Shabir A.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa. [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa. [Marais, Else] Univ Witwatersrand, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa. [Marais, Else] Natl Hlth Lab Serv, Johannesburg, South Africa. [Mariandyshev, Andrei; Yablokova, Elena] Northern State Med Univ, Arkhangelsk, Russia. [Mendez-Echevarria, Ana] Hosp La Paz, Pediat Infect & Trop Dis Dept, Madrid, Spain. [Moore, Brittany Kathryn; Shah, N. Sarita] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA. [Nargiza, Parpieva] Minist Hlth, Republican Sci Med Ctr Phtiziol & Pulmonol, Tashkent, Uzbekistan. [Ozere, Iveta] Riga Eastern Clin Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia. [Padayatchi, Nesri] MRC, TB HIV Pathogenesis Unit, CAPRISA, Durban, South Africa. [Saleem-ur-Rehman] Director Hlth Serv, Kashmir, India. [Rybak, Natasha] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA. [Santiago-Garcia, Begona] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Pediat Infect Dis Unit, Madrid, Spain. [Sharma, Sangeeta] Natl Inst TB & Resp Dis, Dept Pediat, New Delhi, India. [Shim, Tae Sun] Univ Ulsan, Coll Med, Dept Pulm & Crit Care Med, Asan Med Ctr, Seoul, South Korea. [Skrahina, Alena] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS. [Soriano-Arandes, Antoni] Hosp Univ Vall dHebron, Unit Int Hlth TB Drassanes Vall Hebron, Pediat Infect Dis & Immunodeficiencies Unit, Barcelona, Spain. [van den Boom, Martin] WHO Reg Off Europe, Joint TB HIV & Viral Hepatitis Programme, Copenhagen, Denmark. [van der Werf, Marieke J.] European Ctr Dis Prevent & Control, Dis Programme TB, Stockholm, Sweden. [van der Werf, Tjip S.] Univ Med Ctr Groningen, Groningen, Netherlands. [Williams, Bhanu] London Northwest Healthcare NHS Trust, Northwick Pk Hosp, London, England. [Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea. [Furin, Jennifer] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA. [Hicks, Robert M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.
Harausz, EP; Hesseling, AC (reprint author), Stellenbosch Univ, Fac Med & Hlth Sci, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Tygerberg, South Africa.; Harausz, EP (reprint author), Mil HIV Res Program, Bethesda, MD 20817 USA.
epharausz@gmail.com; annekeh@sun.ac.za
AN  - WOS:000440339700002
AU  - Harausz, E. P.
AU  - Garcia-Prats, A. J.
AU  - Law, S.
AU  - Schaaf, H. S.
AU  - Kredo, T.
AU  - Seddon, J. A.
AU  - Menzies, D.
AU  - Turkova, A.
AU  - Achar, J.
AU  - Amanullah, F.
AU  - Barry, P.
AU  - Becerra, M.
AU  - Chan, E. D.
AU  - Chan, P. C.
AU  - Chiotan, D. I.
AU  - Crossa, A.
AU  - Drobac, P. C.
AU  - Fairlie, L.
AU  - Falzon, D.
AU  - Flood, J.
AU  - Gegia, M.
AU  - Hicks, R. M.
AU  - Isaakidis, P.
AU  - Kadri, S. M.
AU  - Kampmann, B.
AU  - Madhi, S. A.
AU  - Marais, E.
AU  - Mariandyshev, A.
AU  - Mendez-Echevarria, A.
AU  - Moore, B. K.
AU  - Nargiza, P.
AU  - Ozere, I.
AU  - Padayatchi, N.
AU  - Saleem ur, Rehman
AU  - Rybak, N.
AU  - Santiago-Garcia, B.
AU  - Shah, N. S.
AU  - Sharma, S.
AU  - Shim, T. S.
AU  - Skrahina, A.
AU  - Soriano-Arandes, A.
AU  - van den Boom, M.
AU  - van der Werf, M. J.
AU  - van der Werf, T. S.
AU  - Williams, B.
AU  - Yablokova, E.
AU  - Yim, J. J.
AU  - Furin, J.
AU  - Hesseling, A. C.
AU  - Collaborative Grp, Meta-Analysis
C7  - e1002591
DA  - Jul
DO  - 10.1371/journal.pmed.1002591
IS  - 7
J2  - PLos Med.
KW  - pulmonary tuberculosis
antiretroviral therapy
young-children
south-africa
disease
management
initiation
trends
General & Internal Medicine
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GO8KY
Times Cited: 14
Cited Reference Count: 51
Harausz, Elizabeth P. Garcia-Prats, Anthony J. Law, Stephanie Schaaf, H. Simon Kredo, Tamara Seddon, James A. Menzies, Dick Turkova, Anna Achar, Jay Amanullah, Farhana Barry, Pennan Becerra, Mercedes Chan, Edward D. Chan, Pei Chun Chiotan, Domnica Ioana Crossa, Aldo Drobac, Peter C. Fairlie, Lee Falzon, Dennis Flood, Jennifer Gegia, Medea Hicks, Robert M. Isaakidis, Petros Kadri, S. M. Kampmann, Beate Madhi, Shabir A. Marais, Else Mariandyshev, Andrei Mendez-Echevarria, Ana Moore, Brittany Kathryn Nargiza, Parpieva Ozere, Iveta Padayatchi, Nesri Saleem-ur-Rehman Rybak, Natasha Santiago-Garcia, Begona Shah, N. Sarita Sharma, Sangeeta Shim, Tae Sun Skrahina, Alena Soriano-Arandes, Antoni van den Boom, Martin van der Werf, Marieke J. van der Werf, Tjip S. Williams, Bhanu Yablokova, Elena Yim, Jae-Joon Furin, Jennifer Hesseling, Anneke C.
padayatchi, nesri/Q-2780-2019; Soriano-Arandes, Antoni/G-6851-2013; Maryandyshev, Andrey/D-1744-2018
padayatchi, nesri/0000-0003-2543-9071; Soriano Arandes, Antoni/0000-0001-9613-7228; Maryandyshev, Andrey/0000-0002-8485-5625; Seddon, James/0000-0002-2296-2302; ANA, MENDEZ ECHEVARRIA/0000-0002-7455-9080; Madhi, Shabir/0000-0002-7629-0636; Achar, Jay/0000-0002-2521-4422; Schaaf, Hendrik Simon/0000-0001-5755-4133; Isaakidis, Petros/0000-0002-7881-1554
USAID by the World Health OrganizationUnited States Agency for International Development (USAID)
Funding for this study was provided through a USAID grant made available by the World Health Organization. DF, MG, and MvdB are WHO employees but not involved in decisions to allocate funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
16
1
3
Public library science
San francisco
1549-1676
PY  - 2018
SN  - 1549-1277
SP  - 26
ST  - Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
T2  - Plos Medicine
TI  - Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
UR  - <Go to ISI>://WOS:000440339700002
VL  - 15
ID  - 16
ER  - 

TY  - JOUR
AD  - [Hill, Mary K.; Pishkenari, Azin Kheirandish] Univ Colorado, Sch Med, Aurora, CO USA. [Armstrong, April W.; Dunnick, Cory A.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA.
AN  - WOS:000412760201242
AU  - Hill, M. K.
AU  - Pishkenari, A. K.
AU  - Armstrong, A. W.
AU  - Dunnick, C. A.
DA  - May
IS  - 5
J2  - J. Am. Acad. Dermatol.
KW  - Dermatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: FJ5BR
Times Cited: 0
Cited Reference Count: 0
Hill, Mary K. Pishkenari, Azin Kheirandish Armstrong, April W. Dunnick, Cory A.
74th Annual Meeting of the American-Academy-of-Dermatology
Mar 04-08, 2016
Washington, DC
Amer Acad Dermatol
0
Mosby-elsevier
New york
1
PY  - 2016
SN  - 0190-9622
SP  - AB86-AB86
ST  - Current trends in the use of disease severity and quality of life measures for atopic dermatitis: A systematic review
T2  - Journal of the American Academy of Dermatology
TI  - Current trends in the use of disease severity and quality of life measures for atopic dermatitis: A systematic review
UR  - <Go to ISI>://WOS:000412760201242
VL  - 74
ID  - 87
ER  - 

TY  - JOUR
AD  - [Hines, Brittany; Wright, Benjamin L.; Marks, Lisa] Mayo Clin, Scottsdale, AZ USA. [Rank, Matthew A.] Mayo Clin & Mayo Fdn, Scottsdale, AZ USA. [Greenhawt, Matthew J.] Childrens Hosp Colorado, Aurora, CO USA. [Dellon, Evan S.] Univ N Carolina, Chapel Hill, NC USA.
AN  - WOS:000429306700438
AU  - Hines, B.
AU  - Rank, M. A.
AU  - Wright, B. L.
AU  - Marks, L.
AU  - Greenhawt, M. J.
AU  - Dellon, E. S.
DA  - Feb
IS  - 2
J2  - J. Allergy Clin. Immunol.
KW  - Allergy
Immunology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GB8DX
Times Cited: 0
Cited Reference Count: 0
Hines, Brittany Rank, Matthew A. Wright, Benjamin L. Marks, Lisa Greenhawt, Matthew J. Dellon, Evan S.
American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress
Mar 02-08, 2018
Orlando, FL
Amer Acad Allergy Asthma & Immunol, World Allergy Org
0
1
Mosby-elsevier
New york
1097-6825
S
PY  - 2018
SN  - 0091-6749
SP  - AB139-AB139
ST  - Failure to Consider Atopic Status Limits Existing Minimally-Invasive Biomarker Studies in Eosinophilic Esophagitis: A Systematic Review
T2  - Journal of Allergy and Clinical Immunology
TI  - Failure to Consider Atopic Status Limits Existing Minimally-Invasive Biomarker Studies in Eosinophilic Esophagitis: A Systematic Review
UR  - <Go to ISI>://WOS:000429306700438
VL  - 141
ID  - 32
ER  - 

TY  - JOUR
AB  - Background: This umbrella review aimed at eliciting good practice characteristics of interventions and policies aiming at healthy diet, increasing physical activity, and lowering sedentary behaviors. Applying the World Health Organization's framework, we sought for 3 types of characteristics, reflecting: (1) main intervention/policy characteristics, referring to the design, targets, and participants, (2) monitoring and evaluation processes, and (3) implementation issues. This investigation was undertaken by the DEDPIAC Knowledge Hub (the Knowledge Hub on the DEterminants of DIet and Physical ACtivity), which is an action of the European Union's joint programming initiative. Methods: A systematic review of reviews and stakeholder documents was conducted. Data from 7 databases was analyzed (99 documents met inclusion criteria). Additionally, resources of 7 major stakeholders (e. g., World Health Organization) were systematically searched (10 documents met inclusion criteria). Overall, the review yielded 74 systematic reviews, 16 position review papers, and 19 stakeholders' documents. Across characteristics, 25% were supported by = 4 systematic reviews. Further, 25% characteristics were supported by = 3 stakeholders' documents. If identified characteristics were included in at least 4 systematic reviews or at least 3 stakeholders' documents, these good practice characteristics were classified as relevant. Results: We derived a list of 149 potential good practice characteristics, of which 53 were classified as relevant. The main characteristics of intervention/policy (n = 18) fell into 6 categories: the use of theory, participants, target behavior, content development/management, multidimensionality, practitioners/settings. Monitoring and evaluation characteristics (n = 18) were grouped into 6 categories: costs/funding, outcomes, evaluation of effects, time/effect size, reach, the evaluation of participation and generalizability, active components/underlying processes. Implementation characteristics (n = 17) were grouped into eight categories: participation processes, training for practitioners, the use/integration of existing resources, feasibility, maintenance/sustainability, implementation partnerships, implementation consistency/adaptation processes, transferability. Conclusions: The use of the proposed list of 53 good practice characteristics may foster further development of health promotion sciences, as it would allow for identification of success vectors in the domains of main characteristics of interventions/policies, their implementation, evaluation and monitoring processes.
AD  - [Horodyska, Karolina; Luszczynska, Aleksandra] Univ Social Sci & Humanities, Dept Psychol, PL-53238 Wroclaw, Poland. [Luszczynska, Aleksandra] Univ Colorado, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80933 USA. [van den Berg, Matthijs; Hendriksen, Marieke] Natl Inst Publ Hlth & Environm, NL-3721 Bilthoven, Netherlands. [Roos, Gun] SIFO Natl Inst Consumer Res, N-0405 Oslo, Norway. [De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium. [Brug, Johannes] Vrije Univ Amsterdam Med Ctr, NL-1081 BT Amsterdam, Netherlands.
Luszczynska, A (reprint author), Univ Social Sci & Humanities, Dept Psychol, 30b Ostrowskiego St, PL-53238 Wroclaw, Poland.
aluszczy@uccs.edu
AN  - WOS:000349415300003
AU  - Horodyska, K.
AU  - Luszczynska, A.
AU  - van den Berg, M.
AU  - Hendriksen, M.
AU  - Roos, G.
AU  - De Bourdeaudhuij, I.
AU  - Brug, J.
C7  - 19
DA  - Jan
DO  - 10.1186/s12889-015-1354-9
J2  - BMC Public Health
KW  - Physical activity
Sedentary behavior
Diet
Good practice
Intervention
Policy
Systematic review
health behavior-change
obesity prevention interventions
school-based
interventions
life-style interventions
childhood obesity
weight-gain
body-weight
sedentary behaviors
systematic reviews
cancer prevention
Public, Environmental & Occupational Health
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: CB1VE
Times Cited: 33
Cited Reference Count: 125
Horodyska, Karolina Luszczynska, Aleksandra van den Berg, Matthijs Hendriksen, Marieke Roos, Gun De Bourdeaudhuij, Ilse Brug, Johannes
Luszczynska, Aleksandra/F-3692-2014; Brug, Johannes/A-8242-2018
Luszczynska, Aleksandra/0000-0002-4704-9544; Brug, Johannes/0000-0002-1904-7349; Roos, Gun/0000-0001-8551-2491
DEDIPAC Knowledge Hub; Joint Programming Initiative (JPI) a Healthy Diet for a Healthy Life, a research and innovation initiative of European Union member states and associated countries; Belgium: Research Foundation - Flanders; Netherlands: The Netherlands Organisation for Health Research and Development (ZonMw); Norway: The Research Council of Norway; Poland: The National Centre for Research and Development
The preparation of this paper was supported by the DEDIPAC Knowledge Hub. The DEDIPAC project is funded under the Joint Programming Initiative (JPI) a Healthy Diet for a Healthy Life, a research and innovation initiative of European Union member states and associated countries. The content of this article reflects only the authors' views and the Joint Programming Initiative (JPI) a Healthy Diet for a Healthy Life is not liable for any use that may be made of the information contained therein. This article is supported by the following funding agencies (in alphabetical order of participating Member State): Belgium: Research Foundation - Flanders; The Netherlands: The Netherlands Organisation for Health Research and Development (ZonMw); Norway: The Research Council of Norway; Poland: The National Centre for Research and Development.
33
0
45
Bmc
London
PY  - 2015
SN  - 1471-2458
SP  - 16
ST  - Good practice characteristics of diet and physical activity interventions and policies: an umbrella review
T2  - Bmc Public Health
TI  - Good practice characteristics of diet and physical activity interventions and policies: an umbrella review
UR  - <Go to ISI>://WOS:000349415300003
VL  - 15
ID  - 122
ER  - 

TY  - JOUR
AB  - Background Health services often manage agitated or violent people, and such behaviour is particularly prevalent in emergency psychiatric services (10%). The drugs used in such situations should ensure that the person becomes calm swiftly and safely. Objectives To examine whether haloperidol plus promethazine is an effective treatment for psychosis-induced aggression. Search methods On 6 May 2015 we searched the Cochrane Schizophrenia Group's Register of Trials, which is compiled by systematic searches of major resources (including MEDLINE, EMBASE, AMED, BIOSIS, CINAHL, PsycINFO, PubMed, and registries of clinical trials) and their monthly updates, handsearches, grey literature, and conference proceedings. Selection criteria All randomised clinical trials with useable data focusing on haloperidol plus promethazine for psychosis-induced aggression. Data collection and analysis We independently extracted data. For binary outcomes, we calculated risk ratio (RR) and its 95% confidence interval (CI), on an intention-to-treat basis. For continuous data, we estimated the mean difference (MD) between groups and its 95% CI. We employed a fixed-effect model for analyses. We assessed risk of bias for included studies and created 'Summary of findings' tables using GRADE. Main results We found two new randomised controlled trials (RCTs) from the 2015 update searching. The review now includes six studies, randomising 1367 participants and presenting data relevant to six comparisons. When haloperidol plus promethazine was compared with haloperidol alone for psychosis-induced aggression for the outcome not tranquil or asleep at 30 minutes, the combination treatment was clearly more effective (n=316, 1 RCT, RR 0.65, 95% CI 0.49 to 0.87, high-quality evidence). There were 10 occurrences of acute dystonia in the haloperidol alone arm and none in the combination group. The trial was stopped early as haloperidol alone was considered to be too toxic. When haloperidol plus promethazine was compared with olanzapine, high-quality data showed both approaches to be tranquillising. It was suggested that the combination of haloperidol plus promethazine was more effective, but the difference between the two approaches did not reach conventional levels of statistical significance (n=300, 1 RCT, RR 0.60, 95% CI 0.22 to 1.61, high-quality evidence). Lower-quality data suggested that the risk of unwanted excessive sedation was less with the combination approach (n=116, 2 RCTs, RR 0.67, 95% CI 0.12 to 3.84). When haloperidol plus promethazine was compared with ziprasidone all data were of lesser quality. We identified no binary data for the outcome tranquil or asleep. The average sedation score (Ramsay Sedation Scale) was lower for the combination approach but not to conventional levels of statistical significance (n=60, 1 RCT, MD -0.1, 95% CI -0.58 to 0.38). These data were of low quality and it is unclear what they mean in clinical terms. The haloperidol plus promethazine combination appeared to cause less excessive sedation but again the difference did not reach conventional levels of statistical significance (n=111, 2 RCTs, RR 0.30, 95% CI 0.06 to 1.43). We found few data for the comparison of haloperidol plus promethazine versus haloperidol plus midazolam. Average Ramsay Sedation Scale scores suggest the combination of haloperidol plus midazolam to be the most sedating (n=60, 1 RCT, MD -0.6, 95% CI -1.13 to -0.07, low-quality evidence). The risk of excessive sedation was considerably less with haloperidol plus promethazine (n=117, 2 RCTs, RR 0.12, 95% CI 0.03 to 0.49, low-quality evidence). Haloperidol plus promethazine seemed to decrease the risk of needing restraints by around 12 hours (n=60, 1 RCT, RR 0.24, 95% CI 0.10 to 0.55, low-quality evidence). It may be that use of midazolam with haloperidol sedates swiftly, but this effect does not last long. When haloperidol plus promethazine was compared with lorazepam, haloperidol plus promethazine seemed to more effectively cause sedation or tranquillisation by 30 minutes (n=200, 1 RCT, RR 0.26, 95% CI 0.10 to 0.68, high-quality evidence). The secondary outcome of needing restraints or seclusion by 12 hours was not clearly different between groups, with about 10% in each group needing this intrusive intervention (moderate-quality evidence). Sedation data were not reported, however, the combination group did have less 'any serious adverse event' in 24-hour follow-up, but there were not clear differences between the groups and we are unsure exactly what the adverse effect was. There were no deaths. When haloperidol plus promethazine was compared with midazolam, there was clear evidence that midazolam is more swiftly tranquillising of an aggressive situation than haloperidol plus promethazine (n=301, 1 RCT, RR 2.90, 95% CI 1.75 to 4.8, high-quality evidence). On its own, midazolam seems to be swift and effective in tranquillising people who are aggressive due to psychosis. There was no difference in risk of serious adverse event overall (n=301, 1 RCT, RR 1.01, 95% CI 0.06 to 15.95, high-quality evidence). However, 1 in 150 participants allocated haloperidol plus promethazine had a swiftly reversed seizure, and 1 in 151 given midazolam had swiftly reversed respiratory arrest. Authors' conclusions Haloperidol plus promethazine is effective and safe, and its use is based on good evidence. Benzodiazepines work, with midazolam being particularly swift, but both midazolam and lorazepam cause respiratory depression. Olanzapine intramuscular and ziprasidone intramuscular do seem to be viable options and their action is swift, but resumption of aggression with subsequent need to re-inject was more likely than with haloperidol plus promethazine. Haloperidol used on its own without something to offset its frequent and serious adverse effects does seem difficult to justify.
AD  - [Huf, Gisele] Fundacao Oswaldo Cruz, Natl Inst Qual Control Hlth, Ave Brasil 4365, BR-21040900 Rio De Janeiro, Brazil. [Alexander, Jacob] Christian Med Ctr, Mental Hlth Ctr, Dept Psychiat, Vellore, Tamil Nadu, India. [Allen, Michael H.] Univ Colorado, Depress Ctr, Dept Psychiat, Aurora, CO USA.
Huf, G (reprint author), Fundacao Oswaldo Cruz, Natl Inst Qual Control Hlth, Ave Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.
gisele.huf@incqs.fiocruz.br
AN  - WOS:000389600100020
AU  - Huf, G.
AU  - Alexander, J.
AU  - Gandhi, P.
AU  - Allen, M. H.
C7  - Cd005146
DO  - 10.1002/14651858.CD005146.pub3
IS  - 11
J2  - Cochrane Database Syst Rev.
KW  - Aggression [drug effects
psychology]
Benzodiazepines [therapeutic
use]
Drug Therapy, Combination
Haloperidol [therapeutic use]
Lorazepam [therapeutic use]
Midazolam [therapeutic use]
Promethazine
[therapeutic use]
Psychomotor Agitation
Psychotic Disorders [drug
therapy
psychology]
Randomized Controlled Trials as Topic
Humans
randomized controlled-trial
emergency psychiatric rooms
rapid
tranquilization
agitated patients
intramuscular haloperidol
physical
restraints
statistics notes
rating-scale
double-blind
trec-save
General & Internal Medicine
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: EE4UF
Times Cited: 14
Cited Reference Count: 111
Huf, Gisele Alexander, Jacob Gandhi, Pinky Allen, Michael H.
Allen, Michael H/A-8776-2011
Allen, Michael H/0000-0002-6479-9793
Universidade Federal de Rio de Janeiro, Brazil; Christian Medical Centre, Vellore, India; University of Colorado School of Medicine, USA; National Institute of Quality Control in Health, Oswald Cruz Foundation, Brazil
Internal sources; Universidade Federal de Rio de Janeiro, Brazil.; Christian Medical Centre, Vellore, India.; University of Colorado School of Medicine, USA.; National Institute of Quality Control in Health, Oswald Cruz Foundation, Brazil.
14
1
9
Wiley
Hoboken
1361-6137
PY  - 2016
SN  - 1469-493X
SP  - 151
ST  - Haloperidol plus promethazine for psychosis-induced aggression
T2  - Cochrane Database of Systematic Reviews
TI  - Haloperidol plus promethazine for psychosis-induced aggression
UR  - <Go to ISI>://WOS:000389600100020
ID  - 96
ER  - 

TY  - JOUR
AD  - [Iftikhar, I. H.; McGuire, F.; Moizuddin, M.; Lewis, A.] Univ South Carolina, Sch Med, Columbia, SC USA. [Christ, C.] Palmetto Hlth Richland, Columbia, SC USA. [Musani, A.] Natl Jewish Hlth, Denver, CO USA.
imran.iftikhar@uscmed.sc.edu
AN  - WOS:000209838201590
AU  - Iftikhar, I. H.
AU  - McGuire, F.
AU  - Moizuddin, M.
AU  - Lewis, A.
AU  - Christ, C.
AU  - Musani, A.
J2  - Am. J. Respir. Crit. Care Med.
KW  - General & Internal Medicine
Respiratory System
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: V45TF
Times Cited: 0
Cited Reference Count: 0
Iftikhar, I. H. McGuire, F. Moizuddin, M. Lewis, A. Christ, C. Musani, A.
0
Amer thoracic soc
New york
1535-4970
PY  - 2014
SN  - 1073-449X
SP  - 3
ST  - Efficacy Of Bronchoscopic Lung Volume Reduction: A Meta-Analysis
T2  - American Journal of Respiratory and Critical Care Medicine
TI  - Efficacy Of Bronchoscopic Lung Volume Reduction: A Meta-Analysis
UR  - <Go to ISI>://WOS:000209838201590
VL  - 189
ID  - 151
ER  - 

TY  - JOUR
AB  - OBJECTIVE. To determine whether probiotic prophylaxes reduce the odds of Clostridium difficile infection (CDI) in adults and children. DESIGN. Individual participant data (IPD) meta-analysis of randomized controlled trials (RCTs), adjusting for risk factors. METHODS. We searched 6 databases and 11 grey literature sources from inception to April 2016. We identified 32 RCTs (n=8,713); among them, 18 RCTs provided IPD (n=6,851 participants) comparing probiotic prophylaxis to placebo or no treatment (standard care). One reviewer prepared the IPD, and 2 reviewers extracted data, rated study quality, and graded evidence quality. RESULTS. Probiotics reduced CDI odds in the unadjusted model (n=6,645; odds ratio [OR] 0.37; 95% confidence interval [CI], 0.25-0.55) and the adjusted model (n=5,074; OR, 0.35; 95% CI, 0.23-0.55). Using 2 or more antibiotics increased the odds of CDI (OR, 2.20; 95% CI, 1.11-4.37), whereas age, sex, hospitalization status, and high-risk antibiotic exposure did not. Adjusted subgroup analyses suggested that, compared to no probiotics, multispecies probiotics were more beneficial than single-species probiotics, as was using probiotics in clinical settings where the CDI risk is 5%. Of 18 studies, 14 reported adverse events. In 11 of these 14 studies, the adverse events were retained in the adjusted model. Odds for serious adverse events were similar for both groups in the unadjusted analyses (n=4,990; OR, 1.06; 95% CI, 0.89-1.26) and adjusted analyses (n=4,718; OR, 1.06; 95% CI, 0.89-1.28). Missing outcome data for CDI ranged from 0% to 25.8%. Our analyses were robust to a sensitivity analysis for missingness. CONCLUSIONS. Moderate quality (ie, certainty) evidence suggests that probiotic prophylaxis may be a useful and safe CDI prevention strategy, particularly among participants taking 2 or more antibiotics and in hospital settings where the risk of CDI is >= 5%.
AD  - [Johnston, Bradley C.] Dalhousie Univ, Fac Med, Dept Community Hlth & Epidemiol, Halifax, NS, Canada. [Lytvyn, Lyubov; Mbuagbaw, Lawrence; Sadeghirad, Behnam; Thabane, Lehana; Mertz, Dominik] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada. [Lo, Calvin Ka-Fung] McMaster Univ, Hamilton, ON, Canada. [Allen, Stephen J.; Wang, Duolao] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England. [Szajewska, Hania] Med Univ Warsaw, Dept Pediat, Warsaw, Poland. [Miller, Mark; Sampalis, John] McGill Univ, Montreal, PQ, Canada. [Ehrhardt, Stephan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA. [Duman, Deniz G.] Marmara Univ, Sch Med, Dept Gastroenterol, Istanbul, Turkey. [Pozzoni, Pietro; Colli, Agostino] A Manzoni Hosp AO Provincia Lecco, Dept Internal Med, Lecce, Italy. [Lonnermark, Elisabet] Gothenburg Univ, Dept Infect Dis, Gothenburg, Sweden. [Selinger, Christian P.] St James Univ Hosp, Dept Gastroenterol, Leeds, W Yorkshire, England. [Wong, Samford] Stoke Mandeville Hosp, Natl Spinal Injuries Ctr, Aylesbury, Bucks, England. [Plummer, Susan] Cultech Ltd, Res & Dev Dept, Port Talbot, Wales. [Hickson, Mary] Plymouth Univ, Nutr & Dietet Res Grp, Plymouth, Devon, England. [Pancheva, Ruzha] Med Univ, Dept Hyg, Varna, Bulgaria. [Hirsch, Sandra] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Chile. [Klarin, Bengt] Lund Univ Hosp, Dept Anesthesiol & Intens Care, Lund, Sweden. [Goldenberg, Joshua Z.] Bastyr Univ, Res Inst, Washington, DC USA. [Wang, Li] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada. [Wang, Li] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada. [Foster, Gary] St Josephs Healthcare Hamilton, Hamilton, ON, Canada. [Maw, Anna] Univ Colorado, Dept Med, Div Hosp Med, Denver, CO USA. [Mertz, Dominik] McMaster Univ, Dept Med, Hamilton, ON, Canada.
Johnston, BC (reprint author), Dalhousie Univ, Fac Med, Ctr Clin Res, Dept Community Hlth & Epidemiol, Room 404,5790 Univ Ave, Halifax, NS B3H 1V7, Canada.
bjohnston@dal.ca
AN  - WOS:000437436200002
AU  - Johnston, B. C.
AU  - Lytvyn, L.
AU  - Lo, C. K. F.
AU  - Allen, S. J.
AU  - Wang, D. L.
AU  - Szajewska, H.
AU  - Miller, M.
AU  - Ehrhardt, S.
AU  - Sampalis, J.
AU  - Duman, D. G.
AU  - Pozzoni, P.
AU  - Colli, A.
AU  - Lonnermark, E.
AU  - Selinger, C. P.
AU  - Wong, S.
AU  - Plummer, S.
AU  - Hickson, M.
AU  - Pancheva, R.
AU  - Hirsch, S.
AU  - Klarin, B.
AU  - Goldenberg, J. Z.
AU  - Wang, L.
AU  - Mbuagbaw, L.
AU  - Foster, G.
AU  - Maw, A.
AU  - Sadeghirad, B.
AU  - Thabane, L.
AU  - Mertz, D.
DA  - Jul
DO  - 10.1017/ice.2018.84
IS  - 7
J2  - Infect. Control Hosp. Epidemiol.
KW  - antibiotic-associated diarrhea
double-blind
saccharomyces-boulardii
efficacy
appropriate
diagnosis
consensus
outcomes
burden
trial
Public, Environmental & Occupational Health
Infectious Diseases
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GL8BJ
Times Cited: 7
Cited Reference Count: 51
Johnston, Bradley C. Lytvyn, Lyubov Lo, Calvin Ka-Fung Allen, Stephen J. Wang, Duolao Szajewska, Hania Miller, Mark Ehrhardt, Stephan Sampalis, John Duman, Deniz G. Pozzoni, Pietro Colli, Agostino Lonnermark, Elisabet Selinger, Christian P. Wong, Samford Plummer, Susan Hickson, Mary Pancheva, Ruzha Hirsch, Sandra Klarin, Bengt Goldenberg, Joshua Z. Wang, Li Mbuagbaw, Lawrence Foster, Gary Maw, Anna Sadeghirad, Behnam Thabane, Lehana Mertz, Dominik
Szajewska, Hania/M-4141-2018; Sadeghirad, Behnam/A-1772-2009; Sadeghirad, Behnam/C-4995-2019; Mbuagbaw, Lawrence/H-3205-2019; Selinger, Christian P/H-8008-2019; Mbuagbaw, Lawrence/D-9381-2015
Szajewska, Hania/0000-0002-4596-2874; Sadeghirad, Behnam/0000-0001-9422-5232; Sadeghirad, Behnam/0000-0001-9422-5232; Selinger, Christian P/0000-0003-2022-5859; Mbuagbaw, Lawrence/0000-0001-5855-5461; Allen, Stephen/0000-0001-6675-249X; Wang, Duolao/0000-0003-2788-2464
7
1
14
Cambridge univ press
New york
1559-6834
PY  - 2018
SN  - 0899-823X
SP  - 771-781
ST  - Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants
T2  - Infection Control and Hospital Epidemiology
TI  - Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants
UR  - <Go to ISI>://WOS:000437436200002
VL  - 39
ID  - 14
ER  - 

TY  - JOUR
AD  - MedStar Washington Hosp Ctr, Washington, DC USA. Univ Colorado, Div Cardiol, Denver VA Med Ctr, Denver, CO 80202 USA.
AN  - WOS:000429659702347
AU  - Jonnalagadda, A. K.
AU  - Texakalidis, P.
AU  - Giannopoulos, S.
AU  - Kokkinidis, D. G.
AU  - Armstrong, E. J.
AU  - Machinis, T.
AU  - Pascal, J. M.
DA  - Mar
DO  - 10.1016/s0735-1097(18)31638-3
IS  - 11
J2  - J. Am. Coll. Cardiol.
KW  - Cardiovascular System & Cardiology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GC3BT
Times Cited: 0
Cited Reference Count: 0
Jonnalagadda, Anil Kumar Texakalidis, Pavlos Giannopoulos, Stefanos Kokkinidis, Damianos G. Armstrong, Ehrin J. Machinis, Theofilos Pascal, Jabbour M.
67th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC)
Mar 10-12, 2018
Orlando, FL
Amer Coll Cardiol
JONNALAGADDA, ANIL KUMAR/X-5875-2019; Giannopoulos, Stefanos/W-9294-2019
JONNALAGADDA, ANIL KUMAR/0000-0001-9817-6140; Giannopoulos, Stefanos/0000-0002-1942-911X
0
1
Elsevier science inc
New york
1558-3597
S
PY  - 2018
SN  - 0735-1097
SP  - 1097-1097
ST  - CAROTID ARTERY ENDARTERECTOMY VERSUS CAROTID ARTERY STENTING FOR RESTENOSIS AFTER CAROTID ARTERY ENDARTERECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS
T2  - Journal of the American College of Cardiology
TI  - CAROTID ARTERY ENDARTERECTOMY VERSUS CAROTID ARTERY STENTING FOR RESTENOSIS AFTER CAROTID ARTERY ENDARTERECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS
UR  - <Go to ISI>://WOS:000429659702347
VL  - 71
ID  - 26
ER  - 

TY  - JOUR
AD  - [Jonnalagadda, Anil Kumar K.] MedStar Washington Hosp Ctr, Washington, DC USA. [Texakalidis, Pavlos] Emory Univ, Div Neurosurg, Atlanta, GA 30322 USA. [Giannopoulos, Stefanos] 251 Air Force Hosp Athens, Div Vasc Surg, Athens, Greece. [Armstrong, Ehrin J.; Kokkinidis, Damianos G.] Univ Colorado, Denver VA Med Ctr, Div Cardiol, Denver, CO 80202 USA.
AN  - WOS:000425386600074
AU  - Jonnalagadda, A. K. K.
AU  - Texakalidis, P.
AU  - Giannopoulos, S.
AU  - Armstrong, E. J.
AU  - Kokkinidis, D. G.
DA  - Feb
IS  - 4
J2  - JACC-Cardiovasc. Interv.
KW  - Cardiovascular System & Cardiology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: FW5VF
Times Cited: 0
Cited Reference Count: 0
Jonnalagadda, Anil Kumar K. Texakalidis, Pavlos Giannopoulos, Stefanos Armstrong, Ehrin J. Kokkinidis, Damianos G.
JONNALAGADDA, ANIL KUMAR/X-5875-2019; Giannopoulos, Stefanos/W-9294-2019
JONNALAGADDA, ANIL KUMAR/0000-0001-9817-6140; Giannopoulos, Stefanos/0000-0002-1942-911X
0
1
Elsevier science inc
New york
1876-7605
S
PY  - 2018
SN  - 1936-8798
SP  - S29-S30
ST  - Preoperative Use of Statins in Carotid Artery Stenting: A Systematic Review and Meta-analysis
T2  - Jacc-Cardiovascular Interventions
TI  - Preoperative Use of Statins in Carotid Artery Stenting: A Systematic Review and Meta-analysis
UR  - <Go to ISI>://WOS:000425386600074
VL  - 11
ID  - 30
ER  - 

TY  - JOUR
AD  - [Jonnalagadda, Anil Kumar K.] MedStar Washington Hosp Ctr, Washington, DC USA. [Texakalidis, Pavlos] Emory Univ, Div Neurosurg, Atlanta, GA 30322 USA. [Giannopoulos, Stefanos] 251 Air Force Hosp Athens, Div Vasc Surg, Athens, Greece. [Kokkinidis, Damianos G.; Armstrong, Ehrin J.] Univ Colorado, Div Cardiol, Denver VA Med Ctr, Denver, CO 80202 USA. [Machinis, Theofilos] Virgina Commonwealth Univ, Div Neurosurg, Richmond, VA USA. [Pascal, Jabbour M.] Thomas Jefferson Univ, Dept Neurol Surg, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.
AN  - WOS:000425386600089
AU  - Jonnalagadda, A. K. K.
AU  - Texakalidis, P.
AU  - Giannopoulos, S.
AU  - Kokkinidis, D. G.
AU  - Armstrong, E. J.
AU  - Machinis, T.
AU  - Pascal, J. M.
DA  - Feb
IS  - 4
J2  - JACC-Cardiovasc. Interv.
KW  - Cardiovascular System & Cardiology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: FW5VF
Times Cited: 0
Cited Reference Count: 0
Jonnalagadda, Anil Kumar K. Texakalidis, Pavlos Giannopoulos, Stefanos Kokkinidis, Damianos G. Armstrong, Ehrin J. Machinis, Theofilos Pascal, Jabbour M.
JONNALAGADDA, ANIL KUMAR/X-5875-2019; Giannopoulos, Stefanos/W-9294-2019
JONNALAGADDA, ANIL KUMAR/0000-0001-9817-6140; Giannopoulos, Stefanos/0000-0002-1942-911X
0
1
Elsevier science inc
New york
1876-7605
S
PY  - 2018
SN  - 1936-8798
SP  - S35-S35
ST  - Carotid Artery Endarterectomy vs. Carotid Artery Stenting For Restenosis After Carotid Artery Endarterectomy: A Systematic Review and Meta-analysis
T2  - Jacc-Cardiovascular Interventions
TI  - Carotid Artery Endarterectomy vs. Carotid Artery Stenting For Restenosis After Carotid Artery Endarterectomy: A Systematic Review and Meta-analysis
UR  - <Go to ISI>://WOS:000425386600089
VL  - 11
ID  - 29
ER  - 

TY  - JOUR
AB  - Genomic analysis of longevity offers the potential to illuminate the biology of human aging. Here, using genome-wide association meta-analysis of 606,059 parents' survival, we discover two regions associated with longevity (HLA-DQA1/DRB1 and LPA). We also validate previous suggestions that APOE, CHRNA3/5, CDKN2A/B, SH2B3 and FOXO3A influence longevity. Next we show that giving up smoking, educational attainment, openness to new experience and high-density lipoprotein (HDL) cholesterol levels are most positively genetically correlated with lifespan while susceptibility to coronary artery disease (CAD), cigarettes smoked per day, lung cancer, insulin resistance and body fat are most negatively correlated. We suggest that the effect of education on lifespan is principally mediated through smoking while the effect of obesity appears to act via CAD. Using instrumental variables, we suggest that an increase of one body mass index unit reduces lifespan by 7 months while 1 year of education adds 11 months to expected lifespan.
AD  - [Joshi, Peter K.; Pirastu, Nicola; Kentistou, Katherine A.; Schraut, Katharina E.; Clark, David W.; Barnes, Catriona L. K.; Timmers, Paul R. H. J.; Shen, Xia; Campbell, Harry; Wilson, James F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh EH8 9AG, Midlothian, Scotland. [Kentistou, Katherine A.; Schraut, Katharina E.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland. [Fischer, Krista; Magi, Reedik; Milani, Lili; Metspalu, Andres; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia. [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, A-8036 Graz, Austria. [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, A-8036 Graz, Austria. [Nutile, Teresa; Ruggiero, Daniela; Ciullo, Marina] Inst Genet & Biophys A Buzzati Traverso, CNR, I-80131 Naples, Italy. [Shen, Xia] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden. [Gandin, Ilaria] Univ Trieste, Dept Med Sci, I-34100 Trieste, Italy. [Gandin, Ilaria] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, I-34137 Trieste, Italy. [McDaid, Aaron F.; Kutalik, Zoltan] Lausanne Univ Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland. [McDaid, Aaron F.; Kutalik, Zoltan] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland. [Hansen, Thomas Folkmann; Werge, Thomas] Mental Hlth Ctr Sct Hans, Mental Hlth Serv Copenhagen, Inst Biol Psychiat, DK-4000 Roskilde, Denmark. [Hansen, Thomas Folkmann; Borglum, Anders D.; Hougaard, David M.; Wang, Yunpeng; Werge, Thomas] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, DK-8000 Aarhus, Denmark. [Gordon, Scott D.; Medland, Sarah E.; Whitfield, John B.; Martin, Nicholas G.] QIMR Berghofer Inst Med Res, Brisbane, Qld 4006, Australia. [Giulianini, Franco; Ridker, Paul M.; Chasman, Daniel] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA. [Boutin, Thibaud S.; Nagy, Reka; Hayward, Caroline; Wilson, James F.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland. [Abdellaoui, Abdel; Hottenga, Jouke-Jan; Ligthart, Lannie; Boomsma, Dorret I.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Inst APH, Dept Biol Psychol, Netherlands Twin Register, NL-1081BT Amsterdam, Netherlands. [Zhao, Wei; Bielak, Lawrence F.; Peyser, Patricia A.; Smith, Jennifer A.; Kardia, Sharon L. R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA. [Medina-Gomez, Carolina; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 CN Rotterdam, Netherlands. [Medina-Gomez, Carolina; van der Spek, Ashley; Amin, Najaf; Ikram, M. Arfan; Rivadeneira, Fernando; van Rooij, Frank J. A.; van Duijn, Cornelia M.; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3015 Rotterdam, Netherlands. [Bartz, Traci M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Biostat, Seattle, WA 98101 USA. [Bartz, Traci M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA. [Trompet, Stella] Leiden Univ, Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, NL-2300RC Leiden, Netherlands. [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300RC Leiden, Netherlands. [Lange, Leslie A.] Univ Colorado Denver, Anschutz Med Campus, Dept Med, Aurora, CO 80045 USA. [Raffield, Laura] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA. [Galesloot, Tessel E.; Verbeek, Andre L.; Vermeulen, Sita H.; Kiemeney, Lambertus] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, NL-6500 HB Nijmegen, Netherlands. [Proitsi, Petroula; Kuh, Diana; Wong, Andrew] UCL, MRC Unit Lifelong Hlth & Ageing UCL, London WC1B 5JU, England. [Yanek, Lisa R.; Becker, Diane M.] Johns Hopkins Univ, Sch Med, GeneSTAR Res Program, Dept Med, Baltimore, MD 21287 USA. [Payton, Antony] Univ Manchester, Ctr Epidemiol, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester M13 9PL, Lancs, England. [Murgia, Federico; Gogele, Martin; Pramstaller, Peter P.; Fuchsberger, Christian] European Acad Bozen Bolzano EURAC, Ctr Biomed, I-39100 Bolzano, Italy. [Murgia, Federico; Gogele, Martin; Pramstaller, Peter P.; Fuchsberger, Christian] Univ Lubeck, Affiliated Inst, Lubeck, Germany. [Concas, Maria Pina; Pirastu, Mario] Natl Res Council Italy, Inst Genet & Biomed Res Support Unity, I-07100 Sassari, Italy. [Biino, Ginevra] Natl Res Council Italy, Inst Mol Genet, I-27100 Pavia, Italy. [Tajuddin, Salman M.; Zonderman, Alan B.; Evans, Michele K.] NIA, NIH, Lab Epidemiol & Populat Sci, Baltimore, MD 21224 USA. [Seppala, Ilkka; Lehtimaki, Terho] Univ Tampere, Fimlab Lab, Dept Clin Chem, Tampere 33014, Finland. [Seppala, Ilkka; Hurme, Mikko A.; Lehtimaki, Terho] Univ Tampere, Fac Med & Life Sci, Tampere 33014, Finland. [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr Houston, UTHlth Sch Publ, Houston, TX 77030 USA. [Borglum, Anders D.] Aarhus Univ, Dept Biomed Human Genet, DK-8000 Aarhus, Denmark. [Borglum, Anders D.] Aarhus Univ, Ctr Integrat Sequencing, iSEQ, DK-8000 Aarhus, Denmark. [Campbell, Archie] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland. [Demerath, Ellen W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA. [Demuth, Ilja; Steinhagen-Thiessen, Elisabeth] Univ Med Berlin, Res Grp Geriatr, Charite, D-13347 Berlin, Germany. [Demuth, Ilja] Univ Med Berlin, Interdisciplinary Metab Ctr, Lipid Clin, Charite, D-13353 Berlin, Germany. [Demuth, Ilja] Univ Med Berlin, Inst Med & Human Genet, Charite, D-13353 Berlin, Germany. [Faul, Jessica D.; Smith, Jennifer A.; Weir, David R.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI 48014 USA. [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland. [Gialluisi, Alessandro; Ciullo, Marina] IRCCS Neuromed, I-86077 Pozzilli, IS, Italy. [Graff, MariaElisa; Franceschini, Nora; North, Kari E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA. [Hingorani, Aroon] UCL, Inst Cardiovasc Sci, London WC1E 6BT, England. [Hougaard, David M.] Statens Serum Inst, Ctr Neonatal Screening, Dept Congenital Disorders, DK-2300 Copenhagen, Denmark. [Hurme, Mikko A.] Univ Tampere, Fimlab Lab, Dept Microbiol & Immunol, Tampere 33014, Finland. [Jylha, Marja] Univ Tampere, Fac Social Sci, Gerontol Res Ctr, Tampere 33104, Finland. [Lill, Christina M.] Univ Lubeck, Inst Neurogenet, Genet & Mol Epidemiol Grp, D-23562 Lubeck, Germany. [Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, D-14195 Berlin, Germany. [Lindenberger, Ulman] Max Planck UCL Ctr Computat Psychiat & Ageing Res, D-14195 Berlin, Germany. [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1010, New Zealand. [Marques-Vidal, Pedro; Vollenweider, Peter] Lausanne Univ Hosp, Dept Med, Internal Med, CH-1011 Lausanne, Switzerland. [Ollier, William E. R.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Hlth Sci, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester M13 9PL, Lancs, England. [Ridker, Paul M.; Chasman, Daniel] Harvard Med Sch, TH Chan Sch Publ Hlth, Boston, MA 02115 USA. [Saba, Yasaman; Schmidt, Helena] Med Univ Graz, Austrian Stroke Prevent Study, Inst Mol Biol & Biochem, Ctr Mol Med, A-8010 Graz, Austria. [Slagboom, P. Eline] Leiden Univ, Med Ctr, Sec Mol Epidemiol, Dept Med Stat, NL-2300RC Leiden, Netherlands. [Smith, Blair H.] Univ Dundee, Ninewells Hosp & Med Sch, Div Populat Hlth Sci, Dundee DD1 9SY, Scotland. [Sotoodehnia, Nona] Univ Washington, Div Cardiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA. [Wang, Yunpeng] Univ Oslo, NORMENT, KG Jebsen Ctr Psychosis Res, Inst Clin Med, N-0450 Oslo, Norway. [Bertram, Lars] Univ Lubeck, Lubeck Interdisciplinary Platform Genome Analyt, Inst Neurogenet & Cardiogenet, D-23562 Lubeck, Germany. [Bertram, Lars] Imperial Coll, Sch Publ Hlth, Neuroepidemiol & Ageing Res Grp, London W6 8RP, England. [Pendleton, Neil] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biol Sci, Div Neurosci & Expt Psychol, Manchester M13 9PL, Greater Manches, England. [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA. [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA. [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA. [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA. [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA. [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TD, Lanark, Scotland. [Esko, Tonu] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.
Joshi, PK (reprint author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh EH8 9AG, Midlothian, Scotland.
peter.joshi@ed.ac.uk
AN  - WOS:000412871300006
AU  - Joshi, P. K.
AU  - Pirastu, N.
AU  - Kentistou, K. A.
AU  - Fischer, K.
AU  - Hofer, E.
AU  - Schraut, K. E.
AU  - Clark, D. W.
AU  - Nutile, T.
AU  - Barnes, C. L. K.
AU  - Timmers, Prhj
AU  - Shen, X.
AU  - Gandin, I.
AU  - McDaid, A. F.
AU  - Hansen, T. F.
AU  - Gordon, S. D.
AU  - Giulianini, F.
AU  - Boutin, T. S.
AU  - Abdellaoui, A.
AU  - Zhao, W.
AU  - Medina-Gomez, C.
AU  - Bartz, T. M.
AU  - Trompet, S.
AU  - Lange, L. A.
AU  - Raffield, L.
AU  - van der Spek, A.
AU  - Galesloot, T. E.
AU  - Proitsi, P.
AU  - Yanek, L. R.
AU  - Bielak, L. F.
AU  - Payton, A.
AU  - Murgia, F.
AU  - Concas, M. P.
AU  - Biino, G.
AU  - Tajuddin, S. M.
AU  - Seppala, I.
AU  - Amin, N.
AU  - Boerwinkle, E.
AU  - Borglum, A. D.
AU  - Campbell, A.
AU  - Demerath, E. W.
AU  - Demuth, I.
AU  - Faul, J. D.
AU  - Ford, I.
AU  - Gialluisi, A.
AU  - Gogele, M.
AU  - Graff, M.
AU  - Hingorani, A.
AU  - Hottenga, J. J.
AU  - Hougaard, D. M.
AU  - Hurme, M. A.
AU  - Ikram, M. A.
AU  - Jylha, M.
AU  - Kuh, D.
AU  - Ligthart, L.
AU  - Lill, C. M.
AU  - Lindenberger, U.
AU  - Lumley, T.
AU  - Magi, R.
AU  - Marques-Vidal, P.
AU  - Medland, S. E.
AU  - Milani, L.
AU  - Nagy, R.
AU  - Ollier, W. E. R.
AU  - Peyser, P. A.
AU  - Pramstaller, P. P.
AU  - Ridker, P. M.
AU  - Rivadeneira, F.
AU  - Ruggiero, D.
AU  - Saba, Y.
AU  - Schmidt, R.
AU  - Schmidt, H.
AU  - Slagboom, P. E.
AU  - Smith, B. H.
AU  - Smith, J. A.
AU  - Sotoodehnia, N.
AU  - Steinhagen-Thiessen, E.
AU  - van Rooij, F. J. A.
AU  - Verbeek, A. L.
AU  - Vermeulen, S. H.
AU  - Vollenweider, P.
AU  - Wang, Y. P.
AU  - Werge, T.
AU  - Whitfield, J. B.
AU  - Zonderman, A. B.
AU  - Lehtimaki, T.
AU  - Evans, M. K.
AU  - Pirastu, M.
AU  - Fuchsberger, C.
AU  - Bertram, L.
AU  - Pendleton, N.
AU  - Kardia, S. L. R.
AU  - Ciullo, M.
AU  - Becker, D. M.
AU  - Wong, A.
AU  - Psaty, B. M.
AU  - van Duijn, C. M.
AU  - Wilson, J. G.
AU  - Jukema, J. W.
AU  - Kiemeney, L.
AU  - Uitterlinden, A. G.
AU  - Franceschini, N.
AU  - North, K. E.
AU  - Weir, D. R.
AU  - Metspalu, A.
AU  - Boomsma, D. I.
AU  - Hayward, C.
AU  - Chasman, D.
AU  - Martin, N. G.
AU  - Sattar, N.
AU  - Campbell, H.
AU  - Esko, T.
AU  - Kutalik, Z.
AU  - Wilson, J. F.
C7  - 910
DA  - Oct
DO  - 10.1038/s41467-017-00934-5
J2  - Nat. Commun.
KW  - susceptibility loci
genetic-variants
blood-pressure
survival
risk
age
population
disease
individuals
apoe
Science & Technology - Other Topics
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: FJ6MG
Times Cited: 27
Cited Reference Count: 53
Joshi, Peter K. Pirastu, Nicola Kentistou, Katherine A. Fischer, Krista Hofer, Edith Schraut, Katharina E. Clark, David W. Nutile, Teresa Barnes, Catriona L. K. Timmers, Paul R. H. J. Shen, Xia Gandin, Ilaria McDaid, Aaron F. Hansen, Thomas Folkmann Gordon, Scott D. Giulianini, Franco Boutin, Thibaud S. Abdellaoui, Abdel Zhao, Wei Medina-Gomez, Carolina Bartz, Traci M. Trompet, Stella Lange, Leslie A. Raffield, Laura van der Spek, Ashley Galesloot, Tessel E. Proitsi, Petroula Yanek, Lisa R. Bielak, Lawrence F. Payton, Antony Murgia, Federico Concas, Maria Pina Biino, Ginevra Tajuddin, Salman M. Seppala, Ilkka Amin, Najaf Boerwinkle, Eric Borglum, Anders D. Campbell, Archie Demerath, Ellen W. Demuth, Ilja Faul, Jessica D. Ford, Ian Gialluisi, Alessandro Gogele, Martin Graff, MariaElisa Hingorani, Aroon Hottenga, Jouke-Jan Hougaard, David M. Hurme, Mikko A. Ikram, M. Arfan Jylha, Marja Kuh, Diana Ligthart, Lannie Lill, Christina M. Lindenberger, Ulman Lumley, Thomas Magi, Reedik Marques-Vidal, Pedro Medland, Sarah E. Milani, Lili Nagy, Reka Ollier, William E. R. Peyser, Patricia A. Pramstaller, Peter P. Ridker, Paul M. Rivadeneira, Fernando Ruggiero, Daniela Saba, Yasaman Schmidt, Reinhold Schmidt, Helena Slagboom, P. Eline Smith, Blair H. Smith, Jennifer A. Sotoodehnia, Nona Steinhagen-Thiessen, Elisabeth van Rooij, Frank J. A. Verbeek, Andre L. Vermeulen, Sita H. Vollenweider, Peter Wang, Yunpeng Werge, Thomas Whitfield, John B. Zonderman, Alan B. Lehtimaki, Terho Evans, Michele K. Pirastu, Mario Fuchsberger, Christian Bertram, Lars Pendleton, Neil Kardia, Sharon L. R. Ciullo, Marina Becker, Diane M. Wong, Andrew Psaty, Bruce M. van Duijn, Cornelia M. Wilson, James G. Jukema, J. Wouter Kiemeney, Lambertus Uitterlinden, Andre G. Franceschini, Nora North, Kari E. Weir, David R. Metspalu, Andres Boomsma, Dorret I. Hayward, Caroline Chasman, Daniel Martin, Nicholas G. Sattar, Naveed Campbell, Harry Esko, Tonu Kutalik, Zoltan Wilson, James F.
Verbeek, A.L.M./H-8103-2014; Bertram, Lars/K-3889-2015; Hansen, Thomas F/O-5965-2014; Wong, Andrew/M-8899-2016; Kiemeney, Lambertus A./D-3357-2009; Medina-Gomez, Carolina/I-1725-2019; Colaus, PsyColaus/K-6607-2013; Milani, Lili/N-1097-2019; Timmers, Paul/U-9612-2019; Campbell, Harry/E-2959-2010; Schmidt, Reinhold/E-1137-2014; Galesloot, Tessel/P-6667-2015; Concas, Maria Pina/K-2266-2018; Pendleton, Neil/F-2333-2015; Gialluisi, Alessandro/K-1195-2018; Vermeulen, S.H.H.M./L-4716-2015; BIINO, GINEVRA/B-5334-2013; Smith, Blair/G-2834-2012; ruggiero, daniela/K-5638-2016; Marques-Vidal, Pedro/C-9449-2009
Verbeek, A.L.M./0000-0002-2319-5002; Bertram, Lars/0000-0002-0108-124X; Hansen, Thomas F/0000-0001-6703-7762; Wong, Andrew/0000-0003-2079-4779; Kiemeney, Lambertus A./0000-0002-2368-1326; Medina-Gomez, Carolina/0000-0001-7999-5538; Milani, Lili/0000-0002-5323-3102; Timmers, Paul/0000-0002-5197-1267; Campbell, Harry/0000-0002-6169-6262; Galesloot, Tessel/0000-0002-2717-3679; Concas, Maria Pina/0000-0003-3598-2537; Pendleton, Neil/0000-0003-0794-2386; Gialluisi, Alessandro/0000-0002-7388-4463; Smith, Jennifer/0000-0002-3575-5468; Raffield, Laura/0000-0002-7892-193X; Boutin, Thibaud/0000-0003-4754-1675; BIINO, GINEVRA/0000-0002-9936-946X; Hingorani, Aroon/0000-0001-8365-0081; Joshi, Peter/0000-0002-6361-5059; Smith, Blair/0000-0002-5362-9430; ruggiero, daniela/0000-0003-3898-7827; Shen, Xia/0000-0003-4390-1979; Proitsi, Petroula/0000-0002-2553-6974; NUTILE, TERESA/0000-0001-7062-8352; GANDIN, ILARIA/0000-0003-3196-2491; Nagy, Reka/0000-0002-8583-2652; Tajuddin, Salman M./0000-0002-7919-8528; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Marques-Vidal, Pedro/0000-0002-4548-8500; Murgia, Federico/0000-0002-3608-845X; Kentistou, Katherine/0000-0002-5816-664X; Ciullo, Marina/0000-0002-9621-9984
UK Medical Research Council Human Genetics Unit
We thank the UK Biobank Resource, approved under application 8304; we acknowledge funding from the UK Medical Research Council Human Genetics Unit. We would like to thank the authors of LDHub and MRbase and all the groups who contributed summary statistics there, as well as the BCAC and CHARGE-CRP consortia for sharing their summary statistics with us directly. We also thank Neil Robertson, Wellcome Trust Centre for Human Genetics, Oxford, for use of his author details management software, Authorial, and Tom Haller of the University of Tartu, for tailoring RegScan so we could use it with compressed files. We would also like to thank the researchers, funders and participants of all the contributing cohorts. Study specific acknowledgements are listed in Supplementary Note 1.
27
1
17
Nature publishing group
London
PY  - 2017
SN  - 2041-1723
SP  - 13
ST  - Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity
T2  - Nature Communications
TI  - Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity
UR  - <Go to ISI>://WOS:000412871300006
VL  - 8
ID  - 46
ER  - 

TY  - JOUR
AB  - IMPORTANCE Major depressive disorder (MDD) has been linked to imbalanced communication among large-scale brain networks, as reflected by abnormal resting-state functional connectivity (rsFC). However, given variable methods and results across studies, identifying consistent patterns of network dysfunction in MDD has been elusive. OBJECTIVE To investigate network dysfunction in MDD through a meta-analysis of rsFC studies. DATA SOURCES Seed-based voxelwise rsFC studies comparing individuals with MDD with healthy controls (published before June 30, 2014) were retrieved from electronic databases (PubMed, Web of Science, and EMBASE) and authors contacted for additional data. STUDY SELECTION Twenty-seven seed-based voxel-wise rsFC data sets from 25 publications (556 individuals with MDD and 518 healthy controls) were included in the meta-analysis. DATA EXTRACTION AND SYNTHESIS Coordinates of seed regions of interest and between-group effects were extracted. Seeds were categorized into seed-networks by their location within a priori functional networks. Multilevel kernel density analysis of between-group effects identified brain systems in which MDD was associated with hyperconnectivity (increased positive or reduced negative connectivity) or hypoconnectivity (increased negative or reduced positive connectivity) with each seed-network. RESULTS Major depressive disorder was characterized by hypoconnectivity within the frontoparietal network, a set of regions involved in cognitive control of attention and emotion regulation, and hypoconnectivity between frontoparietal systems and parietal regions of the dorsal attention network involved in attending to the external environment. Major depressive disorder was also associated with hyperconnectivity within the default network, a network believed to support internally oriented and self-referential thought, and hyperconnectivity between frontoparietal control systems and regions of the default network. Finally, the MDD groups exhibited hypoconnectivity between neural systems involved in processing emotion or salience and midline cortical regions that may mediate top-down regulation of such functions. CONCLUSIONS AND RELEVANCE Reduced connectivity within frontoparietal control systems and imbalanced connectivity between control systems and networks involved in internal or external attention may reflect depressive biases toward internal thoughts at the cost of engaging with the external world. Meanwhile, altered connectivity between neural systems involved in cognitive control and those that support salience or emotion processing may relate to deficits regulating mood. These findings provide an empirical foundation for a neurocognitive model in which network dysfunction underlies core cognitive and affective abnormalities in depression.
AD  - [Kaiser, Roselinde H.; Pizzagalli, Diego A.] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA. [Kaiser, Roselinde H.; Pizzagalli, Diego A.] McLean Hosp, Ctr Depress Anxiety & Stress Res, Belmont, MA 02478 USA. [Andrews-Hanna, Jessica R.; Wager, Tor D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.
Kaiser, RH (reprint author), Harvard Univ, Sch Med, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA.
RHKaiser@mclean.harvard.edu
AN  - WOS:000355807400011
AU  - Kaiser, R. H.
AU  - Andrews-Hanna, J. R.
AU  - Wager, T. D.
AU  - Pizzagalli, D. A.
DA  - Jun
DO  - 10.1001/jamapsychiatry.2015.0071
IS  - 6
J2  - JAMA Psychiatry
KW  - anterior cingulate cortex
prefrontal cortex
cognitive-control
default
mode
human brain
neuroimaging data
mood disorders
naive patients
organization
1st-episode
Psychiatry
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: CJ9FH
Times Cited: 381
Cited Reference Count: 75
Kaiser, Roselinde H. Andrews-Hanna, Jessica R. Wager, Tor D. Pizzagalli, Diego A.
Pizzagalli, Diego A./Z-1595-2019; Kaiser, Roselinde/F-3180-2017
Kaiser, Roselinde/0000-0002-0369-0583
National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH068376, R01 MH101521, R01 MH076136]; Phyllis and Jerome Lyle Rappaport Mental Health Research Fellowship (McLean Hospital)
This project was partially supported by grants R01 MH068376 and R01 MH101521 (Dr Pizzagalli), R01 MH101521 (Drs Wager and Andrews-Hanna), and R01 MH076136 (Drs Wager and Andrews-Hanna) from the National Institute of Mental Health and by The Phyllis and Jerome Lyle Rappaport Mental Health Research Fellowship (McLean Hospital) (Dr Kaiser).
397
11
122
Amer medical assoc
Chicago
2168-6238
PY  - 2015
SN  - 2168-622X
SP  - 603-611
ST  - Large-Scale Network Dysfunction in Major Depressive Disorder A Meta-analysis of Resting-State Functional Connectivity
T2  - Jama Psychiatry
TI  - Large-Scale Network Dysfunction in Major Depressive Disorder A Meta-analysis of Resting-State Functional Connectivity
UR  - <Go to ISI>://WOS:000355807400011
VL  - 72
ID  - 113
ER  - 

TY  - JOUR
AD  - [Kaiser, S. V.; Cabana, M. D.] Univ Calif San Francisco, San Francisco, CA 94143 USA. [Huynh, T.] Univ Calif Berkeley, Berkeley, CA 94720 USA. [Bacharier, L. B.] Washington Univ, Sch Med, Div Allergy Immunol & Pulm Med, St Louis, MO USA. [Parkin, P.] Hosp Sick Children, Toronto, ON, Canada. [Rosenthal, J.] Univ Calif Davis, Sacramento, CA 95817 USA. [Bakel, L.] Univ Colorado, Aurora, CO USA.
sunitha.kaiser@ucsf.edu
AN  - WOS:000390749603182
AU  - Kaiser, S. V.
AU  - Huynh, T.
AU  - Bacharier, L. B.
AU  - Parkin, P.
AU  - Rosenthal, J.
AU  - Bakel, L.
AU  - Cabana, M. D.
J2  - Am. J. Respir. Crit. Care Med.
KW  - General & Internal Medicine
Respiratory System
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: EG0VE
Times Cited: 0
Cited Reference Count: 0
Kaiser, S. V. Huynh, T. Bacharier, L. B. Parkin, P. Rosenthal, J. Bakel, L. Cabana, M. D.
International Conference of the American-Thoracic-Society (ATS)
May 13-18, 2016
San Francisco, CA
Amer Thorac Soc
0
Amer thoracic soc
New york
1535-4970
PY  - 2016
SN  - 1073-449X
SP  - 2
ST  - Preventing Severe Exacerbations In Preschool Children With Recurrent Wheeze: A Systematic Review And Meta-Analysis
T2  - American Journal of Respiratory and Critical Care Medicine
TI  - Preventing Severe Exacerbations In Preschool Children With Recurrent Wheeze: A Systematic Review And Meta-Analysis
UR  - <Go to ISI>://WOS:000390749603182
VL  - 193
ID  - 95
ER  - 

TY  - JOUR
AB  - Objective: Several studies have assessed the effect of allopurinol on endothelial function, but these studies were relatively small in size and used different methods of evaluating endothelial function. We conducted a meta-analysis to investigate the effect of allopurinol on both endothelial-dependent and -independent vasodilatation. Methods: Electronic databases, Medline, PubMed, EMBASE, SCOPUS, EBSCO and the Cochrane Library Central Register of Clinical Trials were searched from January 1985 to July 2013 on clinical trials (randomized and non-randomized) which assessed the effect of allopurinol on endothelial function. We conducted a sensitivity analysis to assess the contribution of each study to the pooled treatment effect by excluding each study one at a time and recalculating the pooled treatment effect for the remaining studies. Treatment effect was significant if p < 0.05. We assessed for heterogeneity in treatment estimates using the Cochran Q test and the x(2) statistic (with substantial heterogeneity defined as values > 50%). Results: The final analysis consisted of 11 studies (2 observational and 9 randomized). For the endothelial-dependent vasodilatation there were 6 studies, including 257 patients, that evaluated flow-mediated dilatation and 5 studies with 87 patients that reported data on forearm blood flow response to acetylcholine or flow-dependent vasodilatation. Overall, there was a significant increase in the endothelium-dependent vasodilatation with allopurinol treatment (MD 2.69%, 95% CI 2.49, 2.89%, p < 0.001; heterogeneity x(2) = 319.1, I-2 = 96%, p < 0.001). There was only 1 study (100 patients) assessing nitrate-mediated dilatation and 4 studies (73 patients) evaluating forearm blood flow response to sodium nitroprusside as measures of endothelial-independent vasodilatation. The overall analysis (MD -0.08, 95% CI -0.50, 0.34, p = 0.70; heterogeneity x(2) = 9.0, I-2 = 44%, p = 0.11) showed no effect of allopurinol treatment on endothelium-independent vasodilatation. Conclusions: We found that treatment of hyperuricemia with allopurinol is associated with an improvement in the endothelial-dependent, but not with the endothelial-independent vasodilatation. (C) 2014 S. Karger AG, Basel
AD  - [Kanbay, Mehmet; Elcioglu, Omer C.; Telci, Ozge; Takir, Mumtaz] Istanbul Med Univ, Sch Med, Div Nephrol, Dept Med, TR-34710 Istanbul, Turkey. [Siriopol, Dimitrie; Nistor, Ionut; Covic, Adrian] Univ Med Grigore T Popa, Dept Nephrol, Iasi, Romania. [Johnson, Richard J.] Univ Colorado, Div Renal Dis & Hypertens, Denver, CO 80202 USA.
Kanbay, M (reprint author), Istanbul Med Univ, Sch Med, Div Nephrol, Dept Med, TR-34710 Istanbul, Turkey.
drkanbay@yahoo.com
AN  - WOS:000336013700009
AU  - Kanbay, M.
AU  - Siriopol, D.
AU  - Nistor, I.
AU  - Elcioglu, O. C.
AU  - Telci, O.
AU  - Takir, M.
AU  - Johnson, R. J.
AU  - Covic, A.
DO  - 10.1159/000360609
IS  - 4
J2  - Am. J. Nephrol.
KW  - Uric acid
Allopurinol
Endothelial dysfunction
Cardiovascular disease
serum uric-acid
improves endothelial function
chronic kidney-disease
chronic heart-failure
nitric-oxide
cardiovascular risk
cell-proliferation
oxidative stress
renal-function
hypertension
Urology & Nephrology
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AH3HG
Times Cited: 22
Cited Reference Count: 48
Kanbay, Mehmet Siriopol, Dimitrie Nistor, Ionut Elcioglu, Omer C. Telci, Ozge Takir, Mumtaz Johnson, Richard J. Covic, Adrian
Covic, Adrian/G-5017-2016; 1, 1/L-6277-2019
Covic, Adrian/0000-0002-9985-2486; Nistor, Ionut/0000-0002-1641-8992
University of Medicine and Pharmacy, Iasi [1640/01.02.2013, 1641/01.02.2013, IDEI-PCE 2011, PN-II-ID-PCE-2011-3-0637]
Part of this study was funded by the University of Medicine and Pharmacy, Iasi (grants Nos. 1640/01.02.2013, 1641/01.02.2013 and IDEI-PCE 2011, PN-II-ID-PCE-2011-3-0637).
23
1
17
Karger
Basel
1421-9670
PY  - 2014
SN  - 0250-8095
SP  - 348-356
ST  - Effects of Allopurinol on Endothehial Dysfunction: A Meta-Analysis
T2  - American Journal of Nephrology
TI  - Effects of Allopurinol on Endothehial Dysfunction: A Meta-Analysis
UR  - <Go to ISI>://WOS:000336013700009
VL  - 39
ID  - 149
ER  - 

TY  - JOUR
AB  - The literature on the reproductive health and healthcare of women Veterans has increased dramatically, though there are important gaps. This article aims to synthesize recent literature on reproductive health and healthcare of women Veterans. We updated a literature search to identify manuscripts published between 2008 and July 1, 2017. We excluded studies that were not original research, only included active-duty women, or had few women Veterans in their sample. Manuscripts were reviewed using a standardized abstraction form. We identified 52 manuscripts. Nearly half (48%) of the new manuscripts addressed contraception and preconception care (n=15) or pregnancy (n=10). The pregnancy and family planning literature showed that (1) contraceptive use and unintended pregnancy among women Veterans using VA healthcare is similar to that of the general population; (2) demand for VA maternity care is increasing; and (3) women Veterans using VA maternity care are a high-risk population for adverse pregnancy outcomes. A recurrent finding across topics was that history of lifetime sexual assault and mental health conditions were highly prevalent among women Veterans and associated with a wide variety of adverse reproductive health outcomes across the life course. The literature on women Veterans' reproductive health is rapidly expanding, but remains largely observational. Knowledge gaps persist in the areas of sexually transmitted infections, infertility, and menopause.
AD  - [Katon, Jodie G.; Callegari, Lisa; Gray, Kristen E.; Ma, Erica W.] US Dept Vet Affairs VA Puget Sound Hlth Care Syst, Hlth Serv Res & Dev HSR&D Ctr Innovat Vet Ctr & V, Seattle, WA USA. [Katon, Jodie G.; Gray, Kristen E.] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA. [Zephyrin, Laurie; Galvan, Ileana V.; Haeger, Kristin O.] Womens Hlth Serv, VA Off Patient Care Serv, Washington, DC USA. [Zephyrin, Laurie] VA Harbor Med Ctr, Dept Obstet & Gynecol, New York, NY USA. [Zephyrin, Laurie] New York Sch Med, Dept Obstet & Gynecol, New York, NY USA. [Meoli, Anne] SimLEARN Natl Simulat Ctr, VHA, Orlando, FL USA. [Hulugalle, Avanthi] NYU, Coll Global Publ Hlth, New York, NY USA. [Bosch, Jeane] VA San Diego Healthcare Syst, San Diego, CA USA. [Callegari, Lisa] Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA. [Hoffmire, Claire] VA Eastern Colorado Hlth Care Syst, Rocky Mt MIRECC Suicide Prevent, Denver, CO USA. [Hoffmire, Claire] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA. [Levis, Silvina] Miami Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Miami, FL USA. [Mccabe, Jennifer E.] VA Puget Sound Healthcare Syst, Seattle, WA USA. [Nillni, Yael I.; Pineles, Suzanne L.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA. [Nillni, Yael I.; Pineles, Suzanne L.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA. [Reddy, Shivani M.] VA Boston Healthcare Syst, Boston, MA USA. [Savitz, David A.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA. [Shaw, Jonathan G.] Stanford Univ, Sch Med, Div Primary Care & Populat Hlth, Palo Alto, CA 94304 USA. [Shaw, Jonathan G.] VA Palo Alto Healthcare Syst, Ctr Innovat Implementat, Palo Alto, CA USA. [Patton, Elizabeth W.] VA Boston Healthcare Syst, Div Gynecol, Dept Surg, Boston, MA USA. [Patton, Elizabeth W.] Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA. [Reddy, Shivani M.] RTI Int, Ctr Adv Methods Dev, Waltham, MA USA.
Katon, JG (reprint author), VA Puget Sound Med Ctr, 1660 S Columbian Way,S-152, Seattle, WA 98108 USA.
Jodie.Katon@va.gov
AN  - WOS:000466199300003
AU  - Katon, J. G.
AU  - Zephyrin, L.
AU  - Meoli, A.
AU  - Hulugalle, A.
AU  - Bosch, J.
AU  - Callegari, L.
AU  - Galvan, I. V.
AU  - Gray, K. E.
AU  - Haeger, K. O.
AU  - Hoffmire, C.
AU  - Levis, S.
AU  - Ma, E. W.
AU  - McCabe, J. E.
AU  - Nillni, Y. I.
AU  - Pineles, S. L.
AU  - Reddy, S. M.
AU  - Savitz, D. A.
AU  - Shaw, J. G.
AU  - Patton, E. W.
DA  - Nov
DO  - 10.1055/s-0039-1678750
IS  - 6
J2  - Semin. Reprod. Med.
KW  - women Veterans
reproductive health
health services
deployment
women's health
posttraumatic-stress-disorder
sexually-transmitted infections
maternity care coordination
female veterans
mental-health
contraceptive adherence
pregnant veterans
military service
birth-weight
outcomes
Obstetrics & Gynecology
Reproductive Biology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: HV7ZC
Times Cited: 0
Cited Reference Count: 80
Katon, Jodie G. Zephyrin, Laurie Meoli, Anne Hulugalle, Avanthi Bosch, Jeane Callegari, Lisa Galvan, Ileana V. Gray, Kristen E. Haeger, Kristin O. Hoffmire, Claire Levis, Silvina Ma, Erica W. Mccabe, Jennifer E. Nillni, Yael I. Pineles, Suzanne L. Reddy, Shivani M. Savitz, David A. Shaw, Jonathan G. Patton, Elizabeth W.
VA Women's Health Research Network - U.S. Department of Veterans Affairs (VA) Health Services Research and Development (HSRD) Service [SDR 10-012]; Evidence Based Synthesis Program located at the Minneapolis VA Healthcare System - VA Office of Research and Development, Quality Enhancement Research Initiative; VA Puget Sound HSR&D Center of Innovation (COIN) for Veteran-Centered and Value Driven Care; Veterans Affairs Office of Patient Care Services, Office of Women's Health; HSR&D Career Development Award [VA HSRD CDA 13-266]; Advanced Fellowship in Women's Health from the Veterans Affairs Office of Academic Affiliations; HSR&D Career Development Awards [VA HSRD CDA 16-154, CDA 14-412]; K23 award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [1K23HD087428-01A1]; Division of Reproductive Health, VA Office of Patient Care Services, Women's Health Services
This work was supported in part by the VA Women's Health Research Network funded by the U.S. Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Service (SDR 10-012) and the Evidence Based Synthesis Program located at the Minneapolis VA Healthcare System funded by the VA Office of Research and Development, Quality Enhancement Research Initiative. Dr. Katon was supported by the VA Puget Sound HSR&D Center of Innovation (COIN) for Veteran-Centered and Value Driven Care, the Veterans Affairs Office of Patient Care Services, Office of Women's Health, and by a HSR&D Career Development Award (VA HSRD CDA 13-266). Dr. Bosch is supported by an Advanced Fellowship in Women's Health from the Veterans Affairs Office of Academic Affiliations. Drs. Gray and Callegari were supported by HSR&D Career Development Awards (VA HSRD CDA 16-154 and CDA 14-412). Dr. Yael Nillni was supported by a K23 award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1K23HD087428-01A1). Dr. Elizabeth Patton was supported by the Division of Reproductive Health, VA Office of Patient Care Services, Women's Health Services. The views expressed herein are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.
0
2
Thieme medical publ inc
New york
1526-4564
PY  - 2018
SN  - 1526-8004
SP  - 315-322
ST  - Reproductive Health of Women Veterans: A Systematic Review of the Literature from 2008 to 2017
T2  - Seminars in Reproductive Medicine
TI  - Reproductive Health of Women Veterans: A Systematic Review of the Literature from 2008 to 2017
UR  - <Go to ISI>://WOS:000466199300003
VL  - 36
ID  - 3
ER  - 

TY  - JOUR
AD  - [Keswani, Rajesh N.] Northwestern Univ, Med, Chicago, IL 60611 USA. [O'Dwyer, Linda] Feinberg Sch Med, Chicago, IL USA. [Wani, Sachin] Univ Colorado, Med, Denver, CO 80202 USA. [Qumseya, Bashar J.] Florida State Univ, Archbold Med Grp, Thomasville, GA USA. [Qumseya, Bashar J.] Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.
AN  - WOS:000381906900329
AU  - Keswani, R. N.
AU  - Qumseya, B. J.
AU  - O'Dwyer, L.
AU  - Wani, S.
DA  - May
DO  - 10.1016/j.gie.2016.03.348
IS  - 5
J2  - Gastrointest. Endosc.
KW  - Gastroenterology & Hepatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: DU0PL
Times Cited: 0
Cited Reference Count: 0
Keswani, Rajesh N. Qumseya, Bashar J. O'Dwyer, Linda Wani, Sachin
Digestive Disease Week (DDW) / Meeting of the American-Society-for-Gastrointestinal-Endoscopy (ASGE)
May 21-24, 2016
San Diego, CA
Amer Soc Gastrointestinal Endoscopy
0
Mosby-elsevier
New york
1097-6779
S
PY  - 2016
SN  - 0016-5107
SP  - AB246-AB247
ST  - Endoscopist and Center ERCP Volume Are Associated With Increased Success Rates: A Systematic Review and Meta-Analysis
T2  - Gastrointestinal Endoscopy
TI  - Endoscopist and Center ERCP Volume Are Associated With Increased Success Rates: A Systematic Review and Meta-Analysis
UR  - <Go to ISI>://WOS:000381906900329
VL  - 83
ID  - 81
ER  - 

TY  - JOUR
AD  - [Kokkinidis, Damianos; Avner, Seth] Albert Einstein Coll Med, Jacobi Med Ctr, New York, NY USA. [Katsaros, Ioannis] Democritus Univ Thrace, Alexandroupolis, Greece. [Jonnalagadda, Anil] Medstar Washington Hosp Ctr, Washington, DC USA. [Armstrong, Ehrin] Univ Colorado, Denver, CO 80202 USA.
AN  - WOS:000455137100248
AU  - Kokkinidis, D.
AU  - Katsaros, I.
AU  - Jonnalagadda, A.
AU  - Avner, S.
AU  - Armstrong, E.
DA  - Sep
DO  - 10.1016/j.jacc.2018.08.1380
IS  - 13
J2  - J. Am. Coll. Cardiol.
KW  - Cardiovascular System & Cardiology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: HG6ZK
Times Cited: 0
Cited Reference Count: 0
Kokkinidis, Damianos Katsaros, Ioannis Jonnalagadda, Anil Avner, Seth Armstrong, Ehrin
30th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT)
Sep 21-25, 2018
San Diego, CA
Jonnalagadda, anil kumar/x-5875-2019
Jonnalagadda, anil kumar/0000-0001-9817-6140
0
Elsevier science inc
New york
1558-3597
B
PY  - 2018
SN  - 0735-1097
SP  - B104-B104
ST  - Use, safety and effectiveness of Subintimal Angioplasty and Re-entry Devices for the Treatment of Femoropopliteal Chronic Total Occlusions; a Systematic Review of 87 Studies and 4,671 Patients
T2  - Journal of the American College of Cardiology
TI  - Use, safety and effectiveness of Subintimal Angioplasty and Re-entry Devices for the Treatment of Femoropopliteal Chronic Total Occlusions; a Systematic Review of 87 Studies and 4,671 Patients
UR  - <Go to ISI>://WOS:000455137100248
VL  - 72
ID  - 7
ER  - 

TY  - JOUR
AD  - [Komanduri, Srinadh] NW Mem Hosp, Dept Gastroenterol, Chicago, IL 60611 USA. [Korrapati, Praneet] NW Mem Hosp, Chicago, IL 60611 USA. [Ciolino, Jody] Northwestern Univ, Biostat Collaborat Ctr, Chicago, IL 60611 USA. [Wani, Sachin] Univ Colorado, Dept Gastroenterol & Hepatol, Aurora, CO USA.
AN  - WOS:000363715903111
AU  - Komanduri, S.
AU  - Korrapati, P.
AU  - Ciolino, J.
AU  - Wani, S.
DA  - Oct
J2  - Am. J. Gastroenterol.
KW  - Gastroenterology & Hepatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: CU7KO
Times Cited: 0
Cited Reference Count: 0
Komanduri, Srinadh Korrapati, Praneet Ciolino, Jody Wani, Sachin
80th Annual Scientific Meeting of the American-College-of-Gastroenterology
Oct 16-21, 2015
Honolulu, HI
Amer Coll Gastroenterol
0
Nature publishing group
New york
1572-0241
1
PY  - 2015
SN  - 0002-9270
SP  - S645-S647
ST  - Clinical Efficacy of Peroral Cholangioscopy (POC) in the Management of Difficult Bile Duct Stones and Indeterminate Biliary Strictures: A Systematic Review and Meta-analysis
T2  - American Journal of Gastroenterology
TI  - Clinical Efficacy of Peroral Cholangioscopy (POC) in the Management of Difficult Bile Duct Stones and Indeterminate Biliary Strictures: A Systematic Review and Meta-analysis
UR  - <Go to ISI>://WOS:000363715903111
VL  - 110
ID  - 103
ER  - 

TY  - JOUR
AD  - [Kourbelis, C.; Foote, J.; Marin, T.; Clark, R. A.] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, SA, Australia. [Kourbelis, C.; Foote, J.; Marin, T.; Clark, R. A.] Flinders Med Ctr, Coll Nursing & Hlth Sci, Adelaide, SA, Australia. [Brown, A.] South Australian Hlth & Med Res Inst, Wardliparingga Aboriginal Res Unit, Adelaide, SA, Australia. [Ganesan, A.] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia. [Ganesan, A.] Flinders Med Ctr, Coll Med & Publ Hlth, Adelaide, SA, Australia. [Daniel, M.; Coffee, N.] Univ Canberra, UC Hlth Res Inst, Canberra, ACT, Australia. [Newman, P.] Flinders Univ S Australia, Flinders Univ Lib, Adelaide, SA, Australia. [Newman, P.] Flinders Med Ctr, Flinders Univ Lib, Adelaide, SA, Australia. [Nicholls, S.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.
AN  - WOS:000440339600019
AU  - Kourbelis, C.
AU  - Foote, J.
AU  - Marin, T.
AU  - Brown, A.
AU  - Ganesan, A.
AU  - Daniel, M.
AU  - Coffee, N.
AU  - Newman, P.
AU  - Nicholls, S.
AU  - Clark, R. A.
DA  - Aug
J2  - Eur. J. Cardiovasc. Nurs.
KW  - Cardiovascular System & Cardiology
Nursing
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GO8KX
Times Cited: 0
Cited Reference Count: 0
Kourbelis, C. Foote, J. Marin, T. Brown, A. Ganesan, A. Daniel, M. Coffee, N. Newman, P. Nicholls, S. Clark, R. A.
Ganesan, Anand/A-4902-2019; Clark, Robyn A/D-1604-2009; Coffee, Neil/F-4357-2013
Ganesan, Anand/0000-0002-2734-3025; Clark, Robyn A/0000-0002-5063-2618; Coffee, Neil/0000-0002-5075-0737
National Heart Foundation of AustraliaNational Heart Foundation of Australia [101443]; Heart Foundation [100847]
National Heart Foundation of Australia Vanguard Grant, Award ID 101443; Heart Foundation Future Leader Fellow(App ID: 100847)
0
Sage publications ltd
London
1873-1953
1
PY  - 2018
SN  - 1474-5151
SP  - 12-12
ST  - The lack of evidence for the effectiveness of discharge education on clinical outcomes in acute coronary syndrome patients: a systematic review. where to from here?
T2  - European Journal of Cardiovascular Nursing
TI  - The lack of evidence for the effectiveness of discharge education on clinical outcomes in acute coronary syndrome patients: a systematic review. where to from here?
UR  - <Go to ISI>://WOS:000440339600019
VL  - 17
ID  - 10
ER  - 

TY  - JOUR
AD  - [Kuperus, J. S.; de Gendt, E. E.; Oner, F. C.; Verlaan, J. -J.] Univ Med Ctr Utrecht, Orthoped, Utrecht, Netherlands. [de Jong, P. A.; Buckens, S. C.] Univ Med Ctr Utrecht, Radiol, Utrecht, Netherlands. [van der Merwe, A. E.] Acad Med Ctr, Anat, Amsterdam, Netherlands. [Maat, G. J.] Leiden Univ, Med Ctr, Anat, Leiden, Netherlands. [Regan, E. A.] Natl Jewish Hlth, Med, Denver, CO USA. [Resnick, D.] Univ Calif San Diego, Radiol, San Diego, CA 92103 USA. [Mader, R.] HaEmek Med Ctr, Rheumatol, Afula, Israel.
AN  - WOS:000413181404319
AU  - Kuperus, J. S.
AU  - de Gendt, E. E.
AU  - Oner, F. C.
AU  - de Jong, P. A.
AU  - Buckens, S. C.
AU  - van der Merwe, A. E.
AU  - Maat, G. J.
AU  - Regan, E. A.
AU  - Resnick, D.
AU  - Mader, R.
AU  - Verlaan, J. J.
DA  - Jun
DO  - 10.1136/annrheumdis-2017-eular.4656
J2  - Ann. Rheum. Dis.
KW  - features
Rheumatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: FK0PH
Times Cited: 0
Cited Reference Count: 4
Kuperus, J. S. de Gendt, E. E. Oner, F. C. de Jong, P. A. Buckens, S. C. van der Merwe, A. E. Maat, G. J. Regan, E. A. Resnick, D. Mader, R. Verlaan, J. -J.
Annual European Congress of Rheumatology
Jun 14-17, 2017
Madrid, SPAIN
0
Bmj publishing group
London
1468-2060
2
PY  - 2017
SN  - 0003-4967
SP  - 1423-1423
ST  - QUALITATIVE SYSTEMATIC REVIEW: LACK OF CONSENSUS ON THE CLASSIFICATION CRITERIA FOR DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS
T2  - Annals of the Rheumatic Diseases
TI  - QUALITATIVE SYSTEMATIC REVIEW: LACK OF CONSENSUS ON THE CLASSIFICATION CRITERIA FOR DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS
UR  - <Go to ISI>://WOS:000413181404319
VL  - 76
ID  - 57
ER  - 

TY  - JOUR
AB  - Study objective: We estimate the proportion of patients with crotaline snake envenomation who are treated with Crotalidae polyvalent immune Fab (ovine) antivenom and who develop medically significant late bleeding. Methods: We performed a systematic review of all published cohort studies of North American crotaline snake envenomation patients treated with Fab antivenom. We searched Pub Med, Ovid MEDLINE, and EMBASE from January 1, 1997, to April 30, 2012. Data were extracted by 2 trained researchers. Late bleeding was defined as bleeding that began or recurred after initial control of the envenomation syndrome. Medically significant late bleeding was defined a priori as late bleeding treated with RBC transfusion, vasoactive drug infusion, surgery, or rehospitalization or associated with a hemoglobin decrease of greater than or equal to 3 g/dL, hematocrit decrease of greater than or equal to 8%, disability, or death. Summary incidence and 95% confidence intervals (Cis) were calculated with a random-effects Poisson regression model. Results: Nineteen unique cohort studies were identified. Four studies collected data prospectively, and in 9 studies, patients were followed actively after hospital discharge. A total of 1,017 subjects were enrolled in these cohort studies. Late bleeding was reported in 9 subjects (0.9%; 95% Cl 0.4% to 2.2%), of whom 5 subjects (0.5%; 95% Cl 0.1% to 1.7%) had medically significant late bleeding. Three patients received RBC transfusion; no deaths or permanent sequelae were reported. Estimates of risk may be affected by underreporting. Conclusion: Medically significant late bleeding appears to be uncommon in snakebite victims treated with Fab antivenom.
AD  - [Lavonas, Eric J.; Khatri, Vaishali; Bucher-Bartelson, Becki; Dart, Richard C.] Denver Hlth & Hosp Author, Rocky Mt Poison & Drug Ctr, Denver, CO 80208 USA. [Lavonas, Eric J.; Dart, Richard C.] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA. [Daugherty, Claire; King, Thomas] BTG Int Inc, W Conshohocken, PA USA.
Lavonas, EJ (reprint author), Denver Hlth & Hosp Author, Rocky Mt Poison & Drug Ctr, Denver, CO 80208 USA.
eric.lavonas@rmpdc.org
AN  - WOS:000329890300017
AU  - Lavonas, E. J.
AU  - Khatri, V.
AU  - Daugherty, C.
AU  - Bucher-Bartelson, B.
AU  - King, T.
AU  - Dart, R. C.
DA  - Jan
DO  - 10.1016/j.annemergmed.2013.03.002
IS  - 1
J2  - Ann. Emerg. Med.
KW  - polyvalent immune fab
rattlesnake envenomation
recurrent coagulopathy
ovine antivenom
united-states
snake bites
pit viper
venom
experience
trial
Emergency Medicine
LA  - English
M3  - Article; Proceedings Paper
N1  - ISI Document Delivery No.: 292GN
Times Cited: 21
Cited Reference Count: 43
Lavonas, Eric J. Khatri, Vaishali Daugherty, Claire Bucher-Bartelson, Becki King, Thomas Dart, Richard C.
17th World Congress of the International-Society-of-Toxinology (IST) / Venom Week / 4th International Scientific Symposium on All Things Venomous
Jul 08-13, 2012
Honolulu, HI
Int Soc Toxinol, Rare Dis Therapeut Inc, BTG Int Ltd, Inst Bioclon, Silanes Labs SA, Toxicon Amer Int Rattlesnake Museum, Chiricahua Desert Museum, Elsevier, Univ Hawaii, Coll Pharm, Univ New Mexico Hlth Sci Ctr, Midwest Tongs
NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR025780.]
21
0
4
Mosby-elsevier
New york
PY  - 2014
SN  - 0196-0644
SP  - 71-78
ST  - Medically Significant Late Bleeding After Treated Crotaline Envenomation: A Systematic Review
T2  - Annals of Emergency Medicine
TI  - Medically Significant Late Bleeding After Treated Crotaline Envenomation: A Systematic Review
UR  - <Go to ISI>://WOS:000329890300017
VL  - 63
ID  - 150
ER  - 

TY  - JOUR
AD  - [Lederer, D. J.] Columbia Univ, New York, NY USA. [Albera, C.] Univ Turin, Turin, Italy. [Bradford, W. Z.; Fagan, E. A.; Fishman, R. S.; Leff, J. A.] Intermune Inc, Brisbane, CA USA. [Costabel, U.] Ruhrlandklin, Essen, Germany. [Costabel, U.] Univ Duisburg Essen, Essen, Germany. [du Bois, R. M.] Imperial Coll, London, England. [Glaspole, I.] Alfred Hosp, Melbourne, Vic, Australia. [Glassberg, M. K.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA. [King, T. E.] Univ Calif San Francisco, San Francisco, CA 94143 USA. [Lancaster, L.] Vanderbilt Univ, Med Ctr, Nashville, TN USA. [Nathan, S. D.] Inova Fairfax Hosp, Falls Church, VA USA. [Pereira, C. A.] Univ Fed Sao Paulo, Paulista Sch Med, Sao Paulo, Brazil. [Sahn, S. A.] Med Univ South Carolina, Charleston, SC USA. [Swigris, J. J.] Natl Jewish Hlth, Denver, CO USA. [Valeyre, D.] Avicenne Univ Hosp, AP HP, Bobigny, France. [Noble, P. W.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
AN  - WOS:000209838200418
AU  - Lederer, D. J.
AU  - Albera, C.
AU  - Bradford, W. Z.
AU  - Costabel, U.
AU  - du Bois, R. M.
AU  - Fagan, E. A.
AU  - Fishman, R. S.
AU  - Glaspole, I.
AU  - Glassberg, M. K.
AU  - King, T. E.
AU  - Lancaster, L.
AU  - Leff, J. A.
AU  - Nathan, S. D.
AU  - Pereira, C. A.
AU  - Sahn, S. A.
AU  - Swigris, J. J.
AU  - Valeyre, D.
AU  - Noble, P. W.
J2  - Am. J. Respir. Crit. Care Med.
KW  - General & Internal Medicine
Respiratory System
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: V45TF
Times Cited: 0
Cited Reference Count: 0
Lederer, D. J. Albera, C. Bradford, W. Z. Costabel, U. du Bois, R. M. Fagan, E. A. Fishman, R. S. Glaspole, I. Glassberg, M. K. King, T. E. Lancaster, L. Leff, J. A. Nathan, S. D. Pereira, C. A. Sahn, S. A. Swigris, J. J. Valeyre, D. Noble, P. W.
0
Amer thoracic soc
New york
1535-4970
PY  - 2014
SN  - 1073-449X
SP  - 2
ST  - Effect Of Treatment With Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis (ipf): A Meta-Analysis Of 5 Randomized, Double-Blind, Placebo Controlled Clinical Trials
T2  - American Journal of Respiratory and Critical Care Medicine
TI  - Effect Of Treatment With Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis (ipf): A Meta-Analysis Of 5 Randomized, Double-Blind, Placebo Controlled Clinical Trials
UR  - <Go to ISI>://WOS:000209838200418
VL  - 189
ID  - 152
ER  - 

TY  - JOUR
AB  - Implantable cardioverter-defibrillators (ICDs) are used for patients at risk of sudden cardiac death. Patients considering ICD therapy are faced with several preference-sensitive decisions. Our aim was to explore patients' ICD decision-making experiences from the decision to implant to the consideration of deactivation at end of life. We conducted an integrative review using Whittemore and Knafl's five steps. MEDLINE, CINAHL, PubMed, PsycINFO, and the Cochrane library were searched from 2000 to 2013. Eligible studies focused on the patient response regarding ICD decision-making. Key themes were identified and used as a framework to discuss findings through the chronological course of decisions faced by these patients. Of 354 potential citations, 25 articles were included. The trajectory of key decision points was whether or not to initiate ICD therapy, replace the battery, and deactivate at end of life. Three common themes from patients' perspectives were the influence of the patient-practitioner consultation on knowledge uptake, patients' decision-making preference, and their desire to live. Patients faced with ICD-related decisions often misunderstood the functionality of their ICD, or overestimated its benefit. They also expressed mixed preferences for the desire to be involved in decisions. The decisions around ICDs are particularly difficult for patients given the life and death trade off. Clinicians involved in the care of these patients could better support them by verifying their understanding and eliciting their preferences. Using a shared decision-making approach has the potential to achieve improved patient outcomes.
AD  - [Lewis, Krystina B.; Stacey, Dawn] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada. [Lewis, Krystina B.] Univ Ottawa Heart Inst, Ottawa, ON K1Y4W7, Canada. [Stacey, Dawn] Ottawa Hosp Res Inst, Ottawa, ON, Canada. [Matlock, Dan D.] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA.
Lewis, KB (reprint author), Univ Ottawa Heart Inst, 40 Ruskin St,Room H1285, Ottawa, ON K1Y4W7, Canada.
KBLewis@ottawaheart.ca
AN  - WOS:000344367000003
AU  - Lewis, K. B.
AU  - Stacey, D.
AU  - Matlock, D. D.
DA  - Sep
DO  - 10.1007/s40271-014-0055-2
IS  - 3
J2  - Patient
KW  - of-life
heart-failure
deactivation
perceptions
care
preferences
encounter
pacemaker
framework
attitudes
Health Care Sciences & Services
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: AS6II
Times Cited: 34
Cited Reference Count: 59
Lewis, Krystina B. Stacey, Dawn Matlock, Dan D.
National Institutes on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG040696]
The authors have no conflicts of interest to disclose. No funding was received for the completion of this study. Dr. Matlock was supported by a career development award from the National Institutes on Aging (K23AG040696).
34
0
8
Adis int ltd
Northcote
1178-1661
PY  - 2014
SN  - 1178-1653
SP  - 243-260
ST  - Making Decisions About Implantable Cardioverter-Defibrillators from Implantation to End of Life: An Integrative Review of Patients' Perspectives
T2  - Patient-Patient Centered Outcomes Research
TI  - Making Decisions About Implantable Cardioverter-Defibrillators from Implantation to End of Life: An Integrative Review of Patients' Perspectives
UR  - <Go to ISI>://WOS:000344367000003
VL  - 7
ID  - 137
ER  - 

TY  - JOUR
AB  - The ability to experience pleasant or unpleasant feelings or to represent objects as "positive" or "negative" is known as representing hedonic "valence." Although scientists overwhelmingly agree that valence is a basic psychological phenomenon, debate continues about how to best conceptualize it scientifically. We used a meta-analysis of 397 functional magnetic resonance imaging (fMRI) and positron emission tomography studies (containing 914 experimental contrasts and 6827 participants) to test 3 competing hypotheses about the brain basis of valence: the bipolarity hypothesis that positive and negative affect are supported by a brain system that monotonically increases and/or decreases along the valence dimension, the bivalent hypothesis that positive and negative affect are supported by independent brain systems, and the affective workspace hypothesis that positive and negative affect are supported by a flexible set of valence-general regions. We found little evidence for the bipolar or bivalent hypotheses. Findings instead supported the hypothesis that, at the level of brain activity measurable by fMRI, valence is flexibly implemented across instances by a set of valence-general limbic and paralimbic brain regions.
AD  - [Lindquist, Kristen A.] Univ N Carolina, Dept Psychol, Davie Hall 321,CB 3270, Chapel Hill, NC 27510 USA. [Lindquist, Kristen A.] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27510 USA. [Satpute, Ajay B.] Pomona Coll, Claremont, CA 91711 USA. [Wager, Tor D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA. [Weber, Jochen] Columbia Univ, Dept Psychol, New York, NY 10027 USA. [Barrett, Lisa Feldman] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA. [Barrett, Lisa Feldman] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Martinos Ctr Biomed Imaging,Dept Psychiat & Radio, Boston, MA USA.
Lindquist, KA (reprint author), Univ N Carolina, Dept Psychol, Davie Hall 321,CB 3270, Chapel Hill, NC 27510 USA.
kristen.lindquist@unc.edu
AN  - WOS:000377469500006
AU  - Lindquist, K. A.
AU  - Satpute, A. B.
AU  - Wager, T. D.
AU  - Weber, J.
AU  - Barrett, L. F.
DA  - May
DO  - 10.1093/cercor/bhv001
IS  - 5
J2  - Cereb. Cortex
KW  - affect
meta-analysis
neuroimaging
valence
value
multivariate pattern-analysis
functional architecture
anterior insula
emotion
amygdala
networks
science
stimuli
valence
system
Neurosciences & Neurology
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: DO0LD
Times Cited: 107
Cited Reference Count: 81
Lindquist, Kristen A. Satpute, Ajay B. Wager, Tor D. Weber, Jochen Barrett, Lisa Feldman
Satpute, Ajay/I-8845-2019
Satpute, Ajay/0000-0003-0227-0816
National Institute of Health Director's Pioneer AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP1OD003312]; U.S. Army Research Institute for the Behavioral and Social Sciences [W5J9CQ-11-C-0046]
This work was supported by National Institute of Health Director's Pioneer Award (DP1OD003312) and by the U.S. Army Research Institute for the Behavioral and Social Sciences (contract W5J9CQ-11-C-0046) awarded to L.F.B. Conflict of Interest
110
2
51
Oxford univ press inc
Cary
1460-2199
PY  - 2016
SN  - 1047-3211
SP  - 1910-1922
ST  - The Brain Basis of Positive and Negative Affect: Evidence from a Meta-Analysis of the Human Neuroimaging Literature
T2  - Cerebral Cortex
TI  - The Brain Basis of Positive and Negative Affect: Evidence from a Meta-Analysis of the Human Neuroimaging Literature
UR  - <Go to ISI>://WOS:000377469500006
VL  - 26
ID  - 86
ER  - 

TY  - JOUR
AB  - OBJECTIVE. Prevention of Clostridium difficile infection (CDI) in acute-care hospitals is a priority for hospitals and clinicians. We performed a qualitative systematic review to update the evidence on interventions to prevent CDI published since 2009. DESIGN. We searched Ovid, MEDLINE, EMBASE, The Cochrane Library, CINAHL, the ISI Web of Knowledge, and grey literature databases from January 1, 2009 to August 1, 2015. SETTING. We included studies performed in acute-care hospitals. PATIENTS OR PARTICIPANTS. We included studies conducted on hospitalized patients that investigated the impact of specific interventions on CDI rates. INTERVENTIONS. We used the QI-Minimum Quality Criteria Set (QI-MQCS) to assess the quality of included studies. Interventions were grouped thematically: environmental disinfection, antimicrobial stewardship, hand hygiene, chlorhexidine bathing, probiotics, bundled approaches, and others. A meta-analysis was performed when possible. RESULTS. Of 3,236 articles screened, 261 met the criteria for full-text review and 46 studies were ultimately included. The average quality rating was 82% according to the QI-MQCS. The most effective interventions, resulting in a 45% to 85% reduction in CDI, included daily to twice daily disinfection of high-touch surfaces (including bed rails) and terminal cleaning of patient rooms with chlorine-based products. Bundled interventions and antimicrobial stewardship showed promise for reducing CDI rates. Chlorhexidine bathing and intensified hand hygiene practices were not effective for reducing CDI rates. CONCLUSIONS. Daily and terminal cleaning of patient rooms using chlorine-based products were most effective in reducing CDI rates in hospitals. Further studies are needed to identify the components of bundled interventions that reduce CDI rates.
AD  - [Louh, Irene K.; Davidson, Karina W.; Falzon, Louise] Columbia Univ, Dept Med, Ctr Behav Cardiovasc Hlth, Coll Phys & Surg, New York, NY USA. [Louh, Irene K.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY USA. [Greendyke, William G.; Furuya, E. Yoko] Columbia Univ, Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY USA. [Hermann, Emilia A.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Gen Med, New York, NY USA. [Louh, Irene K.; Greendyke, William G.; Hermann, Emilia A.; Vawdrey, David K.; Calfee, David P.; Furuya, E. Yoko; Ting, Henry H.] New York Presbyterian Hosp, New York, NY USA. [Calfee, David P.] Weill Cornell Med Coll, Dept Med, Div Infect Dis, New York, NY USA. [Shaffer, Jonathan A.] Univ Colorado, Dept Psychol, Denver, CO 80202 USA. [Vawdrey, David K.] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY USA. [Vawdrey, David K.; Ting, Henry H.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Cardiovasc Dis, New York, NY USA.
Ting, HH (reprint author), Columbia Univ, Coll Med, 622 W 168th St, New York, NY 10032 USA.
hting@nyp.org
AN  - WOS:000397352300015
AU  - Louh, I. K.
AU  - Greendyke, W. G.
AU  - Hermann, E. A.
AU  - Davidson, K. W.
AU  - Falzon, L.
AU  - Vawdrey, D. K.
AU  - Shaffer, J. A.
AU  - Calfee, D. P.
AU  - Furuya, E. Y.
AU  - Ting, H. H.
DA  - Apr
DO  - 10.1017/ice.2016.324
IS  - 4
J2  - Infect. Control Hosp. Epidemiol.
KW  - antimicrobial stewardship program
resistant staphylococcus-aureus
antibiotic stewardship
fluoroquinolone use
impact
health
implementation
restriction
outbreak
outcomes
Public, Environmental & Occupational Health
Infectious Diseases
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: EP4LP
Times Cited: 7
Cited Reference Count: 60
Louh, Irene K. Greendyke, William G. Hermann, Emilia A. Davidson, Karina W. Falzon, Louise Vawdrey, David K. Shaffer, Jonathan A. Calfee, David P. Furuya, E. Yoko Ting, Henry H.
Falzon, Louise/0000-0002-9449-6056; Davidson, Karina/0000-0002-9162-477X
Value Institute of NewYork-Presbyterian Hospital; Patient-Centered Outcomes Research Institute [ME-1403-12304]; National Institutes of Health K23 career development award [K23 HL112850]; New York State Department of Health's Empire Clinical Research Investigator Program (ECRIP)
This review was supported by the Value Institute of NewYork-Presbyterian Hospital, and New York State Department of Health's Empire Clinical Research Investigator Program (ECRIP). Additional support was provided by the Patient-Centered Outcomes Research Institute (contract no. ME-1403-12304). Dr Shaffer is supported by National Institutes of Health K23 career development award (grant no. K23 HL112850).
7
0
6
Cambridge univ press
New york
1559-6834
PY  - 2017
SN  - 0899-823X
SP  - 476-482
ST  - Clostridium Difficile Infection in Acute Care Hospitals: Systematic Review and Best Practices for Prevention
T2  - Infection Control and Hospital Epidemiology
TI  - Clostridium Difficile Infection in Acute Care Hospitals: Systematic Review and Best Practices for Prevention
UR  - <Go to ISI>://WOS:000397352300015
VL  - 38
ID  - 66
ER  - 

TY  - JOUR
AD  - [Luoma, Kelsey; Leavitt, Ian M.; Nederveld, Andrea; Regensteiner, Judith G.; Huebschmann, Amy G.] Univ Colorado, Sch Med, Aurora, CO USA. [Marrs, Joel C.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA. [Regensteiner, Judith G.; Huebschmann, Amy G.] Univ Colorado, Ctr Womens Hlth Res, Aurora, CO USA. [Dunn, Andrea L.] AL Dunn Hlth Consulting LLC, Loveland, CO USA. [Glasgow, Russell E.] Univ Colorado, Aurora, CO USA.
AN  - WOS:000392201600288
AU  - Luoma, K.
AU  - Leavitt, I. M.
AU  - Marrs, J. C.
AU  - Nederveld, A.
AU  - Regensteiner, J. G.
AU  - Dunn, A. L.
AU  - Glasgow, R. E.
AU  - Huebschmann, A. G.
DA  - May
J2  - J. Gen. Intern. Med.
KW  - Health Care Sciences & Services
General & Internal Medicine
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: EI0YL
Times Cited: 0
Cited Reference Count: 0
Luoma, Kelsey Leavitt, Ian M. Marrs, Joel C. Nederveld, Andrea Regensteiner, Judith G. Dunn, Andrea L. Glasgow, Russell E. Huebschmann, Amy G.
Meeting of the Society-of-General-Internal-Medicine (SGIM)
May 11-14, 2015-2016
Hollywood, FL
Soc Gen Internal Med
0
Springer
New york
1525-1497
2
PY  - 2016
SN  - 0884-8734
SP  - S248-S248
ST  - HOW CAN CLINICAL PRACTICES PRAGMATICALLY INCREASE PHYSICAL ACTIVITY FOR PATIENTS WITH TYPE 2 DIABETES? A SYSTEMATIC REVIEW
T2  - Journal of General Internal Medicine
TI  - HOW CAN CLINICAL PRACTICES PRAGMATICALLY INCREASE PHYSICAL ACTIVITY FOR PATIENTS WITH TYPE 2 DIABETES? A SYSTEMATIC REVIEW
UR  - <Go to ISI>://WOS:000392201600288
VL  - 31
ID  - 84
ER  - 

TY  - JOUR
AB  - We aim to review the available literature on obese patients treated with one-anastomosis gastric bypass (OAGB) or laparoscopic sleeve gastrectomy (LSG), in order to compare the clinical outcomes and intraoperative parameters of the two methods. A systematic literature search was performed in PubMed, Cochrane Library, and Scopus databases, in accordance with the PRISMA guidelines. Seventeen studies met the inclusion criteria incorporating 6761 patients. This study reveals increased weight loss, remission of comorbidities, shorter mean hospital stay, and lower mortality in the OAGB group. The incidence of leaks and intra-abdominal bleeding was similar between the two approaches. Well-designed, randomized controlled studies, comparing LSG to OAGB, are necessary to further assess their clinical outcomes.
AD  - [Magouliotis, Dimitrios E.; Sioka, Eleni; Zacharoulis, Dimitrios] Univ Hosp Larissa, Dept Surg, Viopolis 41110, Larissa, Greece. [Tasiopoulou, Vasiliki S.] Univ Thessaly, Sch Hlth Sci, Fac Med, Viopolis, Larissa, Greece. [Svokos, Alexis A.] Riverside Reg Med Ctr, Newport News, VA USA. [Svokos, Konstantina A.] Childrens Hosp Colorado, Denver, CO USA.
Magouliotis, DE (reprint author), Univ Hosp Larissa, Dept Surg, Viopolis 41110, Larissa, Greece.
dmagouliotis@gmail.com; vasilikitasiopoulou@gmail.com; Alexis.svokos@gmail.com; konstantina.svokos@gmail.com; konstantinasioka@gmail.com; zachadim@yahoo.com
AN  - WOS:000407971600041
AU  - Magouliotis, D. E.
AU  - Tasiopoulou, V. S.
AU  - Svokos, A. A.
AU  - Svokos, K. A.
AU  - Sioka, E.
AU  - Zacharoulis, D.
DA  - Sep
DO  - 10.1007/s11695-017-2807-2
IS  - 9
J2  - Obes. Surg.
KW  - One-anastomosis gastric bypass
Sleeve gastrectomy
Obesity
Bariatric
surgery
OAGB
single anastomosis
bariatric surgery
outcomes
quality
profile
Surgery
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FE1IJ
Times Cited: 11
Cited Reference Count: 33
Magouliotis, Dimitrios E. Tasiopoulou, Vasiliki S. Svokos, Alexis A. Svokos, Konstantina A. Sioka, Eleni Zacharoulis, Dimitrios
Magouliotis, Dimitrios/0000-0001-5417-6392
11
0
1
Springer
New york
1708-0428
PY  - 2017
SN  - 0960-8923
SP  - 2479-2487
ST  - One-Anastomosis Gastric Bypass Versus Sleeve Gastrectomy for Morbid Obesity: a Systematic Review and Meta-analysis
T2  - Obesity Surgery
TI  - One-Anastomosis Gastric Bypass Versus Sleeve Gastrectomy for Morbid Obesity: a Systematic Review and Meta-analysis
UR  - <Go to ISI>://WOS:000407971600041
VL  - 27
ID  - 52
ER  - 

TY  - JOUR
AB  - We aim to review the available literature on obese patients treated with laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG) after failed laparoscopic adjustable gastric banding (LAGB), in order to compare the clinical outcomes of the two methods. A systematic literature search was performed in PubMed, CENTRAL, and Scopus databases, in accordance with the PRISMA guidelines. Eight studies met the inclusion criteria incorporating 635 patients. Both procedures are associated with comparable complications, conversions, mean hospital stay, and weight loss at 6 and 12 months. In the LRYGB group, % excess weight loss (%EWL) and BMI reduction after 24 months were increased. Well-designed, randomized controlled studies, comparing revisional LRYGB and LSG, are necessary to further assess their outcomes.
AD  - [Magouliotis, Dimitrios E.; Sioka, Eleni; Zacharoulis, Dimitrios] Univ Hosp Larissa, Dept Surg, Viopolis 41110, Larissa, Greece. [Tasiopoulou, Vasiliki S.] Univ Thessaly, Sch Hlth Sci, Fac Med, Viopolis, Larissa, Greece. [Svokos, Alexis A.] Riverside Reg Med Ctr, Newport News, VA USA. [Svokos, Konstantina A.] Childrens Hosp Colorado, Denver, CO USA.
Magouliotis, DE (reprint author), Univ Hosp Larissa, Dept Surg, Viopolis 41110, Larissa, Greece.
dmagouliotis@gmail.com; vasilikitasiopoulou@gmail.com; Alexis.svokos@gmail.com; konstantina.svokos@gmail.com; konstantinasioka@gmail.com; zacharoulis@med.uth.gr
AN  - WOS:000400029400036
AU  - Magouliotis, D. E.
AU  - Tasiopoulou, V. S.
AU  - Svokos, A. A.
AU  - Svokos, K. A.
AU  - Sioka, E.
AU  - Zacharoulis, D.
DA  - May
DO  - 10.1007/s11695-017-2644-3
IS  - 5
J2  - Obes. Surg.
KW  - Adjustable gastric band
Failed LAGB
Roux-en-Y gastric bypass
Sleeve
gastrectomy
LRYGB
LSG
laparoscopic conversion
morbid-obesity
experience
ghrelin
Surgery
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: ET1KX
Times Cited: 14
Cited Reference Count: 28
Magouliotis, Dimitrios E. Tasiopoulou, Vasiliki S. Svokos, Alexis A. Svokos, Konstantina A. Sioka, Eleni Zacharoulis, Dimitrios
Magouliotis, Dimitrios/0000-0001-5417-6392
14
0
Springer
New york
1708-0428
PY  - 2017
SN  - 0960-8923
SP  - 1365-1373
ST  - Roux-En-Y Gastric Bypass versus Sleeve Gastrectomy as Revisional Procedure after Adjustable Gastric Band: a Systematic Review and Meta-Analysis
T2  - Obesity Surgery
TI  - Roux-En-Y Gastric Bypass versus Sleeve Gastrectomy as Revisional Procedure after Adjustable Gastric Band: a Systematic Review and Meta-Analysis
UR  - <Go to ISI>://WOS:000400029400036
VL  - 27
ID  - 64
ER  - 

TY  - JOUR
AB  - Introduction: The purpose of this study was to review the existing evidence on obese patients treated with single-incision laparoscopic sleeve gastrectomy (SILSG) or conventional laparoscopic sleeve gastrectomy (LSG), to compare the perioperative parameters and outcomes of the two bariatric procedures. Materials and Methods: A systematic literature search was performed in PubMed, Scopus, and Cochrane library, in accordance with the PRISMA guidelines. Seventeen articles met the inclusion criteria and incorporated 3843 patients. Results: This study reveals comparable mean operative time, length of hospital stay, and complications between the two approaches. The SILSG approach was associated with enhanced cosmetic results, but increased incisional hernia rate. Conclusions: These outcomes should be treated with caution given the small number of included comparative studies. Well-designed, randomized controlled studies, comparing LSG to SILSG, are necessary to assess further their clinical outcomes.
AD  - [Magouliotis, Dimitrios E.] Univ Hosp Larissa, Dept Surg, Larisa 41222, Greece. [Tasiopoulou, Vasiliki S.] Univ Thessaly, Sch Hlth Sci, Fac Med, Viopolis, Larissa, Greece. [Svokos, Alexis A.] Riverside Reg Med Ctr, Newport News, VA USA. [Svokos, Konstantina A.] Childrens Hosp Colorado, Denver, CO USA. [Sioka, Eleni; Zacharoulis, Dimitrios] Univ Hosp Larissa, Dept Surg, Larisa, Greece. [Svokos, Konstantina A.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
Magouliotis, DE (reprint author), Univ Hosp Larissa, Dept Surg, Larisa 41222, Greece.
dmagouliotis@gmail.com
AN  - WOS:000424079300001
AU  - Magouliotis, D. E.
AU  - Tasiopoulou, V. S.
AU  - Svokos, A. A.
AU  - Svokos, K. A.
AU  - Sioka, E.
AU  - Zacharoulis, D.
DA  - Jun
DO  - 10.1089/lap.2017.0245
IS  - 6
J2  - J. Laparoendosc. Adv. Surg. Tech.
KW  - SILSG
LSG
single-incision sleeve gastrectomy
laparoscopic sleeve
gastrectomy
sleeve gastrectomy
obesity
bariatric surgery
improved cosmesis
cholecystectomy
Surgery
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GJ1DA
Times Cited: 0
Cited Reference Count: 34
Magouliotis, Dimitrios E. Tasiopoulou, Vasiliki S. Svokos, Alexis A. Svokos, Konstantina A. Sioka, Eleni Zacharoulis, Dimitrios
Magouliotis, Dimitrios/0000-0001-5417-6392
0
2
Mary ann liebert, inc
New rochelle
1557-9034
PY  - 2018
SN  - 1092-6429
SP  - 690-699
ST  - Single Incision Versus Conventional Laparoscopic Sleeve Gastrectomy for Morbid Obesity: A Meta-Analysis
T2  - Journal of Laparoendoscopic & Advanced Surgical Techniques
TI  - Single Incision Versus Conventional Laparoscopic Sleeve Gastrectomy for Morbid Obesity: A Meta-Analysis
UR  - <Go to ISI>://WOS:000424079300001
VL  - 28
ID  - 31
ER  - 

TY  - JOUR
AD  - [Mahajerin, A.] Univ Calif Irvine, Pediat, Irvine, CA USA. [Mahajerin, A.] CHOC Childrens Specialists, Hematol, Orange, CA USA. [Branchford, B. R.] Univ Colorado, Pediat, Denver, CO 80202 USA. [Amankwah, E. A.] All Childrens Res Inst, Clin & Translat Res, St Petersburg, FL USA. [Raffini, L.] Univ Penn, Sch Med, Pediat, Philadelphia, PA 19104 USA. [Chalmers, E.] Royal Hosp Sick Children, Haematol, Glasgow G3 8SJ, Lanark, Scotland. [van Ommen, C. H.] Emma Childrens Hosp, Pediat Haematol, Amsterdam, Netherlands. [Goldenberg, N. A.] Johns Hopkins Univ, Sch Med, Pediat, St Petersburg, FL USA.
AN  - WOS:000356426901157
AU  - Mahajerin, A.
AU  - Branchford, B. R.
AU  - Amankwah, E. A.
AU  - Raffini, L.
AU  - Chalmers, E.
AU  - van Ommen, C. H.
AU  - Goldenberg, N. A.
DA  - Jun
J2  - J. Thromb. Haemost.
KW  - Hematology
Cardiovascular System & Cardiology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: CK7QJ
Times Cited: 0
Cited Reference Count: 0
Mahajerin, A. Branchford, B. R. Amankwah, E. A. Raffini, L. Chalmers, E. van Ommen, C. H. Goldenberg, N. A.
Branchford, Brian/H-7581-2019
Branchford, Brian/0000-0002-4076-270X
0
1
Wiley-blackwell
Hoboken
1538-7836
2
Si
PY  - 2015
SN  - 1538-7933
SP  - 58-58
ST  - Hospital-associated venous thromboembolism (HA-VTE) IN pediatrics: a systematic review and meta-analysis of risk factors and risk assessment models
T2  - Journal of Thrombosis and Haemostasis
TI  - Hospital-associated venous thromboembolism (HA-VTE) IN pediatrics: a systematic review and meta-analysis of risk factors and risk assessment models
UR  - <Go to ISI>://WOS:000356426901157
VL  - 13
ID  - 111
ER  - 

TY  - JOUR
AB  - Objectives: Shiga toxin-producing Escherichia coli (STEC) are an important cause of foodborne disease, yet global estimates of disease burden do not exist. Our objective was to estimate the global annual number of illnesses due to pathogenic STEC, and resultant hemolytic uremic syndrome (HUS), end-stage renal disease (ESRD), and death. Materials: We searched Medline, Scopus, SIGLE/OpenGrey, and CABI and World Health Organization (WHO) databases for studies of STEC incidence in the general population, published between January 1, 1990 and April 30, 2012, in all languages. We searched health institution websites for notifiable disease data and reports, cross-referenced citations, and consulted international knowledge experts. We employed an a priori hierarchical study selection process and synthesized results using a stochastic simulation model to account for uncertainty inherent in the data. Results: We identified 16 articles and databases from 21 countries, from 10 of the 14 WHO Sub-Regions. We estimated that STEC causes 2,801,000 acute illnesses annually (95% Credible Interval [Cr. I.]: 1,710,000; 5,227,000), and leads to 3890 cases of HUS (95% Cr. I.: 2400; 6700), 270 cases of ESRD (95% Cr. I.: 20; 800), and 230 deaths (95% Cr. I.: 130; 420). Sensitivity analyses indicated these estimates are likely conservative. Conclusions: These are the first estimates of the global incidence of STEC-related illnesses, which have not been explicitly included in previous global burden of disease estimations. Compared to other pathogens with a foodborne transmission component, STEC appears to cause more cases than alveolar echinococcosis each year, but less than typhoid fever, foodborne trematodes, and nontyphoidal salmonellosis. Applications: Given the persistence of STEC globally, efforts aimed at reducing the burden of foodborne disease should consider the relative contribution of STEC in the target population.
AD  - [Majowicz, Shannon E.; Yeung, Derrick H.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada. [Scallan, Elaine] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO USA. [Jones-Bitton, Andria; Sargeant, Jan M.] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada. [Jones-Bitton, Andria; Sargeant, Jan M.] Univ Guelph, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada. [Stapleton, Jackie] Univ Waterloo Lib, Waterloo, ON, Canada. [Angulo, Frederick J.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA. [Kirk, Martyn D.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Acton, ACT, Australia.
Majowicz, SE (reprint author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
smajowicz@uwaterloo.ca
AN  - WOS:000337177400005
AU  - Majowicz, S. E.
AU  - Scallan, E.
AU  - Jones-Bitton, A.
AU  - Sargeant, J. M.
AU  - Stapleton, J.
AU  - Angulo, F. J.
AU  - Yeung, D. H.
AU  - Kirk, M. D.
DA  - Jun
DO  - 10.1089/fpd.2013.1704
IS  - 6
J2  - Foodborne Pathog. Dis.
KW  - vtec infection
united-states
risk-factors
burden
population
disease
bacterial
children
diarrhea
food
Food Science & Technology
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AI8OA
Times Cited: 96
Cited Reference Count: 49
Majowicz, Shannon E. Scallan, Elaine Jones-Bitton, Andria Sargeant, Jan M. Stapleton, Jackie Angulo, Frederick J. Yeung, Derrick H. Kirk, Martyn D.
Jones-Bitton, Andria/K-6093-2017
Stapleton, Jackie/0000-0002-9215-6998; Kirk, Martyn/0000-0001-5432-5984; Majowicz, Shannon/0000-0002-0006-8369
School of Public Health and Health Systems; World Health Organization's Foodborne Diseases Epidemiology Reference Group (FERG); Faculty of Applied Health Sciences (University of Waterloo)
The authors thank Janet Harris (Public Health Agency of Canada) for assistance creating the search strings and conducting the review and extraction. The School of Public Health and Health Systems and the Faculty of Applied Health Sciences (University of Waterloo) and the World Health Organization's Foodborne Diseases Epidemiology Reference Group (FERG) supported this work. FERG was consulted during study design, assisted with obtaining identified references, provided feedback on preliminary results, and had the opportunity to comment on the final manuscript.
98
7
46
Mary ann liebert, inc
New rochelle
1556-7125
PY  - 2014
SN  - 1535-3141
SP  - 447-455
ST  - Global Incidence of Human Shiga Toxin-Producing Escherichia coli Infections and Deaths: A Systematic Review and Knowledge Synthesis
T2  - Foodborne Pathogens and Disease
TI  - Global Incidence of Human Shiga Toxin-Producing Escherichia coli Infections and Deaths: A Systematic Review and Knowledge Synthesis
UR  - <Go to ISI>://WOS:000337177400005
VL  - 11
ID  - 140
ER  - 

TY  - JOUR
AD  - [Martinez, Omar; Munoz-Laboy, Miguel; Levine, Ethan C.; Eisenberg, Rebecca; Draine, Jeffrey] Temple Univ, Sch Social Work, Philadelphia, PA 19122 USA. [Martinez, Omar] Temple Univ, Coll Publ Hlth, Philadelphia, PA 19122 USA. [Boles, Jeffrey] Temple Univ, Fox Sch Business, Philadelphia, PA 19122 USA. [Ayamele, Chukwuemeka] Columbia Univ, New York, NY 10027 USA. [Manusov, Justin] Univ Colorado Boulder, Sch Law, Boulder, CO USA.
Martinez, O (reprint author), Temple Univ, Sch Social Work, Philadelphia, PA 19122 USA.; Martinez, O (reprint author), Temple Univ, Coll Publ Hlth, Philadelphia, PA 19122 USA.
AN  - WOS:000405574300011
AU  - Martinez, O.
AU  - Boles, J.
AU  - Munoz-Laboy, M.
AU  - Levine, E. C.
AU  - Ayamele, C.
AU  - Eisenberg, R.
AU  - Manusov, J.
AU  - Draine, J.
DA  - Jun
DO  - 10.1177/1073110517720654
IS  - 2
J2  - J. Law Med. Ethics
KW  - information exchange
records
privacy
illness
Social Sciences - Other Topics
Government & Law
Medical Ethics
Legal
Medicine
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: FA6SL
Times Cited: 1
Cited Reference Count: 24
Martinez, Omar Boles, Jeffrey Munoz-Laboy, Miguel Levine, Ethan C. Ayamele, Chukwuemeka Eisenberg, Rebecca Manusov, Justin Draine, Jeffrey
1
2
3
Sage publications inc
Thousand oaks
1748-720x
PY  - 2017
SN  - 1073-1105
SP  - 260-273
ST  - Bridging Health Disparity Gaps through the Use of Medical Legal Partnerships in Patient Care: A Systematic Review
T2  - Journal of Law Medicine & Ethics
TI  - Bridging Health Disparity Gaps through the Use of Medical Legal Partnerships in Patient Care: A Systematic Review
UR  - <Go to ISI>://WOS:000405574300011
VL  - 45
ID  - 58
ER  - 

TY  - JOUR
AB  - Introduction: Central nervous system (CNS) metastases are common in non-small cell lung cancer (NSCLC), yet clinical trials of new drugs in advanced NSCLC have varying inclusion and exclusion criteria for CNS disease. The true extent of variation in CNS-related enrollment criteria in NSCLC clinical trials has not been documented. Methods: We performed a systematic search of the ClinicalTrials.gov website to characterize interventional drug trials enrolling adult patients with advanced NSCLC. Results: Of 413 open trials, 78 (19%) strictly excluded patients with leptomeningeal disease (LMD). Separate from LMD, patients with any history of CNS metastases were strictly excluded in 59 trials (14%), allowed after local treatment in 169 (41%), and allowed with no prior treatment in 106 (26%). No explicit mention of CNS disease was made in 79 trials (19%). In multivariate analysis looking at trial phase, location, sponsor, and treatment type, only sponsor was statistically significant, with pharmaceutical industry-sponsored trials having higher odds of excluding patients with brain metastases than did university or investigator-initiated trials (OR = 2.262, 95% confidence interval: 1.063-4.808, p = 0.0342) Conclusions: With 14% to 19% of trials excluding any history of LMD or CNS parenchymal metastatic disease and 41% of trials permitting CNS disease only after prior CNS-directed treatment, direct evidence of activity of a treatment on CNS disease cannot be reliably generated in most NSCLC trials. Given the high frequency of CNS disease in NSCLC and only sponsor being associated with specific CNS exclusion criteria, sponsors should consider tailoring trial designs to explore CNS benefit more explicitly. (C) 2015 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
AD  - [McCoach, Caroline E.; Berge, Eamon M.; Camidge, D. Ross] Univ Colorado, Div Med Oncol, Denver, CO 80202 USA. [Lu, Xian; Baron, Anna E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Denver, CO USA.
McCoach, CE (reprint author), Mail Stop 8117,12801 E 17th Ave,Room 8105, Aurora, CO 80045 USA.
Caroline.McCoach@ucdenver.edu
AN  - WOS:000371446400014
AU  - McCoach, C. E.
AU  - Berge, E. M.
AU  - Lu, X.
AU  - Baron, A. E.
AU  - Camidge, D. R.
DA  - Mar
DO  - 10.1016/j.jtho.2015.10.024
IS  - 3
J2  - J. Thorac. Oncol.
KW  - NSCLC
CNS metastases
Clinical trial enrollment
Clinicaltrials.gov
Leptomeningeal disease
tumor brain metastases
pembrolizumab
safety
alk
Oncology
Respiratory System
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: DF6DP
Times Cited: 24
Cited Reference Count: 16
McCoach, Caroline E. Berge, Eamon M. Lu, Xian Baron, Anna E. Camidge, D. Ross
24
0
5
Elsevier science inc
New york
1556-1380
PY  - 2016
SN  - 1556-0864
SP  - 407-413
ST  - A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non-Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry
T2  - Journal of Thoracic Oncology
TI  - A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non-Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry
UR  - <Go to ISI>://WOS:000371446400014
VL  - 11
ID  - 89
ER  - 

TY  - JOUR
AB  - Objective. Juvenile idiopathic arthritis (JIA) is the most common childhood rheumatic disease and has a strong genomic component. To date, JIA genetic association studies have had limited sample sizes, used heterogeneous patient populations, or included only candidate regions. The aim of this study was to identify new associations between JIA patients with oligoarticular disease and those with IgM rheumatoid factor (RF)-negative polyarticular disease, which are clinically similar and the most prevalent JIA disease subtypes. Methods. Three cohorts comprising 2,751 patients with oligoarticular or RF-negative polyarticular JIA were genotyped using the Affymetrix Genome-Wide SNP Array 6.0 or the Illumina HumanCoreExome-12+ Array. Overall, 15,886 local and out-of-study controls, typed on these platforms or the Illumina HumanOmni2.5, were used for association analyses. High-quality single-nucleotide polymorphisms (SNPs) were used for imputation to 1000 Genomes prior to SNP association analysis. Results. Meta-analysis showed evidence of association (P < 1 x 10(-6)) at 9 regions: PRR9_LOR (P = 5.12 x 10(-8)), ILDR1_CD86 (P = 6.73 x 10(-8)), WDFY4 (P = 1.79 x 10(-7)), PTH1R (P = 1.87 x 10(-7)), RNF215 (P = 3.09 x 10(-7)), AHI1_LINC00271 (P = 3.48 x 10(-7)), JAK1 (P = 4.18 x 10(-7)), LINC00951 (P = 5.80 x 10(-7)), and HBP1 (P = 7.29 x 10(-7)). Of these, PRR9_LOR, ILDR1_CD86, RNF215, LINC00951, and HBP1 were shown, for the first time, to be autoimmune disease susceptibility loci. Furthermore, associated SNPs included cis expression quantitative trait loci for WDFY4, CCDC12, MTP18, SF3A1, AHI1, COG5, HBP1, and GPR22. Conclusion. This study provides evidence of both unique JIA risk loci and risk loci overlapping between JIA and other autoimmune diseases. These newly associated SNPs are shown to influence gene expression, and their bounding regions tie into molecular pathways of immunologic relevance. Thus, they likely represent regions that contribute to the pathology of oligoarticular JIA and RF-negative polyarticular JIA.
AD  - [McIntosh, Laura A.; Sudman, Marc; Lovell, Daniel J.; Moncrieffe, Halima; Thompson, Susan D.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA. [McIntosh, Laura A.; Lovell, Daniel J.; Moncrieffe, Halima; Howard, Timothy D.; Langefeld, Carl D.; Thompson, Susan D.] Univ Cincinnati, Cincinnati, OH 45221 USA. [Marion, Miranda C.; Comeau, Mary E.] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA. [Becker, Mara L.] Childrens Mercy Kansas City, Kansas City, MO USA. [Bohnsack, John F.] Univ Utah, Salt Lake City, UT USA. [Fingerlin, Tasha E.; Maier, Lisa A.] Natl Jewish Hlth, Denver, CO USA. [Fingerlin, Tasha E.; Maier, Lisa A.] Univ Colorado, Denver, CO 80202 USA. [Griffin, Thomas A.] Levine Childrens Specialty Ctr, Charlotte, NC USA. [Haas, J. Peter] German Ctr Pediat & Adolescent Rheumatol, Garmisch Partenkirchen, Germany. [Nigrovic, Peter A.] Boston Childrens Hosp, Boston, MA USA. [Nigrovic, Peter A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA. [Nigrovic, Peter A.] Harvard Med Sch, Boston, MA USA. [Prahalad, Sampath] Emory Univ, Sch Med, Atlanta, GA USA. [Punaro, Marilynn] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA. [Punaro, Marilynn; Wise, Carol A.] UT Southwestern Med Ctr, Dallas, TX USA. [Rose, Carlos D.] DuPont Childrens Hosp, Wilmington, DE USA. [Wallace, Carol A.] Seattle Childrens Hosp & Res Inst, Seattle, WA USA. [Wise, Carol A.] Texas Scottish Rite Hosp Children, McDermott Ctr Human Growth & Dev, Dallas, TX 75219 USA.
Thompson, SD (reprint author), Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.; Thompson, SD (reprint author), Univ Cincinnati, Cincinnati, OH 45221 USA.
susan.thompson@cchmc.org
AN  - WOS:000414011300018
AU  - McIntosh, L. A.
AU  - Marion, M. C.
AU  - Sudman, M.
AU  - Comeau, M. E.
AU  - Becker, M. L.
AU  - Bohnsack, J. F.
AU  - Fingerlin, T. E.
AU  - Griffin, T. A.
AU  - Haas, J. P.
AU  - Lovell, D. J.
AU  - Maier, L. A.
AU  - Nigrovic, P. A.
AU  - Prahalad, S.
AU  - Punaro, M.
AU  - Rose, C. D.
AU  - Wallace, C. A.
AU  - Wise, C. A.
AU  - Moncrieffe, H.
AU  - Howard, T. D.
AU  - Langefeld, C. D.
AU  - Thompson, S. D.
DA  - Nov
DO  - 10.1002/art.40216
IS  - 11
J2  - Arthritis Rheumatol.
KW  - systemic-lupus-erythematosus
rheumatoid-arthritis
disease
population
variant
identification
expression
enhancers
resource
complex
Rheumatology
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: FL1YV
Times Cited: 12
Cited Reference Count: 48
McIntosh, Laura A. Marion, Miranda C. Sudman, Marc Comeau, Mary E. Becker, Mara L. Bohnsack, John F. Fingerlin, Tasha E. Griffin, Thomas A. Haas, J. Peter Lovell, Daniel J. Maier, Lisa A. Nigrovic, Peter A. Prahalad, Sampath Punaro, Marilynn Rose, Carlos D. Wallace, Carol A. Wise, Carol A. Moncrieffe, Halima Howard, Timothy D. Langefeld, Carl D. Thompson, Susan D.
Moncrieffe, Halima/0000-0001-9744-4879
Cincinnati Children's Research Foundation and its Cincinnati Genomic Control Cohort; NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS])United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [N01-AR-42272, P01-AR-048929, P30-AR-473639, P30-AR-070549, P30-AR-070253]; NIH (National Heart, Lung, and Blood Institute)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01-HL-11487]; NIH (National Institute of Environmental Health Sciences)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P0-ES-0118101]; NIH (National Institute for Research Resources) [UL1-RR-025780]; Fundacion Bechara; PhRMA Foundation; Rheumatology Research Foundation; NIH (NIAMS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [RC1-AR-058587]; BMBFFederal Ministry of Education & Research (BMBF) [01GM0907, 01 ZZ 0403]
Supported in part by the Cincinnati Children's Research Foundation and its Cincinnati Genomic Control Cohort. Recruitment and DNA preparation in the US were supported by the NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS] grants N01-AR-42272, P01-AR-048929, P30-AR-473639, P30-AR-070549, and P30-AR-070253, National Heart, Lung, and Blood Institute grant R01-HL-11487, National Institute of Environmental Health Sciences grant P0-ES-0118101, and National Institute for Research Resources grant UL1-RR-025780), the Fundacion Bechara, the PhRMA Foundation, and the Rheumatology Research Foundation. Genotyping of JIA and control collections in the US was supported by the NIH (NIAMS grant RC1-AR-058587). Recruitment and DNA preparation in Germany were supported by the BMBF (grants 01GM0907 and 01 ZZ 0403).
12
0
8
Wiley
Hoboken
2326-5205
PY  - 2017
SN  - 2326-5191
SP  - 2222-2232
ST  - Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci
T2  - Arthritis & Rheumatology
TI  - Genome-Wide Association Meta-Analysis Reveals Novel Juvenile Idiopathic Arthritis Susceptibility Loci
UR  - <Go to ISI>://WOS:000414011300018
VL  - 69
ID  - 44
ER  - 

TY  - JOUR
AD  - [McNally, J. Dayre] Univ Ottawa, Childrens Hosp Eastern Ontario, Fac Med, Dept Pediat,Div Critical Care, Ottawa, ON, Canada. [Ginde, Adit A.] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA. [Amrein, Karin] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria.
McNally, JD (reprint author), Univ Ottawa, Childrens Hosp Eastern Ontario, Fac Med, Dept Pediat,Div Critical Care, Ottawa, ON, Canada.
dmcnally@cheo.on.ca
AN  - WOS:000397314800026
AU  - McNally, J. D.
AU  - Ginde, A. A.
AU  - Amrein, K.
DA  - Apr
DO  - 10.1007/s00134-016-4643-6
IS  - 4
J2  - Intensive Care Med.
KW  - General & Internal Medicine
LA  - English
M3  - Letter
N1  - ISI Document Delivery No.: EP3XK
Times Cited: 6
Cited Reference Count: 5
McNally, J. Dayre Ginde, Adit A. Amrein, Karin
Amrein, Karin/0000-0003-0915-085X
6
0
5
Springer
New york
1432-1238
PY  - 2017
SN  - 0342-4642
SP  - 595-596
ST  - Clarification needed for the systematic review of vitamin D trials in the ICU
T2  - Intensive Care Medicine
TI  - Clarification needed for the systematic review of vitamin D trials in the ICU
UR  - <Go to ISI>://WOS:000397314800026
VL  - 43
ID  - 67
ER  - 

TY  - JOUR
AB  - Background and aims Cannabis is one of the most commonly used substances among adolescents and young adults. Earlier age at cannabis initiation is linked to adverse life outcomes, including multi-substance use and dependence. This study estimated the heritability of age at first cannabis use and identified associations with genetic variants. Methods A twin-based heritability analysis using 8055 twins from three cohorts was performed. We then carried out a genome-wide association meta-analysis of age at first cannabis use in a discovery sample of 24953 individuals from nine European, North American and Australian cohorts, and a replication sample of 3735 individuals. Results The twin-based heritability for age at first cannabis use was 38% [95% confidence interval (CI) = 19-60%]. Shared and unique environmental factors explained 39% (95% CI = 20-56%) and 22% (95% CI = 16-29%). The genome-wide association meta-analysis identified five single nucleotide polymorphisms (SNPs) on chromosome 16 within the calcium-transporting ATPase gene (ATP2C2) at P < 5E-08. All five SNPs are in high linkage disequilibrium (LD) (r(2) > 0.8), with the strongest association at the intronic variant rs1574587 (P = 4.09E-09). Gene-based tests of association identified the ATP2C2 gene on 16q24.1 (P = 1.33e-06). Although the five SNPs and ATP2C2 did not replicate, ATP2C2 has been associated with cocaine dependence in a previous study. ATP2B2, which is a member of the same calcium signalling pathway, has been associated previously with opioid dependence. SNP-based heritability for age at first cannabis use was non-significant. Conclusion Age at cannabis initiation appears to be moderately heritable in western countries, and individual differences in onset can be explained by separate but correlated genetic liabilities. The significant association between age of initiation and ATP2C2 is consistent with the role of calcium signalling mechanisms in substance use disorders.
AD  - [Minica, Camelia C.; Verweij, Karin J. H.; Mbarek, Hamdi; Abdellaoui, Abdel; Fedko, Iryna O.; Hottenga, Jouke Jan; Boomsma, Dorret I.] Vrije Univ Amsterdam, Netherlands Twin Register, Dept Biol Psychol, Amsterdam, Netherlands. [Verweij, Karin J. H.; Vink, Jacqueline M.] Radboud Univ Nijmegen, Inst Behav Sci, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands. [van der Most, Peter J.; Nolte, Ilja M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands. [Bernard, Manon; Pausova, Zdenka; Shin, Jean] Hosp Sick Children, Res Inst, Toronto, ON, Canada. [van Eijk, Kristel R.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands. [Lind, Penelope A.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Psychiat Genet, Brisbane, Qld, Australia. [Liu, Meng Zhen; Corley, Robin P.; Stallings, Michael C.; Hewitt, John K.] Univ Colorado, Inst Behav Genet, Dept Psychol & Neurosci, Boulder, CO 80309 USA. [Maciejewski, Dominique F.; van Lier, Pol A. C.; Koot, Hans M.] Vrije Univ Amsterdam, Dept Clin Dev Psychol, Amsterdam, Netherlands. [Maciejewski, Dominique F.] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, GGZ inGeest, Amsterdam, Netherlands. [Maciejewski, Dominique F.] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Psychiat, Amsterdam, Netherlands. [Palviainen, Teemu; Kaprio, Jaakko; Korhonen, Tellervo; Loukola, Anu] Univ Helsinki, FIMM, Helsinki, Finland. [Sanchez-Mora, Cristina; Casas, Miguel; Garcia-Martinez, Iris; Ramos-Quiroga, Josep A.; Richarte, Vanesa; Ribases, Marta] Univ Autonoma Barcelona, VHIR, Psychiat Genet Unit, Grp Psychiat Mental Hlth & Addict, Barcelona, Spain. [Sanchez-Mora, Cristina; Casas, Miguel; Garcia-Martinez, Iris; Ramos-Quiroga, Josep A.; Richarte, Vanesa; Ribases, Marta] Hosp Univ Vall dHebron, Dept Psychiat, Barcelona, Spain. [Sanchez-Mora, Cristina; Casas, Miguel; Ramos-Quiroga, Josep A.; Richarte, Vanesa; Ribases, Marta] Inst Salud Carlos III, Biomed Network Res Ctr Mental Hlth CIBERSAM, Madrid, Spain. [Sherva, Richard] Boston Univ, Sch Med, Biomed Genet Dept, Boston, MA 02118 USA. [Taylor, Michelle; Davey-Smith, George; Ware, Jennifer J.; Munafo, Marcus R.] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England. [Taylor, Michelle; Davey-Smith, George; Hickman, Matthew; Ware, Jennifer J.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England. [Walters, Raymond K.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA. [Walters, Raymond K.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA. [Walters, Raymond K.] Harvard Med Sch, Dept Med, Boston, MA USA. [Bigdeli, Timothy B.; Gillespie, Nathan A.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA USA. [Branje, Susan J. T.; Meeus, Wim H. J.] Univ Utrecht, Res Ctr Adolescent Dev, Utrecht, Netherlands. [Brown, Sandra A.] Univ Calif San Diego, Dept Psychiat & Psychol, La Jolla, CA 92093 USA. [Casas, Miguel; Ramos-Quiroga, Josep A.] Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Barcelona, Spain. [Davies, Gareth E.; Ehli, Erik A.] Avera Inst Human Genet, Sioux Falls, SD USA. [Farrer, Lindsay] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA. [Gordon, Scott D.; Martin, Nicholas G.; Gillespie, Nathan A.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld, Australia. [Hartman, Catharina A.; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands. [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA. [Hickie, Ian B.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW, Australia. [Hopfer, Christian J.] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA. [Kahn, Rene S.; Boks, Marco P.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, Utrecht, Netherlands. [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland. [Korhonen, Tellervo] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland. [Kranzler, Henry R.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA. [Krauter, Ken] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA. [van Lier, Pol A. C.] Erasmus Univ, Dept Psychol Educ & Child Studies, Rotterdam, Netherlands. [Neale, Michael C.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA. [Neale, Michael C.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA. [Meeus, Wim H. J.] Tilburg Univ, Dev Psychol, Tilburg, Netherlands. [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia. [Pausova, Zdenka] Univ Toronto, Physiol & Nutr Sci, Toronto, ON, Canada. [Rose, Richard J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA. [Wall, Tamara L.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA. [Wright, Margaret J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia. [Zhao, Hongyu] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA. [Zhao, Hongyu] VA CT, New Haven, CT USA. [Paus, Tomas] Baycrest, Rotman Res Inst, Toronto, ON, Canada. [Paus, Tomas] Univ Toronto, Psychol & Psychiat, Toronto, ON, Canada. [Paus, Tomas] Child Mind Inst, Ctr Developing Brain, New York, NY USA. [Munafo, Marcus R.] Univ Bristol, Sch Expt Psychol, Ctr Tobacco & Alcohol Studies, Bristol, Avon, England. [Gelernter, Joel] Yale Univ, Sch Med, Psychiat Genet & Neurosci, West Haven, CT 06516 USA. [Gelernter, Joel] VA CT, West Haven, CT USA. [Derks, Eske M.] Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands. [Derks, Eske M.] QIMR Berghofer Med Res Inst, Translat Neurogen Grp, Brisbane, Qld, Australia. [Verweij, Karin J. H.; Abdellaoui, Abdel] Univ Amsterdam, Amsterdam UMC, Dept Psychiat, Amsterdam, Netherlands.
Vink, JM (reprint author), Radboud Univ Nijmegen, Inst Behav Sci, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands.; Derks, EM (reprint author), QIMR Berghofer, Translat Neurogen Grp, 300 Herston Rd, Herston, Qld 4006, Australia.; Minica, CC (reprint author), Vrije Univ Amsterdam, Dept Biol Psychol, Van der Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.
camelia.minica@vu.nl; j.vink@bsi.ru.nl; eske.derks@qimrberghofer.edu.au
AN  - WOS:000446549800012
AU  - Minica, C. C.
AU  - Verweij, K. J. H.
AU  - van der Most, P. J.
AU  - Mbarek, H.
AU  - Bernard, M.
AU  - van Eijk, K. R.
AU  - Lind, P. A.
AU  - Liu, M. Z.
AU  - Maciejewski, D. F.
AU  - Palviainen, T.
AU  - Sanchez-Mora, C.
AU  - Sherva, R.
AU  - Taylor, M.
AU  - Walters, R. K.
AU  - Abdellaoui, A.
AU  - Bigdeli, T. B.
AU  - Branje, S. J. T.
AU  - Brown, S. A.
AU  - Casas, M.
AU  - Corley, R. P.
AU  - Davey-Smith, G.
AU  - Davies, G. E.
AU  - Ehli, E. A.
AU  - Farrer, L.
AU  - Fedko, I. O.
AU  - Garcia-Martinez, I.
AU  - Gordon, S. D.
AU  - Hartman, C. A.
AU  - Heath, A. C.
AU  - Hickie, I. B.
AU  - Hickman, M.
AU  - Hopfer, C. J.
AU  - Hottenga, J. J.
AU  - Kahn, R. S.
AU  - Kaprio, J.
AU  - Korhonen, T.
AU  - Kranzler, H. R.
AU  - Krauter, K.
AU  - van Lier, P. A. C.
AU  - Madden, P. A. F.
AU  - Medland, S. E.
AU  - Neale, M. C.
AU  - Meeus, W. H. J.
AU  - Montgomery, G. W.
AU  - Nolte, I. M.
AU  - Oldehinkel, A. J.
AU  - Pausova, Z.
AU  - Ramos-Quiroga, J. A.
AU  - Richarte, V.
AU  - Rose, R. J.
AU  - Shin, J.
AU  - Stallings, M. C.
AU  - Wall, T. L.
AU  - Ware, J. J.
AU  - Wright, M. J.
AU  - Zhao, H. Y.
AU  - Koot, H. M.
AU  - Paus, T.
AU  - Hewitt, J. K.
AU  - Ribases, M.
AU  - Loukola, A.
AU  - Boks, M. P.
AU  - Snieder, H.
AU  - Munafo, M. R.
AU  - Gelernter, J.
AU  - Boomsma, D. I.
AU  - Martin, N. G.
AU  - Gillespie, N. A.
AU  - Vink, J. M.
AU  - Derks, E. M.
DA  - Nov
DO  - 10.1111/add.14368
IS  - 11
J2  - Addiction
KW  - Age at first use
ATP2C2
cannabis initiation
genome-wide association
heritability
substance use
later substance use
illicit drug-use
conduct problems
environmental-influences
use initiation
gene ontology
mental-health
marijuana use
of-onset
alcohol
Substance Abuse
Psychiatry
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GW0JL
Times Cited: 2
Cited Reference Count: 76
Minica, Camelia C. Verweij, Karin J. H. van der Most, Peter J. Mbarek, Hamdi Bernard, Manon van Eijk, Kristel R. Lind, Penelope A. Liu, Meng Zhen Maciejewski, Dominique F. Palviainen, Teemu Sanchez-Mora, Cristina Sherva, Richard Taylor, Michelle Walters, Raymond K. Abdellaoui, Abdel Bigdeli, Timothy B. Branje, Susan J. T. Brown, Sandra A. Casas, Miguel Corley, Robin P. Davey-Smith, George Davies, Gareth E. Ehli, Erik A. Farrer, Lindsay Fedko, Iryna O. Garcia-Martinez, Iris Gordon, Scott D. Hartman, Catharina A. Heath, Andrew C. Hickie, Ian B. Hickman, Matthew Hopfer, Christian J. Hottenga, Jouke Jan Kahn, Rene S. Kaprio, Jaakko Korhonen, Tellervo Kranzler, Henry R. Krauter, Ken van Lier, Pol A. C. Madden, Pamela A. F. Medland, Sarah E. Neale, Michael C. Meeus, Wim H. J. Montgomery, Grant W. Nolte, Ilja M. Oldehinkel, Albertine J. Pausova, Zdenka Ramos-Quiroga, Josep A. Richarte, Vanesa Rose, Richard J. Shin, Jean Stallings, Michael C. Wall, Tamara L. Ware, Jennifer J. Wright, Margaret J. Zhao, Hongyu Koot, Hans M. Paus, Tomas Hewitt, John K. Ribases, Marta Loukola, Anu Boks, Marco P. Snieder, Harold Munafo, Marcus R. Gelernter, Joel Boomsma, Dorret I. Martin, Nicholas G. Gillespie, Nathan A. Vink, Jacqueline M. Derks, Eske M.
Hickman, Matthew/Y-2400-2019; Hickie, Ian B/K-8975-2015; Lind, Penelope A/B-2553-2009; Wright, Margaret Jane/A-4560-2016; Ribases, Marta/B-5309-2019; Davey Smith, George/A-7407-2013; Derks, Eske/A-1652-2017
Hickman, Matthew/0000-0001-9864-459X; Hickie, Ian B/0000-0001-8832-9895; Lind, Penelope A/0000-0002-3887-2598; Wright, Margaret Jane/0000-0001-7133-4970; Ramos-Quiroga, Josep Antoni/0000-0003-1622-0350; Palviainen, Teemu/0000-0002-7847-8384; van der Most, Peter/0000-0001-8450-3518; Sherva, Richard/0000-0003-2133-1493; Mbarek, Hamdi/0000-0002-1108-0371; Kaprio, Jaakko/0000-0002-3716-2455; Ribases, Marta/0000-0003-1039-1116; Minica, Camelia/0000-0001-7140-8167; Sanchez-Mora, Cristina/0000-0003-4211-1107; Munafo, Marcus/0000-0002-4049-993X; Davey Smith, George/0000-0002-1407-8314; Loukola, Anu-Maria/0000-0003-0542-5967; Derks, Eske/0000-0002-6292-6883; Garcia Martinez, Iris/0000-0001-6656-3322
European Research CouncilEuropean Research Council (ERC) [ERC-284167]; Foundation Volksbond Rotterdam; 2014 NARSAD Young Investigator Grant from Brain and Behavior Research Foundation; US National Institutes of Health, National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R00DA023549]; NIDA grant [DA-018673]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 MH094432]; NSFNational Science Foundation (NSF) [BCS-1229450]; Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [NWO 480-05-003]; Dutch Brain Foundation; VU University Amsterdam
J.M.V., C.C.M. and H.M. are supported by the European Research Council (Beyond the Genetics of Addiction ERC-284167, Principal Investigator J.M.V.). E.M.D. is supported by the Foundation Volksbond Rotterdam. K.J.H.V. is supported by a 2014 NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation. N.A.G. is supported by US National Institutes of Health, National Institute on Drug Abuse R00DA023549. C.C.M. and M.C.N. are supported by NIDA grant DA-018673. R.W. is supported by NIH U01 MH094432 and NSF BCS-1229450. Statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org) hosted by SURFsara and supported financially by the Netherlands Organization for Scientific Research (NWO 480-05-003 Principal Investigator D. Posthuma), along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam.
2
17
Wiley
Hoboken
1360-0443
PY  - 2018
SN  - 0965-2140
SP  - 2073-2086
ST  - Genome-wide association meta-analysis of age at first cannabis use
T2  - Addiction
TI  - Genome-wide association meta-analysis of age at first cannabis use
UR  - <Go to ISI>://WOS:000446549800012
VL  - 113
ID  - 4
ER  - 

TY  - JOUR
AB  - eHealth, mHealth and "Web 2.0" social media strategies can effectively reach and engage key populations in HIV prevention across the testing, treatment, and care continuum. To assess how these tools are currently being used within the field of HIV prevention and care, we systematically reviewed recent (2013-2014) published literature, conference abstracts, and funded research. Our searches identified 23 published intervention studies and 32 funded projects underway. In this synthesis we describe the technology modes applied and the stages of the HIV care cascade addressed, including both primary and secondary prevention activities. Overall trends include use of new tools including social networking sites, provision of real-time assessment and feedback, gamification and virtual reality. While there has been increasing attention to use of technology to address the care continuum, gaps remain around linkage to care, retention in care, and initiation of antiretroviral therapy.
AD  - [Muessig, Kathryn E.; Nekkanti, Manali] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27599 USA. [Bauermeister, Jose] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA. [Bull, Sheana] Univ Colorado, Sch Publ Hlth, Dept Community & Behav Hlth, Aurora, CO 80045 USA. [Hightow-Weidman, Lisa B.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA.
Hightow-Weidman, LB (reprint author), Univ N Carolina, Dept Med, 130 Mason Farm Rd,Bioinformat Bldg CB 7030, Chapel Hill, NC 27599 USA.
kmuessig@med.unc.edu; nekkanti@live.unc.edu; jbauerme@umich.edu; Sheana.Bull@ucdenver.edu; lisa_hightow@med.unc.edu
AN  - WOS:000351307700018
AU  - Muessig, K. E.
AU  - Nekkanti, M.
AU  - Bauermeister, J.
AU  - Bull, S.
AU  - Hightow-Weidman, L. B.
DA  - Mar
DO  - 10.1007/s11904-014-0239-3
IS  - 1
J2  - Curr. Hiv/Aids Rep.
KW  - mHealth
eHealth
Internet
HIV
Mobile phone
Smartphone
Social media
Intervention
Prevention
randomized controlled-trial
african-american
prevention interventions
developing-countries
health intervention
social networking
behavior-change
risk reduction
weight-loss
pilot test
Infectious Diseases
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: CD7XD
Times Cited: 100
Cited Reference Count: 78
Muessig, Kathryn E. Nekkanti, Manali Bauermeister, Jose Bull, Sheana Hightow-Weidman, Lisa B.
Bauermeister, Jose/X-8960-2018; Muessig, Kate/P-1242-2018
Bauermeister, Jose/0000-0002-9276-2306;
NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Gilead SciencesGilead Sciences; Janssen Therapeutics
Kathryn E. Muessig, Manali Nekkanti, Jose Bauermeister, and Sheana Bull report that they have NIH-funded grants.; Lisa B. Hightow-Weidman reports personal fees from Gilead Sciences and personal fees from Janssen Therapeutics.
103
11
57
Springer
New york
1548-3576
PY  - 2015
SN  - 1548-3568
SP  - 173-190
ST  - A Systematic Review of Recent Smartphone, Internet and Web 2.0 Interventions to Address the HIV Continuum of Care
T2  - Current Hiv/Aids Reports
TI  - A Systematic Review of Recent Smartphone, Internet and Web 2.0 Interventions to Address the HIV Continuum of Care
UR  - <Go to ISI>://WOS:000351307700018
VL  - 12
ID  - 120
ER  - 

TY  - JOUR
AD  - [Nair, K.] Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA. [Vollmer, T.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA. [Lipman, K.; Flood, E.; Davey, C.] ICON Plc, Gaithersburg, MD USA. [Huang, W.] Univ San Francisco, San Francisco, CA 94117 USA. [Jhaveri, M.; Lee, L.; Licata, S.; Naoshy, S.] Biogen, Cambridge, MA USA.
AN  - WOS:000413730205283
AU  - Nair, K.
AU  - Vollmer, T.
AU  - Lipman, K.
AU  - Flood, E.
AU  - Davey, C.
AU  - Huang, W.
AU  - Jhaveri, M.
AU  - Lee, L.
AU  - Licata, S.
AU  - Naoshy, S.
DA  - Oct
J2  - Mult. Scler. J.
KW  - Neurosciences & Neurology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: FK8AS
Times Cited: 0
Cited Reference Count: 0
Nair, K. Vollmer, T. Lipman, K. Flood, E. Davey, C. Huang, W. Jhaveri, M. Lee, L. Licata, S. Naoshy, S.
7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Scle rosis (ACTRIMS)
Oct 25-28, 2017
Paris, FRANCE
European Comm Treatment & Res Multiple Sclerosis, Americas Comm Treatment & Res Multiple Sclerosis
AstellasAstellas Pharmaceuticals; BiogenBiogen; GenentechRoche HoldingGenentech; NovartisNovartis; GileadGilead Sciences; GenzymeGenzyme Corporation; Teva Neuroscience; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Rocky Mountain MS Center; EMD SeronoMerck Serono; Biogen IdecBiogen; Ono Pharmaceuticals; MedimmuneAstraZeneca; TG Therapeutics Inc.
K Nair received personal compensation for consulting from Astellas and grant funding from Biogen, Genentech, Novartis and Gilead. T Vollmer received honoraria for serving on scientific advisory boards, lectures and for consulting services from AbbVie Inc, Aclimed, American Academy of Neurology, CB Partners, Capmaels and Rasford, Celestial Intas Pharmaceuticals Ltd, Compass Learning, Genentech/Roche, Genzyme/Sanofi, Goodwin Procter LLP, IMS Consulting Group, Medscape, Novartis Pharmaceuticals, Oxford Pharmagenesis, Patient Centered Outcomes Research Institute, Sommer Consulting, and Teva Neuroscience as well as research support from Genzyme, Teva Neuroscience, NIH/NINDS, Rocky Mountain MS Center, EMD Serono, Biogen Idec, Ono Pharmaceuticals, Medimmune and TG Therapeutics Inc. K Lipman is an employee of ICON, which was commissioned to conduct the research. E Flood is an employee of ICON, which was commissioned to conduct the research. C Davey is an employee of ICON, which was commissioned to conduct the research. W Huang is an employee of University of California San Francisco and is conducting a fellowship at Biogen. M Jhaveri is an employee of, and holds stock/stock options in Biogen. L Lee is an employee of, and holds stock/stock options in Biogen. S Licata is an employee of, and holds stock/stock options in Biogen. S Naoshy is an employee of, and holds stock/stock options in Biogen.
0
Sage publications ltd
London
1477-0970
3
PY  - 2017
SN  - 1352-4585
SP  - 949-950
ST  - Natalizumab treatment is associated with improved patient-reported outcomes in the treatment of multiple sclerosis: results from a systematic literature review
T2  - Multiple Sclerosis Journal
TI  - Natalizumab treatment is associated with improved patient-reported outcomes in the treatment of multiple sclerosis: results from a systematic literature review
UR  - <Go to ISI>://WOS:000413730205283
VL  - 23
ID  - 47
ER  - 

TY  - JOUR
AD  - Inova Fairfax Hosp, Falls Church, VA USA. Univ Turin, Turin, Italy. InterMune Inc, Brisbane, CA USA. Ruhrlandklin, Essen, Germany. Roche, Basel, Switzerland. Univ London Imperial Coll Sci Technol & Med, London, England. Alfred Hosp, Melbourne, Vic, Australia. Monash Univ, Melbourne, Vic 3004, Australia. Univ Miami, Miller Sch Med, Miami, FL 33136 USA. Univ Calif San Francisco, San Francisco, CA 94143 USA. Vanderbilt Univ, Med Ctr, Nashville, TN USA. Columbia Univ, Med Ctr, New York, NY USA. Univ Fed Sao Paulo, Paulista Sch Med, Sao Paulo, Brazil. Natl Jewish Hlth, Denver, CO USA. AP HP, Bobigny, France.
AN  - WOS:000366134400353
AU  - Nathan, S.
AU  - Albera, C.
AU  - Bradford, W.
AU  - Costabel, U.
AU  - Daigl, M.
AU  - Kirchgaessler, K. U.
AU  - Du Bois, R.
AU  - Glaspole, I.
AU  - Glassberg, M.
AU  - King, T.
AU  - Lancaster, L.
AU  - Lederer, D.
AU  - Pereira, C.
AU  - Swigris, J.
AU  - Valeyre, D.
AU  - Noble, P.
DA  - Oct
DO  - 10.1378/chest.2250247
IS  - 4
J2  - Chest
KW  - General & Internal Medicine
Respiratory System
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: CY0ZB
Times Cited: 0
Cited Reference Count: 0
Nathan, Steven Albera, Carlo Bradford, Williamson Costabel, Ulrich Daigl, Monica Kirchgaessler, Klaus-Uwe Du Bois, Roland Glaspole, Ian Glassberg, Marilyn King, Talmadge Lancaster, Lisa Lederer, David Pereira, Carlos Swigris, Jeffrey Valeyre, Dominique Noble, Paul
0
3
Amer coll chest physicians
Glenview
S
PY  - 2015
SN  - 0012-3692
SP  - 3
ST  - Effect of Pirfenidone on All-Cause Mortality in Patients With Idiopathic Pulmonary Fibrosis (IPF): Comparison of Pooled Analysis With Meta-analysis From the ASCEND and CAPACITY Trials
T2  - Chest
TI  - Effect of Pirfenidone on All-Cause Mortality in Patients With Idiopathic Pulmonary Fibrosis (IPF): Comparison of Pooled Analysis With Meta-analysis From the ASCEND and CAPACITY Trials
UR  - <Go to ISI>://WOS:000366134400353
VL  - 148
ID  - 102
ER  - 

TY  - JOUR
AB  - Background: Recent studies show that intraoperative mechanical ventilation using low tidal volumes (V-T) can prevent postoperative pulmonary complications (PPCs). The aim of this individual patient data meta-analysis is to evaluate the individual associations between V-T size and positive end-expiratory pressure (PEEP) level and occurrence of PPC. Methods: Randomized controlled trials comparing protective ventilation (low V-T with or without high levels of PEEP) and conventional ventilation (high V-T with low PEEP) in patients undergoing general surgery. The primary outcome was development of PPC. Predefined prognostic factors were tested using multivariate logistic regression. Results: Fifteen randomized controlled trials were included (2,127 patients). There were 97 cases of PPC in 1,118 patients (8.7%) assigned to protective ventilation and 148 cases in 1,009 patients (14.7%) assigned to conventional ventilation (adjusted relative risk, 0.64; 95% CI, 0.46 to 0.88; P < 0.01). There were 85 cases of PPC in 957 patients (8.9%) assigned to ventilation with low V-T and high PEEP levels and 63 cases in 525 patients (12%) assigned to ventilation with low V-T and low PEEP levels (adjusted relative risk, 0.93; 95% CI, 0.64 to 1.37; P = 0.72). A dose-response relationship was found between the appearance of PPC and V-T size (R-2 = 0.39) but not between the appearance of PPC and PEEP level (R-2 = 0.08). Conclusions: These data support the beneficial effects of ventilation with use of low V-T in patients undergoing surgery. Further trials are necessary to define the role of intraoperative higher PEEP to prevent PPC during nonopen abdominal surgery.
AD  - [Serpa Neto, Ary; Hemmes, Sabrine N. T.; Binnekade, Jan M.; Hollmann, Markus W.; Wolthuis, Esther K.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands. [Serpa Neto, Ary; Barbas, Carmen S. V.] Univ Sao Paulo, Heart Inst INCOR, Fac Med, Dept Pneumol,Hosp Clin, Sao Paulo, Brazil. [Serpa Neto, Ary; Barbas, Carmen S. V.] Hosp Israelita Albert Einstein, Dept Crit Care Med, Sao Paulo, Brazil. [Beiderlinden, Martin; Treschan, Tanja] Dusseldorf Univ Hosp, Dept Anaesthesiol, Dusseldorf, Germany. [Beiderlinden, Martin] Marien Hosp, Dept Anaesthesiol, Osnabruck, Germany. [Biehl, Michelle; Gajic, Ognjen; Sprung, Juraj] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA. [Canet, Jaume] Univ Hosp, Dept Anesthesiol, Barcelona, Spain. [Canet, Jaume] Germans Trias & Pujol, Barcelona, Spain. [Fernandez-Bustamante, Ana; Moine, Pierre] Univ Colorado, Dept Anesthesiol, Aurora, CO USA. [Futier, Emmanuel] Estaing Univ Hosp, Dept Anesthesiol & Crit Care Med, Clermont Ferrand, France. [Hedenstierna, Goran] Univ Uppsala Hosp, Dept Med Sci, Sect Clin Physiol, Uppsala, Sweden. [Jaber, Samir] St Eloi Univ Hosp, Dept Crit Care Med & Anesthesiol SAR B, Montpellier, France. [Kozian, Alf; Schilling, Thomas] Univ Magdeburg, Dept Anesthesiol & Intens Care Med, D-39106 Magdeburg, Germany. [Licker, Marc] Univ Hosp Geneva, Fac Med, Dept Anaesthesiol Pharmacol & Intens Care, Geneva, Switzerland. [Lin, Wen-Qian] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China. [Maslow, Andrew D.] Brown Univ, Dept Anesthesiol, Warren Alpert Sch, Providence, RI 02912 USA. [Memtsoudis, Stavros G.] Cornell Univ, Weill Med Coll, Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA. [Miranda, Dinis Reis] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands. [Ng, Thomas] Brown Univ, Dept Surg, Warren Alpert Sch, Providence, RI 02912 USA. [Paparella, Domenico] Univ Bari Aldo Moro, Dept Emergency & Organ Transplant, Div Cardiac Surg, Bari, Italy. [Putensen, Christian] Univ Bonn, Dept Anesthesiol, Bonn, Germany. [Ranieri, Marco] Univ Turin, Dipartimento Discipline Med Chirurg, Anestesiol & Rianimaz, Turin, Italy. [Scavonetto, Federica; Weingarten, Toby N.] Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN USA. [Scavonetto, Federica; Weingarten, Toby N.] Mayo Clin, Coll Med, Anesthesia Clin Res Unit, Rochester, MN USA. [Schmid, Werner] Med Univ, Dept Cardiothorac & Vasc Anesthesia & Intens Care, Vienna, Austria. [Selmo, Gabriele; Severgnini, Paolo] Univ Insubria, Dept Environm Hlth & Safety, Varese, Italy. [Sundar, Sugantha; Talmor, Daniel] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA. [Unzueta, Carmen] Hosp Santa Creu & Sant Pau, Dept Anaesthesiol, Barcelona, Spain. [Wrigge, Hermann] Univ Leipzig, Dept Anesthesiol & Intens Care Med, D-04109 Leipzig, Germany. [de Abreu, Marcelo Gama] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Anesthesiol & Intens Care Med, D-01062 Dresden, Germany. [Pelosi, Paolo] Univ Genoa, IRCCS San Martino IST, Dept Surg Sci & Integrated Diagnost, Genoa, Italy. [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands.
Neto, AS (reprint author), Hosp Israelita Albert Einstein, Dept Crit Care, Albert Einstein Ave 700, Sao Paulo, Brazil.
aryserpa@terra.com.br
AN  - WOS:000363536300011
AU  - Neto, A. S.
AU  - Hemmes, S. N. T.
AU  - Barbas, C. S. V.
AU  - Beiderlinden, M.
AU  - Biehl, M.
AU  - Binnekade, J. M.
AU  - Canet, J.
AU  - Fernandez-Bustamante, A.
AU  - Futier, E.
AU  - Gajic, O.
AU  - Hedenstierna, G.
AU  - Hollmann, M. W.
AU  - Jaber, S.
AU  - Kozian, A.
AU  - Licker, M.
AU  - Lin, W. Q.
AU  - Maslow, A. D.
AU  - Memtsoudis, S. G.
AU  - Miranda, D. R.
AU  - Moine, P.
AU  - Ng, T.
AU  - Paparella, D.
AU  - Putensen, C.
AU  - Ranieri, M.
AU  - Scavonetto, F.
AU  - Schilling, T.
AU  - Schmid, W.
AU  - Selmo, G.
AU  - Severgnini, P.
AU  - Sprung, J.
AU  - Sundar, S.
AU  - Talmor, D.
AU  - Treschan, T.
AU  - Unzueta, C.
AU  - Weingarten, T. N.
AU  - Wolthuis, E. K.
AU  - Wrigge, H.
AU  - de Abreu, M. G.
AU  - Pelosi, P.
AU  - Schultz, M. J.
AU  - Investigators, Prove Network
DA  - Jul
DO  - 10.1097/aln.0000000000000706
IS  - 1
J2  - Anesthesiology
KW  - tidal-volume ventilation
randomized controlled-trial
acute lung
injury
respiratory-distress-syndrome
end-expiratory pressure
mechanical ventilation
abdominal-surgery
general-anesthesia
cardiopulmonary bypass
thoracic-surgery
Anesthesiology
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: CU4YB
Times Cited: 114
Cited Reference Count: 41
Serpa Neto, Ary Hemmes, Sabrine N. T. Barbas, Carmen S. V. Beiderlinden, Martin Biehl, Michelle Binnekade, Jan M. Canet, Jaume Fernandez-Bustamante, Ana Futier, Emmanuel Gajic, Ognjen Hedenstierna, Goran Hollmann, Markus W. Jaber, Samir Kozian, Alf Licker, Marc Lin, Wen-Qian Maslow, Andrew D. Memtsoudis, Stavros G. Miranda, Dinis Reis Moine, Pierre Ng, Thomas Paparella, Domenico Putensen, Christian Ranieri, Marco Scavonetto, Federica Schilling, Thomas Schmid, Werner Selmo, Gabriele Severgnini, Paolo Sprung, Juraj Sundar, Sugantha Talmor, Daniel Treschan, Tanja Unzueta, Carmen Weingarten, Toby N. Wolthuis, Esther K. Wrigge, Hermann de Abreu, Marcelo Gama Pelosi, Paolo Schultz, Marcus J.
Serpa Neto, Ary/D-1927-2012; Barbas, Carmen Silvia Valente/H-1048-2013; Meyer-Treschan, Tanja A./S-6624-2017
Serpa Neto, Ary/0000-0003-1520-9387; Barbas, Carmen Silvia Valente/0000-0002-3922-6256; Meyer-Treschan, Tanja A./0000-0001-9363-1028; Fernandez-Bustamante, Ana/0000-0002-2996-7704; Severgnini, Paolo/0000-0001-8027-0059; Hedenstierna, Goran/0000-0002-2923-6012; Paparella, Domenico/0000-0003-2261-7098
118
1
22
Lippincott williams & wilkins
Philadelphia
1528-1175
PY  - 2015
SN  - 0003-3022
SP  - 66-78
ST  - Protective versus Conventional Ventilation for Surgery A Systematic Review and Individual Patient Data Meta-analysis
T2  - Anesthesiology
TI  - Protective versus Conventional Ventilation for Surgery A Systematic Review and Individual Patient Data Meta-analysis
UR  - <Go to ISI>://WOS:000363536300011
VL  - 123
ID  - 110
ER  - 

TY  - JOUR
AB  - Background: Transfusion of blood products and mechanical ventilation with injurious settings are considered risk factors for postoperative lung injury in surgical Patients. Methods: A systematic review and individual patient data meta-analysis was done to determine the independent effects of peri-operative transfusion of blood products, intra-operative tidal volume and airway pressure in adult patients undergoing mechanical ventilation for general surgery, as well as their interactions on the occurrence of postoperative acute respiratory distress syndrome (ARDS). Observational studies and randomized trials were identified by a systematic search of MEDLINE, CINAHL, Web of Science, and CENTRAL and screened for inclusion into a meta-analysis. Individual patient data were obtained from the corresponding authors. Patients were stratified according to whether they received transfusion in the perioperative period [ red blood cell concentrates (RBC) and/or fresh frozen plasma (FFP)], tidal volume size [<= 7 mL/kg predicted body weight (PBW), 7-10 and > 10 mL/kg PBW] and airway pressure level used during surgery (<= 15, 15-20 and > 20 cmH(2)O). The primary outcome was development of postoperative ARDS. Results: Seventeen investigations were included (3,659 patients). Postoperative ARDS occurred in 40 (7.2%) patients who received at least one blood product compared to 40 patients (2.5%) who did not [ adjusted hazard ratio (HR), 2.32; 95% confidence interval (CI), 1.25-4.33; P=0.008]. Incidence of postoperative ARDS was highest in patients ventilated with tidal volumes of > 10 mL/kg PBW and having airway pressures of > 20 cmH(2)O receiving both RBC and FFP, and lowest in patients ventilated with tidal volume of <= 7 mL/kg PBW and having airway pressures of <= 15 cmH(2)O with no transfusion. There was a significant interaction between transfusion and airway pressure level (P=0.002) on the risk of postoperative ARDS. Conclusions: Peri-operative transfusion of blood products is associated with an increased risk of postoperative ARDS, which seems more dependent on airway pressure than tidal volume size.
AD  - [Neto, Ary Serpa; Juffermans, Nicole P.; Hemmes, Sabrine N. T.; Wolthuis, Esther K.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, Amsterdam, Netherlands. [Neto, Ary Serpa] ABC, Fac Med, Program Postgrad Res & Innovat, Sao Paulo, Brazil. [Neto, Ary Serpa; Barbas, Carmen S. V.] Hosp Israelita Albert Einstein, Dept Crit Care Med, Sao Paulo, Brazil. [Beiderlinden, Martin; Treschan, Tanja] Dusseldorf Univ Hosp, Dept Anaesthesiol, Dusseldorf, Germany. [Beiderlinden, Martin] Marienhospital Osnabruck, Dept Anaesthesiol, Osnabruck, Germany. [Biehl, Michelle; Gajic, Ognjen] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA. [Fernandez-Bustamante, Ana; Moine, Pierre] Univ Colorado, Dept Anesthesiol, Aurora, CO USA. [Futier, Emmanuel] Estaing Univ Hosp, Dept Anesthesiol & Crit Care Med, Clermont Ferrand, France. [Jaber, Samir] St Eloi Univ Hosp, Dept Crit Care Med & Anesthesiol SAR B, Montpellier, France. [Kozian, Alf; Schilling, Thomas] Otto von Guericke Univ, Dept Anesthesiol & Intens Care Med, Magdeburg, Germany. [Licker, Marc] Univ Hosp Geneva, Fac Med, Dept Anaesthesiol Pharmacol & Intens Care, Geneva, Switzerland. [Lin, Wen-Qian] Sun Yat Sen Univ Canc Ctr, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China. [Memtsoudis, Stavros G.] Cornell Univ, Hosp Special Surg, Weill Med Coll, Dept Anesthesiol, New York, NY 10021 USA. [Miranda, Dinis Reis] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands. [Paparella, Domenico] Univ Bari Aldo Moro, Dept Emergency & Organ Transplant DETO, Div Cardiac Surg, Bari, Italy. [Ranieri, Marco] Sapienza Univ Rome, Policlin Umberto Hosp 1, Department Anesthesia & Intens Care Med, Rome, Italy. [Scavonetto, Federica; Sprung, Juraj; Weingarten, Toby N.] Mayo Clin, Mayo Clin Coll Med, Dept Anesthesiol, Rochester, MN USA. [Scavonetto, Federica; Sprung, Juraj; Weingarten, Toby N.] Mayo Clin, Mayo Clin Coll Med, Anesthesia Clin Res Unit, Rochester, MN USA. [Selmo, Gabriele; Severgnini, Paolo] Univ Insubria, Dept Environm Hlth & Safety, Varese, Italy. [Sundar, Sugantha; Talmor, Daniel] Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA. [Sundar, Sugantha; Talmor, Daniel] Harvard Med Sch, Boston, MA USA. [Unzueta, Carmen] Hosp Sant Pau, Dept Anaesthesiol & Intens Care, Barcelona, Spain. [Wrigge, Hermann] Univ Leipzig, Dept Anesthesiol & Intens Care Med, Leipzig, Germany. [de Abreu, Marcelo Gama] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Anesthesiol & Intens Care Med, Dresden, Germany. [Pelosi, Paolo] Univ Genoa, IRCCS San Martino IST, Dept Surg Sci & Integrated Diagnost, Genoa, Italy. [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, Amsterdam, Netherlands.
Neto, AS (reprint author), Hosp Israelita Albert Einstein, Dept Crit Care, Albert Einstein Ave 700, Sao Paulo, Brazil.
aryserpa@terra.com.br
AN  - WOS:000423443000014
AU  - Neto, A. S.
AU  - Juffermans, N. P.
AU  - Hemmes, S. N. T.
AU  - Barbas, C. S. V.
AU  - Beiderlinden, M.
AU  - Biehl, M.
AU  - Fernandez-Bustamante, A.
AU  - Futier, E.
AU  - Gajic, O.
AU  - Jaber, S.
AU  - Kozian, A.
AU  - Licker, M.
AU  - Lin, W. Q.
AU  - Memtsoudis, S. G.
AU  - Miranda, D. R.
AU  - Moine, P.
AU  - Paparella, D.
AU  - Ranieri, M.
AU  - Scavonetto, F.
AU  - Schilling, T.
AU  - Selmo, G.
AU  - Severgnini, P.
AU  - Sprung, J.
AU  - Sundar, S.
AU  - Talmor, D.
AU  - Treschan, T.
AU  - Unzueta, C.
AU  - Weingarten, T. N.
AU  - Wolthuis, E. K.
AU  - Wrigge, H.
AU  - de Abreu, M. G.
AU  - Pelosi, P.
AU  - Schultz, M. J.
AU  - Investigators, Prove Network
C7  - 23
DA  - Jan
DO  - 10.21037/atm.2018.01.16
IS  - 2
J2  - Ann. Transl. Med.
KW  - Acute respiratory distress syndrome (ARDS)
surgery
transfusion
tidal
volume
ventilator-associated lung injury
acute lung injury
respiratory-distress-syndrome
fresh-frozen plasma
mechanical ventilation
protective ventilation
general-anesthesia
cardiac-surgery
critically-ill
abdominal-surgery
inflammatory
responses
Oncology
Research & Experimental Medicine
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: FT8ZZ
Times Cited: 1
Cited Reference Count: 55
Neto, Ary Serpa Juffermans, Nicole P. Hemmes, Sabrine N. T. Barbas, Carmen S. V. Beiderlinden, Martin Biehl, Michelle Fernandez-Bustamante, Ana Futier, Emmanuel Gajic, Ognjen Jaber, Samir Kozian, Alf Licker, Marc Lin, Wen-Qian Memtsoudis, Stavros G. Miranda, Dinis Reis Moine, Pierre Paparella, Domenico Ranieri, Marco Scavonetto, Federica Schilling, Thomas Selmo, Gabriele Severgnini, Paolo Sprung, Juraj Sundar, Sugantha Talmor, Daniel Treschan, Tanja Unzueta, Carmen Weingarten, Toby N. Wolthuis, Esther K. Wrigge, Hermann de Abreu, Marcelo Gama Pelosi, Paolo Schultz, Marcus J.
Barbas, Carmen Silvia Valente/H-1048-2013; Meyer-Treschan, Tanja A./S-6624-2017
Barbas, Carmen Silvia Valente/0000-0002-3922-6256; Meyer-Treschan, Tanja A./0000-0001-9363-1028
1
0
3
Ame publ co
Shatin
2305-5847
PY  - 2018
SN  - 2305-5839
SP  - 20
ST  - Interaction between peri-operative blood transfusion, tidal volume, airway pressure and postoperative ARDS: an individual patient data meta-analysis
T2  - Annals of Translational Medicine
TI  - Interaction between peri-operative blood transfusion, tidal volume, airway pressure and postoperative ARDS: an individual patient data meta-analysis
UR  - <Go to ISI>://WOS:000423443000014
VL  - 6
ID  - 40
ER  - 

TY  - JOUR
AB  - In many patients with brain metastases, the primary therapeutic aim is symptom palliation and maintenance of neurologic function, but in a subgroup, long-term survival is possible. Local control in the brain, and absent or controlled extracranial sites of disease are prerequisites for favorable survival. Stereotactic radiosurgery (SRS) is a focal, highly precise treatment option with a long track record. Its clinical development and implementation by several pioneering institutions eventually rendered possible cooperative group randomized trials. A systematic review of those studies and other landmark studies was undertaken. Most clinicians are aware of the potential benefits of SRS such as a short treatment time, a high probability of treated-lesion control and, when adhering to typical dose/volume recommendations, a low normal tissue complication probability. However, SRS as sole first-line treatment carries a risk of failure in non-treated brain regions, which has resulted in controversy around when to add whole-brain radiotherapy (WBRT). SRS might also be prescribed as salvage treatment in patients relapsing despite previous SRS and/or WBRT. An optimal balance between intracranial control and side effects requires continued research efforts.
AD  - [Nieder, Carsten] Nordland Hosp, Dept Oncol & Palliat Med, N-8092 Bodo, Norway. [Grosu, Anca L.] Univ Hosp Freiburg, Dept Radiat Oncol, D-79106 Freiburg, Germany. [Gaspar, Laurie E.] Univ Colorado, Dept Radiat Oncol, Aurora, CO 80045 USA.
Nieder, C (reprint author), Nordland Hosp, Dept Oncol & Palliat Med, N-8092 Bodo, Norway.
carsten.nieder@nlsh.no
AN  - WOS:000339592700002
AU  - Nieder, C.
AU  - Grosu, A. L.
AU  - Gaspar, L. E.
C7  - 155
DA  - Jul
DO  - 10.1186/1748-717x-9-155
J2  - Radiat. Oncol.
KW  - Brain metastases
Radiation treatment
Radiotherapy
Stereotactic
radiosurgery
recursive partitioning analysis
gamma-knife radiosurgery
radiation-therapy
prognostic-factors
surgical resection
cerebral
metastases
salvage radiosurgery
american society
supportive care
follow-up
Oncology
Radiology, Nuclear Medicine & Medical Imaging
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: AM1FV
Times Cited: 60
Cited Reference Count: 104
Nieder, Carsten Grosu, Anca L. Gaspar, Laurie E.
61
0
17
Bmc
London
PY  - 2014
SN  - 1748-717X
SP  - 9
ST  - Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
T2  - Radiation Oncology
TI  - Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
UR  - <Go to ISI>://WOS:000339592700002
VL  - 9
ID  - 138
ER  - 

TY  - JOUR
AB  - Background: Patients who have had an acute coronary syndrome (ACS) event have an increased risk for depression. Purpose: To evaluate the diagnostic accuracy of depression screening instruments and to compare safety and effectiveness of depression treatments in adults within 3 months of an ACS event. Data Sources: MEDLINE, EMBASE, PsycINFO, CINAHL, and Cochrane Database of Systematic Reviews from January 2003 to August 2017, and a manual search of citations from key primary and review articles. Study Selection: English-language studies of post-ACS patients that evaluated the diagnostic accuracy of depression screening tools or compared the safety and effectiveness of a broad range of pharmacologic and nonpharmacologic depression treatments. Data Extraction: 2 investigators independently screened each article for inclusion; abstracted the data; and rated the quality, applicability, and strength of evidence. Data Synthesis: Evidence from 6 of the 10 included studies showed that a range of depression screening instruments pro-duces acceptable levels of diagnostic sensitivity, specificity, and negative predictive values (70% to 100%) but low positive predictive values (below 50%). The Beck Depression Inventory-II was the most studied tool. A large study found that a combination of cognitive behavioral therapy (CBT) and antidepressant medication improved depression symptoms, mental health-related function, and overall life satisfaction more than usual care. Limitation: Few studies, no evaluation of the influence of screening on clinical outcomes, and no studies addressing several clinical interventions of interest. Conclusion: Depression screening instruments produce diagnostic accuracy metrics that are similar in post-ACS patients and other clinical populations. Depression interventions have an uncertain effect on cardiovascular outcomes, but CBT combined with antidepressant medication produces modest improvement in psychosocial outcomes.
AD  - Duke Univ, Sch Med, Durham, NC USA. Duke Univ, Vet Affairs Mid Atlantic Mental Illness Res Educ, Durham, NC USA. Durham Vet Affairs Evidence Synth Ctr, Durham, NC USA. Southern Calif Permanente Med Grp, Anaheim, CA USA. Univ Washington, Boise, ID USA. [Nieuwsma, Jason A.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, 3022 Croasdaile Dr,Suite 301, Durham, NC 27705 USA. [Williams, John W., Jr.] Durham VA Evidence Synth Ctr, 411 West Chapel Hill St,Suite 500, Durham, NC 27701 USA. [Namdari, Natasha] Southern Calif Permanente Med Grp, Dept Psychiat, 4220 North Roxboro Rd, Durham, NC 27704 USA. [Washam, Jeffrey B.] Duke Heart Ctr, Med Ctr, Box 3943, Durham, NC 27710 USA. [Raitz, Giselle] Duke Univ, Sch Med, Dept Med, 2400 Pratt St,Duke Box 3850, Durham, NC 27710 USA. [Blumenthal, James A.] Duke Univ, Sch Med, Med Ctr, Dept Psychiat & Behav Sci, Box 3119, Durham, NC 27710 USA. [Jiang, Wei] Duke Univ, Sch Med, Med Ctr, Dept Psychiat & Behav Sci, Box 3366, Durham, NC 27710 USA. [Yapa, Roshini] Univ Colorado, Dept Med, 12700 East 19th Ave, Aurora, CO 80045 USA. [McBroom, Amanda J.; Lallinger, Kathryn; Schmidt, Robyn; Sanders, Gillian D.] Duke Univ, Sch Med, Duke Clin Res Inst, 2400 Pratt St,Room 0311, Durham, NC 27705 USA. [Kosinski, Andrzej S.] Duke Univ, Sch Med, Dept Biostat & Bioinformat, POB 17969, Durham, NC 27715 USA.
Nieuwsma, JA (reprint author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, 3022 Croasdaile Dr,Suite 301, Durham, NC 27705 USA.
jason.nieuwsma@duke.edu
AN  - WOS:000416584200016
AU  - Nieuwsma, J. A.
AU  - Williams, J. W.
AU  - Namdari, N.
AU  - Washam, J. B.
AU  - Raitz, G.
AU  - Blumenthal, J. A.
AU  - Jiang, W.
AU  - Yapa, R.
AU  - McBroom, A. J.
AU  - Lallinger, K.
AU  - Schmidt, R.
AU  - Kosinski, A. S.
AU  - Sanders, G. D.
DA  - Nov
DO  - 10.7326/m17-1811
IS  - 10
J2  - Ann. Intern. Med.
KW  - randomized-controlled-trial
acute myocardial-infarction
american-heart-association
enhancing recovery
clinical-trial
disease
patients
artery-disease
social support
cardiac events
inventory-ii
General & Internal Medicine
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FO2DP
Times Cited: 4
Cited Reference Count: 52
Nieuwsma, Jason A. Williams, John W., Jr. Namdari, Natasha Washam, Jeffrey B. Raitz, Giselle Blumenthal, James A. Jiang, Wei Yapa, Roshini McBroom, Amanda J. Lallinger, Kathryn Schmidt, Robyn Kosinski, Andrzej S. Sanders, Gillian D.
AHRQ, U.S. Department of Health and Human ServicesUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [HHSA290201500004I]
This project was funded under contract HHSA290201500004I from AHRQ, U.S. Department of Health and Human Services.
4
0
3
Amer coll physicians
Philadelphia
1539-3704
PY  - 2017
SN  - 0003-4819
SP  - 725-+
ST  - Diagnostic Accuracy of Screening Tests and Treatment for Post-Acute Coronary Syndrome Depression A Systematic Review
T2  - Annals of Internal Medicine
TI  - Diagnostic Accuracy of Screening Tests and Treatment for Post-Acute Coronary Syndrome Depression A Systematic Review
UR  - <Go to ISI>://WOS:000416584200016
VL  - 167
ID  - 42
ER  - 

TY  - JOUR
AB  - Study Design: A systematic review with meta-analysis. Objective: To combine published data, focusing on the development of optimal spinopelvic parameters in adult asymptomatic subjects without spine deformity while taking into consideration the impact of potential confounders. Summary of Background Data: A well-grounded approach to define the optimal spinopelvic parameters is necessary for planning surgical correction of spine deformity. Materials: Selection criteria: (1) randomized and nonrandomized prospective, cross-sectional, and retrospective studies; (2) participants: asymptomatic subjects without spine deformity aged above 18 years; (3) studied parameters: lumbar lordosis (LL), pelvic incidence, sacral slope, and pelvic tilt; (4) potential confounders: method of measurement, sex, age, ethnicity, weight, height, and body mass index. Search method: OvidMEDLINE (1946-current) and EMBASE (1980-current), all years through October 2015 were included. Data were collected: number of enrolled subjects, means of the studied characteristics, SD, SE of the means, 95% confidence intervals. A meta-analysis was performed to evaluate the pooled means and range of optimal values (pooled mean +/- pooled SD) taking into consideration the impact of confounders. The GRADE approach was applied to evaluate the level of evidence. Results: Seventeen of 1018 studies were included (2926 subjects from 9 countries). The pooled means and the optimal ranges were: LL (L1-S1), 54.6 (42-67) degrees; LL (L1-L5), 37.0 (22-53) degrees; pelvic incidence, 50.6 (39-62) degrees; sacral slope, 37.7 (28-48) degrees; pelvic tilt, 12.6 (3-22) degrees. The pooled results were statistically significant (P<0.001), but heterogeneous. Impact of the following confounders was revealed: method of measurement, ethnicity, age, and body mass index. A methodology was created to define an individualized optimal value and range of each studied parameter taking into consideration the influence of confounders. Conclusions: The pooled results and developed methodology can be used as diagnostic criteria for evaluation of the spinopelvic parameters, planning of surgical interventions and evaluation of the treatment effect.
AD  - [Noshchenko, Andriy; Cain, Christopher M. J.; Patel, Vikas V.; Burger, Evalina L.] Univ Colorado, Dept Orthopaed, Anschutz Med Campus, Aurora, CO USA. [Hoffecker, Lilian] Univ Colorado, Hlth Sci Lib, Anschutz Med Campus, Aurora, CO USA.
Noshchenko, A (reprint author), 13001 E 17th Pl,Mail Stop F432, Aurora, CO 80045 USA.
andriy.noshchenko@ucdenver.edu
AN  - WOS:000417429200025
AU  - Noshchenko, A.
AU  - Hoffecker, L.
AU  - Cain, C. M. J.
AU  - Patel, V. V.
AU  - Burger, E. L.
DA  - Nov
IS  - 9
J2  - Clin. Spine Surg.
KW  - spinal balance
lumbar lordosis
sacral slope
pelvic incidence
pelvic
tilt
spinopelvic
standing lateral radiographs
sagittal plane alignment
lumbar lordosis
pelvic parameters
adult volunteers
gravity line
balance
prediction
patient
age
Neurosciences & Neurology
Orthopedics
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FP2EP
Times Cited: 3
Cited Reference Count: 53
Noshchenko, Andriy Hoffecker, Lilian Cain, Christopher M. J. Patel, Vikas V. Burger, Evalina L.
Hoffecker, Lilian/0000-0001-8277-2300
3
0
Lippincott williams & wilkins
Philadelphia
PY  - 2017
SN  - 2380-0186
SP  - 392-403
ST  - Spinopelvic Parameters in Asymptomatic Subjects Without Spine Disease and Deformity A Systematic Review With Meta-Analysis
T2  - Clinical Spine Surgery
TI  - Spinopelvic Parameters in Asymptomatic Subjects Without Spine Disease and Deformity A Systematic Review With Meta-Analysis
UR  - <Go to ISI>://WOS:000417429200025
VL  - 30
ID  - 43
ER  - 

TY  - JOUR
AB  - Study Design: Systematic review with meta-analysis. Objective: To (1) evaluate long-term patient-centered clinical outcomes after lumbar arthrodesis with or without decompression for lumbar spondylosis (LS); and (2) compare these outcomes with those of alternative treatments, including nonsurgical and surgical which maintain mobility of the lumbar spine. Summary of Background Data: The effective treatment of LS is a complex clinical and economic concern for patients and health care providers. Methods: Selection criteria: (1) randomized controlled clinical trials (RCTs) comparing treatment effects of lumbar arthrodesis with other interventions; (2) participants: skeletally mature adults with lumbar degenerative disk disease. Search methods: Ovid MEDLINE, Embase, the Cochrane Library, and others. All years through February of 2013 were included. Patient-centered clinical outcomes before treatment, at 12, 24, or >24 months of follow-up, and rate of complications and additional surgical treatment were collected. A meta-analysis was performed to evaluate pooled treatment effects. The GRADE approach was applied to evaluate the level of evidence. Results: The review included 38 studies of 5738 participants. All studies showed strong or at least moderate treatment effects of lumbar arthrodesis at 12, 24, and 48-72 months of follow-up. The level of evidence was moderate at 12 and 24 months, and low at 48-72 months. The pooled long-term treatment effect of lumbar arthrodesis exceeded those of: nonsurgical treatment (P<0.0001) with a moderate level of evidence, and decompression without fusion (P=0.005) with a low level of evidence. The treatment effect of lumbar arthrodesis showed a small inferiority versus arthroplasty at 12 and 24 months of follow-up (P<0.001), but not after 24 months postoperative. Conclusions: This review indicates that surgical stabilization of the lumbar spine is an effective treatment for LS; in particular, for patients with severe chronic low back pain that has been resistant to >= 3 months of conservative therapy.
AD  - [Noshchenko, Andriy; Lindley, Emily M.; Burger, Evalina L.; Cain, Christopher M. J.; Patel, Vikas V.] Univ Colorado, Dept Orthopaed, Aurora, CO 80045 USA. [Hoffecker, Lilian] Univ Colorado, Hlth Sci Lib, Aurora, CO 80045 USA.
Noshchenko, A (reprint author), Univ Colorado, Dept Orthopaed, Anschutz Med Campus,13001 E 17th Pl, Aurora, CO 80045 USA.
andriy.noshchenko@ucdenver.edu
AN  - WOS:000364286200001
AU  - Noshchenko, A.
AU  - Hoffecker, L.
AU  - Lindley, E. M.
AU  - Burger, E. L.
AU  - Cain, C. M. J.
AU  - Patel, V. V.
DA  - Nov
DO  - 10.1097/bsd.0000000000000124
IS  - 9
J2  - J. Spinal Disord. Tech.
KW  - lumbar spondylosis
lumbar arthrodesis
lumbar arthroplasty
long-term
treatment effects
low-back-pain
investigational-device-exemption
randomized
controlled-trial
oswestry disability index
bone morphogenetic
protein-2
2-year follow-up
spine-study-group
iliac crest bone
short-form 36
interbody fusion
Neurosciences & Neurology
Orthopedics
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: CV5DG
Times Cited: 9
Cited Reference Count: 111
Noshchenko, Andriy Hoffecker, Lilian Lindley, Emily M. Burger, Evalina L. Cain, Christopher M. J. Patel, Vikas V.
Hoffecker, Lilian/0000-0001-8277-2300
9
0
5
Lippincott williams & wilkins
Philadelphia
1539-2465
PY  - 2015
SN  - 1536-0652
SP  - E493-E521
ST  - Long-term Treatment Effects of Lumbar Arthrodeses in Degenerative Disk Disease A Systematic Review With Meta-Analysis
T2  - Journal of Spinal Disorders & Techniques
TI  - Long-term Treatment Effects of Lumbar Arthrodeses in Degenerative Disk Disease A Systematic Review With Meta-Analysis
UR  - <Go to ISI>://WOS:000364286200001
VL  - 28
ID  - 100
ER  - 

TY  - JOUR
AB  - Study Design.Meta-analysis of 4 randomized controlled clinical trials (RCTs).Objective.The aim of the study was to determine if patients with degenerative disc disease who achieve radiographic fusion after single-level lumbar interbody arthrodesis have better clinical outcomes than patients with radiographic pseudarthrosis at 12 and 24 months postoperative.Summary of Background Data.The clinical relevance of successful fusion after lumbar arthrodesis with recombinant human bone morphogenetic protein-2 or iliac crest bone autograft has recently been questioned in the literature.Methods.Individual patient-level data of 4 RCTs were obtained from the Yale University Open Data Access Project project and analyzed. Clinical outcomes (Oswestry Disability Index [ODI]; Numeric Rating Scales [NRSs] for back and leg pain) were compared between patients with radiographically confirmed fusion and those with radiographic nonunion 1 and 2 years postoperative. The results of each study were first analyzed separately, and then were pooled by meta-analysis. The GRADE approach was applied to evaluate the level of evidence.Results.A total of 496 patients with clinical and radiographic data at 1- and 2-year follow-ups were identified. Of these, 5.5% (95% confidence interval: 3.7; 8.3) had radiographic nonunion which did not require reoperation. Patients with fusion had better improvements in ODI (P<0.001) and NRS back pain scores (P<0.001). The overall percentage of fused patients with ODI and NRS back pain scores that exceeded the criteria for minimal clinically important differences was also significantly higher than that of patients with nonunion (ODI, odds ratio [OR]=2.7, P=0.019; NRS back pain, OR=3.5, P=0.033). The predictive values of fusion for clinical outcomes, however, were poor, with low specificity and low negative predictive values.Conclusion.The presence of radiographic fusion is clinically significant, as patients with fusion had better clinical outcomes at 1 and 2 years postoperative than those with nonunion; however, patient-centered clinical outcomes should also be taken into consideration as independent, complimentary variables when assessing treatment success.Level of Evidence: 1
AD  - [Noshchenko, Andriy; Lindley, Emily M.; Burger, Evalina L.; Cain, Christopher M. J.; Patel, Vikas V.] Univ Colorado, Anschutz Med Campus, Dept Orthoped, Aurora, CO 80045 USA.
Noshchenko, A (reprint author), Univ Colorado, Anschutz Med Campus, Dept Orthoped, 13001 E 17th Pl,Mail Stop F432, Aurora, CO 80045 USA.
Andriy.Noshchenko@ucdenver.edu
AN  - WOS:000368509600005
AU  - Noshchenko, A.
AU  - Lindley, E. M.
AU  - Burger, E. L.
AU  - Cain, C. M. J.
AU  - Patel, V. V.
DA  - Jan
DO  - 10.1097/brs.0000000000001113
IS  - 1
J2  - Spine
KW  - lumbar arthrodesis
meta-analysis
patient-centered clinical outcomes
radiographic fusion
YODA
bone morphogenetic protein-2
spine fusion
long-term
outcomes
spondylolisthesis
metaanalysis
guidelines
rhbmp-2
cages
Neurosciences & Neurology
Orthopedics
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: DB4UR
Times Cited: 6
Cited Reference Count: 25
Noshchenko, Andriy Lindley, Emily M. Burger, Evalina L. Cain, Christopher M. J. Patel, Vikas V.
Yale Open Access Data Project (YODA); Medtronic Sofamor Danek (Memphis, TN)Medtronic
The authors thank administration of the Yale Open Access Data Project (YODA) and Medtronic Sofamor Danek (Memphis, TN) for ability to use primary results of studies that were sponsored by this Company.
6
0
12
Lippincott williams & wilkins
Philadelphia
1528-1159
PY  - 2016
SN  - 0362-2436
SP  - 9-17
ST  - What Is the Clinical Relevance of Radiographic Nonunion After Single-Level Lumbar Interbody Arthrodesis in Degenerative Disc Disease? A Meta-Analysis of the YODA Project Database
T2  - Spine
TI  - What Is the Clinical Relevance of Radiographic Nonunion After Single-Level Lumbar Interbody Arthrodesis in Degenerative Disc Disease? A Meta-Analysis of the YODA Project Database
UR  - <Go to ISI>://WOS:000368509600005
VL  - 41
ID  - 97
ER  - 

TY  - JOUR
AD  - [Nutalapati, Venkat; Kanakadandi, Vijay; Desai, Madhav; Bansal, Ajay; Olyaee, Mojtaba S.; Rastogi, Amit] Univ Kansas, Med Ctr, Gastroenterol, Kansas City, KS 66103 USA. [Wani, Sachin] Univ Colorado, Gastroenterol & Hepatol, Aurora, CO USA. [Bansal, Ajay] Kansas City VA Med Ctr, Gastroenterol, Kansas City, MO USA.
AN  - WOS:000392524900098
AU  - Nutalapati, V.
AU  - Kanakadandi, V.
AU  - Desai, M.
AU  - Wani, S.
AU  - Bansal, A.
AU  - Olyaee, M. S.
AU  - Rastogi, A.
DA  - May
DO  - 10.1016/j.gie.2016.03.1099
IS  - 5
J2  - Gastrointest. Endosc.
KW  - Gastroenterology & Hepatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: EI5HM
Times Cited: 0
Cited Reference Count: 0
Nutalapati, Venkat Kanakadandi, Vijay Desai, Madhav Wani, Sachin Bansal, Ajay Olyaee, Mojtaba S. Rastogi, Amit
DDW ASGE Meeting
May 21-24, 2016
San Diego, CA
Asge
Desai, Madhav/H-3755-2019
Desai, Madhav/0000-0001-8871-3627
0
Mosby-elsevier
New york
1097-6779
S
PY  - 2016
SN  - 0016-5107
SP  - AB540-AB540
ST  - Cap-Assisted Colonoscopy Improves Cecal Intubation Rate and Time: A Systematic Review and Meta-Analysis
T2  - Gastrointestinal Endoscopy
TI  - Cap-Assisted Colonoscopy Improves Cecal Intubation Rate and Time: A Systematic Review and Meta-Analysis
UR  - <Go to ISI>://WOS:000392524900098
VL  - 83
ID  - 85
ER  - 

TY  - JOUR
AB  - A history of mild traumatic brain injury (mTBI) is common among military members who served in Operations Enduring Freedom, Iraqi Freedom, and New Dawn (OEF/OIF/OND). We completed a systematic review to describe the cognitive, mental health, physical health, functional, social, and cost consequences of mTBI in Veteran and military personnel. Of 2668 reviewed abstracts, the 31 included studies provided very low strength evidence for the questions of interest. Cognitive, physical, and mental health symptoms were commonly reported by Veterans/military members with a history of mTBI. On average, these symptoms were not significantly more common in those with a history of mTBI than in those without, although a lack of significant mean differences does not preclude the possibility that some individuals could experience substantial effects related to mTBI history. Evidence of potential risk or protective factors moderating mTBI outcomes was unclear. Although the overall strength of evidence is very low due to methodological limitations of included studies, our findings are consistent with civilian studies. Appropriate re-integration services are needed to address common comorbid conditions, such as treatment for post-traumatic stress disorder, substance use disorders, headaches, and other difficulties that Veterans and members of the military may experience after deployment regardless of mTBI history.
AD  - [O'Neil, Maya E.; Carlson, Kathleen F.; Storzbach, Daniel; Freeman, Michele; Quinones, Ana R.; Motu'apuaka, Makalapua; Kansagara, Devan] Portland VA Med Ctr, Portland, OR USA. [O'Neil, Maya E.; Carlson, Kathleen F.; Storzbach, Daniel; Freeman, Michele; Kansagara, Devan] Oregon Hlth & Sci Univ, Portland, OR 97201 USA. [Brenner, Lisa A.] VISN 19 MIRECC, Denver VA Med Ctr, Denver, CO USA. [Brenner, Lisa A.] Univ Colorado, Denver, CO 80202 USA.
O'Neil, ME (reprint author), 3710 SW US Vet Hosp Rd,Mail Code R&D 71, Portland, OR 97239 USA.
maya.oneil@va.gov
AN  - WOS:000339561800001
AU  - O'Neil, M. E.
AU  - Carlson, K. F.
AU  - Storzbach, D.
AU  - Brenner, L. A.
AU  - Freeman, M.
AU  - Quinones, A. R.
AU  - Motu'apuaka, M.
AU  - Kansagara, D.
DA  - Mar
DO  - 10.1017/s135561771300146x
IS  - 3
J2  - J. Int. Neuropsychol. Soc.
KW  - Mild traumatic brain injury
Veteran
Military
Systematic review
Combat deployment
Cognitive functioning
Deployment related conditions
posttraumatic-stress-disorder
service members
neuropsychological
performance
postconcussive symptoms
oef/oif veterans
blast
concussion
headaches
impact
utility
Neurosciences & Neurology
Psychiatry
Psychology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: AM0UG
Times Cited: 25
Cited Reference Count: 39
O'Neil, Maya E. Carlson, Kathleen F. Storzbach, Daniel Brenner, Lisa A. Freeman, Michele Quinones, Ana R. Motu'apuaka, Makalapua Kansagara, Devan
Quinones, Ana/0000-0001-6554-7734
Veterans Affairs Quality Enhancement Research Initiative (QUERI) Evidence-based Synthesis Program (ESP)
This study was funded by the Veterans Affairs Quality Enhancement Research Initiative (QUERI) Evidence-based Synthesis Program (ESP). The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. All authors declare no conflicts of interests involved in the research presented in the manuscript. The corresponding author (MEO) declares she had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. We thank Edwin Reid and Tomiye Akagi for their editorial assistance, and Rose Relevo for library assistance.
26
1
18
Cambridge univ press
New york
1469-7661
PY  - 2014
SN  - 1355-6177
SP  - 249-261
ST  - Factors Associated with Mild Traumatic Brain Injury in Veterans and Military Personnel: A Systematic Review
T2  - Journal of the International Neuropsychological Society
TI  - Factors Associated with Mild Traumatic Brain Injury in Veterans and Military Personnel: A Systematic Review
UR  - <Go to ISI>://WOS:000339561800001
VL  - 20
ID  - 145
ER  - 

TY  - JOUR
AD  - [Okuyama, Sonia; Jones, Whitney; Ricklefs, Christine; Marcus, Al] Univ Colorado, Ctr Canc, Aurora, CO USA.
AN  - WOS:000331088700127
AU  - Okuyama, S.
AU  - Jones, W.
AU  - Ricklefs, C.
AU  - Marcus, A.
DA  - Feb
J2  - Psycho-Oncol.
KW  - Oncology
Psychology
Biomedical Social Sciences
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: AA4TI
Times Cited: 0
Cited Reference Count: 0
Okuyama, Sonia Jones, Whitney Ricklefs, Christine Marcus, Al
0
1
Wiley-blackwell
Hoboken
1099-1611
Si
PY  - 2014
SN  - 1057-9249
SP  - 72-72
ST  - Psychosocial Telephone Interventions for Cancer Patients: A Systematic Review
T2  - Psycho-Oncology
TI  - Psychosocial Telephone Interventions for Cancer Patients: A Systematic Review
UR  - <Go to ISI>://WOS:000331088700127
VL  - 23
ID  - 148
ER  - 

TY  - JOUR
AB  - Purpose:Anesthetics used to decrease pain during peripheral intravenous catheter insertion have been studied with equivocal results. This meta-analysis determined if lidocaine or bacteriostatic normal saline (BaNS) is more effective in reducing pain associated with peripheral intravenous catheter cannulation in adults. Methods: PubMed, EMBASE, CINAHL, Pro Quest Dissertation and Theses, and Web of Science databases were queried. Thirteen randomized controlled trials were analyzed. Results: Mean sample was 119.9 (+/- 82.0); combined N was 1,559. Mean effect size was z = 0.46 (confidence interval = 0.24-0.68) indicating lidocaine was more effective than BaNS in providing pain relief (P < .001). Conclusion: Cost-benefit issues and lidocaine drug shortages must be considered when making definitive practice recommendations.
AD  - [Oman, Kathleen S.; Fink, Regina; Makic, Mary Beth Flynn; Wenger, Barbara; Mancuso, Mary] Univ Colorado Hosp, Aurora, CO 80045 USA. [Oman, Kathleen S.; Makic, Mary Beth Flynn; Schmiege, Sarah; Cook, Paul] Univ Colorado, Coll Nursing, Aurora, CO USA. [Kleinen, Catherine] Catholic Hlth Initiat, Englewood, CO USA. [Hoffecken, Lilian] Univ Colorado, Hlth Sci Lib, Aurora, CO USA. [Cook, Paul] Ctr Nursing Res, Aurora, CO USA.
Oman, KS (reprint author), Univ Colorado Hosp, Aurora, CO 80045 USA.
kathy.oman@uchealth.org
AN  - WOS:000343021600006
AU  - Oman, K. S.
AU  - Fink, R.
AU  - Kleinen, C.
AU  - Makic, M. B. F.
AU  - Wenger, B.
AU  - Hoffecken, L.
AU  - Mancuso, M.
AU  - Schmiege, S.
AU  - Cook, P.
DA  - Oct
DO  - 10.1016/j.jopan.2013.12.008
IS  - 5
J2  - J. PeriAnesthesia Nurs.
KW  - lidocaine
normal saline
intravenous catheter insertion
meta-analysis
buffered lidocaine
benzyl alcohol
Nursing
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AQ7TH
Times Cited: 4
Cited Reference Count: 20
Oman, Kathleen S. Fink, Regina Kleinen, Catherine Makic, Mary Beth Flynn Wenger, Barbara Hoffecken, Lilian Mancuso, Mary Schmiege, Sarah Cook, Paul
Hoffecker, Lilian/0000-0001-8277-2300
4
0
Elsevier science inc
New york
1532-8473
PY  - 2014
SN  - 1089-9472
SP  - 367-376
ST  - Intradermal Lidocaine or Bacteriostatic Normal Saline to Decrease Pain Before Intravenous Catheter Insertion: A Meta-Analysis
T2  - Journal of Perianesthesia Nursing
TI  - Intradermal Lidocaine or Bacteriostatic Normal Saline to Decrease Pain Before Intravenous Catheter Insertion: A Meta-Analysis
UR  - <Go to ISI>://WOS:000343021600006
VL  - 29
ID  - 132
ER  - 

TY  - JOUR
AB  - Anxiety disorders (ADs), namely generalized AD, panic disorder and phobias, are common, etiologically complex conditions with a partially genetic basis. Despite differing on diagnostic definitions based on clinical presentation, ADs likely represent various expressions of an underlying common diathesis of abnormal regulation of basic threat-response systems. We conducted genome-wide association analyses in nine samples of European ancestry from seven large, independent studies. To identify genetic variants contributing to genetic susceptibility shared across interview-generated DSM-based ADs, we applied two phenotypic approaches: (1) comparisons between categorical AD cases and supernormal controls, and (2) quantitative phenotypic factor scores (FS) derived from a multivariate analysis combining information across the clinical phenotypes. We used logistic and linear regression, respectively, to analyze the association between these phenotypes and genome-wide single nucleotide polymorphisms. Meta-analysis for each phenotype combined results across the nine samples for over 18 000 unrelated individuals. Each meta-analysis identified a different genome-wide significant region, with the following markers showing the strongest association: for case-control contrasts, rs1709393 located in an uncharacterized non-coding RNA locus on chromosomal band 3q12.3 (P = 1.65 x 10(-8)); for FS, rs1067327 within CAMKMT encoding the calmodulin-lysine N-methyltransferase on chromosomal band 2p21 (P = 2.86 x 10(-9)). Independent replication and further exploration of these findings are needed to more fully understand the role of these variants in risk and expression of ADs.
AD  - [Otowa, T.; Lee, M.; Bigdeli, T.; Aggen, S. H.; Hettema, J. M.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, POB 980126, Richmond, VA 23298 USA. [Otowa, T.] Univ Tokyo, Dept Neuropsychiat, Grad Sch Med, Tokyo, Japan. [Hek, K.; Mirza, S. S.; Direk, N.; Hofman, A.; Uitterlinden, A.; Tiemeier, H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands. [Hek, K.] Erasmus MC, Dept Psychiat Epidemiol, Rotterdam, Netherlands. [Hek, K.] Erasmus MC, Social Psychiat Res Inst, Rotterdam, Netherlands. [Byrne, E. M.; Henders, A. K.; Medland, S. E.; Gordon, S.; Martin, N. G.; Montgomery, G.; Wray, N. R.] QIMR Berghofer Inst Med Res, Brisbane, Qld, Australia. [Byrne, E. M.; Henders, A. K.; Wray, N. R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia. [Nivard, M. G.; Middeldorp, C. M.; Boomsma, D.] Vrije Univ Amsterdam, Biol Psychol, Amsterdam, Netherlands. [Adkins, D.; van den Oord, E. J.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Dept Pharm, Richmond, VA USA. [Wolen, A.] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA USA. [Fanous, A.] Washington VA Med Ctr, Mental Hlth Serv Line, Washington, DC USA. [Fanous, A.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA. [Keller, M. C.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA. [Keller, M. C.] Univ Colorado, Inst Behav Genet, Boulder, CO USA. [Castelao, E.; Preisig, M.] Univ Lausanne Hosp, Dept Psychiat, Lausanne, Switzerland. [Kutalik, Z.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland. [Kutalik, Z.] CHU Vaudois, Inst Social & Prevent Med, Lausanne, Switzerland. [Kutalik, Z.] Swiss Inst Bioinformat, Lausanne, Switzerland. [der Auwera, S. V.; Grabe, H. J.] Univ Med Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany. [Homuth, G.] Univ Med, Interfac Inst Genet & Funct Genom, Greifswald, Germany. [Homuth, G.] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany. [Nauck, M.] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany. [Teumer, A.] Univ Med Greifswald, Inst Community Med, Greifswald, Germany. [Milaneschi, Y.; Hottenga, J-J; Penninx, B. W. J. H.] Vrije Univ Amsterdam, GGZ inGeest, Dept Psychiat, Med Ctr, Amsterdam, Netherlands. [Milaneschi, Y.; Hottenga, J-J; Penninx, B. W. J. H.; Boomsma, D.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Med Ctr, Amsterdam, Netherlands. [Uitterlinden, A.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands. [Mulder, C. L.; Tiemeier, H.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands. [Heath, A. C.; Madden, P. A. F.; Pergadia, M. L.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA. [Pergadia, M. L.] Florida Atlantic Univ, Boca Raton, FL USA. [van der Most, P. J.; Nolte, I. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet Epidemiol, Groningen, Netherlands. [van Oort, F. V. A.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands. [Hartman, C. A.; Oldehinkel, A. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands. [Grabe, H. J.] Helios Hosp Stralsund, Dept Psychiat & Psychotherapy, Stralsund, Germany. [Middeldorp, C. M.] GGZ inGeest VU Univ, Med Ctr, Dept Child & Adolescent Psychiat, Amsterdam, Netherlands. [Maher, B. S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA. [Tiemeier, H.] Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands.
Hettema, JM (reprint author), Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, POB 980126, Richmond, VA 23298 USA.
jhettema@vcu.edu
AN  - WOS:000384127000010
AU  - Otowa, T.
AU  - Hek, K.
AU  - Lee, M.
AU  - Byrne, E. M.
AU  - Mirza, S. S.
AU  - Nivard, M. G.
AU  - Bigdeli, T.
AU  - Aggen, S. H.
AU  - Adkins, D.
AU  - Wolen, A.
AU  - Fanous, A.
AU  - Keller, M. C.
AU  - Castelao, E.
AU  - Kutalik, Z.
AU  - der Auwera, S. V.
AU  - Homuth, G.
AU  - Nauck, M.
AU  - Teumer, A.
AU  - Milaneschi, Y.
AU  - Hottenga, J. J.
AU  - Direk, N.
AU  - Hofman, A.
AU  - Uitterlinden, A.
AU  - Mulder, C. L.
AU  - Henders, A. K.
AU  - Medland, S. E.
AU  - Gordon, S.
AU  - Heath, A. C.
AU  - Madden, P. A. F.
AU  - Pergadia, M. L.
AU  - van der Most, P. J.
AU  - Nolte, I. M.
AU  - van Oort, F. V. A.
AU  - Hartman, C. A.
AU  - Oldehinkel, A. J.
AU  - Preisig, M.
AU  - Grabe, H. J.
AU  - Middeldorp, C. M.
AU  - Penninx, Bwjh
AU  - Boomsma, D.
AU  - Martin, N. G.
AU  - Montgomery, G.
AU  - Maher, B. S.
AU  - van den Oord, E. J.
AU  - Wray, N. R.
AU  - Tiemeier, H.
AU  - Hettema, J. M.
DA  - Oct
DO  - 10.1038/mp.2015.197
IS  - 10
J2  - Mol. Psychiatr.
KW  - environmental risk-factors
netherlands twin register
genetic
epidemiology
lifetime prevalence
depression
polygenicity
objectives
morbidity
sample
power
Biochemistry & Molecular Biology
Neurosciences & Neurology
Psychiatry
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: DX1KT
Times Cited: 51
Cited Reference Count: 53
Otowa, T. Hek, K. Lee, M. Byrne, E. M. Mirza, S. S. Nivard, M. G. Bigdeli, T. Aggen, S. H. Adkins, D. Wolen, A. Fanous, A. Keller, M. C. Castelao, E. Kutalik, Z. der Auwera, S. V. Homuth, G. Nauck, M. Teumer, A. Milaneschi, Y. Hottenga, J-J Direk, N. Hofman, A. Uitterlinden, A. Mulder, C. L. Henders, A. K. Medland, S. E. Gordon, S. Heath, A. C. Madden, P. A. F. Pergadia, M. L. van der Most, P. J. Nolte, I. M. van Oort, F. V. A. Hartman, C. A. Oldehinkel, A. J. Preisig, M. Grabe, H. J. Middeldorp, C. M. Penninx, B. W. J. H. Boomsma, D. Martin, N. G. Montgomery, G. Maher, B. S. van den Oord, E. J. Wray, N. R. Tiemeier, H. Hettema, J. M.
Teumer, Alexander/S-7438-2019; Middeldorp, Christel M/L-7728-2017; Medland, Sarah E/C-7630-2013; Montgomery, Grant W/B-7148-2008; Penninx, Brenda WJH/S-7627-2017; Colaus, PsyColaus/K-6607-2013; Byrne, Enda/J-6068-2014; Henders, Anjali/E-3126-2017; Direk, Nese/G-1746-2019; Wolen, Aaron/H-9545-2014
Teumer, Alexander/0000-0002-8309-094X; Middeldorp, Christel M/0000-0002-6218-0428; Medland, Sarah E/0000-0003-1382-380X; Montgomery, Grant W/0000-0002-4140-8139; Penninx, Brenda WJH/0000-0001-7779-9672; Byrne, Enda/0000-0002-9491-7797; Henders, Anjali/0000-0003-3672-1451; Nivard, Michel/0000-0003-2015-1888; Direk, Nese/0000-0002-3631-5990; Wolen, Aaron/0000-0003-2542-2202
NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH87646]; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [21-8373]; IMH Schizophrenia Genetics Initiative U01s [MH046276, MH46289, MH46318]; MGS Part 1 (MGS1); Research Institute for Diseases in the Elderly (RIDE2) [014-93-015]; Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Ageing (NCHA) [050-060-810]; VidiNetherlands Organization for Scientific Research (NWO) [017.106.370]; Erasmus Medical Center, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development; Ministry of Education, Culture and ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Ministry for Health, Welfare and Sports; Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [01ZZ9603, 01ZZ0103, 01ZZ040, 03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania
This overall project was supported by NIH grant R01MH87646 to JMH. TO was supported by a research fellowship from the Japan Society for the Promotion of Science (no. 21-8373). Samples and associated phenotype data for the MGS study were collected under the following grants: NIMH Schizophrenia Genetics Initiative U01s: MH046276 (CR Cloninger), MH46289 (C Kaufmann), and MH46318 (MT Tsuang); and MGS Part 1 (MGS1) and Part 2 (MGS2) R01s: MH67257 (NG Buccola), MH59588 (BJ Mowry), MH59571 (PV Gejman), MH59565(R Freedman), MH59587 (F Amin), MH60870 (WF Byerley), MH59566 (DW Black), MH59586 (JM Silverman), MH61675 (DF Levinson) and MH60879 (CR Cloninger). Analyses in the Rotterdam Study were supported by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), The Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Ageing (NCHA) project No. 050-060-810. The work of HT is supported by Vidi (grant 017.106.370). The Rotterdam Study is funded by Erasmus Medical Center, Rotterdam, The Netherlands Organization for the Health Research and Development (ZonMw), the Ministry of Education, Culture and Science, and the Ministry for Health, Welfare and Sports. SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103 and 01ZZ0403), the Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. This work was also funded by the German Research Foundation (DFG: GR 1912/5-1). The University of Greifswald is a member of the Cach, Campus program of the InterSystems GmbH. The QIMR samples are made available through the generous and willing participation of twins and their families registered at the Australian Twin Registry and through grant funding awarded from many grant funding bodies including the Australian National Health and Medical Research Council (241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496675, 496739, 552485, 552498, 613608), the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254), the US National Institutes of Health (NIH grants AA07535, AA10248, AA13320, AA13321, AA13326, AA14041, MH66206, DA12854, DA019951) and the Center for Inherited Disease Research, Baltimore. We thank Dixie Statham (sample collection); Leanne Wallace, Anthony Caracella and staff of the Molecular Epidemiology Laboratory (DNA processing); David Smyth, Harry Beeby and Daniel Park (IT support). Statistical analyses were partly conducted at the Genetic Cluster Computer (http://www. geneticcluster. org), which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). EMB (1053639), SEM, GM and NRW (613602, 1078901) are supported by the National Health and Medical Research Council Fellowship Scheme. The CoLaus| PsyCoLaus study was and is supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (grants 3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468 and 33CS30-148401).; Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GBMaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), the participating universities, and Accare Center for Child and Adolescent Psychiatry. Statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster. org), which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003) along with a supplement from the Dutch Brain Foundation. Funding for the NESDA/NTR studies was obtained from the Netherlands Organization for Scientific Research (Geestkracht program grant 10-000-1002; 904-61090, 985-10-002, 904-61-193, 480-04-004, 400-05-717, 912-100-20; Spinozapremie 56-464-14192); the Center for Medical Systems Biology (CSMB, NWO Genomics), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL), VU University's Institutes for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam, European Research Council (ERC, 230374), National Institutes of Health (NIH, R01D0042157-01 A, MH081802, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995). Part of the genotyping and analyses were funded by the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health. Computing was supported by BiG Grid, the Dutch eScience Grid, which is financially supported by NWO.
51
3
42
Nature publishing group
London
1476-5578
PY  - 2016
SN  - 1359-4184
SP  - 1391-1399
ST  - Meta-analysis of genome-wide association studies of anxiety disorders
T2  - Molecular Psychiatry
TI  - Meta-analysis of genome-wide association studies of anxiety disorders
UR  - <Go to ISI>://WOS:000384127000010
VL  - 21
ID  - 74
ER  - 

TY  - JOUR
AB  - Purpose: The purpose of this study was to evaluate the response of retinoic acid (RA) in radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC). Methods: Systematic searches of MEDLINE (from inception to December 2016) and of EMBASE (from inception to December 2016) were performed for English-language publications on thyroid cancer treated with RA. Studies were classified according to the response criteria used: (1) 123I or I-131 whole body scintigraphy (WBS), (2) serum thyroglobulin (Tg) level, (3) the response evaluation criteria in solid tumors (RECIST) version 1.0, and (4) World Health Organization (WHO) criteria. Results: Disease response rates as determined by WBS ranged widely between 6.2% and 46.1% with a pooled disease response rate of 27.6% (95% confidence interval: 21.7-34.0%). Response rates as determined by Tg level ranged from 56.6% to 83.3% (pooled response rate 61.3% (51.0-70.9%)), RECIST response rates from 0% to 45.5% (pooled response rate 17.0% (1.4-44.5%)), and according to WHO criteria, the pooled response rate was 30.8% (12.7-52.7%). Conclusions: A minority of patients with RAI-refractory DTC respond to RA treatment. (c) 2018 S. Karger GmbH, Freiburg
AD  - [Pak, Kyoungjune; Shin, Seunghyeon; Kim, In-Joo] Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea. [Pak, Kyoungjune; Shin, Seunghyeon; Kim, In-Joo] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea. [Kim, Seong-Jang] Pusan Natl Univ, Yangsan Hosp, Dept Nucl Med, Yangsan 626870, Gyeongsangnam D, South Korea. [Kim, Seong-Jang] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, Gyeongsangnam D, South Korea. [Chang, Samuel; Koo, Phillip; Kwak, Jennifer] Univ Colorado, Sch Med, Dept Radiol, Aurora, CO USA. [Kim, Jae-Ho] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea.
Kim, SJ (reprint author), Pusan Natl Univ, Yangsan Hosp, Dept Nucl Med, Yangsan 626870, Gyeongsangnam D, South Korea.
growthkim@daum.net
AN  - WOS:000427011300002
AU  - Pak, K.
AU  - Shin, S.
AU  - Kim, S. J.
AU  - Kim, I. J.
AU  - Chang, S.
AU  - Koo, P.
AU  - Kwak, J.
AU  - Kim, J. H.
DO  - 10.1159/000484206
IS  - 3
J2  - Oncol. Res. Treat.
KW  - Retinoids
Meta-analysis
Thyroid neoplasm
Iodine radioisotopes
Cell
differentiation
histone deacetylase inhibitor
acute promyelocytic leukemia
redifferentiation therapy
13-cis-retinoic acid
radioiodine uptake
cell-lines
phase-ii
carcinoma
papillary
differentiation
Oncology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FY6ZL
Times Cited: 1
Cited Reference Count: 50
Pak, Kyoungjune Shin, Seunghyeon Kim, Seong-Jang Kim, In-Joo Chang, Samuel Koo, Phillip Kwak, Jennifer Kim, Jae-Ho
Pak, Kyoungjune/F-3004-2013
Biomedical Research Institute of Pusan National University Hospital [2017-E7]; National Research Foundation of KoreaNational Research Foundation of Korea [NRF-2015R1B1A1A01060977]
This meta-analysis study was made from pooled results of previous studies. The informed consent and guidelines for human studies and animal welfare regulations are not applicable to this study. This study was supported by the grant of Biomedical Research Institute of Pusan National University Hospital (Grant No; 2017-E7). This research was supported by the National Research Foundation of Korea (NRF-2015R1B1A1A01060977).
1
0
Karger
Basel
2296-5262
PY  - 2018
SN  - 2296-5270
SP  - 100-104
ST  - Response of Retinoic Acid in Patients with Radioactive Iodine-Refractory Thyroid Cancer: A Meta-Analysis
T2  - Oncology Research and Treatment
TI  - Response of Retinoic Acid in Patients with Radioactive Iodine-Refractory Thyroid Cancer: A Meta-Analysis
UR  - <Go to ISI>://WOS:000427011300002
VL  - 41
ID  - 39
ER  - 

TY  - JOUR
AB  - Background Gilles de la Tourette syndrome, or Tourette's syndrome, is defined as the presence of both motor and vocal (phonic) tics for more than 12 months, that manifest before the age of 18 years, in the absence of secondary causes. Treatment of motor and phonic tics is difficult and challenging. Objectives To determine the safety and effectiveness of botulinum toxin in treating motor and phonic tics in people with Tourette's syndrome, and to analyse the effect of botulinum toxin on premonitory urge and sensory tics. Search methods We searched the Cochrane Movement Disorders Group Trials Register, CENTRAL, MEDLINE, and two trials registers to 25 October 2017. We reviewed reference lists of relevant articles for additional trials. Selection criteria We considered all randomised, controlled, double-blind studies comparing botulinum toxin to placebo or other medications for the treatment of motor and phonic tics in Tourette's syndrome for this review. We sought both parallel group and cross-over studies of children or adults, at any dose, and for any duration. Data collection and analysis We followed standard Cochrane methods to select studies, assess risk of bias, extract and analyse data. All authors independently abstracted data onto standardized forms; disagreements were resolved by mutual discussion. Main results Only one randomised placebo-controlled, double-blind cross-over study met our selection criteria. In this study, 20 participants with motor tics were enrolled over a three-year recruitment period; 18 (14 of whom had a diagnosis of Tourette's syndrome) completed the study; in total, 21 focal motor tics were treated. Although we considered most bias domains to be at low risk of bias, the study recruited a small number of participants with relatively mild tics and provided limited data for our key outcomes. The effects of botulinum toxin injections on tic frequency, measured by videotape or rated subjectively, and on premonitory urge, are uncertain (very low-quality evidence). The quality of evidence for adverse events following botulinum toxin was very low. Nine people had muscle weakness following the injection, which could have led to unblinding of treatment group assignment. No data were available to evaluate whether botulinum injections led to immunoresistance to botulinum. Authors' conclusions We are uncertain about botulinum toxin effects in the treatment of focal motor and phonic tics in select cases, as we assessed the quality of the evidence as very low. Additional randomised controlled studies are needed to demonstrate the benefits and harms of botulinum toxin therapy for the treatment of motor and phonic tics in patients with Tourette's syndrome.
AD  - [Pandey, Sanjay] GB Pant Hosp, Dept Neurol, New Delhi 110002, India. [Srivanitchapoom, Prachaya] Mahidol Univ, Siriraj Hosp, Div Neurol, Dept Med, Bangkok, Thailand. [Kirubakaran, Richard] Christian Med Coll & Hosp, Cochrane South Asia, Prof BV Moses Ctr Evidence Informed Hlth Care & H, Vellore, Tamil Nadu, India. [Berman, Brian D.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA.
Pandey, S (reprint author), GB Pant Hosp, Dept Neurol, New Delhi 110002, India.
sanjaysgpgi2002@yahoo.co.in
AN  - WOS:000423977300018
AU  - Pandey, S.
AU  - Srivanitchapoom, P.
AU  - Kirubakaran, R.
AU  - Berman, B. D.
C7  - Cd012285
DO  - 10.1002/14651858.CD012285.pub2
IS  - 1
J2  - Cochrane Database Syst Rev.
KW  - neurotoxin type-a
management
release
General & Internal Medicine
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FU6QN
Times Cited: 1
Cited Reference Count: 29
Pandey, Sanjay Srivanitchapoom, Prachaya Kirubakaran, Richard Berman, Brian D.
Soundrarajan, joyson/i-1779-2019
Berman, Brian/0000-0002-0602-9942
Department for International Development (DFID), UK; Effective Healthcare Research Consortium
Department for International Development (DFID), UK.; Project funding for the Effective Healthcare Research Consortium; salary for Richard Kirubakaran during the review stage.
1
7
Wiley
Hoboken
1361-6137
PY  - 2018
SN  - 1469-493X
SP  - 26
ST  - Botulinum toxin for motor and phonic tics in Tourette's syndrome
T2  - Cochrane Database of Systematic Reviews
TI  - Botulinum toxin for motor and phonic tics in Tourette's syndrome
UR  - <Go to ISI>://WOS:000423977300018
ID  - 34
ER  - 

TY  - JOUR
AB  - IMPORTANCE Photodynamic therapy (PDT) is used extensively to treat actinic keratoses (AKs). An analysis of the effectiveness of PDT compared with other treatments may help physicians decide what role it should play in their own clinical practices. OBJECTIVE To determine the effectiveness of PDT for the treatment of AKs relative to other methods. DATA SOURCES MEDLINE, EMBASE, Web of Knowledge, and Cochrane Central Register. No restrictions on years were placed, and all searches extended to the year of each database inception. Our search was conducted on March 20, 2013, and included the search terms solar keratosis, actinic keratosis, photodynamic therapy, and photochemotherapy. No restrictions were used for the search string. STUDY SELECTION Only randomized PDT trials that used aminolevulinic acid hydrochloride or methyl aminolevulinate hydrochloride as stabilizers with 10 or more participants were considered. Two of the authors undertook the search independently. DATA EXTRACTION AND SYNTHESIS Data were extracted independently by the 2 authors. We assessed data quality using the Jadad scoring system and used a random-effects model for pooled data analysis. MAIN OUTCOMES AND MEASURES Primary outcome measures specified a priori were lesion response, cosmetic results, and patient satisfaction after the intervention. RESULTS Our search identified 875 journal articles and meeting abstracts. We excluded 862 owing to lack of adherence to our inclusion criteria or lack of author response to our queries for further information. We assessed 13 studies for inclusion in our final synthesis, of which 4 were eligible for final meta-analysis. The only comparator for which meta-analysis was performed was cryotherapy. The meta-analysis consisted of 641 participants, with a total of 2174 AKs treated with cryotherapy and 2170 AKs treated with PDT. Compared with cryotherapy, the pooled relative risk for the meta-analysis for complete response (lesion clearance) was 1.14 (95% CI, 1.11-1.18) at 3 months after treatment. Visual inspection of a funnel plot revealed no publication bias, which was confirmed by the Begg test (P = .80). CONCLUSIONS AND RELEVANCE Photodynamic therapy has a 14% better chance of complete lesion clearance at 3 months after treatment than cryotherapy for thin AKs on the face and scalp.
AD  - [Patel, Gayatri] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95816 USA. [Armstrong, April W.] Univ Colorado, Dept Dermatol, Aurora, CO USA. [Eisen, Daniel B.] Univ Calif Davis, Med Ctr, Dept Dermatol, Sacramento, CA 95816 USA.
Patel, G (reprint author), Univ Calif Davis, Med Ctr, Dept Dermatol, 3301 C St,Ste 1400, Sacramento, CA 95816 USA.
deisen123@gmail.com
AN  - WOS:000346234500005
AU  - Patel, G.
AU  - Armstrong, A. W.
AU  - Eisen, D. B.
DA  - Dec
DO  - 10.1001/jamadermatol.2014.1253
IS  - 12
J2  - JAMA Dermatol.
KW  - 5-percent imiquimod cream
methyl aminolevulinate
immunocompetent
patients
double-blind
topical 5-fluorouracil
transplant recipients
skin
cryotherapy
scalp
face
Dermatology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: AW4ER
Times Cited: 29
Cited Reference Count: 48
Patel, Gayatri Armstrong, April W. Eisen, Daniel B.
Eisen, Daniel/0000-0001-6741-3182
30
0
15
Amer medical assoc
Chicago
2168-6084
PY  - 2014
SN  - 2168-6068
SP  - 1281-1288
ST  - Efficacy of Photodynamic Therapy vs Other Interventions in Randomized Clinical Trials for the Treatment of Actinic Keratoses A Systematic Review and Meta-analysis
T2  - Jama Dermatology
TI  - Efficacy of Photodynamic Therapy vs Other Interventions in Randomized Clinical Trials for the Treatment of Actinic Keratoses A Systematic Review and Meta-analysis
UR  - <Go to ISI>://WOS:000346234500005
VL  - 150
ID  - 129
ER  - 

TY  - JOUR
AD  - Univ Hosp Virgen del Rocio, Seville, Spain. Eli Lilly & Co, Indianapolis, IN 46285 USA. Prof Dr I Chiricuta Inst Oncol, Cluj Napoca, Cluj County, Romania. Univ Colorado, Ctr Canc, Aurora, CO USA. Eli Lilly & Co, Madrid, Spain. Eli Lilly & Co, Indianaolis, IN USA. Univ Turin, Dept Oncol, Orbassano, Italy.
AN  - WOS:000358613201263
AU  - Paz-Ares, L.
AU  - Zimmermann, A.
AU  - Ciuleanu, T. E.
AU  - Bunn, P. A.
AU  - San Antonio, B.
AU  - Denne, J.
AU  - Iturria, N.
AU  - John, W. J.
AU  - Scagliotti, G. V.
DA  - May
DO  - 10.1200/jco.2014.32.15_suppl.e19040
IS  - 15
J2  - J. Clin. Oncol.
KW  - Oncology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: CN7KL
Times Cited: 0
Cited Reference Count: 0
Paz-Ares, Luis Zimmermann, Annamaria Ciuleanu, Tudor-Eliade Bunn, Paul A. San Antonio, Behan Denne, Jonathan Iturria, Nancy John, William J. Vittorio Scagliotti, Giorgio
50th Annual Meeting of the American-Society-of-Clinical-Oncology
May 30-jun 03, 2014
Chicago, IL
Amer Soc Clin Oncol
0
2
Amer soc clinical oncology
Alexandria
1527-7755
S
PY  - 2014
SN  - 0732-183X
SP  - 1
ST  - Meta-analysis examining impact of age on pemetrexed (pem) efficacy for the treatment of advanced nonsquamous (NS) non-small cell lung cancer (NSCLC)
T2  - Journal of Clinical Oncology
TI  - Meta-analysis examining impact of age on pemetrexed (pem) efficacy for the treatment of advanced nonsquamous (NS) non-small cell lung cancer (NSCLC)
UR  - <Go to ISI>://WOS:000358613201263
VL  - 32
ID  - 142
ER  - 

TY  - JOUR
AB  - Objective: In clinical practice, elderly patients are often undertreated relative to younger patients. This meta-analysis was designed to determine whether older patients with non-squamous non-small cell lung cancer (NSCLC) could derive an overall survival (OS) benefit from pemetrexed treatment comparable to that experienced by younger patients in the first-line, second-line, or maintenance settings. Methods: Data from 2671 patients with non-squamous NSCLC participating in four pemetrexed phase III studies were included in a meta-analysis using a random-effects model. Studies included were: JMEI (second-line pemetrexed, N=399); JMDB (first-line pemetrexed/cisplatin, N=1252); JMEN (pemetrexed maintenance after non-pemetrexed/platinum doublet, N=481); and PARAMOUNT (pemetrexed maintenance after first-line pemetrexeclicisplatin, N=539). Patients were predominantly Eastern Cooperative Oncology Group performance status (PS) 0/1. The ratio of OS hazard ratio (HR) (pemetrexed versus control) for younger patients over that for older patients within each study was used as the measure of the differential effect of pemetrexed. Data were examined using age cutoffs of 65 and 70 years. Results: Among the four studies, 32% of patients were aged >= 65 years and 14% were aged >= 70 years. The test of heterogeneity among studies was non-significant for subgroups defined by age 65 (P=0.083) and age 70 (P=0.848). The pooled ratio of the OS HR (pemetrexed versus control) in patients <65 years to that in patients >= 65 years was 0.92 (95% confidence intervals [CI] 0.67-1.25). Similar results were seen for the analysis using the age 70 years cut-off (0.80 [95% CI 0.62-1.04]). Conclusions: In patients with non-squamous NSCLC with good PS, the effect of pemetrexed on OS was not found to be different in younger and older patients undergoing treatment in the first-line, second-line, or maintenance settings. (C) 2016 Published by Elsevier Ireland Ltd.
AD  - [Paz-Ares, Luis G.] Doce de Octubre Univ Hosp, Madrid, Spain. [Zimmermann, Annamaria; Denne, Jonathan; Iturria, Nancy; John, William] Eli Lilly & Co, Indianapolis, IN 46285 USA. [Ciuleanu, Tudor] Inst Oncol Chiricuta, Cluj Napoca, Romania. [Ciuleanu, Tudor] UMF Cluj Napoca, Cluj Napoca, Romania. [Bunn, Paul A.] Univ Colorado, Ctr Canc, Aurora, CO USA. [Antonio, Belen San] Eli Lilly & Co, Madrid, Spain. [Scagliotti, Giorgio V.] Univ Turin, Dept Oncol, San Luigi Hosp, Turin, Italy.
Paz-Ares, LG (reprint author), Hosp Univ Doce de Octubre, Dept Med Oncol, Av De Cordoba Km 5, Madrid 28041, Spain.
lpazaresr@seom.org
AN  - WOS:000395840900007
AU  - Paz-Ares, L. G.
AU  - Zimmermann, A.
AU  - Ciuleanu, T.
AU  - Bunn, P. A.
AU  - Antonio, B. S.
AU  - Denne, J.
AU  - Iturria, N.
AU  - John, W.
AU  - Scagliotti, G. V.
DA  - Feb
DO  - 10.1016/j.lungcan.2016.12.007
J2  - Lung Cancer
KW  - Elderly
Meta-analysis
Advanced non-small cell lung cancer
Pemetrexed
Overall survival
randomized phase-iii
elderly task-force
leukemia group-b
international society
geriatric oncology
experts opinion
plus
cisplatin
chemotherapy
trials
older
Oncology
Respiratory System
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: EN2LE
Times Cited: 5
Cited Reference Count: 30
Paz-Ares, Luis G. Zimmermann, Annamaria Ciuleanu, Tudor Bunn, Paul A. Antonio, Belen San Denne, Jonathan Iturria, Nancy John, William Scagliotti, Giorgio V.
Eli Lilly and CompanyEli Lilly
This study was sponsored by Eli Lilly and Company.
5
1
3
Elsevier ireland ltd
Clare
1872-8332
PY  - 2017
SN  - 0169-5002
SP  - 45-51
ST  - Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer
T2  - Lung Cancer
TI  - Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer
UR  - <Go to ISI>://WOS:000395840900007
VL  - 104
ID  - 70
ER  - 

TY  - JOUR
AB  - IMPORTANCE Burden of disease should inform research prioritization. OBJECTIVE To determine whether systematic reviews and protocols published in the Cochrane Database of Systematic Reviews (CDSR) appropriately reflect disease burden for otolaryngologic conditions as measured by the Global Burden of Disease (GBD) 2010 project. DESIGN Two investigators independently assessed 10 otolaryngologic conditions in CDSR for systematic review and protocol representation from March to June 2014. The otolaryngologic diseases were matched to their respective GBD 2010 disability-adjusted life-years (DALYs) to assess their correlation. MAIN OUTCOMES AND MEASURES Relationship of CDSR representation (based on systematic reviews and protocols) with percentage of total 2010 DALYs, 2010 DALY rank, and DALY percentage change from 1990 to 2010 for 10 otolaryngologic conditions. RESULTS All 10 otolaryngologic conditions were represented by at least 1 systematic review in CDSR. The number of reviews and protocols in CDSR was well matched with GBD 2010 disability metrics for only 1 disease, mouth cancer. Upper respiratory infections, otitis media, thyroid cancer, and cleft lip and cleft palate were overrepresented in CDSR, and esophageal cancer, "other hearing loss," nasopharynx cancer, larynx cancer, and " cancer of other part of pharynx and oropharynx" were underrepresented. CONCLUSIONS AND RELEVANCE The representation of otolaryngologic conditions in CDSR correlates poorly with DALY metrics. The results of this study may guide future research prioritization and allocation of funds.
AD  - [Pederson, Hannah; Okland, Tyler] Univ Colorado, Sch Med, Aurora, CO USA. [Boyers, Lindsay N.] Georgetown Univ, Sch Med, Washington, DC USA. [Karimkhani, Chante] Columbia Univ, Coll Phys & Surg, New York, NY USA. [Rosenfeld, Richard M.] Suny Downstate Med Ctr, Dept Otolaryngol, Brooklyn, NY 11203 USA. [Nasser, Mona] Univ Plymouth, Peninsula Dent Sch, Plymouth PL4 8AA, Devon, England. [Yoong, Sze Lin] Hunter New England Populat Hlth, Wallsend, NSW, Australia. [Yoong, Sze Lin; Wolfenden, Luke] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia. [Kyu, Hmwe H.; Serina, Peter T.; Coggeshall, Megan] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA. [Dellavalle, Robert P.] Univ Colorado, Dept Dermatol, Aurora, CO USA. [Dellavalle, Robert P.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA. [Dellavalle, Robert P.] US Dept Vet Affairs Med Ctr, Dermatol Serv, Denver, CO USA.
Dellavalle, RP (reprint author), Dept Veteran Affairs Med Ctr, Dermatol Serv, 1055 Clermont St,POB 165, Denver, CO 80220 USA.
robert.dellavalle@ucdenver.edu
AN  - WOS:000347973300012
AU  - Pederson, H.
AU  - Okland, T.
AU  - Boyers, L. N.
AU  - Karimkhani, C.
AU  - Rosenfeld, R. M.
AU  - Nasser, M.
AU  - Yoong, S. L.
AU  - Wolfenden, L.
AU  - Kyu, H. H.
AU  - Serina, P. T.
AU  - Coggeshall, M.
AU  - Dellavalle, R. P.
DA  - Jan
DO  - 10.1001/jamaoto.2014.2700
IS  - 1
J2  - JAMA Otolaryngol-Head Neck Surg.
KW  - injuries
health
Otorhinolaryngology
Surgery
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AZ1AQ
Times Cited: 4
Cited Reference Count: 27
Pederson, Hannah Okland, Tyler Boyers, Lindsay N. Karimkhani, Chante Rosenfeld, Richard M. Nasser, Mona Yoong, Sze Lin Wolfenden, Luke Kyu, Hmwe H. Serina, Peter T. Coggeshall, Megan Dellavalle, Robert P.
Nasser, Mona/0000-0003-2220-6491; Wolfenden, Luke/0000-0002-6178-3868
US Department of Veterans Affairs (VA)US Department of Veteran Affairs; Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Hunter New England Local Health District
Dr Dellavalle receives a salary from the US Department of Veterans Affairs (VA) and is also supported by grants from the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH). Luke Wolfenden receives funding from the National Health and Medical Research Council, and Hunter New England Local Health District. All other authors have no relevant funding/support.
4
0
8
Amer medical assoc
Chicago
2168-619x
PY  - 2015
SN  - 2168-6181
SP  - 67-72
ST  - Identifying Otolaryngology Systematic Review Research Gaps Comparing Global Burden of Disease 2010 Results With Cochrane Database of Systematic Review Content
T2  - Jama Otolaryngology-Head & Neck Surgery
TI  - Identifying Otolaryngology Systematic Review Research Gaps Comparing Global Burden of Disease 2010 Results With Cochrane Database of Systematic Review Content
UR  - <Go to ISI>://WOS:000347973300012
VL  - 141
ID  - 125
ER  - 

TY  - JOUR
AB  - Background: Cell-therapy has beenpromoted among the therapeutic arsenal that can aid in bone formation and remodeling, in early stages of osteonecrosis of the femoral head (ONFH). The purpose of this systematic review was to assess the evidence supporting the (1) clinical efficacy; (2) structural modifying effect, as evaluated radiographically; (3) revision rates; and (4) safety of cell-therapy for the treatment of ONFH. Methods: A systematic review was performed including studies with a level-of-evidence of III or higher. A total of 1483 articles were screened. Eleven studies met the criteria for inclusion in this review (level-of-evidence: 6 level-I, 1 level-II, and 4 level-III), including 683 cases of ONFH. Results: All 10 studies that reported patient-reported outcomes showed improved outcomes in the cell-therapy groups compared with the control group. Overall, 24.5% (93/380 hips) that received cell-therapy showed radiographic progression compared with 40% (98/245 hips) in the control group. Nine of 10 studies that reported failure rates showed a lower total hip arthroplasty conversion rate in the cell-therapy group 16% (62/380 hips) compared with the control group 21% (52/252 hips). There was a low complication rate (<3%) with no major adverse effects. Conclusion: Cell-therapies for the treatment of ONFH have been reported to be safe and suggest improved clinical outcomes with lower disease progression rate. However, there was substantial heterogeneity in the included studies, and in the cell-based therapies used. Specific clinical indications and cell-therapy standardization are required because studies varied widely with respect to cell sourcing, cell characterization, adjuvant therapies, and assessment of outcomes. (C) 2017 Elsevier Inc. All rights reserved.
AD  - [Piuzzi, Nicolas S.; Mont, Michael A.; Muschler, George F.] Cleveland Clin, Dept Orthopaed, Cleveland, OH 44106 USA. [Piuzzi, Nicolas S.; Muschler, George F.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA. [Piuzzi, Nicolas S.; LaPrade, Robert F.] Inst Univ Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina. [Chahla, Jorge] Steadman Philippon Res Inst, Dept Biomed Engn, Vail, CO USA. [Schrock, John B.; Pascual-Garrido, Cecilia] Univ Colorado, Dept Orthopaed, Aurora, CO USA. [LaPrade, Robert F.] Steadman Clin, Vail, CO USA.
Muschler, GF (reprint author), Cleveland Clin, Dept Orthopaed Surg & Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA.
AN  - WOS:000401132100052
AU  - Piuzzi, N. S.
AU  - Chahla, J.
AU  - Schrock, J. B.
AU  - LaPrade, R. F.
AU  - Pascual-Garrido, C.
AU  - Mont, M. A.
AU  - Muschler, G. F.
DA  - May
DO  - 10.1016/j.arth.2016.12.049
IS  - 5
J2  - J. Arthroplast.
KW  - osteonecrosis of the femoral head
cell therapy
hip preservation
systematic review
stem cells
cell-based therapy
early-stage osteonecrosis
marrow mononuclear-cells
mesenchymal
stem-cells
5-year follow-up
bone-marrow
core decompression
avascular
necrosis
clinical-trial
stromal cells
implantation
Orthopedics
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: EU6GK
Times Cited: 31
Cited Reference Count: 52
Piuzzi, Nicolas S. Chahla, Jorge Schrock, John B. LaPrade, Robert F. Pascual-Garrido, Cecilia Mont, Michael A. Muschler, George F.
Piuzzi, Nicolas S./0000-0003-3007-7538
31
3
12
Churchill livingstone inc medical publishers
Philadelphia
1532-8406
PY  - 2017
SN  - 0883-5403
SP  - 1698-1708
ST  - Evidence for the Use of Cell-Based Therapy for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review of the Literature
T2  - Journal of Arthroplasty
TI  - Evidence for the Use of Cell-Based Therapy for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review of the Literature
UR  - <Go to ISI>://WOS:000401132100052
VL  - 32
ID  - 65
ER  - 

TY  - JOUR
AB  - Background: Previous studies have identified significant variability in attention-deficit / hyperactivity disorder (ADHD) prevalence estimates worldwide, largely explained by methodological procedures. However, increasing rates of ADHD diagnosis and treatment throughout the past few decades have fuelled concerns about whether the true prevalence of the disorder has increased over time. Methods: We updated the two most comprehensive systematic reviews on ADHD prevalence available in the literature. Meta-regression analyses were conducted to test the effect of year of study in the context of both methodological variables that determined variability in ADHD prevalence (diagnostic criteria, impairment criterion and source of information), and the geographical location of studies. Results: We identified 154 original studies and included 135 in the multivariate analysis. Methodological procedures investigated were significantly associated with heterogeneity of studies. Geographical location and year of study were not associated with variability in ADHD prevalence estimates. Conclusions: Confirming previous findings, variability in ADHD prevalence estimates is mostly explained by methodological characteristics of the studies. In the past three decades, there has been no evidence to suggest an increase in the number of children in the community who meet criteria for ADHD when standardized diagnostic procedures are followed.
AD  - [Polanczyk, Guilherme V.] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil. [Polanczyk, Guilherme V.] Univ Sao Paulo, Res Support Ctr Neurodev & Mental Hlth, Sao Paulo, Brazil. [Polanczyk, Guilherme V.; Rohde, Luis A.] Natl Inst Dev Psychiat Children & Adolescents INC, Sao Paulo, Brazil. [GWillcutt, Erik] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA. [Salum, Giovanni A.; Kieling, Christian; Rohde, Luis A.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, ADHD Outpatient Program, Child & Adolescent Psychiat Div, Porto Alegre, RS, Brazil.
Rohde, LA (reprint author), Hosp Clin Porto Alegre, ADHD Outpatient Program ProDAH, Room 2201A,Ramiro Barcellos St 2350, BR-90035003 Porto Alegre, RS, Brazil.
lrohde@terra.com.br
AN  - WOS:000335919500013
AU  - Polanczyk, G. V.
AU  - Gwillcutt, E.
AU  - Salum, G. A.
AU  - Kieling, C.
AU  - Rohde, L. A.
DA  - Apr
DO  - 10.1093/ije/dyt261
IS  - 2
J2  - Int. J. Epidemiol.
KW  - ADHD
epidemiology
prevalence
time
cross-cultural
methodology
attention-deficit/hyperactivity disorder
deficit hyperactivity
disorder
school-age-children
epidemiology
diagnosis
adults
trends
Public, Environmental & Occupational Health
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AH1ZD
Times Cited: 399
Cited Reference Count: 26
Polanczyk, Guilherme V. GWillcutt, Erik Salum, Giovanni A. Kieling, Christian Rohde, Luis A.
Polanczyk, Guilherme V/C-2345-2012; Rohde, Luis Augusto P/A-6426-2008; Kieling, Christian/U-3905-2019; Salum, Giovanni Abrahao/A-7849-2010
Polanczyk, Guilherme V/0000-0003-2311-3289; Rohde, Luis Augusto P/0000-0002-4552-4188; Kieling, Christian/0000-0001-7691-4149; Salum, Giovanni Abrahao/0000-0002-7537-7289
National Council for Scientific and Technological Development (CNPq) [Bolsa de Produtividade em Pesquisa]National Council for Scientific and Technological Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS)
This work was supported by the National Council for Scientific and Technological Development (CNPq) [Bolsa de Produtividade em Pesquisa to GVP, LAR], Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [Post-doctoral scholarships to G. A. S. and C.K.].
411
5
122
Oxford univ press
Oxford
1464-3685
PY  - 2014
SN  - 0300-5771
SP  - 434-442
ST  - ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis
T2  - International Journal of Epidemiology
TI  - ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis
UR  - <Go to ISI>://WOS:000335919500013
VL  - 43
ID  - 143
ER  - 

TY  - JOUR
AD  - [Portalupi, Laura B.; Matlock, Daniel D.; Allen, Larry A.] Univ Colorado Denver, Aurora, CO USA. [Pyszczynski, Thomas A.] Univ Colorado, Colorado Springs, CO 80907 USA.
AN  - WOS:000381064700298
AU  - Portalupi, L. B.
AU  - Matlock, D. D.
AU  - Pyszczynski, T. A.
AU  - Allen, L. A.
DA  - Aug
DO  - 10.1016/j.cardfail.2016.06.335
IS  - 8
J2  - J. Card. Fail.
KW  - Cardiovascular System & Cardiology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: DS8WW
Times Cited: 0
Cited Reference Count: 0
Portalupi, Laura B. Matlock, Daniel D. Pyszczynski, Thomas A. Allen, Larry A.
20th Annual Scientific Meeting of the Heart-Failure-Society-of-America
Sep 17-20, 2016
Kissimmee, FL
Heart Failure Soc Amer
0
6
Churchill livingstone inc medical publishers
Philadelphia
1532-8414
S
PY  - 2016
SN  - 1071-9164
SP  - S105-S105
ST  - Evidence for Terror Management Theory in Patients with Chronic Progressive Illness Near the End of Life: A Systematic Review
T2  - Journal of Cardiac Failure
TI  - Evidence for Terror Management Theory in Patients with Chronic Progressive Illness Near the End of Life: A Systematic Review
UR  - <Go to ISI>://WOS:000381064700298
VL  - 22
ID  - 79
ER  - 

TY  - JOUR
AB  - Introduction: 5-fluorouracil has proven to be an effective therapy in the treatment of a variety of dermatologic conditions. Approved by the United States Food and Drug Administration for the topical treatment of actinic keratoses and superficial basal cell carcinoma, 5-fluorouracil has also demonstrated efficacy in the treatment of a variety of other dermatologic diseases. While best known for its use as a topical medication, 5-fluorouracil can also be delivered intralesionally for the treatment of dermatologic disease. Recently, laser-assisted modalities for increased delivery of 5-fluorouracil have also been described Methods: A search of the MEDLINE standard computer database, MEDLINE advanced database, and EMBASE database was conducted. Results: 38 articles met criteria for inclusion in this review. These articles represented 14 randomized controlled trials and 24 case series. Each article was reviewed and summarized.The main limitation of this review is the limited number of large randomized controlled trials, as well as the non-uniformity in treatment regimens between studies. Discussion: Intralesional and laser-assisted 5-fluorouracil are used in a variety of dermatologic disease processes with a wide range of efficacy and levels of evidence. Based on extent and level of evidence, our disease-specific systematic review found that the evidence is strongest for intralesional 5-FU use in the treatment of keloids, hypertrophic scars, and keratoacanthomas. This review serves as a comprehensive summary of intralesional and laser-assisted 5-fluorouracil use in dermatology.
AD  - [Prince, Garrett T.; Cameron, Michael C.; Alkousakis, Theodore] Univ Colorado, Sch Med, Dept Dermatol & Cutaneous Surg, Aurora, CO 80045 USA. [Fathi, Ramin] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA.
Alkousakis, T (reprint author), Univ Colorado, Sch Med, Dept Dermatol & Cutaneous Surg, Aurora, CO 80045 USA.
tjalkousakis@coloradodermatology.com
AN  - WOS:000453940000004
AU  - Prince, G. T.
AU  - Cameron, M. C.
AU  - Fathi, R.
AU  - Alkousakis, T.
DA  - Mar
IS  - 3
J2  - J. Drugs Dermatol.
KW  - squamous-cell carcinoma
topical 5-fluorouracil
nonsurgical treatment
injectable gel
in-situ
combination
triamcinolone
keratoacanthomas
5-flurouracil
fluorouracil
Dermatology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: HF1PX
Times Cited: 1
Cited Reference Count: 46
Prince, Garrett T. Cameron, Michael C. Fathi, Ramin Alkousakis, Theodore
1
0
Journal of drugs in dermatology
New york
PY  - 2018
SN  - 1545-9616
SP  - 274-280
ST  - Intralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review
T2  - Journal of Drugs in Dermatology
TI  - Intralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review
UR  - <Go to ISI>://WOS:000453940000004
VL  - 17
ID  - 28
ER  - 

TY  - JOUR
AD  - [Naylor, Sara-Megumi L.] VA Greater Los Angeles Healthcare Syst, Div Primary Care, Los Angeles, CA USA. [Naylor, Sara-Megumi L.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA. [Dellavalle, Robert] Denver VA Med Ctr, Denver, CO USA. [Dellavalle, Robert] Univ Colorado, Denver, CO 80202 USA. [Que, Syril Keena T.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
AN  - WOS:000440259000241
AU  - Que, S. K. T.
AU  - Naylor, S. M. L.
AU  - Dellavalle, R.
DA  - Apr
J2  - J. Gen. Intern. Med.
KW  - Health Care Sciences & Services
General & Internal Medicine
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GO7OJ
Times Cited: 0
Cited Reference Count: 0
Que, Syril Keena T. Naylor, Sara-Megumi L. Dellavalle, Robert
Annual National Meeting of the Society-of-General-Internal-Medicine (SGIM)
Apr 19-22, 2017
Washington, DC
Soc Gen Internal Med
0
Springer
New york
1525-1497
2
PY  - 2017
SN  - 0884-8734
SP  - S188-S189
ST  - FACILITATING HIGH VALUE CARE THROUGH THE ACCURATE DIAGNOSIS OF SKIN DISEASE: A SYSTEMATIC REVIEW
T2  - Journal of General Internal Medicine
TI  - FACILITATING HIGH VALUE CARE THROUGH THE ACCURATE DIAGNOSIS OF SKIN DISEASE: A SYSTEMATIC REVIEW
UR  - <Go to ISI>://WOS:000440259000241
VL  - 32
ID  - 68
ER  - 

TY  - JOUR
AD  - [Qumseya, Bashar J.; Bukannan, Aymen] Florida State Univ, Archbold Med Grp, Tallahassee, FL 32306 USA. [Wani, Sachin B.] Univ Colorado, GI, Aurora, CO USA. [Qumseya, Amira] Evidence Based Res Inst, Tallahassee, FL USA.
AN  - WOS:000434248200478
AU  - Qumseya, B. J.
AU  - Bukannan, A.
AU  - Qumseya, A.
AU  - Wani, S. B.
DA  - Jun
IS  - 6
J2  - Gastrointest. Endosc.
KW  - Gastroenterology & Hepatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GI3CH
Times Cited: 0
Cited Reference Count: 0
Qumseya, Bashar J. Bukannan, Aymen Qumseya, Amira Wani, Sachin B.
Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week
Jun 02-05, 2018
Washington, DC
Amer Soc Gastrointestinal Endoscopy
0
Mosby-elsevier
New york
1097-6779
S
PY  - 2018
SN  - 0016-5107
SP  - AB273-AB273
ST  - SIGNIFICANT INCREASE IN ABSOLUTE DYSPLASIA DETECTION RATE USING WIDE-AREA TRANS-EPITHELIAL SAMPLING IN BARRETT'S ESOPHAGUS: A SYSTEMATIC REVIEW AND META-ANALYSIS
T2  - Gastrointestinal Endoscopy
TI  - SIGNIFICANT INCREASE IN ABSOLUTE DYSPLASIA DETECTION RATE USING WIDE-AREA TRANS-EPITHELIAL SAMPLING IN BARRETT'S ESOPHAGUS: A SYSTEMATIC REVIEW AND META-ANALYSIS
UR  - <Go to ISI>://WOS:000434248200478
VL  - 87
ID  - 20
ER  - 

TY  - JOUR
AB  - OBJECTIVES: Barrett's esophagus (BE) is the only identifiable premalignant condition for esophageal adenocarcinoma (EAC). Management of BE with low-grade dysplasia continues to be controversial. We aimed to conduct a systematic review and meta-analysis comparing the risk of progression to high-grade dysplasia or EAC among patients with BE with low-grade dysplasia treated with radiofrequency ablation (RFA) compared with surveillance endoscopy. METHODS: Our search included Medline, Embase, and Cochrane Central, was limited to English language articles, and was last searched on 31 December 2015. Studies were reviewed by title and abstract, and then full text by two independent reviewers. Two independent reviewers extracted data. Differences were resolved by consensus. The primary outcome of interest was the relative risk of disease progression among patients with BE with low-grade dysplasia treated with RFAcompared with surveillance. RESULTS: Our search resulted in 2,029 citations, 19 studies were included in the final analysis, totaling 2,746 patients. Relative risk of disease progression in RFA compared with surveillance was 0.14% (95% confidence interval: 0.04-0.45), P = 0.001. This measure was stable when only all studies were included. Absolute risk reduction was 10.9% and the number needed to treat was 9.2. Results were stable over several quality measures, overtime, and when excluding randomized trials. The cumulative rate of progression to high-grade dysplasia/EAC was lower in RFA compared with surveillance (1.7% vs. 12.6%, P < 0.001). CONCLUSIONS: Similarly, the incidence rate of progression among patients with surveillance was significantly higher from those treated with RFA (0.022 vs. 0.005, P < 0.001). RFA results in a significant reduction risk of disease progression to high-grade dysplasia/EAC among patients with BE with low-grade dysplasia.
AD  - [Qumseya, Bashar J.] Florida State Univ, Archbold Med Grp, Div Gastroenterol & Hepatol, 112 Mimosa Dr, Thomasville, GA 31792 USA. [Wani, Sachin; Harnke, Ben] Univ Colorado, Div Gastroenterol & Hepatol, Aurora, CO USA. [Gendy, Sherif] Florida A&M Univ, Tallahassee, FL 32307 USA. [Bergman, Jacques J.] Acad Med Ctr Amsterdam, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands. [Wolfsen, Herbert] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA.
Qumseya, BJ (reprint author), Florida State Univ, Archbold Med Grp, Div Gastroenterol & Hepatol, 112 Mimosa Dr, Thomasville, GA 31792 USA.
bqumseya@archbold.org
AN  - WOS:000402710000011
AU  - Qumseya, B. J.
AU  - Wani, S.
AU  - Gendy, S.
AU  - Harnke, B.
AU  - Bergman, J. J.
AU  - Wolfsen, H.
DA  - Jun
DO  - 10.1038/ajg.2017.70
IS  - 6
J2  - Am. J. Gastroenterol.
KW  - esophageal adenocarcinoma incidence
neoplastic progression
high-risk
endoscopic surveillance
diagnosis
predictors
management
mortality
trends
Gastroenterology & Hepatology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: EW7QT
Times Cited: 20
Cited Reference Count: 32
Qumseya, Bashar J. Wani, Sachin Gendy, Sherif Harnke, Ben Bergman, Jacques J. Wolfsen, Herbert
20
0
1
Lippincott williams & wilkins
Philadelphia
1572-0241
PY  - 2017
SN  - 0002-9270
SP  - 849-865
ST  - Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis
T2  - American Journal of Gastroenterology
TI  - Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis
UR  - <Go to ISI>://WOS:000402710000011
VL  - 112
ID  - 59
ER  - 

TY  - JOUR
AD  - [Qumseya, Bashar J.] Florida State Univ, Gastroenterol, Tallahassee, FL 32306 USA. [Qumseya, Bashar J.; Wolfsen, Herbert C.] Mayo Clin, Jacksonville, FL USA. [Gendy, Sherif] Florida A&M Univ, Tallahassee, FL 32307 USA. [Wani, Sachin] Univ Colorado, Anschutz Med Campus, Aurora, CO USA.
AN  - WOS:000381906900015
AU  - Qumseya, B. J.
AU  - Wolfsen, H. C.
AU  - Wani, S.
AU  - Gendy, S.
DA  - May
DO  - 10.1016/j.gie.2016.03.034
IS  - 5
J2  - Gastrointest. Endosc.
KW  - Gastroenterology & Hepatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: DU0PL
Times Cited: 0
Cited Reference Count: 0
Qumseya, Bashar J. Wolfsen, Herbert C. Wani, Sachin Gendy, Sherif
Digestive Disease Week (DDW) / Meeting of the American-Society-for-Gastrointestinal-Endoscopy (ASGE)
May 21-24, 2016
San Diego, CA
Amer Soc Gastrointestinal Endoscopy
0
2
Mosby-elsevier
New york
1097-6779
S
PY  - 2016
SN  - 0016-5107
SP  - AB121-AB121
ST  - Significant Reduction in the Disease Progression in Barrett's Esophagus Low-Grade Dysplasia Patients Treated With Endoscopic Eradiation Therapy Compared With Surveillance Endoscopy: A Systematic Review and Meta-Analysis
T2  - Gastrointestinal Endoscopy
TI  - Significant Reduction in the Disease Progression in Barrett's Esophagus Low-Grade Dysplasia Patients Treated With Endoscopic Eradiation Therapy Compared With Surveillance Endoscopy: A Systematic Review and Meta-Analysis
UR  - <Go to ISI>://WOS:000381906900015
VL  - 83
ID  - 82
ER  - 

TY  - JOUR
AD  - [Redler, S.; Heilmann, S.; Noethen, M. M.; Betz, R. C.] Univ Bonn, Inst Human Genet, Bonn, Germany. [Petukhova, L.; Yamany, T.; Mackay-Wiggan, J.; de Jong, A.; Bian, L.; Clynes, R.; Christiano, A. M.] Columbia Univ, Dept Dermatol, New York, NY 10027 USA. [Petukhova, L.] Columbia Univ, Dept Epidemiol, New York, NY USA. [Ripke, S.; Huang, H.; Altshuler, D.; Daly, M. J.] Massachusetts Gen Hosp, Analyt & Transfat Genet Unit, Boston, MA 02114 USA. [Ripke, S.; Huang, H.; Altshuler, D.; Daly, M. J.] Harvard Univ, Sch Med, Boston, MA USA. [Ripke, S.; Huang, H.; Altshuler, D.; Daly, M. J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA. [Menelaou, A.; de Bakker, P. I.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands. [Becker, T.] German Ctr Neurodegenerat Dis, Bonn, Germany. [Becker, T.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany. [Heilmann, S.; Noethen, M. M.] Univ Bonn, Dept Genom, Life & Brain Ctr, Boston, Germany. [Duvic, M.] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA. [Hordinsky, M.] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA. [Norris, D.] Univ Colorado, Dept Dermatol, Boulder, CO 80309 USA. [Price, V.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA. [DeStefano, G.; Christiano, A. M.] Columbia Univ, Dept Genet & Dev, New York, NY USA. [Moebus, S.] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany. [Boehm, M.] Univ Munster, Dept Dermatol, D-48149 Munster, Germany. [Blume-Peytavi, U.] Charite, Dept Dermatol & Allergy, Clin Res Ctr Hair & Skin Sci, D-13353 Berlin, Germany. [Wolff, H.] Univ Munich, Dept Dermatol, D-80539 Munich, Germany. [Amos, C.] Dartmouth Coll, Community & Family Med & Genet, Hanover, NH 03755 USA. [Lee, A.; Gregersen, P.] Feinstein Inst Med Res, Manhasset, NY USA. [Blaumeiser, B.] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium. [Clynes, R.] Columbia Univ, Dept Med, New York, NY USA. [de Bakker, P. I.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands.
AN  - WOS:000351939000098
AU  - Redler, S.
AU  - Petukhova, L.
AU  - Ripke, S.
AU  - Huang, H.
AU  - Menelaou, A.
AU  - Becker, T.
AU  - Heilmann, S.
AU  - Yamany, T.
AU  - Duvic, M.
AU  - Hordinsky, M.
AU  - Norris, D.
AU  - Price, V.
AU  - Mackay-Wiggan, J.
AU  - de Jong, A.
AU  - DeStefano, G.
AU  - Moebus, S.
AU  - Bohm, M.
AU  - Blume-Peytavi, U.
AU  - Wolff, H.
AU  - Lutz, G.
AU  - Kruse, R.
AU  - Bian, L.
AU  - Amos, C.
AU  - Lee, A.
AU  - Gregersen, P.
AU  - Blaumeiser, B.
AU  - Altshuler, D.
AU  - Clynes, R.
AU  - de Bakker, P. I.
AU  - Nothen, M. M.
AU  - Daly, M. J.
AU  - Christiano, A. M.
AU  - Betz, R. C.
DA  - Mar
IS  - 3
J2  - Exp. Dermatol.
KW  - Dermatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: CE6IB
Times Cited: 0
Cited Reference Count: 0
Redler, S. Petukhova, L. Ripke, S. Huang, H. Menelaou, A. Becker, T. Heilmann, S. Yamany, T. Duvic, M. Hordinsky, M. Norris, D. Price, V. Mackay-Wiggan, J. de Jong, A. DeStefano, G. Moebus, S. Boehm, M. Blume-Peytavi, U. Wolff, H. Lutz, G. Kruse, R. Bian, L. Amos, C. Lee, A. Gregersen, P. Blaumeiser, B. Altshuler, D. Clynes, R. de Bakker, P. I. Noethen, M. M. Daly, M. J. Christiano, A. M. Betz, R. C.
42nd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF)
Mar 05-07, 2015
Ulm, GERMANY
Arbeitsgemeinschaft Dermatologische Forsch
Heilmann-Heimbach, Stefanie/H-5942-2018; de Bakker, Paul IW/B-8730-2009; Petukhova, Lynn/W-6858-2019
Heilmann-Heimbach, Stefanie/0000-0003-1057-465X; de Bakker, Paul IW/0000-0001-7735-7858;
0
1
Wiley-blackwell
Hoboken
1600-0625
PY  - 2015
SN  - 0906-6705
SP  - E17-E17
ST  - Meta-analysis of genome-wide association studies in alopecia areata resolves HLA associations and reveals two new susceptibility loci
T2  - Experimental Dermatology
TI  - Meta-analysis of genome-wide association studies in alopecia areata resolves HLA associations and reveals two new susceptibility loci
UR  - <Go to ISI>://WOS:000351939000098
VL  - 24
ID  - 118
ER  - 

TY  - JOUR
AB  - Gait speed is an indicator of functional change in older adults. One approach to support older adults' preferences to "age in place" is through the use of technology to monitor gait speed in everyday life. The authors of the current article conducted an integrative review of the scientific literature to summarize the current state of gait speed detection technologies. A total of 539 articles were returned from searches, and 16 were included in the review. Technologies were categorized as body-worn or home-installed sensors. Evidence was classified as emerging (n = 8) or promising (n = 8). Gait speed technology research has advanced beyond the use of customized research hardware prototypes, and consumer technologies are now commonly used in gait speed research. However, a need exists for software systems that integrate data for analysis and presentation to stakeholders with different information needs. Future research should focus on approaches to integrate disparate data sources and visualizations of gait speed data.
AD  - [Reeder, Blaine] Univ Colorado, Coll Nursing, Aurora, CO 80045 USA. [Whitehouse, Kamin] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA.
Reeder, B (reprint author), Univ Colorado, Coll Nursing, Anschutz Med Campus,Mail Stop C288-19, Aurora, CO 80045 USA.
blaine.reeder@ucdenver.edu
AN  - WOS:000353349700003
AU  - Reeder, B.
AU  - Whitehouse, K.
DA  - Jan-Feb
DO  - 10.3928/19404921-20141120-02
IS  - 1
J2  - Res. Gerontol. Nurs.
KW  - mobility-related activities
quality-of-life
monitoring mobility
spatiotemporal parameters
health informatics
physical-activity
wearable systems
randomized-trial
public-health
smart homes
Nursing
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: CG5QW
Times Cited: 0
Cited Reference Count: 79
Reeder, Blaine Whitehouse, Kamin
0
1
18
Slack inc
Thorofare
1938-2464
PY  - 2015
SN  - 1940-4921
SP  - 11-26
ST  - Sensor-Based Detection of Gait Speed in Older Adults An Integrative Review
T2  - Research in Gerontological Nursing
TI  - Sensor-Based Detection of Gait Speed in Older Adults An Integrative Review
UR  - <Go to ISI>://WOS:000353349700003
VL  - 8
ID  - 124
ER  - 

TY  - JOUR
AD  - [Rikke, Brad; Wynes, Murry; Rozeboom, Leslie; Hirsch, Fred R.] Univ Colorado, Div Med Oncol, Aurora, CO USA. [Baron, Anna E.] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA.
AN  - WOS:000370365103470
AU  - Rikke, B.
AU  - Wynes, M.
AU  - Rozeboom, L.
AU  - Baron, A. E.
AU  - Hirsch, F. R.
DA  - Sep
IS  - 9
J2  - J. Thorac. Oncol.
KW  - miRNA
microRNA
validation testing
biomarkers
meta-analysis
lung
cancer
Oncology
Respiratory System
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: DE1CX
Times Cited: 0
Cited Reference Count: 0
Rikke, Brad Wynes, Murry Rozeboom, Leslie Baron, Anna E. Hirsch, Fred R.
0
1
Elsevier science inc
New york
1556-1380
2
PY  - 2015
SN  - 1556-0864
SP  - S735-S735
ST  - Meta-Analysis Criteria Used to Rank Biomarkers for Validation Testing: What Works?
T2  - Journal of Thoracic Oncology
TI  - Meta-Analysis Criteria Used to Rank Biomarkers for Validation Testing: What Works?
UR  - <Go to ISI>://WOS:000370365103470
VL  - 10
ID  - 106
ER  - 

TY  - JOUR
AB  - Objective: Methanol poisoning can induce death and "disability. Treatment includes the administration of antidotes (ethanol or fomepizole and folic/folinic acid) and consideration of extracorporeal treatment for correction of acidemia and/or enhanced elimination. The Extracorporeal Treatments in Poisoning workgroup aimed to develop evidence-based consensus recommendations for extracorporeal treatment in methanol poisoning. Design and Methods: Utilizing predetermined methods, we conducted a systematic review of the literature. Two hundred seventy-two relevant publications were identified but publication and selection biases were noted. Data on clinical outcomes and dialyzability were collated and a two-round modified Delphi process was used to reach a consensus. Results: Recommended indications for extracorporeal treatment: Severe methanol poisoning including any of the following being attributed to methanol: coma, seizures, new vision deficits, metabolic acidosis with blood pH.7.15, persistent metabolic acidosis despite adequate supportive measures and antidotes, serum anion gap higher than 24 mmol/L; or, serum methanol concentration 1) greater than 700 mg/L (21.8 mmol/L) in the context of fomepizole therapy, 2) greater than 600 mg/L or 18.7 mmol/L in the context of ethanol treatment 3) greater than 500 mg/L or 15.6 mmol/L in the absence of an alcohol dehydrogenase blocker; in the absence of a methanol concentration, the osmolal/ osmolar gap may be informative; or, in the context of impaired kidney function. Intermittent hemodialysis is the modality of choice and continuous modalities are acceptable alternatives. Extracorporeal treatment can be terminated when the methanol concentration is <200 mg/L or 6.2 mmol/L and a clinical improvement is observed. Extracorporeal Treatments in Poisoning inhibitors and folic/folinic acid should be continued during extracorporeal treatment. General considerations: Antidotes and extracorporeal treatment should be initiated urgently in the context of severe poisoning. The duration of extracorporeal treatment extracorporeal treatment depends on the type of extracorporeal treatment used and the methanol exposure. Indications for extracorporeal treatment are based on risk factors for poor outcomes. The relative importance of individual indications for the triaging of patients for extracorporeal treatment, in the context of an epidemic when need exceeds resources, is unknown. In the absence of severe poisoning but if the methanol concentration is elevated and there is adequate alcohol dehydrogenase blockade, extracorporeal treatment is not immediately required. Systemic anticoagulation should be avoided during extracorporeal treatment because it may increase the development or severity of intracerebral hemorrhage. Conclusion: Extracorporeal treatment has a valuable role in the treatment of patients with methanol poisoning. A range of clinical indications for extracorporeal treatment is provided and duration of therapy can be guided through the careful monitoring of biomarkers of exposure and toxicity. In the absence of severe poisoning, the decision to use extracorporeal treatment is determined by balancing the cost and complications of extracorporeal treatment to that of fomepizole or ethanol. Given regional differences in cost and availability of fomepizole and extracorporeal treatment, these decisions must be made at a local level.
AD  - [Roberts, Darren M.] Univ Queensland, Sch Med, Brisbane, Qld, Australia. [Roberts, Darren M.] Royal Prince Alfred Hosp, Drug Hlth Serv, Sydney, NSW, Australia. [Yates, Christopher] Hosp Univ Son Espases, Dept Emergency Med, Clin Toxicol Unit, Palma De Mallorca, Spain. [Megarbane, Bruno] Univ Paris Diderot, Hop Lariboisiere, INSERM, U1144, Paris, France. [Winchester, James F.] Mt Sinai Beth Israel, Div Nephrol, New York, NY USA. [Maclaren, Robert] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA. [Gosselin, Sophie] McGill Univ, McGill Univ Hlth Ctr, Dept Emergency Med, Med Toxicol Serv, Montreal, PQ, Canada. [Nolin, Thomas D.] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA. [Nolin, Thomas D.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA. [Lavergne, Valery] Hop Sacre Coeur, Dept Microbiol Med & Infectiol, Montreal, PQ H4J 1C5, Canada. [Hoffman, Robert S.] NYU, Sch Med, Dept Emergency Med, Div Med Toxicol, New York, NY USA. [Ghannoum, Marc] Univ Montreal, Verdun Hosp, Montreal, PQ, Canada.
Roberts, DM (reprint author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.
darren.roberts@uq.edu.au
AN  - WOS:000348096200024
AU  - Roberts, D. M.
AU  - Yates, C.
AU  - Megarbane, B.
AU  - Winchester, J. F.
AU  - Maclaren, R.
AU  - Gosselin, S.
AU  - Nolin, T. D.
AU  - Lavergne, V.
AU  - Hoffman, R. S.
AU  - Ghannoum, M.
AU  - Extracorporeal, Treatments
DA  - Feb
DO  - 10.1097/ccm.0000000000000708
IS  - 2
J2  - Crit. Care Med.
KW  - acidosis
antidotes
consensus guidelines
Delphi process
dialysis
dialyzability
enhanced elimination
extracorporeal treatment
indications
intoxication
methanol
morbidity
mortality
poisoning
systematic review
triage
formate kinetics
prognostic-factors
serum osmolality
ethanol therapy
methyl-alcohol
intoxication
hemodialysis
fomepizole
dialysis
toxicity
General & Internal Medicine
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AZ2YX
Times Cited: 54
Cited Reference Count: 83
Roberts, Darren M. Yates, Christopher Megarbane, Bruno Winchester, James F. Maclaren, Robert Gosselin, Sophie Nolin, Thomas D. Lavergne, Valery Hoffman, Robert S. Ghannoum, Marc
Roberts, Darren/A-8986-2013; Burdmann, Emmanuel/B-7023-2009; Yates, Christopher/E-8718-2018
Roberts, Darren/0000-0001-9101-7577; Burdmann, Emmanuel/0000-0002-7644-8579; Yates, Christopher/0000-0003-0473-5445; Liu, Kathleen/0000-0003-4891-8649; Hoffman, Robert/0000-0002-0091-9573; Anseeuw, Kurt/0000-0002-1996-258X; Megarbane, Bruno/0000-0002-2522-2764
European Commission (European Drug Emergencies Network) [JUST/2012/DPIP/AG/3591]; Hospira; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA
Dr. Roberts received support for travel from Amgen (Australia); the Research Institute from Verdun Hospital (Montreal, QC, Canada); and the Royal Australasian College of Physicians, Australia and New Zealand Society of Nephrology, University of Cambridge, and Amgen (Australia) (In 2011, Dr. Roberts was a recipient of a fellowship to support work in Cambridge in renal medicine and was otherwise unrestricted). Dr. Yates received support for travel from the Research Institute from Verdun Hospital; is employed by Hospital Universitari Son Espases; lectured for Balear School of Public Administration and Colegio de Enfermeria Illes Balears (Nursing College) (lectures in toxicology courses); and received support for travel from Vlada Republike Hrvatske, Ured Za Suzbijane Zlouporabe Droga (Roughly Croatian Agency for combatting drug abuse. Travel expenses to give a talk on novel psychoactive substances). Dr. Yates and his institution received grant support from the European Commission (European Drug Emergencies Network. JUST/2012/DPIP/AG/3591 Payment for work on design, creation, and implementation of research on emergencies from recreational drugs of abuse). Dr. Bruno received support for travel from the Research Institute from Verdun Hospital. Dr. Maclaren consulted for Gordon and Rees; Kennedy Childs; and Rutherford, Mullin, and Moore (medical legal review). His institution received grant support from Hospira (investigator-initiated grant to support dexmedetomidine studies). Dr. Gosselin received support for travel from the Research Institute from Verdun Hospital, consulted for the Quebec Board of Physicians (evaluated physician adequacy for practice and licensing in emergency medicine), and lectured for the Canadian Association of Emergency Physicians and Associations des Medecins d'Urgence du Quebec (travel support and honorarium for conferences and Continuing Medical Education course from these physician associations). Dr. Nolin consulted for Thrasos Innovation (member of Independent Data Monitoring Committee); is employed by the University of Pittsburgh; and received support for travel from the American Society of Nephrology (reimbursement for travel to Kidney Health Initiative and postgraduate education committee meetings). His institution received grant support from the National Institutes of Health (pending grant that is unrelated to the submitted work). Dr. Lavergne lectured for Amgen, Pfizer, Association des specialistes en medecine interne du Quebec, and Association d'Orthopedie du Quebec. Dr. Hoffman received support for travel from Extracorporeal Treatments in Poisoning. Dr. Ghannoum received support for travel (air-fare expense paid by organizing committee/research institution for American Society of Nephrology 2012, World Congress of Nephrology 2013, and the Society of Critical Care Medicine 2014). His institution received support for travel from unrestricted educational support only used for support of travel and received unrestricted support for payment of translators (foreign-language articles). Dr. Winchester has disclosed that he does not have any potential conflicts of interest.
56
0
27
Lippincott williams & wilkins
Philadelphia
1530-0293
PY  - 2015
SN  - 0090-3493
SP  - 461-472
ST  - Recommendations for the Role of Extracorporeal Treatments in the Management of Acute Methanol Poisoning: A Systematic Review and Consensus Statement
T2  - Critical Care Medicine
TI  - Recommendations for the Role of Extracorporeal Treatments in the Management of Acute Methanol Poisoning: A Systematic Review and Consensus Statement
UR  - <Go to ISI>://WOS:000348096200024
VL  - 43
ID  - 121
ER  - 

TY  - JOUR
AB  - Objectives: Doubling on average every 6 years, hypertension-related meta-analyses are now published twice weekly and are often considered the highest level of evidence for clinical practice. However, some hypertension specialists and guideline authors view meta-analyses with skepticism. This article evaluates the quality of hypertension-related meta-analyses of clinical trials. Methods: A systematic search was conducted for meta-analyses of clinical trials recently published over 3.3 years. Specific criteria reproducibly assessed 26 features in the four domains of meta-analysis quality, domains justified by fundamental analytics and extensive research: analyzing trial quality, analyzing heterogeneity, analyzing publication bias, and providing transparency. Results: A total of 143 meta-analyses were identified. A total of 44% had 8R deficient features with no relation to journal impact factor: odds ratio relating 8R deficient features to the upper third versus lower third of impact factor = 1.3 (95% confidence limit 0.6-2.9). A total of 56% had all four domains deficient. Quality did not improve over time. Thirty articles (21%) reported statistically significant results (P<0.05) from inappropriate DerSimonian-Laird models, whereas unreported, appropriate, Knapp-Hartung models gave statistical nonsignificance; 88% of these 30 articles reported the incorrect results in their abstracts. A total of 60% of all meta-analyses failed to conduct analyses in subgroups of quality when indicated, 63% failed to report Tau and Tau 2, 57% omitted testing for publication bias, none conducted a cumulative analysis for publication bias, and 71-77% omitted mentioning in their abstracts problems of trial quality, heterogeneity, and publication bias. Conclusion: Although widespread, deficiencies in hypertension-related meta-analyses are readily corrected and do not represent flaws inherent in the meta-analytic method.
AD  - [Roush, George C.; Singh, Tanveer; Ayele, Hiwot; Araoye, Morakinyo; Yang, Danwen] UCONN Sch Med, Bridgeport, CT USA. [Amante, Brigani] Univ Colorado Hosp, Aurora, CO USA. [Kostis, William J.; Kostis, John B.] Rutgers Robert Wood Johnson Med Sch, Brunswick, NJ USA. [Elliott, William J.] Pacific Northwest Univ Hlth Sci, Yakima, WA USA. [Berlin, Jesse A.] Johnson & Johnson, Titusville, NJ USA.
Roush, GC (reprint author), 217 East 70th St,708, New York, NY 10021 USA.
groush@gcr0.com
AN  - WOS:000387780100003
AU  - Roush, G. C.
AU  - Amante, B.
AU  - Singh, T.
AU  - Ayele, H.
AU  - Araoye, M.
AU  - Yang, D. W.
AU  - Kostis, W. J.
AU  - Elliott, W. J.
AU  - Kostis, J. B.
AU  - Berlin, J. A.
DA  - Dec
DO  - 10.1097/hjh.0000000000001094
IS  - 12
J2  - J. Hypertens.
KW  - blood pressure
hypertension
meta-analysis as topic
randomized
controlled trials [publication type]
review [publication type]
systematic review
publication bias
clinical-trials
outcomes
Cardiovascular System & Cardiology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: EC0HM
Times Cited: 2
Cited Reference Count: 40
Roush, George C. Amante, Brigani Singh, Tanveer Ayele, Hiwot Araoye, Morakinyo Yang, Danwen Kostis, William J. Elliott, William J. Kostis, John B. Berlin, Jesse A.
2
0
3
Lippincott williams & wilkins
Philadelphia
1473-5598
PY  - 2016
SN  - 0263-6352
SP  - 2305-2317
ST  - Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review
T2  - Journal of Hypertension
TI  - Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review
UR  - <Go to ISI>://WOS:000387780100003
VL  - 34
ID  - 73
ER  - 

TY  - JOUR
AD  - [Russell, Andrea M.; Mullen, Rebecca J.] Northwestern Univ, Chicago, IL 60611 USA. [Russell, Andrea M.; Smith, Meredith Y.] Amgen Inc, Thousand Oaks, CA 91320 USA. [Morrato, Elaine H.] Univ Colorado, Aurora, CO USA.
AN  - WOS:000441893801177
AU  - Russell, A. M.
AU  - Mullen, R. J.
AU  - Morrato, E. H.
AU  - Smith, M. Y.
DA  - Aug
J2  - Pharmacoepidemiol. Drug Saf.
KW  - Public, Environmental & Occupational Health
Pharmacology & Pharmacy
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GQ7DF
Times Cited: 0
Cited Reference Count: 0
Russell, Andrea M. Mullen, Rebecca J. Morrato, Elaine H. Smith, Meredith Y.
0
Wiley
Hoboken
1099-1557
2
PY  - 2018
SN  - 1053-8569
SP  - 187-188
ST  - Quality of reporting on risk minimization evaluation studies: A systematic review
T2  - Pharmacoepidemiology and Drug Safety
TI  - Quality of reporting on risk minimization evaluation studies: A systematic review
UR  - <Go to ISI>://WOS:000441893801177
VL  - 27
ID  - 11
ER  - 

TY  - JOUR
AD  - [Sakornsakolpat, P.; Cho, M. H.; Silverman, E. K.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA. [Bakke, P.; Gulsvik, A.] Univ Bergen, Bergen, Norway. [Make, B. J.; Crapo, J. D.] Natl Jewish Hlth, Denver, CO USA.
repsa@channing.harvard.edu
AN  - WOS:000449980305183
AU  - Sakornsakolpat, P.
AU  - Bakke, P.
AU  - Gulsvik, A.
AU  - Make, B. J.
AU  - Crapo, J. D.
AU  - Cho, M. H.
AU  - Silverman, E. K.
J2  - Am. J. Respir. Crit. Care Med.
KW  - General & Internal Medicine
Respiratory System
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: HA1NM
Times Cited: 0
Cited Reference Count: 0
Sakornsakolpat, P. Bakke, P. Gulsvik, A. Make, B. J. Crapo, J. D. Cho, M. H. Silverman, E. K.
International Conference of the American-Thoracic-Society
May 18-23, 2018
San Diego, CA
Amer Thoracic Soc
NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL089897, R01 HL089856]
Supported by NHLBI grants R01 HL089897 This abstract is funded by: NHLBI grants R01 HL089897 and R01 HL089856
0
New york
1535-4970
PY  - 2018
SN  - 1073-449X
SP  - 2
ST  - Genetic Determinants of Diffusing Capacity of Carbon Monoxide: Genome-Wide Association Analyses and Meta-Analysis in Four Cohorts
T2  - American Journal of Respiratory and Critical Care Medicine
TI  - Genetic Determinants of Diffusing Capacity of Carbon Monoxide: Genome-Wide Association Analyses and Meta-Analysis in Four Cohorts
UR  - <Go to ISI>://WOS:000449980305183
VL  - 197
ID  - 36
ER  - 

TY  - JOUR
AD  - [Samuels, Elizabeth A.] Yale Dept Emergency Med, Yale Natl Clinician Scholars Program, New Haven, CT 06450 USA. [Boatright, Dowin] Yale Dept Emergency Med, New Haven, CT USA. [Sanchez, Leon D.; Landry, Alden] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA USA. [Heron, Sheryl L.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA. [Liferidge, Aisha T.] George Washington Sch Med & Hlth Sci, Dept Emergency Med, Washington, DC USA. [Wilson, Taneisha] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA. [Pierce, Ava] Univ Texas Southwestern, Dept Emergency Med, Dallas, TX USA. [Moreno-Walton, Lisa] Louisiana State Univ, Hlth Sci Ctr, Dept Emergency Med, New Orleans, LA USA. [Druck, Jeffrey] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA. [Moll, Joel] Virginia Commonwealth Univ, Sch Med, Dept Emergency Med, Richmond, VA USA. [Lopez, Bernard L.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Emergency Med, Philadelphia, PA 19107 USA.
Samuels, EA (reprint author), Yale Dept Emergency Med, Yale Natl Clinician Scholars Program, New Haven, CT 06450 USA.
elizabeth.samuels@yale.edu
AN  - WOS:000417645200013
AU  - Samuels, E. A.
AU  - Boatright, D.
AU  - Sanchez, L. D.
AU  - Heron, S. L.
AU  - Liferidge, A. T.
AU  - Wilson, T.
AU  - Pierce, A.
AU  - Landry, A.
AU  - Moreno-Walton, L.
AU  - Druck, J.
AU  - Moll, J.
AU  - Lopez, B. L.
DA  - Dec
DO  - 10.1111/acem.13317
IS  - 12
J2  - Acad. Emerg. Med.
KW  - acute coronary syndrome
chest-pain
Emergency Medicine
LA  - English
M3  - Letter
N1  - ISI Document Delivery No.: FP5FK
Times Cited: 0
Cited Reference Count: 10
Samuels, Elizabeth A. Boatright, Dowin Sanchez, Leon D. Heron, Sheryl L. Liferidge, Aisha T. Wilson, Taneisha Pierce, Ava Landry, Alden Moreno-Walton, Lisa Druck, Jeffrey Moll, Joel Lopez, Bernard L.
Samuels, Elizabeth/E-6302-2018
Samuels, Elizabeth/0000-0003-2414-110X
0
2
Wiley
Hoboken
1553-2712
PY  - 2017
SN  - 1069-6563
SP  - 1531-1532
ST  - Clinical Vignettes Inadequate to Assess Impact of Implicit Bias: Concerning Limitations of a Systematic Review
T2  - Academic Emergency Medicine
TI  - Clinical Vignettes Inadequate to Assess Impact of Implicit Bias: Concerning Limitations of a Systematic Review
UR  - <Go to ISI>://WOS:000417645200013
VL  - 24
ID  - 41
ER  - 

TY  - JOUR
AD  - [Savage, Jeanne E.; Jansen, Philip R.; Stringer, Sven; Watanabe, Kyoko; de Leeuw, Christiaan A.; Nagel, Mats; Hammerschlag, Anke R.; Polderman, Tinca J. C.; van der Sluis, Sophie; Posthuma, Danielle] Vrije Univ Amsterdam, Amsterdam Neurosci, Ctr Neurogenom & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands. [Jansen, Philip R.; White, Tonya; Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands. [Bryois, Julien; Karlsson, Robert; Hagg, Sara; Karlsson, Ida K.; Pedersen, Nancy L.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden. [Awasthi, Swapnil; Kaminski, Jakob; Heinz, Andreas; Ripke, Stephan] Charite, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany. [Barr, Peter B.; Dick, Danielle M.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA. [Coleman, Jonathan R. I.; Krapohl, Eva; Zabaneh, Delilah; Quinlan, Erin B.; Schumann, Gunter; Breen, Gerome; Plomin, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, Med Res Council Social Genet & Dev Psychiat Ctr, London, England. [Coleman, Jonathan R. I.; Breen, Gerome] South London & Maudsley NHS Trust, NIHR Biomed Res Ctr Mental Hlth, London, England. [Grasby, Katrina L.; Montgomery, Grant W.; Martin, Nicholas G.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia. [Kaminski, Jakob] BIH, D-10178 Berlin, Germany. [Lam, Max] Inst Mental Hlth, Singapore, Singapore. [Nygaard, Marianne; Christiansen, Lene] Univ Southern Denmark, Danish Twin Registry, Odense, Denmark. [Nygaard, Marianne; Christiansen, Lene] Univ Southern Denmark, Danish Aging Res Ctr, Dept Publ Hlth, Odense, Denmark. [Nygaard, Marianne; Christiansen, Lene; Debrabant, Birgit] Univ Southern Denmark, Dept Publ Hlth, Epidemiol Biostat & Biodemog, Odense, Denmark. [Reynolds, Chandra A.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA. [Trampush, Joey W.] BrainWorkup LLC, Los Angeles, CA USA. [Young, Hannah; Vrieze, Scott I.] Univ Minnesota, Dept Psychol, Minneapolis, MN USA. [Young, Hannah; Vrieze, Scott I.] Univ Minnesota, Dept Psychol, St Paul, MN 55108 USA. [Hansell, Narelle K.; Wright, Margaret J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia. [Linnarsson, Sten; Munoz-Manchado, Ana B.; Skene, Nathan; Hjerling-Leffler, Jens] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Stockholm, Sweden. [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia. [Webb, Bradley T.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA. [Webb, Bradley T.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA. [Webb, Bradley T.; Dick, Danielle M.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA. [Arking, Dan E.; Avramopoulos, Dimitrios] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA. [Attix, Deborah K.; Christoforou, Andrea; Le Hellard, Stephanie; Steen, Vidar M.] Haukeland Hosp, Ctr Med Genet & Mol Med, Dr Einar Martens Res Grp Biol Psychiat, Bergen, Norway. [Attix, Deborah K.] Duke Univ, Med Ctr, Div Med Psychol, Psychiat & Behav Sci, Durham, NC USA. [Attix, Deborah K.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA. [Avramopoulos, Dimitrios] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA. [Bilder, Robert M.; Congdon, Eliza; Freimer, Nelson A.; London, Edythe] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA. [Bitsios, Panos] Univ Crete, Fac Med, Dept Psychiat & Behav Sci, Iraklion, Crete, Greece. [Burdick, Katherine E.; Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA. [Burdick, Katherine E.; Roussos, Panos] James J Peters VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN 2, New York, NY USA. [Burdick, Katherine E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA. [Cannon, Tyrone D.] Yale Univ, Dept Psychol, New Haven, CT USA. [Chiba-Falek, Ornit] Duke Univ, Med Ctr, Dept Neurol, Bryan Alzheimers Dis Res Ctr, Durham, NC USA. [Chiba-Falek, Ornit] Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC USA. [Cirulli, Elizabeth T.] Human Longev Inc, Durham, NC USA. [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland. [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland. [Davies, Gail; Deary, Ian J.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland. [Davies, Gail; Deary, Ian J.; Liewald, David C.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland. [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.; Yu, Jin] Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY USA. [Dickinson, Dwight] NIMH, Clin & Translat Neurosci Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA. [Djurovic, Srdjan] Univ Bergen, Oslo Univ Hosp, Dept Med Genet, Oslo, Norway. [Djurovic, Srdjan; Le Hellard, Stephanie; Melle, Ingrid; Steen, Vidar M.] Univ Bergen, NORMENT, KG Jebsen Ctr Psychosis Res, Bergen, Norway. [Donohoe, Gary; Morris, Derek] Natl Univ Ireland, Sch Psychol, Neuroimaging Cognit & Genom NICOG Ctr, Galway, Ireland. [Donohoe, Gary; Morris, Derek] Natl Univ Ireland, Discipline Biochem, Galway, Ireland. [Conley, Emily Drabant] 23andMe Inc, Mountain View, CA USA. [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland. [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki, Finland. [Espeseth, Thomas; Reinvang, Ivar; Sundet, Kjetil] Univ Oslo, Dept Psychol, Oslo, Norway. [Espeseth, Thomas; Melle, Ingrid; Sundet, Kjetil; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway. [Giakoumaki, Stella] Univ Crete, Dept Psychol, Iraklion, Greece. [Giegling, Ina; Konte, Bettina; Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat, Halle, Germany. [Glahn, David C.; Knowles, Emma] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA. [Hariri, Ahmad R.; Scult, Matthew A.] Duke Univ, Dept Psychol & Neurosci, Lab NeuroGenet, Durham, NC USA. [Hatzimanolis, Alex; Smyrnis, Nikolaos; Stefanis, Nikos C.] Univ Athens, Sch Med, Eginit Hosp, Dept Psychiat, Athens, Greece. [Hatzimanolis, Alex; Smyrnis, Nikolaos; Stefanis, Nikos C.] Univ Mental Hlth Res Inst, Athens, Greece. [Hatzimanolis, Alex; Stefanis, Nikos C.] Theodor Theohari Cozzika Fdn, Neurobiol Res Inst, Athens, Greece. [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA. [Lahti, Jari] Univ Helsinki, Dept Psychol & Logoped, Fac Med, Helsinki, Finland. [Lahti, Jari] Univ Helsinki, Helsinki Coll Adv Studies, Helsinki, Finland. [Lencz, Todd; Malhotra, Anil K.] Hofstra Northwell Sch Med, Dept Psychiat, Hempstead, NY USA. [Lencz, Todd; Malhotra, Anil K.] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA. [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway. [Need, Anna C.] Imperial Coll, Dept Med, Div Brain Sci, London, England. [Ollier, William] Univ Manchester, Inst Populat Hlth, Ctr Integrated Genom Med Res, Manchester, Lancs, England. [Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, FIMM, Helsinki, Finland. [Palotie, Aarno] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England. [Palotie, Aarno] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA. [Payton, Antony] Univ Manchester, Div Populat Hlth Hlth Serv Res & Primary Care, Ctr Epidemiol, Manchester, Lancs, England. [Pendleton, Neil] Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal NHS Fdn Trust, Div Neurosci & Expt Psychol,Sch Biol Sci,Fac Biol, Manchester, Lancs, England. [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA. [Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland. [Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA. [Roussos, Panos] Icahn Sch Med Mt Sinai, Inst Multiscale Biol, New York, NY 10029 USA. [Sabb, Fred W.] Univ Oregon, Robert & Beverly Lewis Ctr Neuroimaging, Eugene, OR 97403 USA. [Smeland, Olav B.; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, NORMENT, KG Jebsen Ctr Psychosis Res, Oslo, Norway. [Smeland, Olav B.; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway. [Smeland, Olav B.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA. [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland. [Straub, Richard E.; Weinberger, Daniel R.] Johns Hopkins Univ, Lieber Inst Brain Dev, Med Campus, Baltimore, MD USA. [Voineskos, Aristotle N.] Univ Toronto, Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Inst, Toronto, ON, Canada. [Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA. [Abecasis, Goncalo] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA. [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway. [Dick, Danielle M.] Virginia Commonwealth Univ, Coll Behav & Emot Hlth Inst, Richmond, VA USA. [Ikram, M. Arfan; Tiemeier, Henning] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands. [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet, Boston, MA 02114 USA. [Ripke, Stephan] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA. [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA. [Wright, Margaret J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia. [Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands.
d.posthuma@vu.nl
AN  - WOS:000427728400089
AU  - Savage, J. E.
AU  - Jansen, P. R.
AU  - Stringer, S.
AU  - Watanabe, K.
AU  - Bryois, J.
AU  - de Leeuw, C. A.
AU  - Nagel, M.
AU  - Awasthi, S.
AU  - Barr, P. B.
AU  - Coleman, J. R. I.
AU  - Grasby, K. L.
AU  - Hammerschlag, A. R.
AU  - Kaminski, J.
AU  - Karlsson, R.
AU  - Krapohl, E.
AU  - Lam, M.
AU  - Nygaard, M.
AU  - Reynolds, C. A.
AU  - Trampush, J. W.
AU  - Young, H.
AU  - Zabaneh, D.
AU  - Hagg, S.
AU  - Hansell, N. K.
AU  - Karlsson, I. K.
AU  - Linnarsson, S.
AU  - Montgomery, G. W.
AU  - Munoz-Manchado, A. B.
AU  - Quinlan, E. B.
AU  - Schumann, G.
AU  - Skene, N.
AU  - Webb, B. T.
AU  - White, T.
AU  - Arking, D. E.
AU  - Attix, D. K.
AU  - Avramopoulos, D.
AU  - Bilder, R. M.
AU  - Bitsios, P.
AU  - Burdick, K. E.
AU  - Cannon, T. D.
AU  - Chiba-Falek, O.
AU  - Christoforou, A.
AU  - Cirulli, E. T.
AU  - Congdon, E.
AU  - Corvin, A.
AU  - Davies, G.
AU  - Deary, I. J.
AU  - DeRosse, P.
AU  - Dickinson, D.
AU  - Djurovic, S.
AU  - Donohoe, G.
AU  - Conley, E. D.
AU  - Eriksson, J. G.
AU  - Espeseth, T.
AU  - Freimer, N. A.
AU  - Giakoumaki, S.
AU  - Giegling, I.
AU  - Gill, M.
AU  - Glahn, D. C.
AU  - Hariri, A. R.
AU  - Hatzimanolis, A.
AU  - Keller, M. C.
AU  - Knowles, E.
AU  - Konte, B.
AU  - Lahti, J.
AU  - Le Hellard, S.
AU  - Lencz, T.
AU  - Liewald, D. C.
AU  - London, E.
AU  - Lundervold, A. J.
AU  - Malhotra, A. K.
AU  - Melle, I.
AU  - Morris, D.
AU  - Need, A. C.
AU  - Ollier, W.
AU  - Palotie, A.
AU  - Payton, A.
AU  - Pendleton, N.
AU  - Poldrack, R. A.
AU  - Raikkonen, K.
AU  - Reinvang, I.
AU  - Roussos, P.
AU  - Rujescu, D.
AU  - Sabb, F. W.
AU  - Scult, M. A.
AU  - Smeland, O. B.
AU  - Smyrnis, N.
AU  - Starr, J. M.
AU  - Steen, V. M.
AU  - Stefanis, N. C.
AU  - Straub, R. E.
AU  - Sundet, K.
AU  - Voineskos, A. N.
AU  - Weinberger, D. R.
AU  - Widen, E.
AU  - Yu, J.
AU  - Abecasis, G.
AU  - Andreassen, O. A.
AU  - Breen, G.
AU  - Christiansen, L.
AU  - Debrabant, B.
AU  - Dick, D. M.
AU  - Heinz, A.
AU  - Hjerling-Leffler, J.
AU  - Ikram, M. A.
AU  - Kendler, K. S.
AU  - Martin, N. G.
AU  - Medland, S. E.
AU  - Pedersen, N. L.
AU  - Plomin, R.
AU  - Polderman, T. J. C.
AU  - Ripke, S.
AU  - van der Sluis, S.
AU  - Sullivan, P. F.
AU  - Tiemeier, H.
AU  - Vrieze, S. I.
AU  - Wright, M. J.
AU  - Posthuma, D.
DA  - Mar
J2  - Hum. Genomics
KW  - genome-wide association
intelligence
consortium
loci
Genetics & Heredity
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: FZ6RY
Times Cited: 0
Cited Reference Count: 7
Savage, Jeanne E. Jansen, Philip R. Stringer, Sven Watanabe, Kyoko Bryois, Julien de Leeuw, Christiaan A. Nagel, Mats Awasthi, Swapnil Barr, Peter B. Coleman, Jonathan R. I. Grasby, Katrina L. Hammerschlag, Anke R. Kaminski, Jakob Karlsson, Robert Krapohl, Eva Lam, Max Nygaard, Marianne Reynolds, Chandra A. Trampush, Joey W. Young, Hannah Zabaneh, Delilah Hagg, Sara Hansell, Narelle K. Karlsson, Ida K. Linnarsson, Sten Montgomery, Grant W. Munoz-Manchado, Ana B. Quinlan, Erin B. Schumann, Gunter Skene, Nathan Webb, Bradley T. White, Tonya Arking, Dan E. Attix, Deborah K. Avramopoulos, Dimitrios Bilder, Robert M. Bitsios, Panos Burdick, Katherine E. Cannon, Tyrone D. Chiba-Falek, Ornit Christoforou, Andrea Cirulli, Elizabeth T. Congdon, Eliza Corvin, Aiden Davies, Gail Deary, Ian J. DeRosse, Pamela Dickinson, Dwight Djurovic, Srdjan Donohoe, Gary Conley, Emily Drabant Eriksson, Johan G. Espeseth, Thomas Freimer, Nelson A. Giakoumaki, Stella Giegling, Ina Gill, Michael Glahn, David C. Hariri, Ahmad R. Hatzimanolis, Alex Keller, Matthew C. Knowles, Emma Konte, Bettina Lahti, Jari Le Hellard, Stephanie Lencz, Todd Liewald, David C. London, Edythe Lundervold, Astri J. Malhotra, Anil K. Melle, Ingrid Morris, Derek Need, Anna C. Ollier, William Palotie, Aarno Payton, Antony Pendleton, Neil Poldrack, Russell A. Raikkonen, Katri Reinvang, Ivar Roussos, Panos Rujescu, Dan Sabb, Fred W. Scult, Matthew A. Smeland, Olav B. Smyrnis, Nikolaos Starr, John M. Steen, Vidar M. Stefanis, Nikos C. Straub, Richard E. Sundet, Kjetil Voineskos, Aristotle N. Weinberger, Daniel R. Widen, Elisabeth Yu, Jin Abecasis, Goncalo Andreassen, Ole A. Breen, Gerome Christiansen, Lene Debrabant, Birgit Dick, Danielle M. Heinz, Andreas Hjerling-Leffler, Jens Ikram, M. Arfan Kendler, Kenneth S. Martin, Nicholas G. Medland, Sarah E. Pedersen, Nancy L. Plomin, Robert Polderman, Tinca J. C. Ripke, Stephan van der Sluis, Sophie Sullivan, Patrick F. Tiemeier, Henning Vrieze, Scott I. Wright, Margaret J. Posthuma, Danielle
Voineskos, Aristotle/J-5014-2013; Pendleton, Neil/F-2333-2015; DeRosse, Pamela/H-1083-2012; Deary, Ian J/C-6297-2009; Knowles, Emma/V-2567-2019; Breen, Gerome D/A-5540-2010; Lahti, Jari/P-7987-2018; Bilder, Robert M/A-8894-2008; Tiemeier, Henning/H-6534-2019; DeRosse, Pamela/X-1412-2019; Lahti, Jari/P-2283-2019; Knowles, Emma/P-3821-2018
Pendleton, Neil/0000-0003-0794-2386; DeRosse, Pamela/0000-0003-0823-8163; Deary, Ian J/0000-0002-1733-263X; Breen, Gerome D/0000-0003-2053-1792; Lahti, Jari/0000-0002-4310-5297; Bilder, Robert M/0000-0001-5085-7852; Tiemeier, Henning/0000-0002-4395-1397; Lahti, Jari/0000-0002-4310-5297; Knowles, Emma/0000-0003-0642-267X; Coleman, Jonathan/0000-0002-6759-0944
0
7
Biomed central ltd
London
1479-7364
1
PY  - 2018
SN  - 1473-9542
SP  - 2
ST  - GWAS meta-analysis (N=279,930) identifies new genes and functional links to general cognitive ability
T2  - Human Genomics
TI  - GWAS meta-analysis (N=279,930) identifies new genes and functional links to general cognitive ability
UR  - <Go to ISI>://WOS:000427728400089
VL  - 12
ID  - 27
ER  - 

TY  - JOUR
AB  - Intelligence is highly heritable(1) and a major determinant of human health and well-being(2). Recent genome-wide meta-analyses have identified 24 genomic loci linked to variation in intelligence3-7, but much about its genetic underpinnings remains to be discovered. Here, we present a large-scale genetic association study of intelligence (n = 269,867), identifying 205 associated genomic loci (190 new) and 1,016 genes (939 new) via positional mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping, and gene-based association analysis. We find enrichment of genetic effects in conserved and coding regions and associations with 146 nonsynonymous exonic variants. Associated genes are strongly expressed in the brain, specifically in striatal medium spiny neurons and hippocampal pyramidal neurons. Gene set analyses implicate pathways related to nervous system development and synaptic structure. We confirm previous strong genetic correlations with multiple health-related outcomes, and Mendelian randomization analysis results suggest protective effects of intelligence for Alzheimer's disease and ADHD and bidirectional causation with pleiotropic effects for schizophrenia. These results are a major step forward in understanding the neurobiology of cognitive function as well as genetically related neurological and psychiatric disorders.
AD  - [Savage, Jeanne E.; Jansen, Philip R.; Stringer, Sven; Watanabe, Kyoko; de Leeuw, Christiaan A.; Hammerschlag, Anke R.; Polderman, Tinca J. C.; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands. [Jansen, Philip R.; White, Tonya; Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands. [Bryois, Julien; Karlsson, Robert; Hagg, Sara; Karlsson, Ida K.; Pedersen, Nancy L.; Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden. [Nagel, Mats; van der Sluis, Sophie; Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands. [Awasthi, Swapnil; Kaminski, Jakob A.; Malhotra, Anil K.; Heinz, Andreas; Ripke, Stephan] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany. [Barr, Peter B.; Dick, Danielle M.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA. [Coleman, Jonathan R. I.; Krapohl, Eva; Zabaneh, Delilah; Breen, Gerome; Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England. [Coleman, Jonathan R. I.; Breen, Gerome] South London & Maudsley NHS Trust, NIHR Biomed Res Ctr Mental Hlth, London, England. [Grasby, Katrina L.; Montgomery, Grant W.; Martin, Nicholas G.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia. [Kaminski, Jakob A.] Berlin Inst Hlth, Berlin, Germany. [Lam, Max] Inst Mental Hlth, Singapore, Singapore. [Nygaard, Marianne; Christiansen, Lene] Univ Southern Denmark, Danish Twin Registry, Odense, Denmark. [Nygaard, Marianne; Christiansen, Lene] Univ Southern Denmark, Danish Aging Res Ctr, Dept Publ Hlth, Odense, Denmark. [Nygaard, Marianne; Christiansen, Lene; Debrabant, Birgit] Univ Southern Denmark, Dept Publ Hlth, Epidemiol Biostat & Biodemog, Odense, Denmark. [Reynolds, Chandra A.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA. [Trampush, Joey W.] BrainWorkup LLC, Los Angeles, CA USA. [Trampush, Joey W.] Univ Southern Calif, Keck Sch Med, Dep Psychiat & Behav Sci, Los Angeles, CA USA. [Young, Hannah; Vrieze, Scott I.] Univ Minnesota, Dept Psychol, St Paul, MN 55108 USA. [Hansell, Narelle K.; Wright, Margaret J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia. [Linnarsson, Sten; Munoz-Manchado, Ana B.; Skene, Nathan G.; Hjerling-Leffler, Jens] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Stockholm, Sweden. [Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia. [Quinlan, Erin B.; Schumann, Gunter] Kings Coll London, MRC SGDP Ctr, Inst Psychiat Psychol & Neurosci, Ctr Populat Neurosci & Precis Med PONS, London, England. [Skene, Nathan G.] UCL, Inst Neurol, Queen Sq, London, England. [Webb, Bradley T.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA. [Webb, Bradley T.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA. [Arking, Dan E.; Avramopoulos, Dimitrios] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA. [Avramopoulos, Dimitrios] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA. [Bilder, Robert M.; Congdon, Eliza; Freimer, Nelson A.; London, Edythe] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA. [Bitsios, Panos] Univ Crete, Dept Psychiat & Behav Sci, Fac Med, Iraklion, Greece. [Burdick, Katherine E.; Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA. [Burdick, Katherine E.; Roussos, Panos] James J Peters VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN 2, Bronx, NY USA. [Burdick, Katherine E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA USA. [Cannon, Tyrone D.] Yale Univ, Dept Psychol, New Haven, CT USA. [Chiba-Falek, Ornit] Duke Univ, Med Ctr, Dept Neurol, Bryan Alzheimers Dis Res Ctr, Durham, NC USA. [Chiba-Falek, Ornit] Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC USA. [Christoforou, Andrea; Le Hellard, Stephanie; Steen, Vidar M.] Haukeland Hosp, Dr Einar Martens Res Grp Biol Psychiat, Ctr Med Genet & Mol Med, Bergen, Norway. [Cirulli, Elizabeth T.] Human Longev Inc, Durham, NC USA. [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland. [Corvin, Aiden; Gill, Michael] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland. [Davies, Gail; Deary, Ian J.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland. [Davies, Gail; Deary, Ian J.; Liewald, David C.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland. [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.; Yu, Jin] Zucker Hillside Hosp, Div Psychiat Res, Glen Oaks, NY USA. [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.] Hofstra Northwell Sch Med, Dept Psychiat, Hempstead, NY USA. [DeRosse, Pamela; Lencz, Todd; Malhotra, Anil K.] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA. [Dickinson, Dwight] NIMH, Clin & Translat Neurosci Branch, Intramural Res Program, US Natl Inst Hlth, Bethesda, MD 20892 USA. [Djurovic, Srdjan] Univ Bergen, Oslo Univ Hosp, Dept Med Genet, Oslo, Norway. [Djurovic, Srdjan; Le Hellard, Stephanie; Melle, Ingrid; Steen, Vidar M.] Univ Bergen, KG Jebsen Ctr Psychosis Res, NORMENT, Bergen, Norway. [Donohoe, Gary; Morris, Derek] Natl Univ Ireland, Neuroimaging Cognit & Genom NICOG, Sch Psychol, Galway, Ireland. [Donohoe, Gary; Morris, Derek] Natl Univ Ireland, Discipline Biochem, Galway, Ireland. [Conley, Emily Drabant] 23andMe Inc, Mountain View, CA USA. [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland. [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki, Finland. [Espeseth, Thomas; Reinvang, Ivar; Sundet, Kjetil] Univ Oslo, Dept Psychol, Oslo, Norway. [Espeseth, Thomas; Melle, Ingrid; Sundet, Kjetil; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway. [Giakoumaki, Stella] Univ Crete, Dept Psychol, Rethimnon, Greece. [Giegling, Ina; Konte, Bettina; Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat, Halle, Germany. [Glahn, David C.; Knowles, Emma] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA. [Hariri, Ahmad R.; Scult, Matthew A.] Duke Univ, Dept Psychol & Neurosci, Lab NeuroGenet, Durham, NC USA. [Hatzimanolis, Alex; Smyrnis, Nikolaos; Stefanis, Nikos C.] Univ Athens, Eginit Hosp, Dept Psychiat, Sch Med, Athens, Greece. [Hatzimanolis, Alex; Smyrnis, Nikolaos; Stefanis, Nikos C.] Univ Mental Hlth Res Inst, Athens, Greece. [Hatzimanolis, Alex; Stefanis, Nikos C.] Theodor Theohari Cozzika Fdn, Neurobiol Res Inst, Athens, Greece. [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA. [Koltai, Deborah] Duke Univ, Med Ctr, Div Med Psychol, Psychiat & Behav Sci, Durham, NC USA. [Koltai, Deborah] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA. [Lahti, Jari] Univ Helsinki, Dept Psychol & Logoped, Fac Med, Helsinki, Finland. [Lahti, Jari] Univ Helsinki, Helsinki Coll Adv Studies, Helsinki, Finland. [London, Edythe] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA. [London, Edythe] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA. [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway. [Lundervold, Astri J.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway. [Need, Anna C.] Imperial Coll London, Dept Med, Div Brain Sci, London, England. [Ollier, William] Univ Manchester, Inst Populat Hlth, Ctr Integrated Genom Med Res, Manchester, Lancs, England. [Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland. [Palotie, Aarno] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England. [Palotie, Aarno] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA. [Payton, Antony] Univ Manchester, Ctr Epidemiol, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, Lancs, England. [Pendleton, Neil] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci,Salford Royal NHS Fdn Trust, Div Neurosci & Expt Psychol,Manchester Acad Hlth, Manchester, Lancs, England. [Poldrack, Russell A.] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA. [Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland. [Roussos, Panos] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA. [Roussos, Panos] Icahn Sch Med Mt Sinai, Inst Multiscale Biol, New York, NY 10029 USA. [Sabb, Fred W.] Univ Oregon, Robert & Beverly Lewis Ctr Neuroimaging, Eugene, OR 97403 USA. [Smeland, Olav B.; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway. [Smeland, Olav B.; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway. [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland. [Straub, Richard E.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Johns Hopkins Univ Med Campus, Baltimore, MD USA. [Tiemeier, Henning; Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands. [Voineskos, Aristotle N.] Univ Toronto, Campbell Family Mental Hlth Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada. [Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA. [Abecasis, Goncalo] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA. [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway. [Dick, Danielle M.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA. [Dick, Danielle M.] Virginia Commonwealth Univ, Coll Behav & Emot Hlth Inst, Richmond, VA USA. [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA. [Ripke, Stephan] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA. [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA. [Wright, Margaret J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.
Posthuma, D (reprint author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands.; Posthuma, D (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands.
d.posthuma@vu.nl
AN  - WOS:000437224400005
AU  - Savage, J. E.
AU  - Jansen, P. R.
AU  - Stringer, S.
AU  - Watanabe, K.
AU  - Bryois, J.
AU  - de Leeuw, C. A.
AU  - Nagel, M.
AU  - Awasthi, S.
AU  - Barr, P. B.
AU  - Coleman, J. R. I.
AU  - Grasby, K. L.
AU  - Hammerschlag, A. R.
AU  - Kaminski, J. A.
AU  - Karlsson, R.
AU  - Krapohl, E.
AU  - Lam, M.
AU  - Nygaard, M.
AU  - Reynolds, C. A.
AU  - Trampush, J. W.
AU  - Young, H.
AU  - Zabaneh, D.
AU  - Hagg, S.
AU  - Hansell, N. K.
AU  - Karlsson, I. K.
AU  - Linnarsson, S.
AU  - Montgomery, G. W.
AU  - Munoz-Manchado, A. B.
AU  - Quinlan, E. B.
AU  - Schumann, G.
AU  - Skene, N. G.
AU  - Webb, B. T.
AU  - White, T.
AU  - Arking, D. E.
AU  - Avramopoulos, D.
AU  - Bilder, R. M.
AU  - Bitsios, P.
AU  - Burdick, K. E.
AU  - Cannon, T. D.
AU  - Chiba-Falek, O.
AU  - Christoforou, A.
AU  - Cirulli, E. T.
AU  - Congdon, E.
AU  - Corvin, A.
AU  - Davies, G.
AU  - Deary, I. J.
AU  - DeRosse, P.
AU  - Dickinson, D.
AU  - Djurovic, S.
AU  - Donohoe, G.
AU  - Conley, E. D.
AU  - Eriksson, J. G.
AU  - Espeseth, T.
AU  - Freimer, N. A.
AU  - Giakoumaki, S.
AU  - Giegling, I.
AU  - Gill, M.
AU  - Glahn, D. C.
AU  - Hariri, A. R.
AU  - Hatzimanolis, A.
AU  - Keller, M. C.
AU  - Knowles, E.
AU  - Koltai, D.
AU  - Konte, B.
AU  - Lahti, J.
AU  - Le Hellard, S.
AU  - Lencz, T.
AU  - Liewald, D. C.
AU  - London, E.
AU  - Lundervold, A. J.
AU  - Malhotra, A. K.
AU  - Melle, I.
AU  - Morris, D.
AU  - Need, A. C.
AU  - Ollier, W.
AU  - Palotie, A.
AU  - Payton, A.
AU  - Pendleton, N.
AU  - Poldrack, R. A.
AU  - Raikkonen, K.
AU  - Reinvang, I.
AU  - Roussos, P.
AU  - Rujescu, D.
AU  - Sabb, F. W.
AU  - Scult, M. A.
AU  - Smeland, O. B.
AU  - Smyrnis, N.
AU  - Starr, J. M.
AU  - Steen, V. M.
AU  - Stefanis, N. C.
AU  - Straub, R. E.
AU  - Sundet, K.
AU  - Tiemeier, H.
AU  - Voineskos, A. N.
AU  - Weinberger, D. R.
AU  - Widen, E.
AU  - Yu, J.
AU  - Abecasis, G.
AU  - Andreassen, O. A.
AU  - Breen, G.
AU  - Christiansen, L.
AU  - Debrabant, B.
AU  - Dick, D. M.
AU  - Heinz, A.
AU  - Hjerling-Leffler, J.
AU  - Ikram, M. A.
AU  - Kendler, K. S.
AU  - Martin, N. G.
AU  - Medland, S. E.
AU  - Pedersen, N. L.
AU  - Plomin, R.
AU  - Polderman, T. J. C.
AU  - Ripke, S.
AU  - van der Sluis, S.
AU  - Sullivan, P. F.
AU  - Vrieze, S. I.
AU  - Wright, M. J.
AU  - Posthuma, D.
DA  - Jul
DO  - 10.1038/s41588-018-0152-6
IS  - 7
J2  - Nature Genet.
KW  - general cognitive function
educational-attainment
test batteries
gwas
traits
risk
loci
heritability
annotation
consortium
Genetics & Heredity
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GL5QU
Times Cited: 54
Cited Reference Count: 53
Savage, Jeanne E. Jansen, Philip R. Stringer, Sven Watanabe, Kyoko Bryois, Julien de Leeuw, Christiaan A. Nagel, Mats Awasthi, Swapnil Barr, Peter B. Coleman, Jonathan R. I. Grasby, Katrina L. Hammerschlag, Anke R. Kaminski, Jakob A. Karlsson, Robert Krapohl, Eva Lam, Max Nygaard, Marianne Reynolds, Chandra A. Trampush, Joey W. Young, Hannah Zabaneh, Delilah Hagg, Sara Hansell, Narelle K. Karlsson, Ida K. Linnarsson, Sten Montgomery, Grant W. Munoz-Manchado, Ana B. Quinlan, Erin B. Schumann, Gunter Skene, Nathan G. Webb, Bradley T. White, Tonya Arking, Dan E. Avramopoulos, Dimitrios Bilder, Robert M. Bitsios, Panos Burdick, Katherine E. Cannon, Tyrone D. Chiba-Falek, Ornit Christoforou, Andrea Cirulli, Elizabeth T. Congdon, Eliza Corvin, Aiden Davies, Gail Deary, Ian J. DeRosse, Pamela Dickinson, Dwight Djurovic, Srdjan Donohoe, Gary Conley, Emily Drabant Eriksson, Johan G. Espeseth, Thomas Freimer, Nelson A. Giakoumaki, Stella Giegling, Ina Gill, Michael Glahn, David C. Hariri, Ahmad R. Hatzimanolis, Alex Keller, Matthew C. Knowles, Emma Koltai, Deborah Konte, Bettina Lahti, Jari Le Hellard, Stephanie Lencz, Todd Liewald, David C. London, Edythe Lundervold, Astri J. Malhotra, Anil K. Melle, Ingrid Morris, Derek Need, Anna C. Ollier, William Palotie, Aarno Payton, Antony Pendleton, Neil Poldrack, Russell A. Raikkonen, Katri Reinvang, Ivar Roussos, Panos Rujescu, Dan Sabb, Fred W. Scult, Matthew A. Smeland, Olav B. Smyrnis, Nikolaos Starr, John M. Steen, Vidar M. Stefanis, Nikos C. Straub, Richard E. Sundet, Kjetil Tiemeier, Henning Voineskos, Aristotle N. Weinberger, Daniel R. Widen, Elisabeth Yu, Jin Abecasis, Goncalo Andreassen, Ole A. Breen, Gerome Christiansen, Lene Debrabant, Birgit Dick, Danielle M. Heinz, Andreas Hjerling-Leffler, Jens Ikram, M. Arfan Kendler, Kenneth S. Martin, Nicholas G. Medland, Sarah E. Pedersen, Nancy L. Plomin, Robert Polderman, Tinca J. C. Ripke, Stephan van der Sluis, Sophie Sullivan, Patrick F. Vrieze, Scott I. Wright, Margaret J. Posthuma, Danielle
DeRosse, Pamela/H-1083-2012; Pendleton, Neil/F-2333-2015; Lahti, Jari/P-7987-2018; Tiemeier, Henning/H-6534-2019; Hansell, Narelle K/A-4553-2016; Knowles, Emma/P-3821-2018; Wright, Margaret Jane/A-4560-2016; Webb, Bradley/N-4044-2019; Voineskos, Aristotle/J-5014-2013; Breen, Gerome D/A-5540-2010; Knowles, Emma/V-2567-2019; Lahti, Jari/P-2283-2019; Karlsson, Ida/S-6064-2019; Kaminski, Jakob/W-1349-2019; Grasby, Katrina/M-7536-2016; DeRosse, Pamela/X-1412-2019; Deary, Ian J/C-6297-2009; Webb, Bradley/B-1459-2009; Bilder, Robert M/A-8894-2008; Hjerling Leffler, Jens/E-3775-2012
DeRosse, Pamela/0000-0003-0823-8163; Pendleton, Neil/0000-0003-0794-2386; Lahti, Jari/0000-0002-4310-5297; Tiemeier, Henning/0000-0002-4395-1397; Hansell, Narelle K/0000-0002-8229-9741; Knowles, Emma/0000-0003-0642-267X; Wright, Margaret Jane/0000-0001-7133-4970; Webb, Bradley/0000-0002-0576-5366; Breen, Gerome D/0000-0003-2053-1792; Lahti, Jari/0000-0002-4310-5297; Karlsson, Ida/0000-0003-3605-7829; Kaminski, Jakob/0000-0001-8155-3683; Grasby, Katrina/0000-0001-8539-0228; Deary, Ian J/0000-0002-1733-263X; Webb, Bradley/0000-0002-0576-5366; Bilder, Robert M/0000-0001-5085-7852; Skene, Nathan/0000-0002-6807-3180; Plomin, Robert/0000-0002-0756-3629; Coleman, Jonathan/0000-0002-6759-0944; Watanabe, Kyoko/0000-0002-3303-8860; Djurovic, Srdjan/0000-0002-8140-8061; Bjerkehagen Smeland, Olav/0000-0002-3761-5215; Zabaneh, Delilah/0000-0003-4740-3862; Giakoumaki, Stella/0000-0002-4166-8125; Polderman, Tinca/0000-0001-5564-301X; Nygaard, Marianne/0000-0003-0703-2665; Young, Hannah/0000-0002-4248-9612; Hjerling Leffler, Jens/0000-0002-4539-1776; Raikkonen, Katri/0000-0003-3124-3470; Awasthi, Swapnil/0000-0002-9692-8123; Walters, James/0000-0002-6980-4053; Posthuma, Danielle/0000-0001-7582-2365; Hagg, Sara/0000-0002-2452-1500
Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [433-09-228, VIDI 452-12-014, VICI 453-13-005, 645-000-003]; Sophia Foundation for Scientific Research (SSWO) [S14-27]; Netherlands Scientific Organization (NWO)Netherlands Organization for Scientific Research (NWO) [480-05-003]; Vrije Universiteit, Amsterdam, The NetherlandsNetherlands Government; Dutch Brain Foundation; Swedish Research CouncilSwedish Research Council [20143863]; Wellcome TrustWellcome Trust [108726/Z/15/Z]; Swedish Brain Foundation; Dutch National Computing and Networking Services, SurfSARA; Swiss National Science FoundationSwiss National Science Foundation (SNSF); UK Biobank resource [16406]
This work was funded by the Netherlands Organization for Scientific Research through the following grants: NWO Brain and Cognition 433-09-228 (D.P.), NWO MagW VIDI 452-12-014 (S.v.d.S.), NWO VICI 453-13-005 (D.P.), and 645-000-003 (D.P.). P.R.J. was funded by the Sophia Foundation for Scientific Research (SSWO, grant S14-27 to P.R.J.). The analyses were carried out on the Genetic Cluster Computer, which is financed by the Netherlands Scientific Organization (NWO: 480-05-003 to D.P.), Vrije Universiteit, Amsterdam, The Netherlands, and the Dutch Brain Foundation, and is hosted by the Dutch National Computing and Networking Services, SurfSARA. J.H.-L. was funded by the Swedish Research Council (Vetenskapsradet, award 20143863), StratNeuro, the Wellcome Trust (108726/Z/15/Z), and the Swedish Brain Foundation (Hjarnfonden). N.G.S. was supported by the Wellcome Trust (108726/Z/15/Z). J.B. was funded by the Swiss National Science Foundation. This research has been conducted using the UK Biobank resource under application 16406. We thank the numerous participants, researchers, and staff from many studies who collected and contributed to the data. Additional acknowledgements can be found in the Supplementary Information.
55
13
57
Nature publishing group
New york
1546-1718
PY  - 2018
SN  - 1061-4036
SP  - 912-+
ST  - Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence
T2  - Nature Genetics
TI  - Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence
UR  - <Go to ISI>://WOS:000437224400005
VL  - 50
ID  - 15
ER  - 

TY  - JOUR
AD  - [Shah, C. S.] SJM Coll Pharm, Chitradurga, India. [Shah, V. N.] Univ Colorado, Boulder, CO 80309 USA. [Likhar, N.; Mothe, R. K.; Kanukula, R.; Dang, A.] MarksMan Healthcare Solut LLP, Navi Mumbai, India.
AN  - WOS:000354498501019
AU  - Shah, C. S.
AU  - Shah, V. N.
AU  - Likhar, N.
AU  - Mothe, R. K.
AU  - Kanukula, R.
AU  - Dang, A.
DA  - May
DO  - 10.1016/j.jval.2015.03.339
IS  - 3
J2  - Value Health
KW  - Business & Economics
Health Care Sciences & Services
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: CI1IZ
Times Cited: 1
Cited Reference Count: 0
Shah, C. S. Shah, V. N. Likhar, N. Mothe, R. K. Kanukula, R. Dang, A.
Shah, Viral N./H-2855-2019
Shah, Viral N./0000-0002-3827-7107
1
0
2
Elsevier science inc
New york
1524-4733
PY  - 2015
SN  - 1098-3015
SP  - A58-A58
ST  - ASSOCIATION BETWEEN BONE MINERAL DENSITY AND TYPE 1 DIABETES MELLITUS: A META-ANALYSIS OF OBSERVATIONAL STUDIES
T2  - Value in Health
TI  - ASSOCIATION BETWEEN BONE MINERAL DENSITY AND TYPE 1 DIABETES MELLITUS: A META-ANALYSIS OF OBSERVATIONAL STUDIES
UR  - <Go to ISI>://WOS:000354498501019
VL  - 18
ID  - 115
ER  - 

TY  - JOUR
AB  - Context The safety of vitamin D replacement in subjects with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency is not well established. Objective To evaluate the safety of vitamin D replacement in PHPT. Data Source Data were searched from Medline, EMBASE, Cochrane CENTRAL and abstracts form annual scientific meetings of various international bone and mineral societies. Study Selection Studies examining the effect of preoperative vitamin D replacement in patients with PHPT and coexisting vitamin D deficiency, irrespective of year and language of the publication were included in the present meta-analysis. Data Extraction Data were extracted from text of the included publications or abstract of conferences. Data Synthesis Ten studies enrolling 340 subjects with PHPT were analysed in this meta-analysis. After vitamin D replacement, there was significant increase in 25(OH) D levels by 55 center dot 3nmol/l (95% CI 33 center dot 3-77 center dot 3), reduction in serum parathyroid hormone levels by 3 center dot 5 pmol/l (5 center dot 8 to -1 center dot 2) without change in serum calcium (-0 center dot 08mmol/l, -0 center dot 2 to +0 center dot 03) and urinary calcium levels (0 center dot 72mmol/24h, P=0 center dot 2) compared to baseline. Conclusion Vitamin D replacement in subjects with PHPT and coexistent vitamin D deficiency increase 25 (OH) D and reduce serum PTH significantly without causing hypercalcaemia and hypercalciuria. The finding of the study needs to be confirmed by a large randomized trial in patient with PHPT and coexistent vitamin D deficiency.
AD  - [Shah, Viral N.] Univ Colorado, Barbara Davis Ctr Diabet, Denver, CO 80045 USA. [Shah, Chirag S.] Natl Inst Pharmaceut Educ & Res, Mohali, India. [Bhadada, Sanjay K.] Postgrad Inst Med Educ & Res, Chandigarh 160012, India. [Rao, D. Sudhakar] Henry Ford Hosp, Detroit, MI 48202 USA.
Shah, VN (reprint author), Univ Colorado, Barbara Davis Ctr Diabet, Mail Stop A14,Room 1318, Denver, CO 80045 USA.
viral.shah@ucdenver.edu
AN  - WOS:000334907900004
AU  - Shah, V. N.
AU  - Shah, C. S.
AU  - Bhadada, S. K.
AU  - Rao, D. S.
DA  - Jun
DO  - 10.1111/cen.12398
IS  - 6
J2  - Clin. Endocrinol.
KW  - mild primary hyperparathyroidism
parathyroid adenoma weight
bone-mineral density
d insufficiency
d repletion
nutrition
surgery
therapy
Endocrinology & Metabolism
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: AF7PV
Times Cited: 22
Cited Reference Count: 29
Shah, Viral N. Shah, Chirag S. Bhadada, Sanjay K. Rao, D. Sudhakar
Shah, Viral N./H-2855-2019
Shah, Viral N./0000-0002-3827-7107
22
0
5
Wiley-blackwell
Hoboken
1365-2265
PY  - 2014
SN  - 0300-0664
SP  - 797-803
ST  - Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature
T2  - Clinical Endocrinology
TI  - Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature
UR  - <Go to ISI>://WOS:000334907900004
VL  - 80
ID  - 141
ER  - 

TY  - JOUR
AB  - Background: An increased risk of unintentional injuries among individuals with disability has been reported in many studies, yet quantitative syntheses of findings from previous studies have not been done. Objectives: We conducted a systematic review and meta-analysis to characterize the relationship between pre-existing disability and unintentional injuries. Methods: We searched 14 electronic databases to identify original research published between Jan 1, 1990 and Feb 28, 2013. Included studies reported the odds ratio (OR) or relative risk (RR) of unintentional injuries in adults 18_ years of age with pre-existing disabilities compared with adults without disabilities. Twenty six eligible studies were included covering 54 586 individuals with disabilities. We conducted quality assessments and then analyzed the pooled effects using random-effect models. Results: The pooled OR of unintentional injuries was 1.77 (95% CI 1.51-2.07) for all studies in individuals with disabilities compared with individuals without disabilities. The pooled ORs were 1.87 (95% CI 1.52-2.30) for overall unintentional injuries, 1.64 (95% CI 1.39-1.94) for falls-related injuries, 1.62 (95% CI 1.24-2.13) for occupational injuries, and 1.91 (95% CI 1.59-2.30) for nonoccupational injuries. Conclusions: Compared with adults without disabilities, individuals with disabilities are at a significantly higher risk of unintentional injuries. Evidence about the association between cognitive disabilities and unintentional injuries is weak. Future researchers are encouraged to use International Classification of Functioning, Disability and Health (ICF) to classify disability and use rigorous evaluation methods to assess and implement the most appropriate injury prevention efforts to mitigate the risks identified. (C) 2015 Elsevier Inc. All rights reserved.
AD  - [Shi, Xiuquan; Wheeler, Krista K.; Shi, Junxin; Xiang, Huiyun] Ohio State Univ, Coll Med, Res Inst, Ctr Injury Res & Policy,Nationwide Childrens Hosp, Columbus, OH 43210 USA. [Shi, Xiuquan] Zunyi Med Coll, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Zunyi, Peoples R China. [Stallones, Lorann] Colorado State Univ, Colorado Injury Control Res Ctr, Ft Collins, CO 80523 USA. [Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand. [Shakespeare, Tom] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.
Xiang, HY (reprint author), Ohio State Univ, Coll Med, Res Inst, Ctr Injury Res & Policy,Nationwide Childrens Hosp, 700 Childrens Dr, Columbus, OH 43210 USA.
xiang.30@osu.edu
AN  - WOS:000351313400002
AU  - Shi, X. Q.
AU  - Wheeler, K. K.
AU  - Shi, J. X.
AU  - Stallones, L.
AU  - Ameratunga, S.
AU  - Shakespeare, T.
AU  - Xiang, H. Y.
DA  - Apr
DO  - 10.1016/j.dhjo.2014.09.012
IS  - 2
J2  - Disabil. Health J.
KW  - Disability
Unintentional injuries
Falls
Occupational injuries
intellectual disability
occupational injuries
developmental-disabilities
agricultural health
prospective cohort
falls
workers
prevalence
people
epidemiology
Health Care Sciences & Services
Public, Environmental & Occupational
Health
Rehabilitation
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: CD7YY
Times Cited: 6
Cited Reference Count: 54
Shi, Xiuquan Wheeler, Krista K. Shi, Junxin Stallones, Lorann Ameratunga, Shanthi Shakespeare, Tom Xiang, Huiyun
Ameratunga, Shanthi/0000-0001-8042-2251
National Institute for Occupational Safety and Health (NIOSH)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH); U.S. Centers for Disease Control and Prevention, USA [1R01OH009585-01A1]
National Institute for Occupational Safety and Health (NIOSH), the U.S. Centers for Disease Control and Prevention (PI: Dr. Huiyun Xiang, Grant #: 1R01OH009585-01A1), USA.
6
0
11
Elsevier science inc
New york
1876-7583
PY  - 2015
SN  - 1936-6574
SP  - 153-164
ST  - Increased risk of unintentional injuries in adults with disabilities: A systematic review and meta-analysis
T2  - Disability and Health Journal
TI  - Increased risk of unintentional injuries in adults with disabilities: A systematic review and meta-analysis
UR  - <Go to ISI>://WOS:000351313400002
VL  - 8
ID  - 117
ER  - 

TY  - JOUR
AD  - [Singh, Namrata; Varghese, Jimmy] Univ Iowa Hosp & Clin, Internal Med, Iowa City, IA 52242 USA. [Singh, Namrata; Schweizer, Marin] Iowa City VA, Iowa City, IA USA. [England, Bryant R.] Nebraska Western IA VA Hlth Care Syst, Dept Internal Med, Div Rheumatol & Immunol, Omaha, NE USA. [England, Bryant R.; Michaud, Kaleb] Univ Nebraska, Med Ctr, Omaha, NE USA. [Solomon, Joshua J.] Natl Jewish Hlth, Div Pulm & Crit Care Med, Denver, CO USA. [Mikuls, Ted R.] Univ Nebraska, Med Ctr, Div Rheumatol, Internal Med, Omaha, NE USA.
AN  - WOS:000411824105234
AU  - Singh, N.
AU  - Varghese, J.
AU  - England, B. R.
AU  - Solomon, J. J.
AU  - Michaud, K.
AU  - Mikuls, T. R.
AU  - Schweizer, M.
DA  - Oct
J2  - Arthritis Rheumatol.
KW  - Rheumatology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: FI2ZP
Times Cited: 0
Cited Reference Count: 0
Singh, Namrata Varghese, Jimmy England, Bryant R. Solomon, Joshua J. Michaud, Kaleb Mikuls, Ted R. Schweizer, Marin
0
Wiley
Hoboken
2326-5205
10
PY  - 2017
SN  - 2326-5191
SP  - 2
ST  - Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
T2  - Arthritis & Rheumatology
TI  - Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
UR  - <Go to ISI>://WOS:000411824105234
VL  - 69
ID  - 49
ER  - 

TY  - JOUR
AB  - Objective: An increasing number of minimally or noninvasive devices are available to measure cardiac output in the critical care setting. This article reviews the underlying physical principles of these devices in addition to examining both animal and human comparative studies in an effort to allow clinicians to make informed decisions when selecting a device to measure cardiac output. Data Sources: Peer-reviewed manuscripts indexed in PubMed. Study Selection: A systematic search of the PubMed database for articles describing the use of cardiac output monitors yielded 1,526 sources that were included in the analysis. Data Extraction: From all published cardiac output monitoring studies reviewed, the animal model, number of independent measurements, and correlation between techniques was extracted. Data Synthesis: Comparative studies in animals and humans between devices designed for measurement of cardiac output and experimental reference standards indicate thermodilution and Doppler-based techniques to have acceptable accuracy across a wide range of hemodynamic conditions, with bioimpedance techniques being less accurate. Thermodilution devices are marginally more accurate than Doppler-based devices but suffer from slower response time, increased invasiveness, and require stable core temperatures, good operator technique, and a competent tricuspid valve. Doppler-based techniques are less invasive and offer beat-to-beat measurements and excellent trending ability, but are dependent on accurate beam alignment and knowledge of aortic cross-sectional area. Studies of newer devices, such as pulse contour analysis, partial rebreathing, and pulse wave velocity, are far less in number and are primarily based on comparisons with thermodilution-based cardiac output measurements. Studies show widely ranging results. Conclusion: Thermodilution is relatively accurate for cardiac output measurements in both animals and humans when compared to experimental reference standards. Doppler-based techniques appear to have similar accuracy as thermodilution pulmonary artery catheters. Bioimpedance, pulse contour, partial rebreathing, and pulse wave velocity-based devices have not been studied as rigorously; however, the majority of studies included in this analysis point towards decreased accuracy.
AD  - [Thiele, Robert H.] Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22904 USA. [Bartels, Karsten] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA. [Gan, Tong J.] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.
Thiele, RH (reprint author), Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22904 USA.
thiele@virginia.edu
AN  - WOS:000346409100042
AU  - Thiele, R. H.
AU  - Bartels, K.
AU  - Gan, T. J.
DA  - Jan
DO  - 10.1097/ccm.0000000000000608
IS  - 1
J2  - Crit. Care Med.
KW  - cardiac output
echocardiography
goal-directed therapy
hemodynamic
monitoring
minimally invasive monitoring
pulmonary artery catheter
pulmonary-artery catheter
pulse-contour analysis
critically-ill
patients
wave-form analysis
respiratory-distress-syndrome
randomized
controlled-trial
lithium dilution technique
blood-pressure
transpulmonary thermodilution
transesophageal doppler
General & Internal Medicine
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: AW6XN
Times Cited: 56
Cited Reference Count: 101
Thiele, Robert H. Bartels, Karsten Gan, Tong J.
Thiele, Robert/0000-0001-7262-0653
58
0
23
Lippincott williams & wilkins
Philadelphia
1530-0293
PY  - 2015
SN  - 0090-3493
SP  - 177-185
ST  - Cardiac Output Monitoring: A Contemporary Assessment and Review
T2  - Critical Care Medicine
TI  - Cardiac Output Monitoring: A Contemporary Assessment and Review
UR  - <Go to ISI>://WOS:000346409100042
VL  - 43
ID  - 126
ER  - 

TY  - JOUR
AD  - [Tilliss, Terri] Univ Colorado, Dept Orthodont, Sch Dent Med, Aurora, CO 80045 USA. [Carey, Clifton M.] Univ Colorado, Sch Dent Med, Translat Res, Dept Craniofacial Biol, Aurora, CO USA.
Tilliss, T (reprint author), Univ Colorado, Dept Orthodont, Sch Dent Med, Aurora, CO 80045 USA.
Terri.Tilliss@ucdenver.edu; clifton.carey@ucdenver.edu
AN  - WOS:000432345100015
AU  - Tilliss, T.
AU  - Carey, C. M.
DA  - Jun
DO  - 10.1016/j.jebdp.2018.03.011
IS  - 2
J2  - J. Evid.-Based Dent. Pract.
KW  - Meta-analysis
Systematic review
Power toothbrush
Orthodontics
Periodontal health
Dentistry, Oral Surgery & Medicine
LA  - English
M3  - Editorial Material
N1  - ISI Document Delivery No.: GG0CF
Times Cited: 1
Cited Reference Count: 2
Tilliss, Terri Carey, Clifton M.
1
0
6
Elsevier inc
San diego
1532-3390
PY  - 2018
SN  - 1532-3382
SP  - 176-177
ST  - INSUFFICIENT EVIDENCE WITHIN A SYSTEMATIC REVIEW AND META-ANALYSIS OF POWERED TOOTHBRUSHES OVER MANUAL TOOTHBRUSHES FOR SOFT TISSUE HEALTH DURING ORTHODONTIC TREATMENT
T2  - Journal of Evidence-Based Dental Practice
TI  - INSUFFICIENT EVIDENCE WITHIN A SYSTEMATIC REVIEW AND META-ANALYSIS OF POWERED TOOTHBRUSHES OVER MANUAL TOOTHBRUSHES FOR SOFT TISSUE HEALTH DURING ORTHODONTIC TREATMENT
UR  - <Go to ISI>://WOS:000432345100015
VL  - 18
ID  - 18
ER  - 

TY  - JOUR
AD  - [Tucker, K.; Sheppard, J. P.; Stevens, R.; Hobbs, F. D. R.; McManus, R. J.] Univ Oxford, Oxford, England. [Bosworth, H. B.] Durham VAMC, Durham, NC USA. [Bove, A.] Temple Univ, Philadelphia, PA 19122 USA. [Bray, E. P.] Univ Cent Lancashire, Preston, Lancs, England. [Godwin, M.] Mem Univ Newfoundland, St John, NF, Canada. [Green, B. B.] Grp Hlth Res Inst, Seattle, WA USA. [Hebert, P.] Univ Washington, Washington, DC USA. [Kantola, I.; Varis, J.] Turku Univ Hosp, Turku, Finland. [Kantola, I.; Varis, J.] Univ Turku, Turku, Finland. [Kerry, S. M.] Queen Mary Univ London, London, England. [Magid, D. J.] Univ Colorado, Denver, CO 80202 USA. [Mant, J.] Univ Cambridge, Cambridge, England. [Margolis, K. L.] HealthPartners Inst Educ & Res, Minneapolis, MN USA. [McKinstry, B.] Univ Edinburgh, Edinburgh, Midlothian, Scotland. [McLaughlin, M. A.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA. [Omboni, S.] Italian Inst Telemed, Varese, Italy. [Ogedegbe, O.] NYU, New York, NY USA. [Parati, G.] Univ Milano Bicocca, Milan, Italy. [Qamar, N.] Univ Birmingham, Birmingham, W Midlands, England. [Verberk, W. J.] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands. [Wakefield, B. J.] Iowa City VA Med Ctr, Iowa City, IA USA. [Wakefield, B. J.] Univ Iowa, Iowa City, IA 52242 USA.
AN  - WOS:000440355100187
AU  - Tucker, K.
AU  - Sheppard, J. P.
AU  - Stevens, R.
AU  - Bosworth, H. B.
AU  - Bove, A.
AU  - Bray, E. P.
AU  - Godwin, M.
AU  - Green, B. B.
AU  - Hebert, P.
AU  - Hobbs, F. D. R.
AU  - Kantola, I.
AU  - Kerry, S. M.
AU  - Magid, D. J.
AU  - Mant, J.
AU  - Margolis, K. L.
AU  - McKinstry, B.
AU  - McLaughlin, M. A.
AU  - Omboni, S.
AU  - Ogedegbe, O.
AU  - Parati, G.
AU  - Qamar, N.
AU  - Varis, J.
AU  - Verberk, W. J.
AU  - Wakefield, B. J.
AU  - McManus, R. J.
DA  - Sep
DO  - 10.1097/01.hjh.0000491517.19347.e5
J2  - J. Hypertens.
KW  - Cardiovascular System & Cardiology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: VE7XX
Times Cited: 0
Cited Reference Count: 0
Tucker, K. Sheppard, J. P. Stevens, R. Bosworth, H. B. Bove, A. Bray, E. P. Godwin, M. Green, B. B. Hebert, P. Hobbs, F. D. R. Kantola, I. Kerry, S. M. Magid, D. J. Mant, J. Margolis, K. L. McKinstry, B. McLaughlin, M. A. Omboni, S. Ogedegbe, O. Parati, G. Qamar, N. Varis, J. Verberk, W. J. Wakefield, B. J. McManus, R. J.
0
1
Lippincott williams & wilkins
Philadelphia
1473-5598
2
PY  - 2016
SN  - 0263-6352
SP  - E69-E70
ST  - INDIVIDUAL PATIENT DATA META-ANALYSIS OF SELF-MONITORING OF BLOOD PRESSURE (BP-SMART)
T2  - Journal of Hypertension
TI  - INDIVIDUAL PATIENT DATA META-ANALYSIS OF SELF-MONITORING OF BLOOD PRESSURE (BP-SMART)
UR  - <Go to ISI>://WOS:000440355100187
VL  - 34
ID  - 77
ER  - 

TY  - JOUR
AB  - Background Self-monitoring of blood pressure (BP) appears to reduce BP in hypertension but important questions remain regarding effective implementation and which groups may benefit most. This individual patient data (IPD) meta-analysis was performed to better understand the effectiveness of BP self-monitoring to lower BP and control hypertension. Methods and findings Medline, Embase, and the Cochrane Library were searched for randomised trials comparing self-monitoring to no self-monitoring in hypertensive patients (9June 2016). Two reviewers independently assessed articles for eligibility and the authors of eligible trials were approached requesting IPD. Of 2,846 articles in the initial search, 36 were eligible. IPD were provided from 25 trials, including 1 unpublished study. Data for the primary outcomes-change in mean clinic or ambulatory BP and proportion controlled below target at 12 months-were available from 15/19 possible studies (97,138/8,292 [86%] of randomised participants). Overall, self-monitoring was associated with reduced clinic systolic blood pressure (9sBP) compared to usual care at 12 months (-3.2 mmHg, [95% CI -4.9, -1.6 mmHg]). However, this effect was strongly influenced by the intensity of co-intervention ranging from no effect with self-monitoring alone (-1.0 mmHg [-3.3, 1.2]), to a 6.1 mmHg (-9.0, -3.2) reduction when monitoring was combined with intensive support. Self-monitoring was most effective in those with fewer antihypertensive medications and higher baseline sBP up to 170 mmHg. No differences in efficacy were seen by sex or by most comorbidities. Ambulatory BP data at 12 months were available from 4 trials (91,478 patients), which assessed selfmonitoring with little or no co-intervention. There was no association between self-monitoring and either lower clinic or ambulatory sBP in this group (9clinic -0.2 mmHg [-2.2, 1.8]; ambulatory 1.1 mmHg [-0.3, 2.5]). Results for diastolic blood pressure (9dBP) were similar. The main limitation of this work was that significant heterogeneity remained. This was at least in part due to different inclusion criteria, self-monitoring regimes, and target BPs in included studies. Conclusions Self-monitoring alone is not associated with lower BP or better control, but in conjunction with co-interventions (9including systematic medication titration by doctors, pharmacists, or patients; education; or lifestyle counselling) leads to clinically significant BP reduction which persists for at least 12 months. The implementation of self-monitoring in hypertension should be accompanied by such co-interventions.
AD  - [Tucker, Katherine L.; Sheppard, James P.; Stevens, Richard; Hobbs, F. D. Richard; McManus, Richard J.] Univ Oxford, Nuffield Dept Primary Care, Oxford, England. [Bosworth, Hayden B.] Durham VAMC, Ctr Hlth Serv Res Primary Care, Durham, NC USA. [Bove, Alfred] Temple Univ, Lewis Katz Sch Med, Cardiol, Philadelphia, PA 19122 USA. [Bray, Emma P.] Univ Cent Lancashire, Sch Psychol, Preston, Lancs, England. [Earley, Kenneth] St Georges NHS Trust, Thomas Addison Diabet Unit, London, England. [George, Johnson] Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Parkville, Vic, Australia. [Godwin, Marshall] Mem Univ Newfoundland, Family Med, St John, NF, Canada. [Greee, Beverly B.] Kaiser Permanente Washington, Hlth Res Inst, Seattle, WA USA. [Hebert, Paul] Univ Washington, Dept Hlth Serv, Sch Publ Hlth, Seattle, WA 98195 USA. [Kantola, Ilkka; Varis, Juha] Turku Univ Hosp, Div Med, Turku, Finland. [Kantola, Ilkka; Varis, Juha] Univ Turku, Turku, Finland. [Kerry, Sally M.] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England. [Leiva, Alfonso] Baleares Hlth Serv IbSalut, Primary Care Res Unit Mallorca, Mallorca, Spain. [Magid, David J.] Univ Colorado, Colorado Sch Publ Hlth, Denver, CO 80202 USA. [Mant, Jonathan] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England. [Margolis, Karen L.] HealthPartners Inst Educ & Res, Minneapolis, MN USA. [McKinstry, Brian] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland. [McLaughlin, Mary Ann] Icahn Sch Med Mt Sinai, New York, NY 10029 USA. [Omboni, Stefano] Italian Inst Telemed, Clin Res Unit, Varese, Italy. [Ogedegbe, Olugbenga] NYU, Langone Sch Med, Ctr Healthful Behav Change, Div Hlth & Behav,Dept Populat Hlth, New York, NY USA. [Parati, Gianfranco] San Luca Hosp, Ist Auxol Italiano, IRCCS, Dept Cardiovasc Neural & Metab Sci, Milan, Italy. [Parati, Gianfranco] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy. [Qamar, Nashat] Univ Birmingham, Primary Care Clin Sci, Birmingham, W Midlands, England. [Tabaei, Bahman P.] New York City Dept Hlth & Mental Hyg, Div Prevent & Primary Care, New York, NY USA. [Verberk, Willem J.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands. [Verberk, Willem J.] Maastricht Univ, Dept Internal Med, Maastricht, Netherlands. [Wakefield, Bonnie J.] Iowa City VA Med Ctr, Ctr Comprehens Access & Delivery Res & Evaluat CA, Dept Vet VA, Hlth Serv Res & Dev, Iowa City, IA USA.
McManus, RJ (reprint author), Univ Oxford, Nuffield Dept Primary Care, Oxford, England.
richard.mcmanus@phc.ox.ac.uk
AN  - WOS:000411970300009
AU  - Tucker, K. L.
AU  - Sheppard, J. P.
AU  - Stevens, R.
AU  - Bosworth, H. B.
AU  - Bove, A.
AU  - Bray, E. P.
AU  - Earley, K.
AU  - George, J.
AU  - Godwin, M.
AU  - Greee, B. B.
AU  - Hebert, P.
AU  - Hobbs, F. D. R.
AU  - Kantola, I.
AU  - Kerry, S. M.
AU  - Leiva, A.
AU  - Magid, D. J.
AU  - Mant, J.
AU  - Margolis, K. L.
AU  - McKinstry, B.
AU  - McLaughlin, M. A.
AU  - Omboni, S.
AU  - Ogedegbe, O.
AU  - Parati, G.
AU  - Qamar, N.
AU  - Tabaei, B. P.
AU  - Varis, J.
AU  - Verberk, W. J.
AU  - Wakefield, B. J.
AU  - McManus, R. J.
C7  - e1002389
DA  - Sep
DO  - 10.1371/journal.pmed.1002389
IS  - 9
J2  - PLos Med.
KW  - randomized controlled-trial
masked hypertension
cost-effectiveness
management
intervention
urban
adherence
community
disease
care
General & Internal Medicine
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: FI4TS
Times Cited: 53
Cited Reference Count: 59
Tucker, Katherine L. Sheppard, James P. Stevens, Richard Bosworth, Hayden B. Bove, Alfred Bray, Emma P. Earley, Kenneth George, Johnson Godwin, Marshall Greee, Beverly B. Hebert, Paul Hobbs, F. D. Richard Kantola, Ilkka Kerry, Sally M. Leiva, Alfonso Magid, David J. Mant, Jonathan Margolis, Karen L. McKinstry, Brian McLaughlin, Mary Ann Omboni, Stefano Ogedegbe, Olugbenga Parati, Gianfranco Qamar, Nashat Tabaei, Bahman P. Varis, Juha Verberk, Willem J. Wakefield, Bonnie J. McManus, Richard J.
Parati, Gianfranco/K-7151-2016; Omboni, Stefano/D-1327-2015; QQ, Simon/D-3888-2014
Parati, Gianfranco/0000-0001-9402-7439; Omboni, Stefano/0000-0002-7124-2096; George, Johnson/0000-0002-0326-0495; Margolis, Karen/0000-0003-1862-7402; Sheppard, James/0000-0002-4461-8756; Tucker, Katherine/0000-0001-6544-8066; Stevens, Richard/0000-0002-9258-4060
Institute for Health Research School for Primary Care Research (NIHR SPCR) [112]; NIHR Professorship [NIHR-RP-02-12-015]; FDRH
This research was funded by the Institute for Health Research School for Primary Care Research (NIHR SPCR number 112) and via an NIHR Professorship for RM (NIHR-RP-02-12-015). JS holds a Medical Research Council (MRC) Strategic Skills Postdoctoral Fellowship (MR/K022032/1). FDRH is part funded as Director of the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR), Theme Leader of the NIHR Oxford Biomedical Research Centre (BRC), and Director of the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
53
2
8
Public library science
San francisco
1549-1676
PY  - 2017
SN  - 1549-1277
SP  - 29
ST  - Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis
T2  - Plos Medicine
TI  - Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis
UR  - <Go to ISI>://WOS:000411970300009
VL  - 14
ID  - 53
ER  - 

TY  - JOUR
AD  - [Tucker, Katherine L.; Sheppard, James P.; Stevens, Richard; Hobbs, F. D. Richard; McManus, Richard J.] Univ Oxford, Nuffield Dept Primary Care, Oxford OX1 2JD, England. [Bosworth, Hayden B.] Durham VAMC, Ctr Hlth Serv Res Primary Care, Durham, NC USA. [Bove, Alfred] Temple Univ, Sch Med, Cardiol, Philadelphia, PA 19122 USA. [Bray, Emma P.; Qamar, Nashat] Univ Birmingham, Primary Care Clin Sci, Birmingham, W Midlands, England. [Godwin, Marshal] Mem Univ Newfoundland, Family Med, St John, NF, Canada. [Green, Beverly] Grp Hlth Res Inst, Seattle, WA USA. [Hebert, Paul] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Washington, DC USA. [Kantola, Ilkka; Varis, Juha] Turku Univ Hosp, Dept Med, Turku, Finland. [Kerry, Sally] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England. [Magid, David J.] Univ Colorado, Colorado Sch Publ Hlth, Denver, CO 80202 USA. [Mant, Jonathan] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge CB2 1TN, England. [Margolis, Karen L.] HealthPartners Inst Educ & Res, Minneapolis, MN USA. [McKinstry, Brian] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9YL, Midlothian, Scotland. [Omboni, Stefano] Italian Inst Telemed, Clin Res Unit, Varese, Italy. [Ogedegbe, Olugbenga] NYU, Langone Sch Med, Ctr Healthful Behav Change, Div Hlth & Behav,Dept Populat Hlth, New York, NY USA. [Parati, Gianfranco] Univ Milano Bicocca, Dept Cardiol, Milan, Italy. [Parati, Gianfranco] Univ Milano Bicocca, Dept Clin Med & Prevent, Milan, Italy. [Verberk, Willem] Maastricht Univ, Cardiovasc Res Inst, Maastricht, Netherlands. [Wakefield, Bonnie J.] Univ Iowa, Dept Vet VA Hlth Serv, Dept Vet VA Hlth Serv Res & Dev, Ctr Comprehens Access & Delivery Res & Evaluat CA, Iowa City, IA 52242 USA.
AN  - WOS:000360986400033
AU  - Tucker, K. L.
AU  - Sheppard, J. P.
AU  - Stevens, R.
AU  - Bosworth, H. B.
AU  - Bove, A.
AU  - Bray, E. P.
AU  - Godwin, M.
AU  - Green, B.
AU  - Hebert, P.
AU  - Hobbs, F. D. R.
AU  - Kantola, I.
AU  - Kerry, S.
AU  - Magid, D. J.
AU  - Mant, J.
AU  - Margolis, K. L.
AU  - McKinstry, B.
AU  - Omboni, S.
AU  - Ogedegbe, O.
AU  - Parati, G.
AU  - Qamar, N.
AU  - Varis, J.
AU  - Verberk, W.
AU  - Wakefield, B. J.
AU  - McManus, R. J.
DA  - Oct
IS  - 10
J2  - J. Hum. Hypertens.
KW  - Cardiovascular System & Cardiology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: CR0CS
Times Cited: 1
Cited Reference Count: 0
Tucker, Katherine L. Sheppard, James P. Stevens, Richard Bosworth, Hayden B. Bove, Alfred Bray, Emma P. Godwin, Marshal Green, Beverly Hebert, Paul Hobbs, F. D. Richard Kantola, Ilkka Kerry, Sally Magid, David J. Mant, Jonathan Margolis, Karen L. McKinstry, Brian Omboni, Stefano Ogedegbe, Olugbenga Parati, Gianfranco Qamar, Nashat Varis, Juha Verberk, Willem Wakefield, Bonnie J. McManus, Richard J.
Omboni, Stefano/D-1327-2015
Omboni, Stefano/0000-0002-7124-2096
1
0
2
Nature publishing group
London
1476-5527
PY  - 2015
SN  - 0950-9240
SP  - 635-635
ST  - Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART)
T2  - Journal of Human Hypertension
TI  - Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART)
UR  - <Go to ISI>://WOS:000360986400033
VL  - 29
ID  - 105
ER  - 

TY  - JOUR
AB  - Introduction: Self-monitoring of blood pressure is effective in reducing blood pressure in hypertension. However previous meta-analyses have shown a considerable amount of heterogeneity between studies, only part of which can be accounted for by meta-regression. This may be due to differences in design, recruited populations, intervention components or results among patient subgroups. To further investigate these differences, an individual patient data (IPD) meta-analysis of self-monitoring of blood pressure will be performed. Methods and analysis: We will identify randomised trials that have compared patients with hypertension who are self-monitoring blood pressure with those who are not and invite trialists to provide IPD including clinic and/or ambulatory systolic and diastolic blood pressure at baseline and all follow-up points where both intervention and control groups were measured. Other data requested will include measurement methodology, length of follow-up, cointerventions, baseline demographic (age, gender) and psychosocial factors (deprivation, quality of life), setting, intensity of self-monitoring, self-monitored blood pressure, comorbidities, lifestyle factors (weight, smoking) and presence or not of antihypertensive treatment. Data on all available patients will be included in order to take an intention-to-treat approach. A two-stage procedure for IPD meta-analysis, stratified by trial and taking into account age, sex, diabetes and baseline systolic BP will be used. Exploratory subgroup analyses will further investigate non-linear relationships between the prespecified variables. Sensitivity analyses will assess the impact of trials which have and have not provided IPD. Ethics and dissemination: This study does not include identifiable data. Results will be disseminated in a peer-reviewed publication and by international conference presentations. Conclusions: IPD analysis should help the understanding of which self-monitoring interventions for which patient groups are most effective in the control of blood pressure.
AD  - [Tucker, Katherine L.; Sheppard, James P.; Stevens, Richard; Hobbs, F. D. Richard; McManus, Richard J.] Univ Oxford, Nuffield Dept Primary Care, Oxford, England. [Bosworth, Hayden B.] Durham VAMC, Ctr Hlth Serv Res Primary Care, Durham, NC USA. [Bray, Emma P.] Temple Univ, Sch Med, Dept Cardiol, Philadelphia, PA 19122 USA. [Bray, Emma P.] Univ Cent Lancashire, Sch Psychol, Preston PR1 2HE, Lancs, England. [Godwin, Marshal] Mem Univ Newfoundland, Family Med, St John, NF, Canada. [Green, Beverly] Grp Hlth Res Inst, Seattle, WA USA. [Hebert, Paul] Univ Washington, Sch Publ Hlth, Dept Hlth Sci, Washington, DC USA. [Kantola, Ilkka; Varis, Juha] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland. [Kerry, Sally] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England. [Magid, David J.] Univ Colorado, Colorado Sch Publ Hlth, Denver, CO 80202 USA. [Mant, Jonathan] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England. [Margolis, Karen L.] Hlth Partners Inst Educ & Res, Minneapolis, MN USA. [McKinstry, Brian] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland. [Omboni, Stefano] Italian Inst Telemed, Clin Res Unit, Solbiate Arno, Varese, Italy. [Ogedegbe, Olugbenga] NYU, Langone Sch Med, Ctr Healthful Behav Change, Dept Populat Hlth,Div Hlth & Behav, New York, NY USA. [Parati, Gianfranco] Univ Milano Bicocca, Dept Cardiol, Milan, Italy. [Parati, Gianfranco] Univ Milano Bicocca, Dept Clin Med & Prevent, Milan, Italy. [Qamar, Nashat] Univ Birmingham, Primary Care Clin Sci, Birmingham, W Midlands, England. [Verberk, Willem] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Internal Med, Maastricht, Netherlands. [Wakefield, Bonnie J.] Univ Iowa, Iowa City VA Med Ctr, Dev Ctr Comprehens Access & Delivery Res & Evalua, Dept Vet VA Hlth Serv Res, Iowa City, IA USA.
McManus, RJ (reprint author), Univ Oxford, Nuffield Dept Primary Care, Oxford, England.
Richard.McManus@phc.ox.ac.uk
AN  - WOS:000363484000065
AU  - Tucker, K. L.
AU  - Sheppard, J. P.
AU  - Stevens, R.
AU  - Bosworth, H. B.
AU  - Bove, A.
AU  - Bray, E. P.
AU  - Godwin, M.
AU  - Green, B.
AU  - Hebert, P.
AU  - Hobbs, F. D. R.
AU  - Kantola, I.
AU  - Kerry, S.
AU  - Magid, D. J.
AU  - Mant, J.
AU  - Margolis, K. L.
AU  - McKinstry, B.
AU  - Omboni, S.
AU  - Ogedegbe, O.
AU  - Parati, G.
AU  - Qamar, N.
AU  - Varis, J.
AU  - Verberk, W.
AU  - Wakefield, B. J.
AU  - McManus, R. J.
C7  - e008532
DO  - 10.1136/bmjopen-2015-008532
IS  - 9
J2  - BMJ Open
KW  - cost-effectiveness
home
hypertension
trials
office
stroke
General & Internal Medicine
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: CU4FZ
Times Cited: 5
Cited Reference Count: 21
Tucker, Katherine L. Sheppard, James P. Stevens, Richard Bosworth, Hayden B. Bove, Alfred Bray, Emma P. Godwin, Marshal Green, Beverly Hebert, Paul Hobbs, F. D. Richard Kantola, Ilkka Kerry, Sally Magid, David J. Mant, Jonathan Margolis, Karen L. McKinstry, Brian Omboni, Stefano Ogedegbe, Olugbenga Parati, Gianfranco Qamar, Nashat Varis, Juha Verberk, Willem Wakefield, Bonnie J. McManus, Richard J.
Parati, Gianfranco/K-7151-2016; Omboni, Stefano/D-1327-2015
Parati, Gianfranco/0000-0001-9402-7439; Omboni, Stefano/0000-0002-7124-2096; Margolis, Karen/0000-0003-1862-7402; Sheppard, James/0000-0002-4461-8756; Varis, Juha/0000-0003-3987-7371; hobbs, richard/0000-0001-7976-7172; Mant, Jonathan/0000-0002-9531-0268
National Institute for Health Research School for Primary Care Research (NIHR SPCR) [112]; NIHRNational Institute for Health Research (NIHR) [NIHR-RP-02-12-015]; Medical Research Council (MRC)Medical Research Council UK (MRC); National Institute for Health ResearchNational Institute for Health Research (NIHR) [CDF/01/017, NF-SI-0611-10273, RP-PG-1209-10051, NIHR-RP-02-12-015]
This research was funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR number 112) and via an NIHR Professorship for RJMcM (NIHR-RP-02-12-015). JS holds a Medical Research Council (MRC) Strategic Skills Postdoctoral Fellowship. The views expressed are those of the author(s) and not necessarily those of the NIHR, the NHS or the Department of Health.
5
0
4
Bmj publishing group
London
PY  - 2015
SN  - 2044-6055
SP  - 5
ST  - Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART): a protocol
T2  - Bmj Open
TI  - Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART): a protocol
UR  - <Go to ISI>://WOS:000363484000065
VL  - 5
ID  - 127
ER  - 

TY  - JOUR
AB  - Background The early period following the onset of acute coronary syndrome (ACS) represents a critical stage of coronary heart disease, with a high risk of recurrent events and deaths. The short-term effects of early treatment with statins on patient-relevant outcomes in patients suffering from ACS are unclear. This is an update of a review previously published in 2011. Objectives To assess the effects, both harms and benefits, of early administered statins in patients with ACS, in terms of mortality and cardiovascular events. Search methods We updated the searches of CENTRAL (2013, Issue 3), MEDLINE (Ovid) (1946 to April Week 1 2013), EMBASE (Ovid) (1947 to 2013 Week 14), and CINAHL (EBSCO) (1938 to 2013) on 12 April 2013. We applied no language restrictions. We supplemented the search by contacting experts in the field, by reviewing the reference lists of reviews and editorials on the topic, and by searching trial registries. Selection criteria Randomized controlled trials (RCTs) comparing statins with placebo or usual care, with initiation of statin therapy within 14 days following the onset of ACS, follow-up of at least 30 days, and reporting at least one clinical outcome. Data collection and analysis Two authors independently assessed risk of bias and extracted data. We calculated risk ratios (RRs) for all outcomes in the treatment and control groups and pooled data using random-effects models. Main results Eighteen studies (14,303 patients) compared early statin treatment versus placebo or no treatment in patients with ACS. The new search did not identify any new studies for inclusion. There were some concerns about risk of bias and imprecision of summary estimates. Based on moderate quality evidence, early statin therapy did not decrease the combined primary outcome of death, non-fatal myocardial infarction, and stroke at one month (risk ratio (RR) 0.93, 95% confidence interval (CI) 0.80 to 1.08) or four months (RR 0.93, 95% CI 0.81 to 1.06) of follow-up when compared to placebo or no treatment. There were no statistically significant risk reductions from statins for total death, total myocardial infarction, total stroke, cardiovascular death, revascularization procedures, and acute heart failure at one month or at four months, although there were favorable trends related to statin use for each of these endpoints. Moderate quality evidence suggests that the incidence of unstable angina was significantly reduced at four months following ACS (RR 0.76, 95% CI 0.59 to 0.96). There were nine individuals with myopathy (elevated creatinine kinase levels more than 10 times the upper limit of normal) in statin-treated patients (0.13%) versus one (0.015%) in the control groups. Serious muscle toxicity was mostly limited to patients treated with simvastatin 80 mg. Authors' conclusions Based on moderate quality evidence, due to concerns about risk of bias and imprecision, initiation of statin therapy within 14 days following ACS does not reduce death, myocardial infarction, or stroke up to four months, but reduces the occurrence of unstable angina at four months following ACS. Serious side effects were rare.
AD  - [Vale, Noah] McGill Univ, St Marys Hosp, Montreal, PQ, Canada. [Nordmann, Alain J.] Univ Basel Hosp, Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland. [Schwartz, Gregory G.] VA Med Ctr, Denver, CO USA. [Schwartz, Gregory G.] Univ Colorado, Denver, CO 80202 USA. [de Lemos, James] Univ Texas Southwestern Med Sch, Dallas, TX USA. [Colivicchi, Furio] S Filippo Neri Hosp, Cardiovasc Dept, Rome, Italy. [den Hartog, Frank] Gelderse Vallei Hosp, Dept Cardiol, Ede, Netherlands. [Ostadal, Petr] Na Homolce Hosp, Dept Cardiol, Prague, Czech Republic. [Macin, Stella M.] Inst Cardiol, Coronary Intens Care Unit, Corrientes, Argentina. [Liem, Anho H.] Franciscus Gasthuis Rotterdam, Dept Cardiol, Rotterdam, Netherlands. [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada. [Bhatnagar, Neera] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada. [Bucher, Heiner C.; Briel, Matthias] Univ Hosp Basel USB, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland.
Briel, M (reprint author), Univ Hosp Basel USB, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland.
matthias.briel@usb.ch
AN  - WOS:000347645800034
AU  - Vale, N.
AU  - Nordmann, A. J.
AU  - Schwartz, G. G.
AU  - de Lemos, J.
AU  - Colivicchi, F.
AU  - den Hartog, F.
AU  - Ostadal, P.
AU  - Macin, S. M.
AU  - Liem, A. H.
AU  - Mills, E. J.
AU  - Bhatnagar, N.
AU  - Bucher, H. C.
AU  - Briel, M.
C7  - Cd006870
DO  - 10.1002/14651858.CD006870.pub3
IS  - 9
J2  - Cochrane Database Syst Rev.
KW  - Acute Coronary Syndrome [drug therapy
mortality]
Angina, Unstable
[prevention & control]
Cardiovascular Diseases [mortality]
Cause of
Death
Drug Administration Schedule
Heart Failure [prevention &
control]
Hydroxymethylglutaryl-CoA Reductase Inhibitors [adverse
effects
therapeutic use]
Myocardial Infarction [prevention & control]
Myocardial Revascularization [utilization]
Randomized Controlled Trials
as Topic
Stroke [prevention & control]
Humans
acute myocardial-infarction
placebo-controlled trial
lipid-lowering
therapy
randomized controlled-trials
dose atorvastatin treatment
unstable angina-pectoris
term clinical-outcomes
adverse cardiac
events
heart-disease
double-blind
General & Internal Medicine
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: AY5YT
Times Cited: 7
Cited Reference Count: 130
Vale, Noah Nordmann, Alain J. Schwartz, Gregory G. de Lemos, James Colivicchi, Furio den Hartog, Frank Ostadal, Petr Macin, Stella M. Liem, Anho H. Mills, Edward J. Bhatnagar, Neera Bucher, Heiner C. Briel, Matthias
Briel, Matthias/0000-0002-2070-5230
Santesuisse, Switzerland; Gottfried and Julia Bangerter-Rhyner-Foundation, Switzerland
Internal sources; Santesuisse, Switzerland.; Gottfried and Julia Bangerter-Rhyner-Foundation, Switzerland.
7
0
10
Wiley
Hoboken
1361-6137
PY  - 2014
SN  - 1469-493X
SP  - 125
ST  - Statins for acute coronary syndrome
T2  - Cochrane Database of Systematic Reviews
TI  - Statins for acute coronary syndrome
UR  - <Go to ISI>://WOS:000347645800034
ID  - 153
ER  - 

TY  - JOUR
AB  - OBJECTIVES: To determine, using systematic review of the biomedical literature, whether pacing reduces risk of recurrent syncope and relevant clinical outcomes among adult patients with reflex-mediated syncope. METHODS: MEDLINE (through PubMed), EMBASE, and the Cochrane Central Register of Controlled Trials (through October 7, 2015) were searched for randomized trials and observational studies examining pacing and syncope, and the bibliographies of known systematic reviews were also examined. Studies were rejected for poor-quality study methods and for the lack of the population, intervention, comparator, or outcome(s) of interest. RESULTS: Of 3188 citations reviewed, 10 studies met the inclusion criteria for systematic review, including a total of 676 patients. These included 9 randomized trials and 1 observational study. Of the 10 studies, 4 addressed patients with carotid sinus hypersensitivity, and the remaining 6 addressed vasovagal syncope. Among the 6 open-label (unblinded) studies, we found that pacing was associated with a 70% reduction in recurrent syncope (relative risk [RR]: 0.30; 95% confidence interval [CI]: 0.15-0.60). When the 2 analyzable studies with double-blinded methodology were considered separately, there was no clear benefit (RR: 0.73; 95% CI: 0.25-2.1), but confidence intervals were wide. The strongest evidence was from the randomized, double-blinded ISSUE-3 (Third International Study on Syncope of Uncertain Etiology) trial, which demonstrated a benefit of pacing among patients with recurrent syncope and asystole documented by implantable loop recorder. CONCLUSIONS: There are limited data with substantive evidence of outcome ascertainment bias, and only 2 studies with a double-blinded study design have been conducted. The evidence does not support the use of pacing for reflex-mediated syncope beyond patients with recurrent vasovagal syncope and asystole documented by implantable loop recorder.
AD  - [Varosy, Paul D.] Univ Colorado Hosp, Clin Cardiac EP Training Program, Aurora, CO 80045 USA. [Varosy, Paul D.] VA Eastern Colorado Healthcare Syst, Cardiovasc EP, Denver, CO 80220 USA. [Chen, Lin Y.] Univ Minnesota, Med Sch, Med, Minneapolis, MN 55455 USA. [Miller, Amy L.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Med, Boston, MA USA. [Noseworthy, Peter A.] Mayo Clin, Coll Med, Med, Rochester, MN USA. [Slotwiner, David J.] New York Presbyterian Queens, Div Cardiol, Flushing, NY USA. [Slotwiner, David J.] Weill Cornell Med, New York, NY USA. [Thiruganasambandamoorthy, Venkatesh] Ottawa Hosp Res Inst, Ottawa, ON, Canada.
Varosy, PD (reprint author), Univ Colorado Hosp, Clin Cardiac EP Training Program, Aurora, CO 80045 USA.; Varosy, PD (reprint author), VA Eastern Colorado Healthcare Syst, Cardiovasc EP, Denver, CO 80220 USA.
AN  - WOS:000406576100001
AU  - Varosy, P. D.
AU  - Chen, L. Y.
AU  - Miller, A. L.
AU  - Noseworthy, P. A.
AU  - Slotwiner, D. J.
AU  - Thiruganasambandamoorthy, V.
DA  - Aug
DO  - 10.1161/cir.0000000000000500
IS  - 5
J2  - Circulation
KW  - AHA Scientific Statements
Evidence Review Committee
pacemaker
pacing
reflex syncope
syncope
syncope-diagnosis
vasovagal syncope
randomized-trial
cardioinhibitory syncope
pacemaker therapy
multicenter
prevention
blind
pace
vps
Cardiovascular System & Cardiology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FC1CX
Times Cited: 8
Cited Reference Count: 25
Varosy, Paul D. Chen, Lin Y. Miller, Amy L. Noseworthy, Peter A. Slotwiner, David J. Thiruganasambandamoorthy, Venkatesh
8
1
7
Lippincott williams & wilkins
Philadelphia
1524-4539
PY  - 2017
SN  - 0009-7322
SP  - E123-+
ST  - Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
T2  - Circulation
TI  - Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
UR  - <Go to ISI>://WOS:000406576100001
VL  - 136
ID  - 54
ER  - 

TY  - JOUR
AB  - OBJECTIVES To determine, using systematic review of the biomedical literature, whether pacing reduces risk of recurrent syncope and relevant clinical outcomes among adult patients with reflex-mediated syncope. METHODS MEDLINE (through PubMed), EMBASE, and the Cochrane Central Register of Controlled Trials (through October 7, 2015) were searched for randomized trials and observational studies examining pacing and syncope, and the bibliographies of known systematic reviews were also examined. Studies were rejected for poor-quality study methods and for the lack of the population, intervention, comparator, or outcome(s) of interest. RESULTS Of 3,188 citations reviewed, 10 studies met the inclusion criteria for systematic review, including a total of 676 patients. These included 9 randomized trials and 1 observational study. Of the 10 studies, 4 addressed patients with carotid sinus hypersensitivity, and the remaining 6 addressed vasovagal syncope. Among the 6 open-label (unblinded) studies, we found that pacing was associated with a 70% reduction in recurrent syncope (relative risk [RR]: 0.30; 95% confidence interval [CI]: 0.15-0.60). When the 2 analyzable studies with double-blinded methodology were considered separately, there was no clear benefit (RR: 0.73; 95% CI: 0.25-2.1), but confidence intervals were wide. The strongest evidence was from the randomized, double-blinded ISSUE-3 (Third International Study on Syncope of Uncertain Etiology) trial, which demonstrated a benefit of pacing among patients with recurrent syncope and asystole documented by implantable loop recorder. CONCLUSIONS There are limited data with substantive evidence of outcome ascertainment bias, and only 2 studies with a double-blinded study design have been conducted. The evidence does not support the use of pacing for reflex-mediated syncope beyond patients with recurrent vasovagal syncope and asystole documented by implantable loop recorder.
AD  - [Varosy, Paul D.] Univ Colorado Hosp, Clin Cardiac EP Training Program, Aurora, CO 80045 USA. [Varosy, Paul D.] VA Eastern Colorado Healthcare Syst, Denver, CO 80220 USA. [Chen, Lin Y.] Univ Minnesota, Med Sch, Cardiovasc EP, Minneapolis, MN 55455 USA. [Miller, Amy L.] Med Brighman & Womens Hosp, Harvard Med Sch, Boston, MA USA. [Noseworthy, Peter A.] Mayo Clin, Coll Med, Med, Rochester, MN USA. [Slotwiner, David J.] New York Presbyterian Queens, Div Cardiol, Whitestone, NY USA. [Slotwiner, David J.] Weill Cornell Med, New York, NY USA. [Thiruganasambandamoorthy, Venkatesh] Ottawa Hosp Res Inst, Ottawa, ON, Canada.
Varosy, PD (reprint author), Univ Colorado Hosp, Clin Cardiac EP Training Program, Aurora, CO 80045 USA.
AN  - WOS:000406496700003
AU  - Varosy, P. D.
AU  - Chen, L. Y.
AU  - Miller, A. L.
AU  - Noseworthy, P. A.
AU  - Slotwiner, D. J.
AU  - Thiruganasambandamoorthy, V.
DA  - Aug
DO  - 10.1016/j.hrthm.2017.03.006
IS  - 8
J2  - Heart Rhythm
KW  - ACC/AHA clinical practice guidelines
Evidence Review Committee
Pacemaker
Pacing
Reflex syncope
Syncope
Syncope-diagnosis
Vasovagal
syncope
randomized-trial
cardioinhibitory syncope
pacemaker therapy
multicenter
prevention
blind
pace
vps
Cardiovascular System & Cardiology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FB9ZA
Times Cited: 5
Cited Reference Count: 24
Varosy, Paul D. Chen, Lin Y. Miller, Amy L. Noseworthy, Peter A. Slotwiner, David J. Thiruganasambandamoorthy, Venkatesh
Slotwiner, David/L-6207-2019
6
0
3
Elsevier science inc
New york
1556-3871
PY  - 2017
SN  - 1547-5271
SP  - E255-E269
ST  - Pacing as a treatment for reflex-mediated (vasovagal, situational, or carotid sinus hypersensitivity) syncope: A systematic review for the 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope
T2  - Heart Rhythm
TI  - Pacing as a treatment for reflex-mediated (vasovagal, situational, or carotid sinus hypersensitivity) syncope: A systematic review for the 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope
UR  - <Go to ISI>://WOS:000406496700003
VL  - 14
ID  - 56
ER  - 

TY  - JOUR
AB  - OBJECTIVES To determine, using systematic review of the biomedical literature, whether pacing reduces risk of recurrent syncope and relevant clinical outcomes among adult patients with reflex-mediated syncope. METHODS MEDLINE (through PubMed), EMBASE, and the Cochrane Central Register of Controlled Trials (through October 7, 2015) were searched for randomized trials and observational studies examining pacing and syncope, and the bibliographies of known systematic reviews were also examined. Studies were rejected for poor-quality study methods and for the lack of the population, intervention, comparator, or outcome(s) of interest. RESULTS Of 3,188 citations reviewed, 10 studies met the inclusion criteria for systematic review, including a total of 676 patients. These included 9 randomized trials and 1 observational study. Of the 10 studies, 4 addressed patients with carotid sinus hypersensitivity, and the remaining 6 addressed vasovagal syncope. Among the 6 open-label (unblinded) studies, we found that pacing was associated with a 70% reduction in recurrent syncope (relative risk [RR]: 0.30; 95% confidence interval [CI]: 0.15- 0.60). When the 2 analyzable studies with double-blinded methodology were considered separately, there was no clear benefit (RR: 0.73; 95% CI: 0.25- 2.1), but confidence intervals were wide. The strongest evidence was from the randomized, double-blinded ISSUE- 3 (Third International Study on Syncope of Uncertain Etiology) trial, which demonstrated a benefit of pacing among patients with recurrent syncope and asystole documented by implantable loop recorder. CONCLUSIONS There are limited data with substantive evidence of outcome ascertainment bias, and only 2 studies with a double-blinded study design have been conducted. The evidence does not support the use of pacing for reflex-mediated syncope beyond patients with recurrent vasovagal syncope and asystole documented by implantable loop recorder.
AD  - [Varosy, Paul D.] Univ Colorado Hosp, Clin Cardiac EP Training Program, Aurora, CO 80045 USA. [Varosy, Paul D.] VA Eastern Colorado Healthcare Syst, Cardiovasc EP, Denver, CO 80220 USA. [Chen, Lin Y.] Univ Minnesota, Med Sch, Med, Minneapolis, MN 55455 USA. [Miller, Amy L.] Harvard Med Sch, Brighman & Womens Hosp, Cardiovasc Med, Boston, MA USA. [Noseworthy, Peter A.] Mayo Clin, Coll Med, Med, Rochester, MN USA. [Slotwiner, David J.] New York Presbyterian Queens, Div Cardiol, Flushing, NY USA. [Slotwiner, David J.] Weill Cornell Med, New York, NY USA. [Thiruganasambandamoorthy, Venkatesh] Ottawa Hosp Res Inst, Ottawa, ON, Canada.
Varosy, PD (reprint author), Univ Colorado Hosp, Clin Cardiac EP Training Program, Aurora, CO 80045 USA.; Varosy, PD (reprint author), VA Eastern Colorado Healthcare Syst, Cardiovasc EP, Denver, CO 80220 USA.
AN  - WOS:000406176000015
AU  - Varosy, P. D.
AU  - Chen, L. Y.
AU  - Miller, A. L.
AU  - Noseworthy, P. A.
AU  - Slotwiner, D. J.
AU  - Thiruganasambandamoorthy, V.
AU  - Levine, G. N.
AU  - O'Gara, P. T.
AU  - Halperin, J. L.
AU  - Al-Khatib, S. M.
AU  - Birtcher, K. K.
AU  - Bozkurt, B.
AU  - Brindis, R. G.
AU  - Cigarroa, J. E.
AU  - Curtis, L. H.
AU  - Fleisher, L. A.
AU  - Gentile, F.
AU  - Gidding, S.
AU  - Hlatky, M. A.
AU  - Ikonomidis, J.
AU  - Joglar, J.
AU  - Pressler, S. J.
AU  - Wijeysundera, D. N.
DA  - Aug
DO  - 10.1016/j.jacc.2017.03.004
IS  - 5
J2  - J. Am. Coll. Cardiol.
KW  - ACC/AHA Clinical Practice Guidelines
Evidence Review Committee
pacemaker
pacing
reflex syncope
syncope
syncope-diagnosis
vasovagal
syncope
cardioinhibitory syncope
pacemaker therapy
trial
metaanalyses
multicenter
prevention
blind
vps
Cardiovascular System & Cardiology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FB5IZ
Times Cited: 7
Cited Reference Count: 25
Varosy, Paul D. Chen, Lin Y. Miller, Amy L. Noseworthy, Peter A. Slotwiner, David J. Thiruganasambandamoorthy, Venkatesh Levine, Glenn N. O'Gara, Patrick T. Halperin, Jonathan L. Al-Khatib, Sana M. Birtcher, Kim K. Bozkurt, Biykem Brindis, Ralph G. Cigarroa, Joaquin E. Curtis, Lesley H. Fleisher, Lee A. Gentile, Federico Gidding, Samuel Hlatky, Mark A. Ikonomidis, John Joglar, Jose Pressler, Susan J. Wijeysundera, Duminda N.
Slotwiner, David/L-6207-2019; Fleisher, Lee/Q-9894-2019
7
1
5
Elsevier science inc
New york
1558-3597
PY  - 2017
SN  - 0735-1097
SP  - 664-679
ST  - Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
T2  - Journal of the American College of Cardiology
TI  - Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
UR  - <Go to ISI>://WOS:000406176000015
VL  - 70
ID  - 55
ER  - 

TY  - JOUR
AD  - [Vollmer, T.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA. [Signorovitch, J. E.; Huynh, L.; Galebach, P.; Kelley, C.] Anal Grp Inc, Boston, MA USA. [Marvel, J.; Di Bernardo, A.; Sasane, R.] Novartis Pharmaceut, E Hanover, NJ USA.
AN  - WOS:000354441300614
AU  - Vollmer, T.
AU  - Signorovitch, J. E.
AU  - Huynh, L.
AU  - Galebach, P.
AU  - Kelley, C.
AU  - Marvel, J.
AU  - Di Bernardo, A.
AU  - Sasane, R.
DA  - Sep
J2  - Mult. Scler. J.
KW  - Neurosciences & Neurology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: CI0QA
Times Cited: 0
Cited Reference Count: 0
Vollmer, T. Signorovitch, J. E. Huynh, L. Galebach, P. Kelley, C. Marvel, J. Di Bernardo, A. Sasane, R.
Joint ACTRIMS-ECTRIMS Meeting
Sep 10-13, 2014
Boston, MA
Actrims, ectrims
0
Sage publications ltd
London
1477-0970
1
PY  - 2014
SN  - 1352-4585
SP  - 268-268
ST  - The natural history of brain volume loss among patients with multiple sclerosis: a systematic literature review and meta-analysis
T2  - Multiple Sclerosis Journal
TI  - The natural history of brain volume loss among patients with multiple sclerosis: a systematic literature review and meta-analysis
UR  - <Go to ISI>://WOS:000354441300614
VL  - 20
ID  - 134
ER  - 

TY  - JOUR
AD  - [Wadden, Thomas A.; Hong, Patricia S.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA. [Butryn, Meghan L.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA. [Tsai, Adam G.] Univ Colorado, Sch Med, Aurora, CO USA. [Tsai, Adam G.] Kaiser Permanente Colorado, Denver, CO USA.
Wadden, TA (reprint author), Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.
AN  - WOS:000351009800013
AU  - Wadden, T. A.
AU  - Butryn, M. L.
AU  - Hong, P. S.
AU  - Tsai, A. G.
DA  - Mar
DO  - 10.1097/01.ogx.0000462918.65978.4f
IS  - 3
J2  - Obstet. Gynecol. Surv.
KW  - Obstetrics & Gynecology
LA  - English
M3  - Editorial Material
N1  - ISI Document Delivery No.: CD3VD
Times Cited: 1
Cited Reference Count: 0
Wadden, Thomas A. Butryn, Meghan L. Hong, Patricia S. Tsai, Adam G.
1
0
4
Lippincott williams & wilkins
Philadelphia
1533-9866
PY  - 2015
SN  - 0029-7828
SP  - 174-175
ST  - Behavioral Treatment of Obesity in Patients Encountered in Primary Care Settings: A Systematic Review
T2  - Obstetrical & Gynecological Survey
TI  - Behavioral Treatment of Obesity in Patients Encountered in Primary Care Settings: A Systematic Review
UR  - <Go to ISI>://WOS:000351009800013
VL  - 70
ID  - 119
ER  - 

TY  - JOUR
AB  - Objective Traditional Chinese Medicine (TCM) is used in China as part of the treatment for non-small-cell lung cancer (NSCLC) and often includes prescription of herbal therapy based on syndrome differentiation. Studies of various Astragalus-based Chinese medicines combined with platinum-based chemotherapy in the treatment of lung cancer are popular in East Asia, particularly in China. The aim of the present study was to perform a systematic review and meta-analysis comparing platinum-based chemotherapy alone with platinum-based chemotherapy plus Astragalus-based Chinese botanicals, with and without prescription based on syndrome differentiation, as first-line treatment for advanced NSCLC. Methods We searched the Chinese Biomedical Literature database, the China National Knowledge Internet, the VIP Chinese Science and Technology Periodicals Database, PubMed, EMBASE, the Cochrane databases, and abstracts presented at meetings of the American Society of Clinical Oncology, the World Conference on Lung Cancer, the European Society for Medical Oncology, and the Chinese Society of Clinical Oncology for all eligible studies. Endpoints were overall survival; 1-year, 2-year, and 3-year survival rates; performance status; overall response rate; and grade 3 or 4 adverse events. Subgroup analyses based on herbal formulae individualized using syndrome differentiation or on oral or injection patent medicines were performed using the Stata software application (version 11.0: StataCorp LP, College Station, TX, U.S.A.) and a fixed-effects or random-effects model in case of heterogeneity. Results are expressed as a hazard ratio (HR) or relative risk (RR), with corresponding 95% confidence intervals (CIS). Results Seventeen randomized studies with scores on the Jadad quality scale of 2 or more, representing 1552 patients, met the inclusion criteria. Compared with platinum-based chemotherapy alone, the addition of Astragalus-based TCM to chemotherapy was associated with significantly increased overall survival (HR: 0.61; 95% CI: 0.42 to 0.89; p = 0.011); 1-year (RR: 0.73; 95% CI: 0.65 to 0.82; p < 0.001), 2-year (RR: 0.3344; 95% CI: 0.237 to 0.4773; p < 0.001), and 3-year survival rates (RR: 0.30; 95% CI: 0.17 to 0.53; p < 0.001); performance status (RR: 0.43; 95% CI: 0.34 to 0.55; p < 0.001); and tumour overall response rate (RR: 0.7982; 95% CI: 0.715 to 0.89; p < 0.001). Subgroup analyses indicated that Astragalus herbal formulae given based on syndrome differentiation were more effective than Astragalus-based oral and injection patent medicines. Side effects-including anemia, neutropenia, thrombocytopenia, fatigue, poor appetite, nausea, and vomiting-were significantly more frequent with platinumbased chemotherapy alone than when platinum-based chemotherapy was combined with Astragalus-based TCM. Conclusions Astragalus-based Chinese botanical therapy, especially when based on syndrome differentiation, is associated with increased efficacy of platinum-based chemotherapy and decreased platinum-derived toxicities for patients with advanced NSCLC.
AD  - [Wang, S. F.; Huang, Y. L.; Zhang, J.] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, 270 Dongan Rd, Shanghai 200032, Peoples R China. [Wang, S. F.; Wang, Q.; Jiao, L. J.; Zhang, J.; Xu, L.] Longhua Hosp, Dept Oncol, 725 South Wanping Rd, Shanghai 200032, Peoples R China. [Wang, S. F.; Huang, Y. L.; Zhang, J.] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China. [Garfield, D.] Univ Colorado Comprehens, Aurora, CO USA.
Zhang, J (reprint author), Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, 270 Dongan Rd, Shanghai 200032, Peoples R China.; Zhang, J; Xu, L (reprint author), Longhua Hosp, Dept Oncol, 725 South Wanping Rd, Shanghai 200032, Peoples R China.
zhangjie2289@hotmail.com; xulq67@aliyun.com
AN  - WOS:000378056300005
AU  - Wang, S. F.
AU  - Wang, Q.
AU  - Jiao, L. J.
AU  - Huang, Y. L.
AU  - Garfield, D.
AU  - Zhang, J.
AU  - Xu, L.
DA  - Jun
DO  - 10.3747/co.23.2920
IS  - 3
J2  - Curr. Oncol.
KW  - Astragalus
TCM
chemotherapy
advanced non-small-cell lung cancer
quality
herbs
statistics
trials
Oncology
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: DO8TI
Times Cited: 16
Cited Reference Count: 34
Wang, S. F. Wang, Q. Jiao, L. J. Huang, Y. L. Garfield, D. Zhang, J. Xu, L.
Special Scientific Research for Traditional Chinese Medicine [201307006]; National Clinical Sites Project; Shanghai Science and Technology Commission Foundation Key Project; Ministry of Education Returned Scientific Research Foundation; Shanghai Municipal Science and Technology Commission Foundation [14JC1401400]; Trans-Century Training Programme Foundation for the Talents by the State Education Commission; Key Technology Support Project of the Field of Medicine and Agriculture Science, Shanghai Municipal Science and Technology Commission [15411951602]; Longhua Medicial Project [LYTD-25]
This work was supported, in part, by these funders: Special Scientific Research for Traditional Chinese Medicine (no. 201307006, 2013); National Clinical Sites Project for TCM, Longhua Medicial Project (LYTD-25); Shanghai Science and Technology Commission Foundation Key Project; Ministry of Education Returned Scientific Research Foundation; key project, Shanghai Municipal Science and Technology Commission Foundation (no. 14JC1401400); Trans-Century Training Programme Foundation for the Talents by the State Education Commission (to JZ); and Key Technology Support Project of the Field of Medicine and Agriculture Science, Shanghai Municipal Science and Technology Commission (no. 15411951602).
16
2
20
Multimed inc
Toronto
PY  - 2016
SN  - 1198-0052
SP  - E188-E195
ST  - Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis
T2  - Current Oncology
TI  - Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis
UR  - <Go to ISI>://WOS:000378056300005
VL  - 23
ID  - 80
ER  - 

TY  - JOUR
AB  - Background: Patients with posttraumatic stress disorder (PTSD) are at increased risk for adverse consequences from comorbid medical conditions. Nonadherence to medications prescribed to treat those comorbid conditions may help explain this increased risk. We sought to determine the association between PTSD and medication nonadherence and whether it varied according to the type of event inducing the PTSD. Methods: Prospective observational cohort or cross-sectional studies relating PTSD and nonadherence among adults prescribed medications for a chronic medical illness were identified by searching MEDLINE, EMBASE, PsycINFO, the Cochrane Library, CINAHL, SCOPUS, and the PILOTS Database and by hand-searching bibliographies from selected articles. Individual estimates of odds ratios were pooled using random effects metaanalysis with inverse variance weighting. Articles were pooled separately according to whether PTSD was induced by a medical versus non-medical event. Outcomes: Sixteen articles comprising 4483 patients met eligibility criteria. The pooled effect size of the risk of PTSD to medication nonadherence was OR 1.22 (95% CI, 1.06-1.41). Among the 6 studies of medical event-induced PTSD, the OR was 2.08 (95% CI, 1.03-4.18); p = 0.04. Among the 8 studies in which PTSD was not induced by a medical event, the OR was 1.10 (95% CI, 0.99-1.24); p = 0.09. Interpretation: Patients with PTSD were more likely to be nonadherent to medications prescribed for chronic medical conditions - an association that may exist specifically when PTSD was induced by a medical event. Medications may serve as aversive reminders among survivors of acute medical events, magnifying avoidance behaviors characteristic of PTSD.
AD  - [Wasson, Lauren Taggart; Edmondson, Donald; Bring, Rachel; Brondolo, Elena; Falzon, Louise; Konrad, Beatrice; Kronish, Ian M.] Columbia Univ, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY 10032 USA. [Shaffer, Jonathan A.] Univ Colorado, Dept Psychol, Coll Liberal Arts & Sci, Denver, CO 80202 USA.
Wasson, LT (reprint author), Columbia Univ, Med Ctr, 622 West 168th St,PH9-311, New York, NY 10032 USA.
lsw2107@cumc.columbia.edu
AN  - WOS:000438660500016
AU  - Wasson, L. T.
AU  - Shaffer, J. A.
AU  - Edmondson, D.
AU  - Bring, R.
AU  - Brondolo, E.
AU  - Falzon, L.
AU  - Konrad, B.
AU  - Kronish, I. M.
DA  - Jul
DO  - 10.1016/j.jpsychires.2018.02.013
J2  - J. Psychiatr. Res.
KW  - acute coronary syndrome
primary-care
antiretroviral adherence
myocardial-infarction
illness beliefs
heart-disease
war veterans
health-care
symptoms
ptsd
Psychiatry
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GN0LS
Times Cited: 2
Cited Reference Count: 53
Wasson, Lauren Taggart Shaffer, Jonathan A. Edmondson, Donald Bring, Rachel Brondolo, Elena Falzon, Louise Konrad, Beatrice Kronish, Ian M.
Falzon, Louise/0000-0002-9449-6056
Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08 HSO24598]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23 HL112850, R01 HL123368, K23 HL098359, R01 HL117832, P01 HL088117, P01 HL047540, K24 HL084034]
Dr. Wasson was supported by the Agency for Healthcare Research and Quality (AHRQ) (K08 HSO24598). Dr. Shaffer was supported by NHLBI (K23 HL112850). Dr. Kronish was supported by NHLBI (R01 HL123368 and K23 HL098359). Dr. Edmondson was supported by NHLBI (R01 HL117832). Ms. Falzon was supported by NHLBI (P01 HL088117, P01 HL047540 and K24 HL084034). The sponsors had no role in the design or conduct of the study, nor in the collection or interpretation of data, nor in the preparation of the manuscript.
2
4
Pergamon-elsevier science ltd
Oxford
1879-1379
PY  - 2018
SN  - 0022-3956
SP  - 102-109
ST  - Posttraumatic stress disorder and nonadherence to medications prescribed for chronic medical conditions: A meta-analysis
T2  - Journal of Psychiatric Research
TI  - Posttraumatic stress disorder and nonadherence to medications prescribed for chronic medical conditions: A meta-analysis
UR  - <Go to ISI>://WOS:000438660500016
VL  - 102
ID  - 17
ER  - 

TY  - JOUR
AD  - [Wee, C. W.; Kang, H. C.; Wu, H. G.; Chie, E. K.; Park, J. M.; Kim, J. I.] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea. [Huang, C. M.] Kaohsiung Med Univ Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan. [Wang, J. Y.] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan. [Ng, S. Y.] Alfred Hlth Radiat Oncol, Dept Radiat Oncol, Melbourne, Vic, Australia. [Goodman, K. A.] Univ Colorado, Denver Sch Med, Dept Radiat Oncol, Aurora, CO USA.
AN  - WOS:000438676100256
AU  - Wee, C. W.
AU  - Kang, H. C.
AU  - Wu, H. G.
AU  - Chie, E. K.
AU  - Park, J. M.
AU  - Kim, J. I.
AU  - Huang, C. M.
AU  - Wang, J. Y.
AU  - Ng, S. Y.
AU  - Goodman, K. A.
DA  - Apr
DO  - 10.1016/s0167-8140(18)31768-7
J2  - Radiother. Oncol.
KW  - Oncology
Radiology, Nuclear Medicine & Medical Imaging
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GN0PQ
Times Cited: 0
Cited Reference Count: 0
Wee, C. W. Kang, H. C. Wu, H. G. Chie, E. K. Park, J. M. Kim, J. I. Huang, C. M. Wang, J. Y. Ng, S. Y. Goodman, K. A.
37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)
Apr 20-24, 2018
Barcelona, SPAIN
European Soc Radiotherapy & Oncol
0
Elsevier ireland ltd
Clare
1879-0887
1
PY  - 2018
SN  - 0167-8140
SP  - S792-S792
ST  - Meta-analysis comparing gastrointestinal toxicity among radiotherapy techniques in rectal cancer
T2  - Radiotherapy and Oncology
TI  - Meta-analysis comparing gastrointestinal toxicity among radiotherapy techniques in rectal cancer
UR  - <Go to ISI>://WOS:000438676100256
VL  - 127
ID  - 24
ER  - 

TY  - JOUR
AB  - IMPORTANCE Current guidelines recommend treating severe depression with pharmacotherapy. Randomized clinical trials as well as traditional meta-analyses have considerable limitations in testing for moderators of treatment outcomes. OBJECTIVES To conduct a systematic literature search, collect primary data from trials, and analyze baseline depression severity as a moderator of treatment outcomes between cognitive behavioral therapy (CBT) and antidepressant medication (ADM). DATA SOURCES A total of 14 902 abstracts were examined from a comprehensive literature search in PubMed, PsycINFO, EMBASE, and Cochrane Registry of Controlled Trials from 1966 to January 1, 2014. STUDY SELECTION Randomized clinical trials in which CBT and ADM were compared in patients with a DSM-defined depressive disorder were included. DATA EXTRACTION AND SYNTHESIS Study authors were asked to provide primary data from their trial. Primary data from 16 of 24 identified trials (67%), with 1700 outpatients (794 from the CBT condition and 906 from the ADM condition), were included. Missing data were imputed with multiple imputation methods. Mixed-effects models adjusting for study-level differences were used to examine baseline depression severity as a moderator of treatment outcomes. MAIN OUTCOMES AND MEASURES Seventeen-item Hamilton Rating Scale for Depression (HAM-D) and Beck Depression Inventory (BDI). RESULTS There was a main effect of ADM over CBT on the HAM-D (beta = -0.88; P = .03) and a nonsignificant trend on the BDI (beta = -1.14; P = .08, statistical test for trend), but no significant differences in response (odds ratio [OR], 1.24; P = .12) or remission (OR, 1.18; P = .22). Mixed-effects models using the HAM-D indicated that baseline depression severity does not moderate reductions in depressive symptoms between CBT and ADM at outcome (beta = 0.00; P = .96). Similar results were seen using the BDI. Baseline depression severity also did not moderate the likelihood of response (OR, 0.99; P = .77) or remission (OR, 1.00; P = .93) between CBT and ADM. CONCLUSIONS AND RELEVANCE Baseline depression severity did not moderate differences between CBT and ADM on the HAM-D or BDI or in response or remission. This finding cannot be extrapolated to other psychotherapies, to individual ADMs, or to inpatients. However, it offers new and substantial evidence that is of relevance to researchers, physicians and therapists, and patients.
AD  - [Weitz, Erica S.; van Straten, Annemieke; Huibers, Marcus J. H.; Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, NL-1081 BT Amsterdam, Netherlands. [Weitz, Erica S.; van Straten, Annemieke; Huibers, Marcus J. H.; Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands. [Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA. [Twisk, Jos] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands. [David, Daniel; Cristea, Ioana A.] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania. [DeRubeis, Robert J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA. [Dimidjian, Sona] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA. [Dunlop, Boadie W.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA. [Faramarzi, Mahbobeh] Babol Univ Med Sci, Fatemeh Zahra Infertil & Reprod Hlth Res Ctr, Babol Sar, Iran. [Hegerl, Ulrich; Mergl, Roland] Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany. [Jarrett, Robin B.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA. [Kheirkhah, Farzan] Babol Univ Med Sci, Fac Med, Dept Psychiat, Babol Sar, Iran. [Kennedy, Sidney H.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada. [Miranda, Jeanne] Univ Calif Los Angeles, Inst Neuropsychiat, Hlth Serv Res Ctr, Los Angeles, CA 90024 USA. [Mohr, David C.] Northwestern Univ, Feinberg Sch Med, Ctr Behav Intervent Technol, Chicago, IL 60611 USA. [Rush, A. John] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore. [Segal, Zindel V.] Univ Toronto Scarborough, Dept Psychol, Toronto, ON, Canada. [Siddique, Juned] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA. [Simons, Anne D.] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA. [Vittengl, Jeffrey R.] Truman State Univ, Dept Psychol, Kirksville, MO USA.
Weitz, ES (reprint author), Vrije Univ Amsterdam, Dept Clin Psychol, Van der Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.
e.weitz@vu.nl
AN  - WOS:000364417600009
AU  - Weitz, E. S.
AU  - Hollon, S. D.
AU  - Twisk, J.
AU  - van Straten, A.
AU  - Huibers, M. J. H.
AU  - David, D.
AU  - DeRubeis, R. J.
AU  - Dimidjian, S.
AU  - Dunlop, B. W.
AU  - Cristea, I. A.
AU  - Faramarzi, M.
AU  - Hegerl, U.
AU  - Jarrett, R. B.
AU  - Kheirkhah, F.
AU  - Kennedy, S. H.
AU  - Mergl, R.
AU  - Miranda, J.
AU  - Mohr, D. C.
AU  - Rush, A. J.
AU  - Segal, Z. V.
AU  - Siddique, J.
AU  - Simons, A. D.
AU  - Vittengl, J. R.
AU  - Cuijpers, P.
DA  - Nov
DO  - 10.1001/jamapsychiatry.2015.1516
IS  - 11
J2  - JAMA Psychiatry
KW  - randomized controlled-trial
young minority women
treating depression
initial severity
rating-scale
efficacy
medications
combination
outpatients
bias
Psychiatry
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: CV6YG
Times Cited: 59
Cited Reference Count: 48
Weitz, Erica S. Hollon, Steven D. Twisk, Jos van Straten, Annemieke Huibers, Marcus J. H. David, Daniel DeRubeis, Robert J. Dimidjian, Sona Dunlop, Boadie W. Cristea, Ioana A. Faramarzi, Mahbobeh Hegerl, Ulrich Jarrett, Robin B. Kheirkhah, Farzan Kennedy, Sidney H. Mergl, Roland Miranda, Jeanne Mohr, David C. Rush, A. John Segal, Zindel V. Siddique, Juned Simons, Anne D. Vittengl, Jeffrey R. Cuijpers, Pim
Cristea, Ioana Alina/E-7490-2011; Dunlop, Boadie/N-3362-2017; van Straten, Annemieke/P-8495-2019; Cuijpers, Pim/G-1703-2013; Faramarzi, mahbobeh/I-8814-2016
Cristea, Ioana Alina/0000-0002-9854-7076; Dunlop, Boadie/0000-0002-4653-0483; van Straten, Annemieke/0000-0001-6875-2215; Faramarzi, Mahbobeh/0000-0002-3568-7039; Hegerl, Ulrich/0000-0002-3039-7470; Mohr, David/0000-0002-5443-7596; kheirkha, farzan/0000-0003-1420-5480; DeRubeis, Robert/0000-0003-3129-0277
National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH60713, MH01697]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH60998, MH-45043]; AstraZenecaAstraZeneca; Bristol-Myers SquibbBristol-Myers Squibb; Forest Laboratories; GlaxoSmithKlineGlaxoSmithKline; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); Otsuka PharmaceuticalOtsuka Pharmaceutical; PfizerPfizer; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH100482, R01 MH095753, P20 MH090318, R34 MH095907]
Dr Hollon reported having received research support from the National Institute of Mental Health (NIMH) (grants MH60713 and MH01697). Dr DeRubeis reported having received research support from the NIMH (grant MH60998). Dr Dunlop reported having received grant support from AstraZeneca, Bristol-Myers Squibb, Forest Laboratories, GlaxoSmithKline, NIMH, Otsuka Pharmaceutical, and Pfizer and reported receiving honoraria for consulting from Hoffmann-LaRoche, MedAvante, and Pfizer. Dr Hegerl reported serving as an advisory board member for Eli Lilly, Lundbeck, Otsuka Pharmaceutical, Takeda, and Servier; reported serving as a consultant for Nycomed (a Takeda company); and reported serving as a speaker for Bristol-Myers Squibb, MEDICE Arzneimittel, Novartis, and Roche Pharma. Dr Jarrett reported using data from grant MH-45043 from the NIMH, reported being a paid consultant to UpToDate, and reported that her medical center receives fees for cognitive therapy that she provides to patients. Dr Mergl reported having a consultancy agreement with Nycomed. Dr Mohr reported having received research support from the National Institutes of Health (grants R01 MH100482, R01 MH095753, P20 MH090318, and R34 MH095907) and reported having a consulting relationship with Otsuka Pharmaceutical. No other disclosures were reported.
61
0
34
Amer medical assoc
Chicago
2168-6238
PY  - 2015
SN  - 2168-622X
SP  - 1102-1109
ST  - Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy An Individual Patient Data Meta-analysis
T2  - JAMA Psychiatry
TI  - Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy An Individual Patient Data Meta-analysis
UR  - <Go to ISI>://WOS:000364417600009
VL  - 72
ID  - 99
ER  - 

TY  - JOUR
AB  - Background Elevated lipoprotein(a) is a genetic risk factor for cardiovascular disease in general population studies. However, its contribution to risk for cardiovascular events in patients with established cardiovascular disease or on statin therapy is uncertain. Methods Patient-level data from seven randomised, placebo-controlled, statin outcomes trials were collated and harmonised to calculate hazard ratios (HRs) for cardiovascular events, defined as fatal or non-fatal coronary heart disease, stroke, or revascularisation procedures. HRs for cardiovascular events were estimated within each trial across predefined lipoprotein(a) groups (15 to <30 mg/dL, 30 to <50 mg/dL, and >= 50 mg/dL, vs <15 mg/dL), before pooling estimates using multivariate random-effects meta-analysis. Findings Analyses included data for 29 069 patients with repeat lipoprotein(a) measurements (mean age 62 years [SD 8]; 8064 [28%] women; 5751 events during 95 576 person-years at risk). Initiation of statin therapy reduced LDL cholesterol (mean change -39% [95% CI -43 to -35]) without a significant change in lipoprotein(a). Associations of baseline and on-statin treatment lipoprotein(a) with cardiovascular disease risk were approximately linear, with increased risk at lipoprotein(a) values of 30 mg/dL or greater for baseline lipoprotein(a) and 50 mg/dL or greater for on-statin lipoprotein(a). For baseline lipoprotein(a), HRs adjusted for age and sex (vs <15 mg/dL) were 1.04 (95% CI 0.91-1.18) for 15 mg/dL to less than 30 mg/dL, 1.11 (1.00-1.22) for 30 mg/dL to less than 50 mg/dL, and 1.31 (1.08-1.58) for 50 mg/dL or higher; respective HRs for on-statin lipoprotein(a) were 0.94 (0.81-1.10), 1.06 (0. 94-1.21), and 1.43 (1.15-1.76). HRs were almost identical after further adjustment for previous cardiovascular disease, diabetes, smoking, systolic blood pressure, LDL cholesterol, and HDL cholesterol. The association of on-statin lipoprotein(a) with cardiovascular disease risk was stronger than for on-placebo lipoprotein(a) (interaction p=0.010) and was more pronounced at younger ages (interaction p=0.008) without effect-modification by any other patient-level or study-level characteristics. Interpretation In this individual-patient data meta-analysis of statin-treated patients, elevated baseline and on-statin lipoprotein(a) showed an independent approximately linear relation with cardiovascular disease risk. This study provides a rationale for testing the lipoprotein(a) lowering hypothesis in cardiovascular disease outcomes trials. Copyright (C) 2018 Elsevier Ltd. All rights reserved.
AD  - [Willeit, Peter] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria. [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England. [Ridker, Paul M.; Mora, Samia] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA. [Nestel, Paul J.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia. [Simes, John] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia. [Tonkin, Andrew M.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia. [Pedersen, Terje R.] Oslo Univ Hosp, Ulleval, Norway. [Pedersen, Terje R.] Univ Oslo, Med Fac, Oslo, Norway. [Schwartz, Gregory G.] VA Med Ctr, Div Cardiol, Denver, CO USA. [Schwartz, Gregory G.] Univ Colorado, Sch Med, Denver, CO USA. [Olsson, Anders G.] Univ Linkoping, Dept Med & Care, Fac Hlth Sci, Linkoping, Sweden. [Colhoun, Helen M.] MRC Inst Genet & Mol Med, Ctr Genom & Expt Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland. [Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria. [Drechsler, Christiane; Wanner, Christoph] Univ Hosp Wurzburg, Div Nephrol, Dept Internal Med 1, Wurzburg, Germany. [Drechsler, Christiane; Wanner, Christoph] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany. [Lesogor, Anastasia] Novartis Pharma AG, Basel, Switzerland. [Tsimikas, Sotirios] Univ Calif San Diego, Vasc Med Program, Sulpizio Cardiovasc Ctr, Div Cardiol,Dept Med, La Jolla, CA 92093 USA.
Willeit, P (reprint author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.; Tsimikas, S (reprint author), Univ Calif San Diego, Vasc Med Program, Sulpizio Cardiovasc Ctr, La Jolla, CA 92093 USA.
peter.willeit@i-med.ac.at; stsimikas@ucsd.edu
AN  - WOS:000447086500032
AU  - Willeit, P.
AU  - Ridker, P. M.
AU  - Nestel, P. J.
AU  - Simes, J.
AU  - Tonkin, A. M.
AU  - Pedersen, T. R.
AU  - Schwartz, G. G.
AU  - Olsson, A. G.
AU  - Colhoun, H. M.
AU  - Kronenberg, F.
AU  - Drechsler, C.
AU  - Wanner, C.
AU  - Mora, S.
AU  - Lesogor, A.
AU  - Tsimikas, S.
DA  - Oct
DO  - 10.1016/s0140-6736(18)31652-0
IS  - 10155
J2  - Lancet
KW  - type-2 diabetes-mellitus
acute coronary syndromes
oxidized
phospholipids
targeting apolipoprotein(a)
myocardial-infarction
series-lipoprotein
primary prevention
aortic-stenosis
heart-disease
double-blind
General & Internal Medicine
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GW6QU
Times Cited: 32
Cited Reference Count: 39
Willeit, Peter Ridker, Paul M. Nestel, Paul J. Simes, John Tonkin, Andrew M. Pedersen, Terje R. Schwartz, Gregory G. Olsson, Anders G. Colhoun, Helen M. Kronenberg, Florian Drechsler, Christiane Wanner, Christoph Mora, Samia Lesogor, Anastasia Tsimikas, Sotirios
Kronenberg, Florian/B-1736-2008; Mora, Samia/W-8126-2019
Kronenberg, Florian/0000-0003-2229-1120;
Novartis Pharma AG
Novartis Pharma AG.
32
6
12
Elsevier science inc
New york
1474-547x
PY  - 2018
SN  - 0140-6736
SP  - 1311-1320
ST  - Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
T2  - Lancet
TI  - Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
UR  - <Go to ISI>://WOS:000447086500032
VL  - 392
ID  - 5
ER  - 

TY  - JOUR
AD  - [Willems, Emileigh L.; Santorico, Stephanie A.] Univ Colorado, Dept Math & Stat Sci, Denver, CO 80202 USA. [Wan, Jia Y.; Norden-Krichmar, Trina M.; Edwards, Karen L.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA. [Santorico, Stephanie A.] Univ Colorado, Human Med Genet & Genom Program, Denver, CO 80202 USA. [Santorico, Stephanie A.] Univ Colorado, Dept Biostat & Informat, Denver, CO 80202 USA.
AN  - WOS:000447523100142
AU  - Willems, E. L.
AU  - Wan, J. Y.
AU  - Norden-Krichmar, T. M.
AU  - Edwards, K. L.
AU  - Santorico, S. A.
DA  - Oct
IS  - 7
J2  - Genet. Epidemiol.
KW  - Genetics & Heredity
Mathematical & Computational Biology
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: GX2BK
Times Cited: 0
Cited Reference Count: 0
Willems, Emileigh L. Wan, Jia Y. Norden-Krichmar, Trina M. Edwards, Karen L. Santorico, Stephanie A.
27th Annual Meeting of the International-Genetic-Epidemiology-Society (IGES)
Oct 14-16, 2018
San Diego, CA
Int Genet Epidemiol Soc
0
Wiley
Hoboken
1098-2272
PY  - 2018
SN  - 0741-0395
SP  - 741-742
ST  - Trans-ethnic meta-analysis of metabolic syndrome in a multi-ethnic study
T2  - Genetic Epidemiology
TI  - Trans-ethnic meta-analysis of metabolic syndrome in a multi-ethnic study
UR  - <Go to ISI>://WOS:000447523100142
VL  - 42
ID  - 6
ER  - 

TY  - JOUR
AD  - [Wilson, K. C.] Boston Univ, Sch Med, Boston, MA 02118 USA. [Checkley, W.; Tonascia, J.; Wise, R. A.] Johns Hopkins Univ, Baltimore, MD USA. [Kiser, T. H.; Moss, M.; Vandivier, R. W.] Univ Colorado Denver, Aurora, CO USA. [Sevransky, J. E.] Emory Univ, Sch Med, Atlanta, GA USA. [Sullivan, J.; Walsh, J.] COPD Fdn, Washington, DC USA. [Krishnan, J. A.] Univ Illinois, Chicago, IL USA.
kwilson@thoracic.org
AN  - WOS:000377582803062
AU  - Wilson, K. C.
AU  - Checkley, W.
AU  - Kiser, T. H.
AU  - Moss, M.
AU  - Sevransky, J. E.
AU  - Sullivan, J.
AU  - Tonascia, J.
AU  - Vandivier, R. W.
AU  - Walsh, J.
AU  - Wise, R. A.
AU  - Krishnan, J. A.
AU  - Investigators, Decide
J2  - Am. J. Respir. Crit. Care Med.
KW  - General & Internal Medicine
Respiratory System
LA  - English
M3  - Meeting Abstract
N1  - ISI Document Delivery No.: DO2AW
Times Cited: 1
Cited Reference Count: 0
Wilson, K. C. Checkley, W. Kiser, T. H. Moss, M. Sevransky, J. E. Sullivan, J. Tonascia, J. Vandivier, R. W. Walsh, J. Wise, R. A. Krishnan, J. A.
International Conference of the American-Thoracic-Society (ATS)
May 15-20, 2015
Denver, CO
Amer Thorac Soc
1
0
Amer thoracic soc
New york
1535-4970
PY  - 2015
SN  - 1073-449X
SP  - 1
ST  - High-Dose Versus Low-Dose Systemic Steroids In The Treatment Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Systematic Review
T2  - American Journal of Respiratory and Critical Care Medicine
TI  - High-Dose Versus Low-Dose Systemic Steroids In The Treatment Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Systematic Review
UR  - <Go to ISI>://WOS:000377582803062
VL  - 191
ID  - 123
ER  - 

TY  - JOUR
AD  - [Wilson, Shandra] Univ Colorado, Sch Med, Dept Surg, Div Urol, 1665 Aurora Ct, Aurora, CO 80045 USA.
Wilson, S (reprint author), Univ Colorado, Sch Med, Dept Surg, Div Urol, 1665 Aurora Ct, Aurora, CO 80045 USA.
Shandra.Wilson@ucdenver.edu
AN  - WOS:000412722800013
AU  - Wilson, S.
DA  - Jan-Dec
DO  - 10.1016/j.ijsu.2015.12.015
J2  - Int. J. Surg.
KW  - Surgery
LA  - English
M3  - Editorial Material
N1  - ISI Document Delivery No.: FJ4PJ
Times Cited: 0
Cited Reference Count: 0
Wilson, Shandra
0
Elsevier science bv
Amsterdam
1743-9159
1
PY  - 2016
SN  - 1743-9191
SP  - 13-13
ST  - Peer review report 4 on "Effect of alvimopan on accelerates gastrointestinal recovery after radical cystectomy: A systematic review and meta-analysis"
T2  - International Journal of Surgery
TI  - Peer review report 4 on "Effect of alvimopan on accelerates gastrointestinal recovery after radical cystectomy: A systematic review and meta-analysis"
UR  - <Go to ISI>://WOS:000412722800013
VL  - 25
ID  - 94
ER  - 

TY  - JOUR
AB  - Introduction: The potential benefit of parenteral glutamine (GLN) supplementation has been one of the most commonly studied nutritional interventions in the critical care setting. The aim of this systematic review was to incorporate recent trials of traditional parenteral GLN supplementation in critical illness with previously existing data. Methods: All randomized controlled trials of parenterally administered GLN in critically ill patients conducted from 1997 to 2013 were identified. Studies of enteral GLN only or combined enteral/parenteral GLN were excluded. Methodological quality of studies was scored and data was abstracted by independent reviewers. Results: A total of 26 studies involving 2,484 patients examining only parenteral GLN supplementation of nutrition support were identified in ICU patients. Parenteral GLN supplementation was associated with a trend towards a reduction of overall mortality (relative risk (RR) 0.88, 95% confidence interval (CI) 0.75, 1.03, P = 0.10) and a significant reduction in hospital mortality (RR 0.68, 95% CI 0.51, 0.90, P = 0.008). In addition, parenteral GLN was associated with a strong trend towards a reduction in infectious complications (RR 0.86, 95% CI 0.73, 1.02, P = 0.09) and ICU length of stay (LOS) (WMD -1.91, (95% CI -4.10, 0.28, P = 0.09) and significant reduction in hospital LOS (WMD -2.56, 95% CI -4.71, -0.42, P = 0.02). In the subset of studies examining patients receiving parenteral nutrition (PN), parenteral GLN supplementation was associated with a trend towards reduced overall mortality (RR 0.84, 95% CI 0.71, 1.01, P = 0.07). Conclusions: Parenteral GLN supplementation given in conjunction with nutrition support continues to be associated with a significant reduction in hospital mortality and hospital LOS. Parenteral GLN supplementation as a component of nutrition support should continue to be considered to improve outcomes in critically ill patients.
AD  - [Wischmeyer, Paul E.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO 80045 USA. [Dhaliwal, Rupinder; Heyland, Daren K.] Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON K7L 2V7, Canada. [McCall, Michele] St Michaels Hosp, Med Surg Intens Care Unit, Toronto, ON M5B 1W8, Canada. [Ziegler, Thomas R.] Emory Univ, Sch Med, Ctr Clin & Mol Nutr, Dept Med, Atlanta, GA 30322 USA. [Heyland, Daren K.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada.
Wischmeyer, PE (reprint author), Univ Colorado, Sch Med, Dept Anesthesiol, 12700 East 19th Ave, Aurora, CO 80045 USA.
Paul.Wischmeyer@ucdenver.edu
AN  - WOS:000339627400094
AU  - Wischmeyer, P. E.
AU  - Dhaliwal, R.
AU  - McCall, M.
AU  - Ziegler, T. R.
AU  - Heyland, D. K.
C7  - R76
DO  - 10.1186/cc13836
IS  - 2
J2  - Crit. Care
KW  - intensive-care-unit
ill patients
double-blind
infectious morbidity
acute-pancreatitis
randomized-trial
clinical-trials
trauma patients
immune-system
nutrition
General & Internal Medicine
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: AM1SA
Times Cited: 88
Cited Reference Count: 48
Wischmeyer, Paul E. Dhaliwal, Rupinder McCall, Michele Ziegler, Thomas R. Heyland, Daren K.
Fresenius Kabi
No funding for the development, writing, or submission of this manuscript was received. Paul Wischmeyer has research funding for the REDOXS trial of glutamine and antioxidants from Fresenius Kabi. Rupinder Dhaliwal has no conflict of interest to declare. Michele McCall has no conflict of interest to declare. Thomas R. Ziegler has research funding for the GLND trial of glutamine-supplemented total parenteral nutrition in surgical critical care from Fresenius Kabi. Daren K. Heyland has research funding for the REDOXS trial of glutamine and antioxidants from Fresenius Kabi.
97
1
18
Biomed central ltd
London
1364-8535
PY  - 2014
SN  - 1466-609X
SP  - 17
ST  - Parenteral glutamine supplementation in critical illness: a systematic review
T2  - Critical Care
TI  - Parenteral glutamine supplementation in critical illness: a systematic review
UR  - <Go to ISI>://WOS:000339627400094
VL  - 18
ID  - 154
ER  - 

TY  - JOUR
AB  - Nearly 100 loci have been identified for pulmonary function, almost exclusively in studies of European ancestry populations. We extend previous research by meta-analyzing genomewide association studies of 1000 Genomes imputed variants in relation to pulmonary function in a multiethnic population of 90,715 individuals of European (N = 60,552), African (N = 8429), Asian (N = 9959), and Hispanic/Latino (N = 11,775) ethnicities. We identify over 50 additional loci at genome-wide significance in ancestry-specific or multiethnic metaanalyses. Using recent fine-mapping methods incorporating functional annotation, gene expression, and differences in linkage disequilibrium between ethnicities, we further shed light on potential causal variants and genes at known and newly identified loci. Several of the novel genes encode proteins with predicted or established drug targets, including KCNK2 and CDK12. Our study highlights the utility of multiethnic and integrative genomics approaches to extend existing knowledge of the genetics of lung function and clinical relevance of implicated loci.
AD  - [Wyss, Annah B.; Lee, Mi Kyeong; London, Stephanie J.] NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA. [Sofer, Tamar] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA. [Sofer, Tamar] Harvard Med Sch, Dept Med, Boston, MA 02115 USA. [Terzikhan, Natalie; Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium. [Terzikhan, Natalie; Lahousse, Lies; Adams, Hieab H. H.; Brusselle, Guy G.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands. [Nguyen, Jennifer N.; Rich, Stephen S.; Manichaikul, Ani] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA. [Lahousse, Lies] Univ Ghent, Dept Bioanal FFW, B-9000 Ghent, Belgium. [Latourelle, Jeanne C.; Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA. [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland. [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland. [Smith, Albert Vernon] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA. [Bartz, Traci M.; Sitlani, Colleen M.; Brody, Jennifer A.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA. [Bartz, Traci M.; Laurie, Cathy C.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA. [Feitosa, Mary F.; Wojczynski, Mary K.; Province, Michael A.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA. [Gao, Wei; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA. [Ahluwalia, Tarunveer S.; Hansen, Torben] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Metab Genet Sect, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark. [Ahluwalia, Tarunveer S.] Steno Diabet Ctr Copenhagen, DK-2820 Gentofte, Denmark. [Tang, Wenbo; Cassano, Patricia A.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA. [Oldmeadow, Christopher; Holliday, Elizabeth G.; Scott, Rodney J.; McEvoy, Mark; Attia, John R.] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2305, Australia. [Oldmeadow, Christopher; Holliday, Elizabeth G.; Scott, Rodney J.; McEvoy, Mark; Attia, John R.] Univ Newcastle, Fac Hlth, Callaghan, NSW 2305, Australia. [Duan, Qing] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA. [de Jong, Kim; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 GZ Groningen, Netherlands. [Wang, Xin-Qun] Univ Virginia, Dept Publ Hlth Sci, Div Biostat, Charlottesville, VA 22908 USA. [Noordam, Raymond] Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Dept Internal Med, NL-2300 RC Leiden, Netherlands. [Hartwig, Fernando Pires; Baptista Menezes, Ana Maria; Wehrmeister, Fernando Cesar; Horta, Bernardo Lessa] Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96020220 Pelotas, Brazil. [Hartwig, Fernando Pires; Paternoster, Lavinia] Univ Bristol, Sch Social & Community Med, Med Res Council Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England. [Jackson, Victoria E.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England. [Wang, Tianyuan] NIEHS, Integrat Bioinformat Support Grp, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA. [Obeidat, Ma'en; Sin, Don D.] Univ British Columbia, Ctr Heart Lung Innovat, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada. [Hobbs, Brian D.; Parker, Margaret M.; Cho, Michael H.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA. [Hobbs, Brian D.; Cho, Michael H.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA. [Huan, Tianxiao] NHLBI, Populat Sci Branch, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA. [Gui, Hongsheng; Xiao, Shujie; Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI 48202 USA. [Hu, Donglei; Liberto, Jennifer; Oh, Sam; Burchard, Esteban G.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA. [Mogil, Lauren S.; Wheeler, Heather E.] Loyola Univ Chicago, Dept Biol, Chicago, IL 60660 USA. [Kichaev, Gleb] Univ Calif Los Angeles, Los Angeles, CA 90095 USA. [Jin, Jianping] Westat Corp, Durham, NC 27703 USA. [Graff, Mariaelisa; Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA. [Harris, Tamara B.; Launer, Lenore J.] NIA, US Dept HHS, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA. [Kalhan, Ravi] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA. [Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA. [Burkart, Kristin M.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY 10032 USA. [Liu, Yongmei; Lohman, Kurt] Wake Forest Sch Med, Winston Salem, NC 27101 USA. [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA. [Sanders, Jason L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA. [Barr, R. Graham] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA. [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA. [de Mutsert, Renee; Rosendaal, Frits R.; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands. [Adams, Hieab H. H.] Erasmus Univ, Med Ctr, Dept Radiol, NL-3015 GD Rotterdam, Netherlands. [van den Berge, Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, NL-9700 AB Groningen, Netherlands. [Joehanes, Roby] Harvard Univ, Hebrew SeniorLife, Boston, MA 02131 USA. [Levin, Albert M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA. [Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Dept Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA. [Celedon, Juan C.] Univ Pittsburgh, UPMC, Childrens Hosp Pittsburgh, Div Pulm Med Allergy & Immunol,Dept Pediat, Pittsburgh, PA 15224 USA. [Kritchevsky, Stephen B.] Wake Forest Sch Med, Sticht Ctr Hlth Aging & Alzheimers Prevent, Winston Salem, NC 27157 USA. [Scott, Rodney J.] NSW Hlth Pathol, Pathol North, Div Mol Med, Newcastle, NSW 2305, Australia. [Christensen, Kaare] Univ Southern Denmark, Dept Epidemiol Biostat & Biodemog, DK-5000 Odense, Denmark. [Rotter, Jerome I.; Taylor, Kent D.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Dept Pediat, Torrance, CA 90502 USA. [Bonten, Tobias N.; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2300 RC Leiden, Netherlands. [Bonten, Tobias N.] Leiden Univ, Med Ctr, Dept Pulmonol, NL-2300 RC Leiden, Netherlands. [Bosse, Yohan] Laval Univ, Inst Univ Cardiol & Pneumol Quebec, Dept Mol Med, Ste Foy, PQ G1V 4G5, Canada. [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA. [Nickle, David C.] Merck & Co Inc, GpGx, Merck Res Labs, Kenilworth, NJ 07033 USA. [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI 48202 USA. [Burchard, Esteban G.] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA. [Sin, Don D.] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC V5Z 1M9, Canada. [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA. [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA. [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA. [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA. [O'Connor, George; Dupuis, Josee] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA. [O'Connor, George] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA. [Cassano, Patricia A.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10065 USA. [Sung, Joohon] Seoul Natl Univ, Sch Publ Hlth, Dept Hlth Sci, Seoul 08826, South Korea. [Kim, Woo Jin] Kangwon Natl Univ, Dept Internal Med, Chunchon 24341, South Korea. [Kim, Woo Jin] Kangwon Natl Univ, Ctr Environm Hlth, Chunchon 24341, South Korea. [Lange, Leslie] Univ Colorado, Denver, CO 80204 USA. [Thyagarajan, Bharat] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA. [Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 CN Rotterdam, Netherlands. [Im, Hae Kyung] Univ Chicago, Sect Genet Med, Chicago, IL 60637 USA. [Brusselle, Guy G.] Erasmus Univ, Med Ctr, Dept Resp Med, NL-3000 CA Rotterdam, Netherlands. [Gharib, Sina A.] Univ Washington, UW Med Sleep Ctr, Ctr Lung Biol, Dept Med,Computat Med Core, Seattle, WA 98109 USA.
London, SJ (reprint author), NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA.
london2@niehs.nih.gov
AN  - WOS:000440149300009
AU  - Wyss, A. B.
AU  - Sofer, T.
AU  - Lee, M. K.
AU  - Terzikhan, N.
AU  - Nguyen, J. N.
AU  - Lahousse, L.
AU  - Latourelle, J. C.
AU  - Smith, A. V.
AU  - Bartz, T. M.
AU  - Feitosa, M. F.
AU  - Gao, W.
AU  - Ahluwalia, T. S.
AU  - Tang, W. B.
AU  - Oldmeadow, C.
AU  - Duan, Q.
AU  - de Jong, K.
AU  - Wojczynski, M. K.
AU  - Wang, X. Q.
AU  - Noordam, R.
AU  - Hartwig, F. P.
AU  - Jackson, V. E.
AU  - Wang, T. Y.
AU  - Obeidat, M.
AU  - Hobbs, B. D.
AU  - Huan, T. X.
AU  - Gui, H. S.
AU  - Parker, M. M.
AU  - Hu, D. L.
AU  - Mogil, L. S.
AU  - Kichaev, G.
AU  - Jin, J. P.
AU  - Graff, M.
AU  - Harris, T. B.
AU  - Kalhan, R.
AU  - Heckbert, S. R.
AU  - Paternoster, L.
AU  - Burkart, K. M.
AU  - Liu, Y. M.
AU  - Holliday, E. G.
AU  - Wilson, J. G.
AU  - Vonk, J. M.
AU  - Sanders, J. L.
AU  - Barr, R. G.
AU  - de Mutsert, R.
AU  - Menezes, A. M. B.
AU  - Adams, H. H. H.
AU  - van den Berge, M.
AU  - Joehanes, R.
AU  - Levin, A. M.
AU  - Liberto, J.
AU  - Launer, L. J.
AU  - Morrison, A. C.
AU  - Sitlani, C. M.
AU  - Celedon, J. C.
AU  - Kritchevsky, S. B.
AU  - Scott, R. J.
AU  - Christensen, K.
AU  - Rotter, J. I.
AU  - Bonten, T. N.
AU  - Wehrmeister, F. C.
AU  - Bosse, Y.
AU  - Xiao, S. J.
AU  - Oh, S.
AU  - Franceschini, N.
AU  - Brody, J. A.
AU  - Kaplan, R. C.
AU  - Lohman, K.
AU  - McEvoy, M.
AU  - Province, M. A.
AU  - Rosendaal, F. R.
AU  - Taylor, K. D.
AU  - Nickle, D. C.
AU  - Williams, L. K.
AU  - Burchard, E. G.
AU  - Wheeler, H. E.
AU  - Sin, D. D.
AU  - Gudnason, V.
AU  - North, K. E.
AU  - Fornage, M.
AU  - Psaty, B. M.
AU  - Myers, R. H.
AU  - O'Connor, G.
AU  - Hansen, T.
AU  - Laurie, C. C.
AU  - Cassano, P. A.
AU  - Sung, J.
AU  - Kim, W. J.
AU  - Attia, J. R.
AU  - Lange, L.
AU  - Boezen, H. M.
AU  - Thyagarajan, B.
AU  - Rich, S. S.
AU  - Mook-Kanamori, D. O.
AU  - Horta, B. L.
AU  - Uitterlinden, A. G.
AU  - Im, H. K.
AU  - Cho, M. H.
AU  - Brusselle, G. G.
AU  - Gharib, S. A.
AU  - Dupuis, J.
AU  - Manichaikul, A.
AU  - London, S. J.
C7  - 2976
DA  - Jul
DO  - 10.1038/s41467-018-05369-0
J2  - Nat. Commun.
KW  - genome-wide association
airway smooth-muscle
lung-function
segregation analysis
large-scale
follow-up
disease
asthma
annotation
population
Science & Technology - Other Topics
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: GO6KC
Times Cited: 6
Cited Reference Count: 80
Wyss, Annah B. Sofer, Tamar Lee, Mi Kyeong Terzikhan, Natalie Nguyen, Jennifer N. Lahousse, Lies Latourelle, Jeanne C. Smith, Albert Vernon Bartz, Traci M. Feitosa, Mary F. Gao, Wei Ahluwalia, Tarunveer S. Tang, Wenbo Oldmeadow, Christopher Duan, Qing de Jong, Kim Wojczynski, Mary K. Wang, Xin-Qun Noordam, Raymond Hartwig, Fernando Pires Jackson, Victoria E. Wang, Tianyuan Obeidat, Ma'en Hobbs, Brian D. Huan, Tianxiao Gui, Hongsheng Parker, Margaret M. Hu, Donglei Mogil, Lauren S. Kichaev, Gleb Jin, Jianping Graff, Mariaelisa Harris, Tamara B. Kalhan, Ravi Heckbert, Susan R. Paternoster, Lavinia Burkart, Kristin M. Liu, Yongmei Holliday, Elizabeth G. Wilson, James G. Vonk, Judith M. Sanders, Jason L. Barr, R. Graham de Mutsert, Renee Baptista Menezes, Ana Maria Adams, Hieab H. H. van den Berge, Maarten Joehanes, Roby Levin, Albert M. Liberto, Jennifer Launer, Lenore J. Morrison, Alanna C. Sitlani, Colleen M. Celedon, Juan C. Kritchevsky, Stephen B. Scott, Rodney J. Christensen, Kaare Rotter, Jerome I. Bonten, Tobias N. Wehrmeister, Fernando Cesar Bosse, Yohan Xiao, Shujie Oh, Sam Franceschini, Nora Brody, Jennifer A. Kaplan, Robert C. Lohman, Kurt McEvoy, Mark Province, Michael A. Rosendaal, Frits R. Taylor, Kent D. Nickle, David C. Williams, L. Keoki Burchard, Esteban G. Wheeler, Heather E. Sin, Don D. Gudnason, Vilmundur North, Kari E. Fornage, Myriam Psaty, Bruce M. Myers, Richard H. O'Connor, George Hansen, Torben Laurie, Cathy C. Cassano, Patricia A. Sung, Joohon Kim, Woo Jin Attia, John R. Lange, Leslie Boezen, H. Marike Thyagarajan, Bharat Rich, Stephen S. Mook-Kanamori, Dennis O. Horta, Bernardo Lessa Uitterlinden, Andre G. Im, Hae Kyung Cho, Michael H. Brusselle, Guy G. Gharib, Sina A. Dupuis, Josee Manichaikul, Ani London, Stephanie J.
Lee, Mi Kyeong/C-3046-2017; Wheeler, Heather/I-9279-2019; Bonten, Tobias/Y-2445-2018; Smith, Albert Vernon/K-5150-2015; Horta, Bernardo/A-7604-2008; Feitosa, Mary F/K-8044-2012; Gui, Hongsheng/D-1063-2013; Jackson, Victoria/L-5782-2019; Vonk, Judith/K-8477-2019; London, Stephanie/C-3734-2019; Lahousse, Lies/O-9426-2019; Christensen, Kaare/C-2360-2009
Lee, Mi Kyeong/0000-0002-3036-3684; Wheeler, Heather/0000-0003-1365-9667; Bonten, Tobias/0000-0002-7719-6182; Smith, Albert Vernon/0000-0003-1942-5845; Horta, Bernardo/0000-0001-9843-412X; Feitosa, Mary F/0000-0002-0933-2410; Gui, Hongsheng/0000-0002-0460-7446; Jackson, Victoria/0000-0002-9758-9784; Vonk, Judith/0000-0001-7531-4547; London, Stephanie/0000-0003-4911-5290; Lahousse, Lies/0000-0002-3494-4363; Christensen, Kaare/0000-0002-5429-5292; de Jong, Kim/0000-0002-3948-1046; Elhawary, Jennifer/0000-0003-3326-1680; Sofer, Tamar/0000-0001-8520-8860; Hansen, Torben/0000-0001-8748-3831; Huan, Tianxiao/0000-0001-5840-9413; Hobbs, Brian/0000-0001-9564-0745; Oldmeadow, Christopher/0000-0001-6104-1322
Intramural Research Program of the National Institutes of Health, NIEHS; National Heart, Lung, and Blood Institute GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL105756]
We thank the International COPD Genetics Consortium (members listed in Supplementary Note 3) for investigating overlap of newly identified lung function loci with COPD in their study. We also thank Huiling Li for expert technical assistance and Dr. Frank Day for computational support, both from the National Institute of Environmental Health Sciences (NIEHS), and Dr. Louise Wain, University of Leicester, for critical reviews of the manuscript. Supported in part by the Intramural Research Program of the National Institutes of Health, NIEHS. Infrastructure for the CHARGE Consortium is supported in part by the National Heart, Lung, and Blood Institute Grant R01HL105756. Study-specific funding and acknowledgments can be found in Supplementary Note 3.
6
2
10
Nature publishing group
London
PY  - 2018
SN  - 2041-1723
SP  - 15
ST  - Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function
T2  - Nature Communications
TI  - Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function
UR  - <Go to ISI>://WOS:000440149300009
VL  - 9
ID  - 12
ER  - 

TY  - JOUR
AB  - BACKGROUND: The role of the extent of surgical resection (EOR) in clinical outcomes for patients with low-grade glioma requires further examination. The goal of the present study was to evaluate the association between variable degrees of EOR and clinical outcomes for patients with low-grade glioma. METHODS: We conducted a systematic review and meta-analysis and searched databases for reports of low-grade glioma EOR. Eligible studies compared patient outcomes, including >= 2 categories of EOR (biopsy, resection of any extent, subtotal resection [STR], or gross total resection [GTR]). Treatment effects were evaluated using pooled estimates, mean differences, or risk ratios (RRs) with corresponding 95% confidence intervals (CIs) using random effects modeling. RESULTS: Our literature search yielded 60 studies with 13,289 patients. Pooled estimates of overall survival (OS) showed an increase from 3.79 years in the biopsy group to 6.68 years in STR to 10.65 years in GTR. OS was favorable with resection of any extent compared with (mean difference, 3.24; 95% CI, 0.64-5.84; P = 0.015). Pooled estimates of seizure control showed an improvement from 47.8% with biopsy to 54.2% with STR and 81.0% with GTR. Compared with STR, GTR delayed malignant transformation (RR, 0.43; 95% CI, 0.20-0.93; P = 0.032), without increasing postoperative mortality (RR, 0.38; 95% CI, 0.07-1.97; P = 0.250) or morbidity (RR, 1.22; 95% CI, 0.65-2.28; P = 0.540). CONCLUSION: Among patients with low-grade gliomas, greater degrees of safe EOR were associated with longer OS and progression-free survival, better seizure control, and delayed malignant transformation, without increasing mortality or morbidity.
AD  - [Yang, Kaiyun; Nath, Siddharth; Koziarz, Alex; Ghayur, Huphy; Sourour, Michel; Catana, Dragos; Alotaibi, Mazen B.; Kameda-Smith, Michelle; Manoranjan, Branavan; Singh, Sheila; Almenawer, Saleh A.] Hamilton Hlth Sci, Div Neurosurg, Hamilton, ON, Canada. [Yang, Kaiyun; Nath, Siddharth; Koziarz, Alex; Ghayur, Huphy; Sourour, Michel; Catana, Dragos; Alotaibi, Mazen B.; Kameda-Smith, Michelle; Manoranjan, Branavan; Singh, Sheila; Almenawer, Saleh A.] McMaster Univ, Hamilton, ON, Canada. [Badhiwala, Jetan H.; Nassiri, Farshad] Univ Toronto, Div Neurosurg, Toronto, ON, Canada. [Aref, Mohammed H.] Univ Colorado, Dept Neurosurg, Aurora, CO USA. [Mansouri, Alireza] NIH, Neurooncol Branch, Bldg 10, Bethesda, MD 20892 USA.
Almenawer, SA (reprint author), Hamilton Hlth Sci, Div Neurosurg, Hamilton, ON, Canada.; Almenawer, SA (reprint author), McMaster Univ, Hamilton, ON, Canada.
dr_menawer@hotmail.com
AN  - WOS:000450668300093
AU  - Yang, K. Y.
AU  - Nath, S.
AU  - Koziarz, A.
AU  - Badhiwala, J. H.
AU  - Ghayur, H.
AU  - Sourour, M.
AU  - Catana, D.
AU  - Nassiri, F.
AU  - Alotaibi, M. B.
AU  - Kameda-Smith, M.
AU  - Manoranjan, B.
AU  - Aref, M. H.
AU  - Mansouri, A.
AU  - Singh, S.
AU  - Almenawer, S. A.
DA  - Dec
DO  - 10.1016/j.wneu.2018.08.163
J2  - World Neurosurg.
KW  - Extent of resection
Low-grade glioma
Meta-analysis
Systematic review
chinese adult patients
long-term survival
prognostic-factors
surgical
resection
radiation-therapy
awake surgery
o-(2-f-18-fluoroethyl)-l-tyrosine pet
seizure characteristics
supratotal resection
volumetric-analysis
Neurosciences & Neurology
Surgery
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: HA9ZO
Times Cited: 2
Cited Reference Count: 84
Yang, Kaiyun Nath, Siddharth Koziarz, Alex Badhiwala, Jetan H. Ghayur, Huphy Sourour, Michel Catana, Dragos Nassiri, Farshad Alotaibi, Mazen B. Kameda-Smith, Michelle Manoranjan, Branavan Aref, Mohammed H. Mansouri, Alireza Singh, Sheila Almenawer, Saleh A.
Nath, Siddharth/O-5872-2018
Nath, Siddharth/0000-0003-4520-7163
2
1
Elsevier science inc
New york
1878-8769
PY  - 2018
SN  - 1878-8750
SP  - E762-E775
ST  - Biopsy Versus Subtotal Versus Gross Total Resection in Patients with Low-Grade Glioma: A Systematic Review and Meta-Analysis
T2  - World Neurosurgery
TI  - Biopsy Versus Subtotal Versus Gross Total Resection in Patients with Low-Grade Glioma: A Systematic Review and Meta-Analysis
UR  - <Go to ISI>://WOS:000450668300093
VL  - 120
ID  - 2
ER  - 

TY  - JOUR
AB  - Background: An estimated 2.6 million newborns died in 2016; over 98.5% of deaths occurred in low-and middle-income countries (LMICs). Neonates born preterm and small for gestational age are particularly at risk given the high incidence of infectious complications, cardiopulmonary, and neurodevelopmental disorders in this group. Quality improvement (QI) initiatives can reduce the burden of mortality and morbidity for hospitalised newborns in these settings. We undertook a systematic review to synthesise evidence from LMICs on QI approaches used, outcome measures employed to estimate effects, and the nature of implementation challenges. Methods: We searched Medline, EMBASE, WHO Global Health Library, Cochrane Library, WHO ICTRP, and ClinicalTrials. gov and scanned the references of identified studies and systematic reviews. Searches covered January 2000 until April 2017. Search terms were "quality improvement", "newborns", " hospitalised",and their derivatives. Studies were excluded if they took place in high-income countries, did not include QI interventions, or did not include small and sick hospitalised newborns. Cochrane Risk of Bias tools were used to quality appraise the studies. Results: From 8110 results, 28 studies were included, covering 23 LMICs and 65,642 participants. Most interventions were meso level (district and clinic level); fewer were micro (patient-provider level) or macro (above district level). In-service training was the most common intervention subtype; service organisation and distribution of referencing materials were also frequently identified. The most commonly assessed outcome was mortality, followed by length of admission, sepsis rates, and infection rates. Key barriers to implementation of quality improvement initiatives included overburdened staff and lack of sufficient equipment. Conclusions: The frequency of meso level, single centre, and educational interventions suggests that these interventions may be easier for programme planners to implement. The success of some interventions in reducing morbidity and mortality rates suggests that QI approaches have a high potential for benefit to newborns. Going forward, there are opportunities to strengthen the focus of QI initiatives and to develop improved, larger-scale, collaborative research into implementation of quality improvement initiatives for this high-risk group.
AD  - [Zaka, Nabila; Manikam, Logan; Pearson, Luwei] UNICEF New York, UNICEF House, 3 United Nations Plaza, New York, NY 10017 USA. [Alexander, Emma C.; Norman, Irena C. F.; Akhbari, Melika] Kings Coll London, GKT Sch Med Educ, Guys Campus, London SE1 1UL, England. [Manikam, Logan] UCL, Inst Epidemiol & Healthcare, 1-19 Torrington Pl, London WC1E 6BT, England. [Moxon, Sarah] London Sch Hyg & Trop Med, Mat Adolescent Reprod & Child Hlth MARCH Ctr, Keppel St, London WC1E 7HT, England. [Moxon, Sarah] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England. [Ram, Pavani Kalluri] Dept Epidemiol & Environm Hlth, 237 Farber Hall, Buffalo, NY 14214 USA. [Ram, Pavani Kalluri; Niermeyer, Susan] USAID, Off Maternal & Child Hlth & Nutr, Washington, DC USA. [Murphy, Georgina; English, Mike] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med Res Bldg, Old Rd Campus,Roosevelt Dr, Oxford OX3 7FZ, England. [Niermeyer, Susan] Univ Colorado, Sch Med, Sect Neonatol, Aurora, CO 80045 USA.
Manikam, L (reprint author), UNICEF New York, UNICEF House, 3 United Nations Plaza, New York, NY 10017 USA.
logan.manikam.10@ucl.ac.uk
AN  - WOS:000423733800001
AU  - Zaka, N.
AU  - Alexander, E. C.
AU  - Manikam, L.
AU  - Norman, I. C. F.
AU  - Akhbari, M.
AU  - Moxon, S.
AU  - Ram, P. K.
AU  - Murphy, G.
AU  - English, M.
AU  - Niermeyer, S.
AU  - Pearson, L.
C7  - 20
DA  - Jan
DO  - 10.1186/s13012-018-0712-2
J2  - Implement. Sci.
KW  - Newborns
Quality improvement
Low- and middle-income countries
Systematic review
Preterm
Neonatal mortality rates
Infection control
Hospital stay
intensive-care units
infection-control approach
control consortium
inicc
blood-stream infections
family-centered care
kangaroo mother
care
for-gestational-age
nosocomial infections
neonatal sepsis
health-care
Health Care Sciences & Services
LA  - English
M3  - Review
N1  - ISI Document Delivery No.: FU3EP
Times Cited: 6
Cited Reference Count: 74
Zaka, Nabila Alexander, Emma C. Manikam, Logan Norman, Irena C. F. Akhbari, Melika Moxon, Sarah Ram, Pavani Kalluri Murphy, Georgina English, Mike Niermeyer, Susan Pearson, Luwei
Alexander, Emma/0000-0001-7063-6846; Akhbari, Melika/0000-0001-7634-2515
National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [DRF-2014-07-005]; Wellcome TrustWellcome Trust [097170, MR/M015386/1]; Health Systems Research Initiative (Department for International Development, UK (DFID); Economic and Social Research Council (ESRC)Economic & Social Research Council (ESRC); Medical Research Council (MRC)Medical Research Council UK (MRC); USAIDUnited States Agency for International Development (USAID)
This research received no specific grant from any funding agency, commercial or not-for-profit sectors. Logan Manikam is funded by a National Institute for Health Research (NIHR) Doctoral Research Fellowship (DRF-2014-07-005) and undertook an unpaid internship at UNICEF New York to complete this project. Mike English is supported by funding from The Wellcome Trust (#097170) and Gina Murphy by funding from Health Systems Research Initiative (Department for International Development, UK (DFID), Economic and Social Research Council (ESRC), Medical Research Council (MRC) and Wellcome Trust, grant number MR/M015386/1. Pavani Ram and Susan Niermeyer are funded by USAID through their respective university roles. Nabila Zaka and Luwei Pearson are UNICEF staff based at the UNICEF New York headquarters. NIHR and all other funders had no role in the design, analysis or writing of this article.
6
1
8
Bmc
London
PY  - 2018
SN  - 1748-5908
SP  - 21
ST  - Quality improvement initiatives for hospitalised small and sick newborns in low- and middle-income countries: a systematic review
T2  - Implementation Science
TI  - Quality improvement initiatives for hospitalised small and sick newborns in low- and middle-income countries: a systematic review
UR  - <Go to ISI>://WOS:000423733800001
VL  - 13
ID  - 33
ER  - 

TY  - JOUR
AB  - BackgroundConventional meta-analysis based on genetic markers may be less powerful for heterogeneous samples. In this study, we introduced a new meta-analysis for 4 genomewide association studies on alcohol dependence that integrated the information of putative causal variants. MethodsA total of 12,481 subjects in 4 independent cohorts were analyzed, including 1 European American cohort (1,409 cases with alcohol dependence and 1,518 controls), 1 European Australian cohort (a total of 6,438 family subjects with 1,645 probands), 1 African American cohort from SAGE+COGA (681 cases and 508 controls), and 1 African American cohort from Yale (1,429 cases and 498 controls). The genomewide association analysis was conducted for each cohort, and then, a new meta-analysis was performed to derive the combined p-values. cis-Acting expression of quantitative locus (cis-eQTL) analysis of each risk variant in human tissues and RNA expression analysis of each risk gene in rat brain served as functional validation. ResultsIn meta-analysis of European American and European Australian cohorts, we found 10 top-ranked single nucleotide polymorphisms (SNPs) (p<10(-6)) that were associated with alcohol dependence. They included 6 at SERINC2 (3.1x10(-8)p9.6x10(-8)), 1 at STK40 (p=1.3x10(-7)), 2 at KIAA0040 (3.3x10(-7)p5.2x10(-7)), and 1 at IPO11 (p=6.9x10(-7)). In meta-analysis of 2 African American cohorts, we found 2 top-ranked SNPs including 1 at SLC6A11 (p=2.7x10(-7)) and 1 at CBLN2 (p=7.4x10(-7)). In meta-analysis of all 4 cohorts, we found 2 top-ranked SNPs in PTP4A1-PHF3 locus (6.0x10(-7)p7.2x10(-7)). In an African American cohort only, we found 1 top-ranked SNP at PLD1 (p=8.3x10(-7); OR=1.56). Many risk SNPs had positive cis-eQTL signals, and all these risk genes except KIAA0040 were found to express in both rat and mouse brains. ConclusionsWe found multiple genes that were significantly or suggestively associated with alcohol dependence. They are among the most appropriate for follow-up as contributors to risk for alcohol dependence.
AD  - [Zuo, Lingjun; Krystal, John; Luo, Xingguang] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA. [Tan, Yunlong; Luo, Xingguang] Beijing Huilongguan Hosp, Biol Psychiat Res Ctr, Beijing, Peoples R China. [Zhang, Xiangyang] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA. [Wang, Xiaoping] Shanghai Jiao Tong Univ, Dept Neurol, Peoples Hosp 1, Shanghai 200030, Peoples R China. [Tabakoff, Boris] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO USA. [Zhong, Chunlong] Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China.
Luo, XG (reprint author), Yale Univ, Sch Med, West Haven, CT 06516 USA.
chunlongzhong@126.com; Xingguang.Luo@yale.edu
AN  - WOS:000358621200011
AU  - Zuo, L. J.
AU  - Tan, Y. L.
AU  - Zhang, X. Y.
AU  - Wang, X. P.
AU  - Krystal, J.
AU  - Tabakoff, B.
AU  - Zhong, C. L.
AU  - Luo, X. G.
DA  - Aug
DO  - 10.1111/acer.12786
IS  - 8
J2  - Alcoholism (NY)
KW  - Alcohol Dependence
Genomewide Association
Meta-Analysis
wide association
unified approach
family
localization
reliability
linkage
region
risk
gaba
tool
Substance Abuse
LA  - English
M3  - Article
N1  - ISI Document Delivery No.: CN7NL
Times Cited: 7
Cited Reference Count: 38
Zuo, Lingjun Tan, Yunlong Zhang, Xiangyang Wang, Xiaoping Krystal, John Tabakoff, Boris Zhong, Chunlong Luo, Xingguang
National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [K01 DA029643]; National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21 AA021380, R21 AA020319, R21 AA023237, R24 AA013162]; National Alliance for Research on Schizophrenia and Depression (NARSAD)French National Research Agency (ANR)NARSAD [17616]; ABMRF/The Foundation for Alcohol Research; [U01 HG004422]; [U01HG004438]; [U01 HG004446]; [U10 AA008401]; [R01 DA013423]; [R01 DA12690]; [R01 DA12849]; [R01 DA18432]; [R01 AA011330]; [R01 AA017535]; [HHSN268200782096C]; [HHSN268201100011I]
This work was supported in part by National Institute on Drug Abuse (NIDA) grant K01 DA029643, National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant R21 AA021380, R21 AA020319, R21 AA023237, and R24 AA013162, the National Alliance for Research on Schizophrenia and Depression (NARSAD) Award 17616 (to LZ), and ABMRF/The Foundation for Alcohol Research (to LZ). We thank NIH GWAS Data Repository (dbGaP), the Contributing Investigator(s) (Drs. Bierut, Edenberg, Heath, Gelernter, and Kranzler) who contributed the phenotype and genotype data (SAGE: phs000092.v1.p1, COGA: phs000125.v1.p1, OZ-ALC: phs000181.v1.p1, and Yale CIDR-Gelernter Study: phs000425.v1.p1) from his/her original study, and the funding support by U01 HG004422, U01HG004438, U01 HG004446, U10 AA008401, R01 DA013423, R01 DA12690, R01 DA12849, R01 DA18432, R01 AA011330, R01 AA017535, HHSN268200782096C, and HHSN268201100011I. We thank for the Center for Inherited Disease Research (CIDR) and the Genetics of Alcohol Dependence in American Populations (CIDR-Gelernter Study), and the National Center for Biotechnology Information.
7
1
8
Wiley-blackwell
Hoboken
1530-0277
PY  - 2015
SN  - 0145-6008
SP  - 1388-1395
ST  - A New Genomewide Association Meta-Analysis of Alcohol Dependence
T2  - Alcoholism-Clinical and Experimental Research
TI  - A New Genomewide Association Meta-Analysis of Alcohol Dependence
UR  - <Go to ISI>://WOS:000358621200011
VL  - 39
ID  - 109
ER  - 

